|
Name |
Accession |
Description |
Interval |
E-value |
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1-1244 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 1164.93 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVrEDRPNDKRIIAYIV----AEEKEP-INLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRK 75
Cdd:PRK12467 932 LLAQPGVREAVVLA-QPGDAGLQLVAYLVpaavADGAEHqATRDELKAQLRQVLPDYMVPAHLLLLDSLPLTPNGKLDRK 1010
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 76 KLPAPDFNGMNNERVA-RNPKEEILCDLFAEVLGVSRINIDDNFFEMGGHSLLASRLMARIRETLSVELGIGKLFESPTV 154
Cdd:PRK12467 1011 ALPKPDASAVQATFVApQTELEKRLAAIWADVLKVERVGLTDNFFELGGHSLLATQVISRVRQRLGIQVPLRTLFEHQTL 1090
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 155 AELAKQLN-HAKSARPAIQKASRPNEVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETL 233
Cdd:PRK12467 1091 AGFAQAVAaQQQGAQPALPDVDRDQPLPLSYAQERQWFLWQLEPGSAAYHIPQALRLKGPLDIEALERSFDALVARHESL 1170
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 234 RTIFPNVLGSSYQKILDMENLNLE---MVITNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIV 310
Cdd:PRK12467 1171 RTTFVQEDGRTRQVIHPVGSLTLEeplLLAADKDEAQLKVYVEAEARQPFDLEQGPLLRVGLLRLAADEHVLVLTLHHIV 1250
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 311 GDGWSLQPLTRDFTAAYKARCQGDRVQLETLPVQYADYALWQQQLL--GDEttpesliSTQLDFWKEELKGLPDQMELPT 388
Cdd:PRK12467 1251 SDGWSMQVLVDELVALYAAYSQGQSLQLPALPIQYADYAVWQRQWMdaGER-------ARQLAYWKAQLGGEQPVLELPT 1323
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 389 DYQRPVETSYRGETIHFHIDEGMHSRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLF 468
Cdd:PRK12467 1324 DRPRPAVQSHRGARLAFELPPALAEGLRALARREGVTLFMLLLASFQTLLHRYSGQDDIRVGVPIANRNRAETEGLIGFF 1403
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 469 VNTLVLRTNTSGDPSFKELLNRVKQVNLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQNTPEATFNAPdleASL 548
Cdd:PRK12467 1404 VNTQVLRAEVDGQASFQQLLQQVKQAALEAQAHQDLPFEQLVEALQPERSLSHSPLFQVMFNHQRDDHQAQAQL---PGL 1480
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 549 EIQSVG----SAKFDLTFEISESnevdgtPNGLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVA 624
Cdd:PRK12467 1481 SVESLSwesqTAQFDLTLDTYES------SEGLQASLTYATDLFEASTIERLAGHWLNLLQGLVADPERRLGELDLLDEA 1554
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 625 EKNTVLEKWNG-GFQIAPEMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRS 703
Cdd:PRK12467 1555 ERRQILEGWNAtHTGYPLARLVHQLIEDQAAATPEAVALVFGEQELTYGELNRRANRLAHRLIALGVGPEVLVGIAVERS 1634
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 704 LNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNSSV--EIECDESLKILVDDvNVMEEIEKYSEENIDE 781
Cdd:PRK12467 1635 LEMVVGLLAILKAGGAYVPLDPEYPRERLAYMIEDSGIELLLTQSHLqaRLPLPDGLRSLVLD-QEDDWLEGYSDSNPAV 1713
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 782 MeclkpLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLV 861
Cdd:PRK12467 1714 N-----LAPQNLAYVIYTSGSTGRPKGAGNRHGALVNRLCATQEAYQLSAADVVLQFTSFAFDVSVWELFWPLINGARLV 1788
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 862 VVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADrenEEVGQKLSLRYVVFGGEALELSRLEDWYSRHPHNApkV 941
Cdd:PRK12467 1789 IAPPGAHRDPEQLIQLIERQQVTTLHFVPSMLQQLLQMD---EQVEHPLSLRRVVCGGEALEVEALRPWLERLPDTG--L 1863
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 942 INMYGITETTVHVSYIELDESIVSLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERF 1021
Cdd:PRK12467 1864 FNLYGPTETAVDVTHWTCRRKDLEGRDSVPIGQPIANLSTYILDASLNPVPIGVAGELYLGGVGLARGYLNRPALTAERF 1943
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1022 IADPFGKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVrEDQPGDKRLVAYI 1101
Cdd:PRK12467 1944 VADPFGTVGSRLYRTGDLARYRADGVIEYLGRIDHQVKIRGFRIELGEIEARLREQGGVREAVVIA-QDGANGKQLVAYV 2022
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1102 VASNNETIDTNE--------MRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEfiASSSSRGPRTPQEEM-- 1171
Cdd:PRK12467 2023 VPTDPGLVDDDEaqvalraiLKNHLKASLPEYMVPAHLVFLARMPLTPNGKLDRKALPAPD--ASELQQAYVAPQSELeq 2100
|
1210 1220 1230 1240 1250 1260 1270
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 1172 -LCDLFTEVLSVSQIGIDDGFFDLGGHSLLAVQLMSRMKEAlGVELNIGTLFAAPTVAGLAERLEIGNGQSALD 1244
Cdd:PRK12467 2101 rLAAIWQDVLGLEQVGLHDNFFELGGDSIISIQVVSRARQA-GIRFTPKDLFQHQTVQSLAAVAQEGDGTVSID 2173
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
166-1389 |
0e+00 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 1149.21 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 166 SARPAIQKASRPNEVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSY 245
Cdd:COG1020 4 AAAAALPPAAAAAPLPLSAAQQRLWLLLLLLLGSAAYNLALALLLLGLLLVAALLLLAALLARRRRALRTRLRTRAGRPV 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 246 QKILDMENLNLEMVI-----TNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLT 320
Cdd:COG1020 84 QVIQPVVAAPLPVVVllvdlEALAEAAAEAAAAAEALAPFDLLRGPLLRLLLLLLLLLLLLLLLALHHIISDGLSDGLLL 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 321 RDFTAAYKARCQGDRVQLETLPVQYADYALWQQQLLGDETTPEslistQLDFWKEELKGLPDQMELPTDYQRPVETSYRG 400
Cdd:COG1020 164 AELLRLYLAAYAGAPLPLPPLPIQYADYALWQREWLQGEELAR-----QLAYWRQQLAGLPPLLELPTDRPRPAVQSYRG 238
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 401 ETIHFHIDEGMHSRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSG 480
Cdd:COG1020 239 ARVSFRLPAELTAALRALARRHGVTLFMVLLAAFALLLARYSGQDDVVVGTPVAGRPRPELEGLVGFFVNTLPLRVDLSG 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 481 DPSFKELLNRVKQVNLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQNTPEATFNAPDLEASLEIQSVGSAKFDL 560
Cdd:COG1020 319 DPSFAELLARVRETLLAAYAHQDLPFERLVEELQPERDLSRNPLFQVMFVLQNAPADELELPGLTLEPLELDSGTAKFDL 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 561 TFEISEsnevdgTPNGLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVAEKNTVLEKWNGGFQIA 640
Cdd:COG1020 399 TLTVVE------TGDGLRLTLEYNTDLFDAATIERMAGHLVTLLEALAADPDQPLGDLPLLTAAERQQLLAEWNATAAPY 472
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 641 P-EMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAG 719
Cdd:COG1020 473 PaDATLHELFEAQAARTPDAVAVVFGDQSLTYAELNARANRLAHHLRALGVGPGDLVGVCLERSLEMVVALLAVLKAGAA 552
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 720 YLPLDPDYPSDRISFMLHDAKPSCVLTNSSVEIEC-DESLKILVDDVnvmEEIEKYSEENIDEmeclkPLAPSHIAYVIY 798
Cdd:COG1020 553 YVPLDPAYPAERLAYMLEDAGARLVLTQSALAARLpELGVPVLALDA---LALAAEPATNPPV-----PVTPDDLAYVIY 624
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 799 TSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLL 878
Cdd:COG1020 625 TSGSTGRPKGVMVEHRALVNLLAWMQRRYGLGPGDRVLQFASLSFDASVWEIFGALLSGATLVLAPPEARRDPAALAELL 704
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 879 VKEKVTVLNQTPSAFYQLMQADREneevgQKLSLRYVVFGGEALELSRLEDWYSRHPHnaPKVINMYGITETTVHVSYIE 958
Cdd:COG1020 705 ARHRVTVLNLTPSLLRALLDAAPE-----ALPSLRLVLVGGEALPPELVRRWRARLPG--ARLVNLYGPTETTVDSTYYE 777
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 959 LDESIVSlRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPGTRMYRTGD 1038
Cdd:COG1020 778 VTPPDAD-GGSVPIGRPIANTRVYVLDAHLQPVPVGVPGELYIGGAGLARGYLNRPELTAERFVADPFGFPGARLYRTGD 856
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1039 LARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHA 1118
Cdd:COG1020 857 LARWLPDGNLEFLGRADDQVKIRGFRIELGEIEAALLQHPGVREAVVVAREDAPGDKRLVAYVVPEAGAAAAAALLRLAL 936
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1119 SGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEFIASSSSRGPRTPQEEMLCDLFTEVLSVSQIGIDDGFFDLGGHS 1198
Cdd:COG1020 937 ALLLPPYMVPAAVVLLLPLPLTGNGKLDRLALPAPAAAAAAAAAAPPAEEEEEEAALALLLLLVVVVGDDDFFFFGGGLG 1016
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1199 LLAVQLMsRMKEALGVELNIGTLFAAPTVAGLAERLEIGNGQSALDVLLPLRASGDQLPLFCVHPAGGLSWCYAGLMKSL 1278
Cdd:COG1020 1017 LLLLLAL-ARAARLLLLLLLLLLLFLAAAAAAAAAAAAAAAAAAAAPLAAAAAPLPLPPLLLSLLALLLALLLLLALLAL 1095
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1279 GTDYPIYGVQARGIAENEELPKSLEEMAADYLKHVREIQPHGPYRLLGWSLGGNVVHAMAAQLQNEGEEVELLVMLDSYP 1358
Cdd:COG1020 1096 LALLLLLLLLLLLLALLLLLALLLALLAALRARRAVRQEGPRLRLLVALAAALALAALLALLLAAAAAAAELLAAAALLL 1175
|
1210 1220 1230
....*....|....*....|....*....|.
gi 1698252301 1359 GHFLPNTEAPTEEEALIALLALGGYDPDNMD 1389
Cdd:COG1020 1176 LLALLLLALLLLLLLLLLLLLLLLLLLLLLL 1206
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
169-1258 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 997.75 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 169 PAIQKASRPNEVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKI 248
Cdd:PRK12467 39 PIPQVRSAFERIPLSYAQERQWFLWQLDPDSAAYNIPTALRLRGELDVSALRRAFDALVARHESLRTRFVQDEEGFRQVI 118
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 249 LDMENLNLEMVITNTCKDE-----LESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDF 323
Cdd:PRK12467 119 DASLSLTIPLDDLANEQGRaresqIEAYINEEVARPFDLANGPLLRVRLLRLADDEHVLVVTLHHIISDGWSMRVLVEEL 198
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 324 TAAYKARCQGDRVQLETLPVQYADYALWQQQLL--GDEttpesliSTQLDFWKEELKGLPDQMELPTDYQRPVETSYRGE 401
Cdd:PRK12467 199 VQLYSAYSQGREPSLPALPIQYADYAIWQRSWLeaGER-------ERQLAYWQEQLGGEHTVLELPTDRPRPAVPSYRGA 271
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 402 TIHFHIDEGMHSRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSGD 481
Cdd:PRK12467 272 RLRVDLPQALSAGLKALAQREGVTLFMVLLASFQTLLHRYSGQSDIRIGVPNANRNRVETERLIGFFVNTQVLKAEVDPQ 351
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 482 PSFKELLNRVKQVNLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQNTPEATFN--APDLEAsLEIQSVG----S 555
Cdd:PRK12467 352 ASFLELLQQVKRTALGAQAHQDLPFEQLVEALQPERSLSHSPLFQVMFNHQNTATGGRDreGAQLPG-LTVEELSwarhT 430
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 556 AKFDLTFEISESnevdgtPNGLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVAEKNTVLEKWNG 635
Cdd:PRK12467 431 AQFDLALDTYES------AQGLWAAFTYATDLFEATTIERLATHWRNLLEAIVAEPRRRLGELPLLDAEERARELVRWNA 504
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 636 GFQIAPEMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLK 715
Cdd:PRK12467 505 PATEYAPDCVHQLIEAQARQHPERPALVFGEQVLSYAELNRQANRLAHVLIAAGVGPDVLVGIAVERSIEMVVGLLAVLK 584
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 716 AGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNSSVEIECD--ESLKILVDDvNVMEEIEKYSEENIDemeclKPLAPSHI 793
Cdd:PRK12467 585 AGGAYVPLDPEYPQDRLAYMLDDSGVRLLLTQSHLLAQLPvpAGLRSLCLD-EPADLLCGYSGHNPE-----VALDPDNL 658
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 794 AYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKE 873
Cdd:PRK12467 659 AYVIYTSGSTGQPKGVAISHGALANYVCVIAERLQLAADDSMLMVSTFAFDLGVTELFGALASGATLHLLPPDCARDAEA 738
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 874 FLQLLVKEKVTVLNQTPSAFYQLMQADReneeVGQKLSLRYVVFGGEALELSRLEDWYSRHPHnaPKVINMYGITETTVH 953
Cdd:PRK12467 739 FAALMADQGVTVLKIVPSHLQALLQASR----VALPRPQRALVCGGEALQVDLLARVRALGPG--ARLINHYGPTETTVG 812
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 954 VSYIEL-DESIVSlrANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPGTR 1032
Cdd:PRK12467 813 VSTYELsDEERDF--GNVPIGQPLANLGLYILDHYLNPVPVGVVGELYIGGAGLARGYHRRPALTAERFVPDPFGADGGR 890
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1033 MYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQvAVIVREDQPGDKRLVAYIVA-----SNNE 1107
Cdd:PRK12467 891 LYRTGDLARYRADGVIEYLGRMDHQVKIRGFRIELGEIEARLLAQPGVRE-AVVLAQPGDAGLQLVAYLVPaavadGAEH 969
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1108 TIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEFIASSSS-RGPRTPQEEMLCDLFTEVLSVSQIG 1186
Cdd:PRK12467 970 QATRDELKAQLRQVLPDYMVPAHLLLLDSLPLTPNGKLDRKALPKPDASAVQATfVAPQTELEKRLAAIWADVLKVERVG 1049
|
1050 1060 1070 1080 1090 1100 1110
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1698252301 1187 IDDGFFDLGGHSLLAVQLMSRMKEALGVELNIGTLFAAPTVAGLAERLeiGNGQSALDVLLPLRASGDQLPL 1258
Cdd:PRK12467 1050 LTDNFFELGGHSLLATQVISRVRQRLGIQVPLRTLFEHQTLAGFAQAV--AAQQQGAQPALPDVDRDQPLPL 1119
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
169-1231 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 909.34 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 169 PAIQKASRPNEVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKI 248
Cdd:PRK12316 39 PIPAGVSSAERDRLSYAQQRMWFLWQLEPQSGAYNLPSAVRLNGPLDRQALERAFASLVQRHETLRTVFPRGADDSLAQV 118
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 249 LDMENLNLEMV-ITNTCKDELESVLSEAVRYS----FNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDF 323
Cdd:PRK12316 119 PLDRPLEVEFEdCSGLPEAEQEARLRDEAQREslqpFDLCEGPLLRVRLLRLGEEEHVLLLTLHHIVSDGWSMNVLIEEF 198
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 324 TAAYKARCQGDRVQLETLPVQYADYALWQQQLL--GDEttpesliSTQLDFWKEELKGLPDQMELPTDYQRPVETSYRGE 401
Cdd:PRK12316 199 SRFYSAYATGAEPGLPALPIQYADYALWQRSWLeaGEQ-------ERQLEYWRAQLGEEHPVLELPTDHPRPAVPSYRGS 271
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 402 TIHFHIDEGMHSRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSGD 481
Cdd:PRK12316 272 RYEFSIDPALAEALRGTARRQGLTLFMLLLGAFNVLLHRYSGQTDIRVGVPIANRNRAEVEGLIGFFVNTQVLRSVFDGR 351
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 482 PSFKELLNRVKQVNLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQNTP---EATFNAPDLE-ASLEIQSvGSAK 557
Cdd:PRK12316 352 TRVATLLAGVKDTVLGAQAHQDLPFERLVEALKVERSLSHSPLFQVMYNHQPLVadiEALDTVAGLEfGQLEWKS-RTTQ 430
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 558 FDLTFEISEsnevdgTPNGLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVAEKNTVLEKWNGGF 637
Cdd:PRK12316 431 FDLTLDTYE------KGGRLHAALTYATDLFEARTVERMARHWQNLLRGMVENPQARVDELPMLDAEERGQLVEGWNATA 504
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 638 QIAPEMT-LPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKA 716
Cdd:PRK12316 505 AEYPLQRgVHRLFEEQVERTPEAPALAFGEETLDYAELNRRANRLAHALIERGVGPDVLVGVAMERSIEMVVALLAILKA 584
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 717 GAGYLPLDPDYPSDRISFMLHDAKPSCVLTNSSVEIECDESLKILVDDVN-VMEEIEKYSEENIDEMeclkpLAPSHIAY 795
Cdd:PRK12316 585 GGAYVPLDPEYPAERLAYMLEDSGVQLLLSQSHLGRKLPLAAGVQVLDLDrPAAWLEGYSEENPGTE-----LNPENLAY 659
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 796 VIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFL 875
Cdd:PRK12316 660 VIYTSGSTGKPKGAGNRHRALSNRLCWMQQAYGLGVGDTVLQKTPFSFDVSVWEFFWPLMSGARLVVAAPGDHRDPAKLV 739
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 876 QLLVKEKVTVLNQTPSafyqLMQADRENEEVGQKLSLRYVVFGGEALELSRLEDWYSRHPHNapKVINMYGITETTVHVS 955
Cdd:PRK12316 740 ELINREGVDTLHFVPS----MLQAFLQDEDVASCTSLRRIVCSGEALPADAQEQVFAKLPQA--GLYNLYGPTEAAIDVT 813
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 956 YieldESIVSLRANSL-IGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKpGTRMY 1034
Cdd:PRK12316 814 H----WTCVEEGGDSVpIGRPIANLACYILDANLEPVPVGVLGELYLAGRGLARGYHGRPGLTAERFVPSPFVA-GERMY 888
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1035 RTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQpgdkRLVAYIVASNNETIDTNEM 1114
Cdd:PRK12316 889 RTGDLARYRADGVIEYAGRIDHQVKLRGLRIELGEIEARLLEHPWVREAAVLAVDGK----QLVGYVVLESEGGDWREAL 964
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1115 RQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEfiASSSSRG---PRTPQEEMLCDLFTEVLSVSQIGIDDGF 1191
Cdd:PRK12316 965 KAHLAASLPEYMVPAQWLALERLPLTPNGKLDRKALPAPE--ASVAQQGyvaPRNALERTLAAIWQDVLGVERVGLDDNF 1042
|
1050 1060 1070 1080
....*....|....*....|....*....|....*....|
gi 1698252301 1192 FDLGGHSLLAVQLMSRMKEAlGVELNIGTLFAAPTVAGLA 1231
Cdd:PRK12316 1043 FELGGDSIVSIQVVSRARQA-GIQLSPRDLFQHQTIRSLA 1081
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1-1250 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 904.33 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVmVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPAP 80
Cdd:PRK12316 2423 LQAHPAVREAVV-VAQDGASGKQLVAYVVPDDAAEDLLAELRAWLAARLPAYMVPAHWVVLERLPLNPNGKLDRKALPKP 2501
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 81 DFNGMNNERVA-RNPKEEILCDLFAEVLGVSRINIDDNFFEMGGHSLLASRLMARIRETLSVELGIGKLFESPTVAELAK 159
Cdd:PRK12316 2502 DVSQLRQAYVApQEGLEQRLAAIWQAVLKVEQVGLDDHFFELGGHSLLATQVVSRVRQDLGLEVPLRILFERPTLAAFAA 2581
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 160 QLNHAKSAR-PAIQKASRPNEVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFP 238
Cdd:PRK12316 2582 SLESGQTSRaPVLQKVTRVQPLPLSHAQQRQWFLWQLEPESAAYHLPSALHLRGVLDQAALEQAFDALVLRHETLRTRFV 2661
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 239 NVLGSSYQKILDMENLNLEMVITNTCKDE-LESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQ 317
Cdd:PRK12316 2662 EVGEQTRQVILPNMSLRIVLEDCAGVADAaIRQRVAEEIQRPFDLARGPLLRVRLLALDGQEHVLVITQHHIVSDGWSMQ 2741
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 318 PLTRDFTAAYKARCQGDRVQLETLPVQYADYALWQQQLLgdettPESLISTQLDFWKEELKGLPDQMELPTDYQRPVETS 397
Cdd:PRK12316 2742 VMVDELVQAYAGARRGEQPTLPPLPLQYADYAAWQRAWM-----DSGEGARQLDYWRERLGGEQPVLELPLDRPRPALQS 2816
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 398 YRGETIHFHIDEGMHSRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTN 477
Cdd:PRK12316 2817 HRGARLDVALDVALSRELLALARREGVTLFMLLLASFQVLLHRYSGQSDIRVGVPIANRNRAETERLIGFFVNTQVLRAQ 2896
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 478 TSGDPSFKELLNRVKQVNLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQNTPEATFNAPDLEASLEIQSVGSAK 557
Cdd:PRK12316 2897 VDAQLAFRDLLGQVKEQALGAQAHQDLPFEQLVEALQPERSLSHSPLFQVMYNHQSGERAAAQLPGLHIESFAWDGAATQ 2976
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 558 FDLTFEISESnevdgtPNGLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVAEKNTVLEKWNGGF 637
Cdd:PRK12316 2977 FDLALDTWES------AEGLGASLTYATDLFDARTVERLARHWQNLLRGMVENPQRSVDELAMLDAEERGQLLEAWNATA 3050
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 638 QIAP-EMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKA 716
Cdd:PRK12316 3051 AEYPlERGVHRLFEEQVERTPDAVALAFGEQRLSYAELNRRANRLAHRLIERGVGPDVLVGVAVERSLEMVVGLLAILKA 3130
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 717 GAGYLPLDPDYPSDRISFMLHDAKPSCVLTNSSVEIECDESLKILVDDvnvmEEIEKYSEENIDEMeclkpLAPSHIAYV 796
Cdd:PRK12316 3131 GGAYVPLDPEYPEERLAYMLEDSGAQLLLSQSHLRLPLAQGVQVLDLD----RGDENYAEANPAIR-----TMPENLAYV 3201
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 797 IYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQ 876
Cdd:PRK12316 3202 IYTSGSTGKPKGVGIRHSALSNHLCWMQQAYGLGVGDRVLQFTTFSFDVFVEELFWPLMSGARVVLAGPEDWRDPALLVE 3281
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 877 LLVKEKVTVLNQTPSafyqLMQADRENEEVGQKLSLRYVVFGGEALELSRLEDWYSRHPhnapkVINMYGITETTVHVSY 956
Cdd:PRK12316 3282 LINSEGVDVLHAYPS----MLQAFLEEEDAHRCTSLKRIVCGGEALPADLQQQVFAGLP-----LYNLYGPTEATITVTH 3352
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 957 IELDESIVslrANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgKPGTRMYRT 1036
Cdd:PRK12316 3353 WQCVEEGK---DAVPIGRPIANRACYILDGSLEPVPVGALGELYLGGEGLARGYHNRPGLTAERFVPDPF-VPGERLYRT 3428
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1037 GDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQpgdkRLVAYIVASNNETIDTNEMRQ 1116
Cdd:PRK12316 3429 GDLARYRADGVIEYIGRVDHQVKIRGFRIELGEIEARLLEHPWVREAVVLAVDGR----QLVAYVVPEDEAGDLREALKA 3504
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1117 HASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEfiASSSSRG---PRTPQEEMLCDLFTEVLSVSQIGIDDGFFD 1193
Cdd:PRK12316 3505 HLKASLPEYMVPAHLLFLERMPLTPNGKLDRKALPRPD--AALLQQDyvaPVNELERRLAAIWADVLKLEQVGLTDNFFE 3582
|
1210 1220 1230 1240 1250 1260
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 1194 LGGHSLLAVQLMSRMKEAlGVELNIGTLFAAPTVAGLAERLEIGNGQ-------SALDVLLPLR 1250
Cdd:PRK12316 3583 LGGDSIISLQVVSRARQA-GIRFTPKDLFQHQTIQGLARVARVGGGVavdqgpvSGETLLLPIQ 3645
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
178-1502 |
0e+00 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 869.75 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 178 NEVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKI--------L 249
Cdd:PRK10252 6 QHLPLVAAQPGIWMAEKLSPLPSAWSVAHYVELTGELDAPLLARAVVAGLAEADTLRMRFTEDNGEVWQWVdpaltfplP 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 250 DMENLNLEMVITNTCKDELESVLSEAVRysfnLD-FEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYK 328
Cdd:PRK10252 86 EIIDLRTQPDPHAAAQALMQADLQQDLR----VDsGKPLVFHQLIQLGDNRWYWYQRYHHLLVDGFSFPAITRRIAAIYC 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 329 ARCQGDRVQLETLPVQ---YADYALWQQqllgDETTpeslistQLD--FWKEELKGLPDQMELPtdyqrPVETSYRGETI 403
Cdd:PRK10252 162 AWLRGEPTPASPFTPFadvVEEYQRYRA----SEAW-------QRDaaFWAEQRRQLPPPASLS-----PAPLPGRSASA 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 404 HFH-----IDEGMHSRLVelGRKNGVSLFMVLQAgLSALF-TRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTN 477
Cdd:PRK10252 226 DILrlkleFTDGAFRQLA--AQASGVQRPDLALA-LVALWlGRLCGRMDYAAGFIFMRRLGSAALTATGPVLNVLPLRVH 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 478 TSGDPSFKELLNRVKQVNLAAYENQDVPFERLVEVLNPVR-TRNSH-PLFQVMLaFQNTPEAtfnaPDLEASLEIQSVGS 555
Cdd:PRK10252 303 IAAQETLPELATRLAAQLKKMRRHQRYDAEQIVRDSGRAAgDEPLFgPVLNIKV-FDYQLDF----PGVQAQTHTLATGP 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 556 AKfDLTFEISesneVDGtPNGLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVAEKnTVLEKWNG 635
Cdd:PRK10252 378 VN-DLELALF----PDE-HGGLSIEILANPQRYDEATLIAHAERLKALIAQFAADPALLCGDVDILLPGEY-AQLAQVNA 450
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 636 GFQIAPEMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLK 715
Cdd:PRK10252 451 TAVEIPETTLSALVAQQAAKTPDAPALADARYQFSYREMREQVVALANLLRERGVKPGDSVAVALPRSVFLTLALHAIVE 530
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 716 AGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNSSveiecdesLKILVDDVNVMEEIEKYSEENIDEMECLKPLAPSHIAY 795
Cdd:PRK10252 531 AGAAWLPLDTGYPDDRLKMMLEDARPSLLITTAD--------QLPRFADVPDLTSLCYNAPLAPQGAAPLQLSQPHHTAY 602
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 796 VIYTSGSTGRPKGVMIPHQNVV-RLLGATDHwFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEF 874
Cdd:PRK10252 603 IIFTSGSTGRPKGVMVGQTAIVnRLLWMQNH-YPLTADDVVLQKTPCSFDVSVWEFFWPFIAGAKLVMAEPEAHRDPLAM 681
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 875 LQLLVKEKVTVLNQTPS---AFyqLMQADRENEeVGQKLSLRYVVFGGEALELSRLEDWYSRHphNAPkVINMYGITETT 951
Cdd:PRK10252 682 QQFFAEYGVTTTHFVPSmlaAF--VASLTPEGA-RQSCASLRQVFCSGEALPADLCREWQQLT--GAP-LHNLYGPTEAA 755
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 952 VHVSYIELD-ESIVSLRANSL-IGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGkP 1029
Cdd:PRK10252 756 VDVSWYPAFgEELAAVRGSSVpIGYPVWNTGLRILDARMRPVPPGVAGDLYLTGIQLAQGYLGRPDLTASRFIADPFA-P 834
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1030 GTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAV-----IVREDQPGD-KRLVAYIVA 1103
Cdd:PRK10252 835 GERMYRTGDVARWLDDGAVEYLGRSDDQLKIRGQRIELGEIDRAMQALPDVEQAVThacviNQAAATGGDaRQLVGYLVS 914
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1104 SNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEFIASSSSRGPRTPQEEMLCDLFTEVLSVS 1183
Cdd:PRK10252 915 QSGLPLDTSALQAQLRERLPPHMVPVVLLQLDQLPLSANGKLDRKALPLPELKAQVPGRAPKTGTETIIAAAFSSLLGCD 994
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1184 QIGIDDGFFDLGGHSLLAVQLMSRMKEALGVELNIGTLFAAPTVAGLAERL---EIGNGQSALDVLLPLRaSGDQLPLFC 1260
Cdd:PRK10252 995 VVDADADFFALGGHSLLAMKLAAQLSRQFARQVTPGQVMVASTVAKLATLLdaeEDESRRLGFGTILPLR-EGDGPTLFC 1073
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1261 VHPAGGLSWCYAGLMKSLGTDYPIYGVQARGIAENEELPKSLEEMAADYLKHVREIQPHGPYRLLGWSLGGNVVHAMAAQ 1340
Cdd:PRK10252 1074 FHPASGFAWQFSVLSRYLDPQWSIYGIQSPRPDGPMQTATSLDEVCEAHLATLLEQQPHGPYHLLGYSLGGTLAQGIAAR 1153
|
1210 1220 1230 1240 1250 1260 1270 1280
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1341 LQNEGEEVELLVMLDSYPghflPNTEAPTEEEAliallalGGYDPDNMDGKPLTMESAVEILRkdgsalASLEEETILNL 1420
Cdd:PRK10252 1154 LRARGEEVAFLGLLDTWP----PETQNWREKEA-------NGLDPEVLAEIDREREAFLAAQQ------GSLSTELFTTI 1216
|
1290 1300 1310 1320 1330 1340 1350 1360
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1421 KETYVNSVGLLGKYVPKVYNGDILFFRST-VIPDWFDPisPNTWLNYLdGDIVQHDIDCRHKDLCQPGPLTEIGQVLAKY 1499
Cdd:PRK10252 1217 EGNYADAVRLLTTAHSVPFDGKATLFVAErTLQEGMSP--EQAWSPWI-AELDVYRQDCAHVDIISPEAFEKIGPILRAT 1293
|
...
gi 1698252301 1500 LQN 1502
Cdd:PRK10252 1294 LNE 1296
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
7-1231 |
0e+00 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 841.37 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 7 IQQAVVMVREDrPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPAPDFNgmN 86
Cdd:PRK05691 1553 VAQAAVLVREG-AAGAQLVGYYTGEAGQEAEAERLKAALAAELPEYMVPAQLIRLDQMPLGPSGKLDRRALPEPVWQ--Q 1629
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 87 NERVA-RNPKEEILCDLFAEVLGVSRINIDDNFFEMGGHSLLASRLMARIRETLSVELGIGKLFESPTVAELAKQLNHAK 165
Cdd:PRK05691 1630 REHVEpRTELQQQIAAIWREVLGLPRVGLRDDFFALGGHSLLATQIVSRTRQACDVELPLRALFEASELGAFAEQVARIQ 1709
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 166 SA-----RPAIQKASRPNEVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNV 240
Cdd:PRK05691 1710 AAgernsQGAIARVDRSQPVPLSYSQQRMWFLWQMEPDSPAYNVGGMARLSGVLDVDRFEAALQALILRHETLRTTFPSV 1789
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 241 LGSSYQKI-----LDMENLNLEMVITNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWS 315
Cdd:PRK05691 1790 DGVPVQQVaedsgLRMDWQDFSALPADARQQRLQQLADSEAHQPFDLERGPLLRACLVKAAEREHYFVLTLHHIVTEGWA 1869
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 316 LQPLTRDFTAAYKARCQGDRVQLETLPVQYADYALWQQQLL-GDETtpesliSTQLDFWKEELKGLPDQMELPTDYQRPV 394
Cdd:PRK05691 1870 MDIFARELGALYEAFLDDRESPLEPLPVQYLDYSVWQRQWLeSGER------QRQLDYWKAQLGNEHPLLELPADRPRPP 1943
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 395 ETSYRGETIHFHIDEGMHSRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVL 474
Cdd:PRK05691 1944 VQSHRGELYRFDLSPELAARVRAFNAQRGLTLFMTMTATLAALLYRYSGQRDLRIGAPVANRIRPESEGLIGAFLNTQVL 2023
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 475 RTNTSGDPSFKELLNRVKQVNLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVML-----AFQNTPEATfnapDLEASLE 549
Cdd:PRK05691 2024 RCQLDGQMSVSELLEQVRQTVIEGQSHQDLPFDHLVEALQPPRSAAYNPLFQVMCnvqrwEFQQSRQLA----GMTVEYL 2099
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 550 IQSVGSAKFDLTFEISEsneVDGTpngLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVAEKNTV 629
Cdd:PRK05691 2100 VNDARATKFDLNLEVTD---LDGR---LGCCLTYSRDLFDEPRIARMAEHWQNLLEALLGDPQQRLAELPLLAAAEQQQL 2173
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 630 LEKWNG-GFQIAPEMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVV 708
Cdd:PRK05691 2174 LDSLAGeAGEARLDQTLHGLFAAQAARTPQAPALTFAGQTLSYAELDARANRLARALRERGVGPQVRVGLALERSLEMVV 2253
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 709 SLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNSSVEiecdESLKILVDDVN--VMEE----IEKYSEENIDEM 782
Cdd:PRK05691 2254 GLLAILKAGGAYVPLDPEYPLERLHYMIEDSGIGLLLSDRALF----EALGELPAGVArwCLEDdaaaLAAYSDAPLPFL 2329
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 783 EclkplAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRlVV 862
Cdd:PRK05691 2330 S-----LPQHQAYLIYTSGSTGKPKGVVVSHGEIAMHCQAVIERFGMRADDCELHFYSINFDAASERLLVPLLCGAR-VV 2403
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 863 VPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQ--ADReneevGQKLSLRYVVFGGEAL---ELSRLEDWYsrhphn 937
Cdd:PRK05691 2404 LRAQGQWGAEEICQLIREQQVSILGFTPSYGSQLAQwlAGQ-----GEQLPVRMCITGGEALtgeHLQRIRQAF------ 2472
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 938 APKVI-NMYGITETTVHVSYIELDESIVSLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGL 1016
Cdd:PRK05691 2473 APQLFfNAYGPTETVVMPLACLAPEQLEEGAASVPIGRVVGARVAYILDADLALVPQGATGELYVGGAGLAQGYHDRPGL 2552
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1017 TAERFIADPFGKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQvAVIVREDQPGDKR 1096
Cdd:PRK05691 2553 TAERFVADPFAADGGRLYRTGDLVRLRADGLVEYVGRIDHQVKIRGFRIELGEIESRLLEHPAVRE-AVVLALDTPSGKQ 2631
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1097 LVAYIV----ASNNETIDT--NEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEF-IASSSSRGPRTPQE 1169
Cdd:PRK05691 2632 LAGYLVsavaGQDDEAQAAlrEALKAHLKQQLPDYMVPAHLILLDSLPLTANGKLDRRALPAPDPeLNRQAYQAPRSELE 2711
|
1210 1220 1230 1240 1250 1260
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1698252301 1170 EMLCDLFTEVLSVSQIGIDDGFFDLGGHSLLAVQLMSRMKEaLGVELNIGTLFAAPTVAGLA 1231
Cdd:PRK05691 2712 QQLAQIWREVLNVERVGLGDNFFELGGDSILSIQVVSRARQ-LGIHFSPRDLFQHQTVQTLA 2772
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
41-1235 |
0e+00 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 815.94 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 41 IRSYVSEslANYMIPSAFVVLE--ELPLTPNGKVDRK---------------KLPAPDFNGMNNERVARNPKEEILCDLF 103
Cdd:PRK05691 518 IRQAVAE--ACQEAPSVVLLLNpgALPKTSSGKLQRSacrlrladgsldsyaLFPALQAVEAAQTAASGDELQARIAAIW 595
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 104 AEVLGVSRINIDDNFFEMGGHSLLASRLMARIRETLSVELGIGKLFESPTV----AELAKQLNHAKSARPAIQKASRPNE 179
Cdd:PRK05691 596 CEQLKVEQVAADDHFFLLGGNSIAATQVVARLRDELGIDLNLRQLFEAPTLaafsAAVARQLAGGGAAQAAIARLPRGQA 675
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 180 VPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKILDMENLNLEMV 259
Cdd:PRK05691 676 LPQSLAQNRLWLLWQLDPQSAAYNIPGGLHLRGELDEAALRASFQRLVERHESLRTRFYERDGVALQRIDAQGEFALQRI 755
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 260 -ITNTCKDELES----VLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQGD 334
Cdd:PRK05691 756 dLSDLPEAEREAraaqIREEEARQPFDLEKGPLLRVTLVRLDDEEHQLLVTLHHIVADGWSLNILLDEFSRLYAAACQGQ 835
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 335 RVQLETLPVQYADYALWQQQLLGDETTpesliSTQLDFWKEELKGLPDQMELPTDYQRPVETSYRGETIHFHIDEGMHSR 414
Cdd:PRK05691 836 TAELAPLPLGYADYGAWQRQWLAQGEA-----ARQLAYWKAQLGDEQPVLELATDHPRSARQAHSAARYSLRVDASLSEA 910
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 415 LVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSGDPSFKELLNRVKQV 494
Cdd:PRK05691 911 LRGLAQAHQATLFMVLLAAFQALLHRYSGQGDIRIGVPNANRPRLETQGLVGFFINTQVLRAQLDGRLPFTALLAQVRQA 990
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 495 NLAAYENQDVPFERLVEVLNPVRtrnSHPLFQVMLAFQN-TPEATFNAPDLEASLEIQSVGSAKFDLTFEISESNevdgt 573
Cdd:PRK05691 991 TLGAQAHQDLPFEQLVEALPQAR---EQGLFQVMFNHQQrDLSALRRLPGLLAEELPWHSREAKFDLQLHSEEDR----- 1062
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 574 pNGLHGL-LEFSTDLYKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVAEKNTVLEkWNGGFQIAPEMTLPQLFEKQ 652
Cdd:PRK05691 1063 -NGRLTLsFDYAAELFDAATIERLAEHFLALLEQVCEDPQRALGDVQLLDAAERAQLAQ-WGQAPCAPAQAWLPELLNEQ 1140
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 653 AHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRI 732
Cdd:PRK05691 1141 ARQTPERIALVWDGGSLDYAELHAQANRLAHYLRDKGVGPDVCVAIAAERSPQLLVGLLAILKAGGAYVPLDPDYPAERL 1220
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 733 SFMLHDAKPSCVLTNSSveiecdeslkiLVDDvnvMEEIEKYSEENIDEMECLK-PLAP-------SHIAYVIYTSGSTG 804
Cdd:PRK05691 1221 AYMLADSGVELLLTQSH-----------LLER---LPQAEGVSAIALDSLHLDSwPSQApglhlhgDNLAYVIYTSGSTG 1286
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 805 RPKGVMIPHQNVVRLLgatdHWFQ----FDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVK 880
Cdd:PRK05691 1287 QPKGVGNTHAALAERL----QWMQatyaLDDSDVLMQKAPISFDVSVWECFWPLITGCRLVLAGPGEHRDPQRIAELVQQ 1362
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 881 EKVTVLNQTPSafyqLMQADRENEEVGQKLSLRYVVFGGEALElSRLEDwysRHPHNAPKVI--NMYGITETTVHVSYIE 958
Cdd:PRK05691 1363 YGVTTLHFVPP----LLQLFIDEPLAAACTSLRRLFSGGEALP-AELRN---RVLQRLPQVQlhNRYGPTETAINVTHWQ 1434
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 959 LDesiVSLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPGTRMYRTGD 1038
Cdd:PRK05691 1435 CQ---AEDGERSPIGRPLGNVLCRVLDAELNLLPPGVAGELCIGGAGLARGYLGRPALTAERFVPDPLGEDGARLYRTGD 1511
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1039 LARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGdKRLVAYIVASNNETIDTNEMRQHA 1118
Cdd:PRK05691 1512 RARWNADGALEYLGRLDQQVKLRGFRVEPEEIQARLLAQPGVAQAAVLVREGAAG-AQLVGYYTGEAGQEAEAERLKAAL 1590
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1119 SGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAP-----EFIAssssrgPRTPQEEMLCDLFTEVLSVSQIGIDDGFFD 1193
Cdd:PRK05691 1591 AAELPEYMVPAQLIRLDQMPLGPSGKLDRRALPEPvwqqrEHVE------PRTELQQQIAAIWREVLGLPRVGLRDDFFA 1664
|
1210 1220 1230 1240
....*....|....*....|....*....|....*....|..
gi 1698252301 1194 LGGHSLLAVQLMSRMKEALGVELNIGTLFAAPTVAGLAERLE 1235
Cdd:PRK05691 1665 LGGHSLLATQIVSRTRQACDVELPLRALFEASELGAFAEQVA 1706
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
657-1150 |
0e+00 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 765.70 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFML 736
Cdd:cd17643 1 PEAVAVVDEDRRLTYGELDARANRLARTLRAEGVGPGDRVALALPRSAELIVALLAILKAGGAYVPIDPAYPVERIAFIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 737 HDAKPSCVLTNssveiecdeslkilvddvnvmeeiekyseenidemeclkplaPSHIAYVIYTSGSTGRPKGVMIPHQNV 816
Cdd:cd17643 81 ADSGPSLLLTD------------------------------------------PDDLAYVIYTSGSTGRPKGVVVSHANV 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 817 VRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQL 896
Cdd:cd17643 119 LALFAATQRWFGFNEDDVWTLFHSYAFDFSVWEIWGALLHGGRLVVVPYEVARSPEDFARLLRDEGVTVLNQTPSAFYQL 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 897 MQADRENEEvgQKLSLRYVVFGGEALELSRLEDWYSRHPHNAPKVINMYGITETTVHVSYIELDESIVSLRANSLIGCSI 976
Cdd:cd17643 199 VEAADRDGR--DPLALRYVIFGGEALEAAMLRPWAGRFGLDRPQLVNMYGITETTVHVTFRPLDAADLPAAAASPIGRPL 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 977 PDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPGTRMYRTGDLARWRQDGTLDYIGRADH 1056
Cdd:cd17643 277 PGLRVYVLDADGRPVPPGVVGELYVSGAGVARGYLGRPELTAERFVANPFGGPGSRMYRTGDLARRLPDGELEYLGRADE 356
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1057 QIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNE 1136
Cdd:cd17643 357 QVKIRGFRIELGEIEAALATHPSVRDAAVIVREDEPGDTRLVAYVVADDGAAADIAELRALLKELLPDYMVPARYVPLDA 436
|
490
....*....|....
gi 1698252301 1137 LPLTPNGKLDRKAL 1150
Cdd:cd17643 437 LPLTVNGKLDRAAL 450
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
181-1358 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 763.55 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 181 PLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGiLNRQALQGAFYDVVEKHETLRTIFpnVLGSSYQKILDMENLNLEMVI 260
Cdd:PRK12467 2648 PLSPMQQGMLFHTLYEGGAGDYINQMRVDVEG-LDVERFRTAWQAVIDRHEILRSGF--LWDGELEEPLQVVYKQARLPF 2724
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 261 TN-------TCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQG 333
Cdd:PRK12467 2725 SRldwrdraDLEQALDALAAADRQQGFDLLSAPLLRLTLVRTGEDRHHLIYTNHHILMDGWSGSQLLGEVLQRYFGQPPP 2804
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 334 DRVQLetlpvqYADYALWQQQLLGDETTPeslistqldFWKEELKGLPDQMEL-PTDYQRPVETSYRGETIHFHIDEGMH 412
Cdd:PRK12467 2805 AREGR------YRDYIAWLQAQDAEASEA---------FWKEQLAALEEPTRLaRALYPAPAEAVAGHGAHYLHLDATQT 2869
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 413 SRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDV--LSDIVGLFVNTLVLRTNTSGDPSFKELLNR 490
Cdd:PRK12467 2870 RQLIEFARRHRVTLNTLVQGAWLLLLQRFTGQDTVCFGATVAGRPAQLrgAEQQLGLFINTLPVIASPRAEQTVSDWLQQ 2949
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 491 VKQVNLAAYENQDVPferLVEVlNPVRTRNSHPLFQVMLAFQNTPeatfnapdLEASLEiqsvGSAKFDLTFEISESNEV 570
Cdd:PRK12467 2950 VQAQNLALREFEHTP---LADI-QRWAGQGGEALFDSILVFENYP--------ISEALK----QGAPSGLRFGAVSSREQ 3013
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 571 DGTPNGLH-GL-----LEFSTD--LYKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVAEKNTVLEKWNGGFQIAP- 641
Cdd:PRK12467 3014 TNYPLTLAvGLgdtleLEFSYDrqHFDAAAIERLAESFDRLLQAMLNNPAARLGELPTLAAHERRQVLHAWNATAAAYPs 3093
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 642 EMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYL 721
Cdd:PRK12467 3094 ERLVHQLIEAQVARTPEAPALVFGDQQLSYAELNRRANRLAHRLIAIGVGPDVLVGVAVERSVEMIVALLAVLKAGGAYV 3173
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 722 PLDPDYPSDRISFMLHDAKPSCVLTNSSVEiecdESLKILVDDVNVMEE---IEKYSEENIDEMeclkpLAPSHIAYVIY 798
Cdd:PRK12467 3174 PLDPEYPRERLAYMIEDSGVKLLLTQAHLL----EQLPAPAGDTALTLDrldLNGYSENNPSTR-----VMGENLAYVIY 3244
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 799 TSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVsRSPKEFLQLL 878
Cdd:PRK12467 3245 TSGSTGKPKGVGVRHGALANHLCWIAEAYELDANDRVLLFMSFSFDGAQERFLWTLICGGCLVVRDNDL-WDPEELWQAI 3323
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 879 VKEKVTVLNQTPSAfyqlMQADRENEEVGQKLSLRYVVFGGEALELSRLEDwYSRHPHNApKVINMYGITETTVHVSYIE 958
Cdd:PRK12467 3324 HAHRISIACFPPAY----LQQFAEDAGGADCASLDIYVFGGEAVPPAAFEQ-VKRKLKPR-GLTNGYGPTEAVVTVTLWK 3397
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 959 LDESIVSLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPGTRMYRTGD 1038
Cdd:PRK12467 3398 CGGDAVCEAPYAPIGRPVAGRSIYVLDGQLNPVPVGVAGELYIGGVGLARGYHQRPSLTAERFVADPFSGSGGRLYRTGD 3477
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1039 LARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGdKRLVAYIVASNNETIDTNEMRQHA 1118
Cdd:PRK12467 3478 LARYRADGVIEYLGRIDHQVKIRGFRIELGEIEARLLQHPSVREAVVLARDGAGG-KQLVAYVVPADPQGDWRETLRDHL 3556
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1119 SGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEFIASSSSRGPRTPQEEMLCDLFTEVLSVSQIGIDDGFFDLGGHS 1198
Cdd:PRK12467 3557 AASLPDYMVPAQLLVLAAMPLGPNGKVDRKALPDPDAKGSREYVAPRSEVEQQLAAIWADVLGVEQVGVTDNFFELGGDS 3636
|
1050 1060 1070 1080 1090 1100 1110 1120
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1199 LLAVQLMSRMKEALGVELNIGTLFAAPTVAGLAERLeiGNGQSALDVLLPLRASGDQLP-LFCVHPAGGLSWCYAGLMKS 1277
Cdd:PRK12467 3637 LLALQVLSRIRQSLGLKLSLRDLMSAPTIAELAGYS--PLGDVPVNLLLDLNRLETGFPaLFCRHEGLGTVFDYEPLAVI 3714
|
1130 1140 1150 1160 1170 1180 1190 1200
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1278 LGTDYPIYGVQARGIAENEELPKSLEEMAADYLKHVREIQPHGPYRLLGWSLGGNVVHAMAAQLQNEGEEVELLVMLDSY 1357
Cdd:PRK12467 3715 LEGDRHVLGLTCRHLLDDGWQDTSLQAMAVQYADYILWQQAKGPYGLLGWSLGGTLARLVAELLEREGESEAFLGLFDNT 3794
|
.
gi 1698252301 1358 P 1358
Cdd:PRK12467 3795 L 3795
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
181-1244 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 723.67 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 181 PLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGiLNRQALQGAFYDVVEKHETLRTIF--PNVLGSSYQ---KILDMENLN 255
Cdd:PRK12316 4104 PLSPMQQGMLFHSLYEQEAGDYINQMRVDVQG-LDVERFRAAWQAALDRHDVLRSGFvwQGELGRPLQvvhKQVSLPFAE 4182
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 256 LEMVITNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARcqgdr 335
Cdd:PRK12316 4183 LDWRGRADLQAALDALAAAERERGFDLQRAPLLRLVLVRTAEGRHHLIYTNHHILMDGWSNSQLLGEVLERYSGR----- 4257
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 336 vQLETLPVQYADYALWQQQllGDETTPESlistqldFWKEELKGLPDQMELPTDYQRPVETSYRGETIHFH-IDEGMHSR 414
Cdd:PRK12316 4258 -PPAQPGGRYRDYIAWLQR--QDAAASEA-------FWREQLAALDEPTRLAQAIARADLRSANGYGEHVReLDATATAR 4327
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 415 LVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVL--SDIVGLFVNTLVLRTNTSGDPSFKELLNRVK 492
Cdd:PRK12316 4328 LREFARTQRVTLNTLVQAAWLLLLQRYTGQDTVAFGATVAGRPAELPgiEGQIGLFINTLPVIATPRAQQSVVEWLQQVQ 4407
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 493 QVNLAAYENQDVPFERLvevlNPVRTRNSHPLFQVMLAFQNTPEATFNAPDLEASLEIQSVGS-----AKFDLTFEISES 567
Cdd:PRK12316 4408 RQNLALREHEHTPLYEI----QRWAGQGGEALFDSLLVFENYPVSEALQQGAPGGLRFGEVTNheqtnYPLTLAVGLGET 4483
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 568 NEVDgtpnglhglLEFSTDLYKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVAEKNTVLEKWN---GGFQIAPemT 644
Cdd:PRK12316 4484 LSLQ---------FSYDRGHFDAATIERLARHLTNLLEAMAEDPQRRLGELQLLEKAEQQRIVALWNrtdAGYPATR--C 4552
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 645 LPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLD 724
Cdd:PRK12316 4553 VHQLVAERARMTPDAVAVVFDEEKLTYAELNRRANRLAHALIARGVGPEVLVGIAMERSAEMMVGLLAVLKAGGAYVPLD 4632
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 725 PDYPSDRISFMLHDAKPSCVLTNS--SVEIECDESLKILVDDVNvmEEIEKYSEENIdemecLKPLAPSHIAYVIYTSGS 802
Cdd:PRK12316 4633 PEYPRERLAYMMEDSGAALLLTQShlLQRLPIPDGLASLALDRD--EDWEGFPAHDP-----AVRLHPDNLAYVIYTSGS 4705
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 803 TGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSrSPKEFLQLLVKEK 882
Cdd:PRK12316 4706 TGRPKGVAVSHGSLVNHLHATGERYELTPDDRVLQFMSFSFDGSHEGLYHPLINGASVVIRDDSLW-DPERLYAEIHEHR 4784
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 883 VTVLNQTPSAFYQLMQADRENEEVGqklSLRYVVFGGEALELSRLEDWYSRHPHNApkVINMYGITETTVHVSYIELDES 962
Cdd:PRK12316 4785 VTVLVFPPVYLQQLAEHAERDGEPP---SLRVYCFGGEAVAQASYDLAWRALKPVY--LFNGYGPTETTVTVLLWKARDG 4859
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 963 IVSLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPGTRMYRTGDLARW 1042
Cdd:PRK12316 4860 DACGAAYMPIGTPLGNRSGYVLDGQLNPLPVGVAGELYLGGEGVARGYLERPALTAERFVPDPFGAPGGRLYRTGDLARY 4939
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1043 RQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQvAVIVREDQPGDKRLVAYIVASNNETIDT--------NEM 1114
Cdd:PRK12316 4940 RADGVIDYLGRVDHQVKIRGFRIELGEIEARLREHPAVRE-AVVIAQEGAVGKQLVGYVVPQDPALADAdeaqaelrDEL 5018
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1115 RQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEfiASSSSRG---PRTPQEEMLCDLFTEVLSVSQIGIDDGF 1191
Cdd:PRK12316 5019 KAALRERLPEYMVPAHLVFLARMPLTPNGKLDRKALPQPD--ASLLQQAyvaPRSELEQQVAAIWAEVLQLERVGLDDNF 5096
|
1050 1060 1070 1080 1090
....*....|....*....|....*....|....*....|....*....|...
gi 1698252301 1192 FDLGGHSLLAVQLMSRMKEALGVELNIGTLFAAPTVAGLAERLEIGNGQSALD 1244
Cdd:PRK12316 5097 FELGGHSLLAIQVTSRIQLELGLELPLRELFQTPTLAAFVELAAAAGSGDDEK 5149
|
|
| LCL_NRPS |
cd19538 |
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; ... |
179-611 |
0e+00 |
|
LCL-type Condensation domain of non-ribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380461 [Multi-domain] Cd Length: 432 Bit Score: 713.27 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 179 EVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKILDMENLNLEM 258
Cdd:cd19538 1 EIPLSFAQRRLWFLHQLEGPSATYNIPLVIKLKGKLDVQALQQALYDVVERHESLRTVFPEEDGVPYQLILEEDEATPKL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 259 VITNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQGDRVQL 338
Cdd:cd19538 81 EIKEVDEEELESEINEAVRYPFDLSEEPPFRATLFELGENEHVLLLLLHHIAADGWSLAPLTRDLSKAYRARCKGEAPEL 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 339 ETLPVQYADYALWQQQLLGDETTPESLISTQLDFWKEELKGLPDQMELPTDYQRPVETSYRGETIHFHIDEGMHSRLVEL 418
Cdd:cd19538 161 APLPVQYADYALWQQELLGDESDPDSLIARQLAYWKKQLAGLPDEIELPTDYPRPAESSYEGGTLTFEIDSELHQQLLQL 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 419 GRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSGDPSFKELLNRVKQVNLAA 498
Cdd:cd19538 241 AKDNNVTLFMVLQAGFAALLTRLGAGTDIPIGSPVAGRNDDSLEDLVGFFVNTLVLRTDTSGNPSFRELLERVKETNLEA 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 499 YENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQNTPEATFNAPDLEASLEIQSVGSAKFDLTFEISESNEvDGTPNGLH 578
Cdd:cd19538 321 YEHQDIPFERLVEALNPTRSRSRHPLFQIMLALQNTPQPSLDLPGLEAKLELRTVGSAKFDLTFELREQYN-DGTPNGIE 399
|
410 420 430
....*....|....*....|....*....|...
gi 1698252301 579 GLLEFSTDLYKRETVQKLIERFILLLDDAATNP 611
Cdd:cd19538 400 GFIEYRTDLFDHETIEALAQRYLLLLESAVENP 432
|
|
| LCL_NRPS-like |
cd19540 |
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; ... |
180-611 |
0e+00 |
|
LCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs) and similar domains; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380463 [Multi-domain] Cd Length: 433 Bit Score: 647.94 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 180 VPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKILDMENLNLEMV 259
Cdd:cd19540 2 IPLSFAQQRLWFLNRLDGPSAAYNIPLALRLTGALDVDALRAALADVVARHESLRTVFPEDDGGPYQVVLPAAEARPDLT 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 260 ITNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQGDRVQLE 339
Cdd:cd19540 82 VVDVTEDELAARLAEAARRGFDLTAELPLRARLFRLGPDEHVLVLVVHHIAADGWSMAPLARDLATAYAARRAGRAPDWA 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 340 TLPVQYADYALWQQQLLGDETTPESLISTQLDFWKEELKGLPDQMELPTDYQRPVETSYRGETIHFHIDEGMHSRLVELG 419
Cdd:cd19540 162 PLPVQYADYALWQRELLGDEDDPDSLAARQLAYWRETLAGLPEELELPTDRPRPAVASYRGGTVEFTIDAELHARLAALA 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 420 RKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSGDPSFKELLNRVKQVNLAAY 499
Cdd:cd19540 242 REHGATLFMVLHAALAVLLSRLGAGDDIPIGTPVAGRGDEALDDLVGMFVNTLVLRTDVSGDPTFAELLARVRETDLAAF 321
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 500 ENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQNTPEATFNAPDLEASLEIQSVGSAKFDLTFEISESNEVDGTPNGLHG 579
Cdd:cd19540 322 AHQDVPFERLVEALNPPRSTARHPLFQVMLAFQNTAAATLELPGLTVEPVPVDTGVAKFDLSFTLTERRDADGAPAGLTG 401
|
410 420 430
....*....|....*....|....*....|..
gi 1698252301 580 LLEFSTDLYKRETVQKLIERFILLLDDAATNP 611
Cdd:cd19540 402 ELEYATDLFDRSTAERLADRFVRVLEAVVADP 433
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
181-1255 |
0e+00 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 635.84 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 181 PLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGiLNRQALQGAFYDVVEKHETLRTIFPNV--LGSSYQKILDMENLNLEM 258
Cdd:PRK12316 1558 PLSPMQQGMLFHSLYEQEAGDYINQLRVDVQG-LDPDRFRAAWQATVDRHEILRSGFLWQdgLEQPLQVIHKQVELPFAE 1636
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 259 VITNTCKDELESV--LSEAVRYS-FNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQGDR 335
Cdd:PRK12316 1637 LDWRGREDLGQALdaLAQAERQKgFDLTRAPLLRLVLVRTGEGRHHLIYTNHHILMDGWSNAQLLGEVLQRYAGQPVAAP 1716
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 336 VQletlpvQYADYALWQQQllGDETTPESlistqldFWKEELKGLPDQMELPTDYQRPVETSYRGEtiHFH-IDEGMHSR 414
Cdd:PRK12316 1717 GG------RYRDYIAWLQR--QDAAASEA-------FWKEQLAALEEPTRLAQAARTEDGQVGYGD--HQQlLDPAQTRA 1779
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 415 LVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDvLSDI---VGLFVNTLVLRTNTSGDPSFKELLNRV 491
Cdd:PRK12316 1780 LAEFARAQKVTLNTLVQAAWLLLLQRYTGQETVAFGATVAGRPAE-LPGIeqqIGLFINTLPVIAAPRPDQSVADWLQEV 1858
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 492 KQVNLAAYENQDVPferLVEVlNPVRTRNSHPLFQVMLAFQNTPEAtfnapdlEAsLEiqsvGSAKFDLTFEISESNEVD 571
Cdd:PRK12316 1859 QALNLALREHEHTP---LYDI-QRWAGQGGEALFDSLLVFENYPVA-------EA-LK----QGAPAGLVFGRVSNHEQT 1922
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 572 GTPNGLH-GL-----LEFSTDL--YKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVAEKNTVLEKWNGGFQIAP-E 642
Cdd:PRK12316 1923 NYPLTLAvTLgetlsLQYSYDRghFDAAAIERLDRHLLHLLEQMAEDAQAALGELALLDAGERQRILADWDRTPEAYPrG 2002
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 643 MTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLP 722
Cdd:PRK12316 2003 PGVHQRIAEQAARAPEAIAVVFGDQHLSYAELDSRANRLAHRLRARGVGPEVRVAIAAERSFELVVALLAVLKAGGAYVP 2082
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 723 LDPDYPSDRISFMLHDAKPSCVLTNSSV--EIECDESLKILvdDVNVMEEIEKYSEENIdemecLKPLAPSHIAYVIYTS 800
Cdd:PRK12316 2083 LDPNYPAERLAYMLEDSGAALLLTQRHLleRLPLPAGVARL--PLDRDAEWADYPDTAP-----AVQLAGENLAYVIYTS 2155
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 801 GSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVsRSPKEFLQLLVK 880
Cdd:PRK12316 2156 GSTGLPKGVAVSHGALVAHCQAAGERYELSPADCELQFMSFSFDGAHEQWFHPLLNGARVLIRDDEL-WDPEQLYDEMER 2234
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 881 EKVTVLNQTPSAFYQLMQadrENEEVGQKLSLRYVVFGGEALELSRLEDWYSRHPhnAPKVINMYGITETTVHVSYIELD 960
Cdd:PRK12316 2235 HGVTILDFPPVYLQQLAE---HAERDGRPPAVRVYCFGGEAVPAASLRLAWEALR--PVYLFNGYGPTEAVVTPLLWKCR 2309
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 961 ESIVSLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPGTRMYRTGDLA 1040
Cdd:PRK12316 2310 PQDPCGAAYVPIGRALGNRRAYILDADLNLLAPGMAGELYLGGEGLARGYLNRPGLTAERFVPDPFSASGERLYRTGDLA 2389
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1041 RWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQvAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASG 1120
Cdd:PRK12316 2390 RYRADGVVEYLGRIDHQVKIRGFRIELGEIEARLQAHPAVRE-AVVVAQDGASGKQLVAYVVPDDAAEDLLAELRAWLAA 2468
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1121 SLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEF-IASSSSRGPRTPQEEMLCDLFTEVLSVSQIGIDDGFFDLGGHSL 1199
Cdd:PRK12316 2469 RLPAYMVPAHWVVLERLPLNPNGKLDRKALPKPDVsQLRQAYVAPQEGLEQRLAAIWQAVLKVEQVGLDDHFFELGGHSL 2548
|
1050 1060 1070 1080 1090 1100
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1698252301 1200 LAVQLMSRMKEALGVELNIGTLFAAPTVAGLAERLEIGNGQSALDVL-----LPLRASGDQ 1255
Cdd:PRK12316 2549 LATQVVSRVRQDLGLEVPLRILFERPTLAAFAASLESGQTSRAPVLQkvtrvQPLPLSHAQ 2609
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
657-1150 |
0e+00 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 629.56 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFML 736
Cdd:cd05930 1 PDAVAVVDGDQSLTYAELDARANRLARYLRERGVGPGDLVAVLLERSLEMVVAILAVLKAGAAYVPLDPSYPAERLAYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 737 HDAKPSCVLTNssveiecdeslkilvddvnvmeeiekyseenidemeclkplaPSHIAYVIYTSGSTGRPKGVMIPHQNV 816
Cdd:cd05930 81 EDSGAKLVLTD------------------------------------------PDDLAYVIYTSGSTGKPKGVMVEHRGL 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 817 VRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQL 896
Cdd:cd05930 119 VNLLLWMQEAYPLTPGDRVLQFTSFSFDVSVWEIFGALLAGATLVVLPEEVRKDPEALADLLAEEGITVLHLTPSLLRLL 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 897 MQADreneEVGQKLSLRYVVFGGEALELSRLEDWYSRHPHnaPKVINMYGITETTVHVSYIELDESIVSLRANSlIGCSI 976
Cdd:cd05930 199 LQEL----ELAALPSLRLVLVGGEALPPDLVRRWRELLPG--ARLVNLYGPTEATVDATYYRVPPDDEEDGRVP-IGRPI 271
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 977 PDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGkPGTRMYRTGDLARWRQDGTLDYIGRADH 1056
Cdd:cd05930 272 PNTRVYVLDENLRPVPPGVPGELYIGGAGLARGYLNRPELTAERFVPNPFG-PGERMYRTGDLVRWLPDGNLEFLGRIDD 350
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1057 QIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNE 1136
Cdd:cd05930 351 QVKIRGYRIELGEIEAALLAHPGVREAAVVAREDGDGEKRLVAYVVPDEGGELDEEELRAHLAERLPDYMVPSAFVVLDA 430
|
490
....*....|....
gi 1698252301 1137 LPLTPNGKLDRKAL 1150
Cdd:cd05930 431 LPLTPNGKVDRKAL 444
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
647-1150 |
0e+00 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 583.39 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 647 QLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPD 726
Cdd:cd12117 1 ELFEEQAARTPDAVAVVYGDRSLTYAELNERANRLARRLRAAGVGPGDVVGVLAERSPELVVALLAVLKAGAAYVPLDPE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 727 YPSDRISFMLHDAKPSCVLTNSSVEiecdESLKILVDDVNVMEEIEKYSEENIDEmeclkPLAPSHIAYVIYTSGSTGRP 806
Cdd:cd12117 81 LPAERLAFMLADAGAKVLLTDRSLA----GRAGGLEVAVVIDEALDAGPAGNPAV-----PVSPDDLAYVMYTSGSTGRP 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 807 KGVMIPHQNVVRLLGATDhWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVL 886
Cdd:cd12117 152 KGVAVTHRGVVRLVKNTN-YVTLGPDDRVLQTSPLAFDASTFEIWGALLNGARLVLAPKGTLLDPDALGALIAEEGVTVL 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 887 NQTPSAFYQLMQADRENEEvgqklSLRYVVFGGEALELSRLEDWYSRHPHnaPKVINMYGITETTVHVSYIELDEsiVSL 966
Cdd:cd12117 231 WLTAALFNQLADEDPECFA-----GLRELLTGGEVVSPPHVRRVLAACPG--LRLVNGYGPTENTTFTTSHVVTE--LDE 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 967 RANSL-IGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGkPGTRMYRTGDLARWRQD 1045
Cdd:cd12117 302 VAGSIpIGRPIANTRVYVLDEDGRPVPPGVPGELYVGGDGLALGYLNRPALTAERFVADPFG-PGERLYRTGDLARWLPD 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1046 GTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVAsnNETIDTNEMRQHASGSLPDY 1125
Cdd:cd12117 381 GRLEFLGRIDDQVKIRGFRIELGEIEAALRAHPGVREAVVVVREDAGGDKRLVAYVVA--EGALDAAELRAFLRERLPAY 458
|
490 500
....*....|....*....|....*
gi 1698252301 1126 MVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd12117 459 MVPAAFVVLDELPLTANGKVDRRAL 483
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
657-1151 |
0e+00 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 569.96 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFML 736
Cdd:cd17652 1 PDAPAVVFGDETLTYAELNARANRLARLLAARGVGPERLVALALPRSAELVVAILAVLKAGAAYLPLDPAYPAERIAYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 737 HDAKPSCVLTNssveiecdeslkilvddvnvmeeiekyseenidemeclkplaPSHIAYVIYTSGSTGRPKGVMIPHQNV 816
Cdd:cd17652 81 ADARPALLLTT------------------------------------------PDNLAYVIYTSGSTGRPKGVVVTHRGL 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 817 VRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQL 896
Cdd:cd17652 119 ANLAAAQIAAFDVGPGSRVLQFASPSFDASVWELLMALLAGATLVLAPAEELLPGEPLADLLREHRITHVTLPPAALAAL 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 897 mqadreneEVGQKLSLRYVVFGGEALELSRLEDWYSRHphnapKVINMYGITETTVHVSYIELDESivslRANSLIGCSI 976
Cdd:cd17652 199 --------PPDDLPDLRTLVVAGEACPAELVDRWAPGR-----RMINAYGPTETTVCATMAGPLPG----GGVPPIGRPV 261
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 977 PDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPGTRMYRTGDLARWRQDGTLDYIGRADH 1056
Cdd:cd17652 262 PGTRVYVLDARLRPVPPGVPGELYIAGAGLARGYLNRPGLTAERFVADPFGAPGSRMYRTGDLARWRADGQLEFLGRADD 341
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1057 QIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNE 1136
Cdd:cd17652 342 QVKIRGFRIELGEVEAALTEHPGVAEAVVVVRDDRPGDKRLVAYVVPAPGAAPTAAELRAHLAERLPGYMVPAAFVVLDA 421
|
490
....*....|....*
gi 1698252301 1137 LPLTPNGKLDRKALP 1151
Cdd:cd17652 422 LPLTPNGKLDRRALP 436
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
649-1151 |
0e+00 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 563.51 E-value: 0e+00
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 649 FEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYP 728
Cdd:cd17651 1 FERQAARTPDAPALVAEGRRLTYAELDRRANRLAHRLRARGVGPGDLVALCARRSAELVVALLAILKAGAAYVPLDPAYP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 729 SDRISFMLHDAKPSCVLTNSsveiecDESLKILVDDVNVMEeIEKYSEENIDEMECLKPLAPSHIAYVIYTSGSTGRPKG 808
Cdd:cd17651 81 AERLAFMLADAGPVLVLTHP------ALAGELAVELVAVTL-LDQPGAAAGADAEPDPALDADDLAYVIYTSGSTGRPKG 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 809 VMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQ 888
Cdd:cd17651 154 VVMPHRSLANLVAWQARASSLGPGARTLQFAGLGFDVSVQEIFSTLCAGATLVLPPEEVRTDPPALAAWLDEQRISRVFL 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 889 TPSAFYQLMQADRENEEVGQklSLRYVVFGGEALEL-SRLEDWYSRHPHnaPKVINMYGITETTVhVSYIELDESIVSLR 967
Cdd:cd17651 234 PTVALRALAEHGRPLGVRLA--ALRYLLTGGEQLVLtEDLREFCAGLPG--LRLHNHYGPTETHV-VTALSLPGDPAAWP 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 968 ANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGkPGTRMYRTGDLARWRQDGT 1047
Cdd:cd17651 309 APPPIGRPIDNTRVYVLDAALRPVPPGVPGELYIGGAGLARGYLNRPELTAERFVPDPFV-PGARMYRTGDLARWLPDGE 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1048 LDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMV 1127
Cdd:cd17651 388 LEFLGRADDQVKIRGFRIELGEIEAALARHPGVREAVVLAREDRPGEKRLVAYVVGDPEAPVDAAELRAALATHLPEYMV 467
|
490 500
....*....|....*....|....
gi 1698252301 1128 PYAFVVVNELPLTPNGKLDRKALP 1151
Cdd:cd17651 468 PSAFVLLDALPLTPNGKLDRRALP 491
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
647-1154 |
3.00e-179 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 543.46 E-value: 3.00e-179
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 647 QLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPD 726
Cdd:cd17655 1 ELFEEQAEKTPDHTAVVFEDQTLTYRELNERANQLARTLREKGVGPDTIVGIMAERSLEMIVGILGILKAGGAYLPIDPD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 727 YPSDRISFMLHDAKPSCVLTNSSVEI-ECDESLKILVDDvnvmEEIEKYSEENIDemeclKPLAPSHIAYVIYTSGSTGR 805
Cdd:cd17655 81 YPEERIQYILEDSGADILLTQSHLQPpIAFIGLIDLLDE----DTIYHEESENLE-----PVSKSDDLAYVIYTSGSTGK 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 806 PKGVMIPHQNVVRL-LGATDHWFQFDADDVwTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVT 884
Cdd:cd17655 152 PKGVMIEHRGVVNLvEWANKVIYQGEHLRV-ALFASISFDASVTEIFASLLSGNTLYIVRKETVLDGQALTQYIRQNRIT 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 885 VLNQTPSAFYQLMQADreneeVGQKLSLRYVVFGGEALELSRLEDWYSRHPHNaPKVINMYGITETTVHVSYIELDESIV 964
Cdd:cd17655 231 IIDLTPAHLKLLDAAD-----DSEGLSLKHLIVGGEALSTELAKKIIELFGTN-PTITNAYGPTETTVDASIYQYEPETD 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 965 SlRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgKPGTRMYRTGDLARWRQ 1044
Cdd:cd17655 305 Q-QVSVPIGKPLGNTRIYILDQYGRPQPVGVAGELYIGGEGVARGYLNRPELTAEKFVDDPF-VPGERMYRTGDLARWLP 382
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1045 DGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNetIDTNEMRQHASGSLPD 1124
Cdd:cd17655 383 DGNIEFLGRIDHQVKIRGYRIELGEIEARLLQHPDIKEAVVIARKDEQGQNYLCAYIVSEKE--LPVAQLREFLARELPD 460
|
490 500 510
....*....|....*....|....*....|
gi 1698252301 1125 YMVPYAFVVVNELPLTPNGKLDRKALPAPE 1154
Cdd:cd17655 461 YMIPSYFIKLDEIPLTPNGKVDRKALPEPD 490
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
646-1150 |
2.47e-178 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 541.10 E-value: 2.47e-178
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 646 PQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDP 725
Cdd:cd17646 1 HALVAEQAARTPDAPAVVDEGRTLTYRELDERANRLAHLLRARGVGPEDRVAVLLPRSADLVVALLAVLKAGAAYLPLDP 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 726 DYPSDRISFMLHDAKPSCVLTNSsveiecDESLKILVDDVNVMEEIEKYSEENIDEMEclKPLAPSHIAYVIYTSGSTGR 805
Cdd:cd17646 81 GYPADRLAYMLADAGPAVVLTTA------DLAARLPAGGDVALLGDEALAAPPATPPL--VPPRPDNLAYVIYTSGSTGR 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 806 PKGVMIPHQNVV-RLLGATDHwFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVT 884
Cdd:cd17646 153 PKGVMVTHAGIVnRLLWMQDE-YPLGPGDRVLQKTPLSFDVSVWELFWPLVAGARLVVARPGGHRDPAYLAALIREHGVT 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 885 VLNQTPSAFYQLMQADReneeVGQKLSLRYVVFGGEALELSRLEDWYSRhPHnAPKViNMYGITETTVHVSYIELDESIV 964
Cdd:cd17646 232 TCHFVPSMLRVFLAEPA----AGSCASLRRVFCSGEALPPELAARFLAL-PG-AELH-NLYGPTEAAIDVTHWPVRGPAE 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 965 SLRAnsLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGkPGTRMYRTGDLARWRQ 1044
Cdd:cd17646 305 TPSV--PIGRPVPNTRLYVLDDALRPVPVGVPGELYLGGVQLARGYLGRPALTAERFVPDPFG-PGSRMYRTGDLARWRP 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1045 DGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASN-NETIDTNEMRQHASGSLP 1123
Cdd:cd17646 382 DGALEFLGRSDDQVKIRGFRVEPGEIEAALAAHPAVTHAVVVARAAPAGAARLVGYVVPAAgAAGPDTAALRAHLAERLP 461
|
490 500
....*....|....*....|....*..
gi 1698252301 1124 DYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd17646 462 EYMVPAAFVVLDALPLTANGKLDRAAL 488
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
657-1150 |
3.74e-176 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 534.56 E-value: 3.74e-176
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFML 736
Cdd:cd12116 1 PDATAVRDDDRSLSYAELDERANRLAARLRARGVGPGDRVAVYLPRSARLVAAMLAVLKAGAAYVPLDPDYPADRLRYIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 737 HDAKPSCVLTNSsveiECDESLKILVDDVNVMEEIEKYSEENIDEmeclkPLAPSHIAYVIYTSGSTGRPKGVMIPHQNV 816
Cdd:cd12116 81 EDAEPALVLTDD----ALPDRLPAGLPVLLLALAAAAAAPAAPRT-----PVSPDDLAYVIYTSGSTGRPKGVVVSHRNL 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 817 VRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQL 896
Cdd:cd12116 152 VNFLHSMRERLGLGPGDRLLAVTTYAFDISLLELLLPLLAGARVVIAPRETQRDPEALARLIEAHSITVMQATPATWRML 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 897 MQADRENEEvgqklSLRYVVfGGEALELSRLEDWYSRhphnAPKVINMYGITETTVHVSYIELDESIVSLRanslIGCSI 976
Cdd:cd12116 232 LDAGWQGRA-----GLTALC-GGEALPPDLAARLLSR----VGSLWNLYGPTETTIWSTAARVTAAAGPIP----IGRPL 297
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 977 PDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPGTRMYRTGDLARWRQDGTLDYIGRADH 1056
Cdd:cd12116 298 ANTQVYVLDAALRPVPPGVPGELYIGGDGVAQGYLGRPALTAERFVPDPFAGPGSRLYRTGDLVRRRADGRLEYLGRADG 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1057 QIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDqPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNE 1136
Cdd:cd12116 378 QVKIRGHRIELGEIEAALAAHPGVAQAAVVVRED-GGDRRLVAYVVLKAGAAPDAAALRAHLRATLPAYMVPSAFVRLDA 456
|
490
....*....|....
gi 1698252301 1137 LPLTPNGKLDRKAL 1150
Cdd:cd12116 457 LPLTANGKLDRKAL 470
|
|
| LCL_NRPS-like |
cd19531 |
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar ... |
179-611 |
1.29e-172 |
|
LCL-type Condensation (C) domain of non-ribosomal peptide synthetases(NRPSs) and similar domains including the C-domain of SgcC5, a free-standing NRPS with both ester- and amide- bond forming activity; LCL-type Condensation (C) domains catalyze peptide bond formation between two L-amino acids, ((L)C(L)). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). In addition to the LCL-type, there are various subtypes of C-domains such as the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. Streptomyces globisporus SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. An HHxx[SAG]DGxSx(6)[ED] motif is characteristic of LCL-type C-domains.
Pssm-ID: 380454 [Multi-domain] Cd Length: 427 Bit Score: 523.46 E-value: 1.29e-172
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 179 EVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKILDMENLNLEM 258
Cdd:cd19531 1 PLPLSFAQQRLWFLDQLEPGSAAYNIPGALRLRGPLDVAALERALNELVARHEALRTTFVEVDGEPVQVILPPLPLPLPV 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 259 V-----ITNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQG 333
Cdd:cd19531 81 VdlsglPEAEREAEAQRLAREEARRPFDLARGPLLRATLLRLGEDEHVLLLTMHHIVSDGWSMGVLLRELAALYAAFLAG 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 334 DRVQLETLPVQYADYALWQQQLLGDETtpeslISTQLDFWKEELKGLPDQMELPTDYQRPVETSYRGETIHFHIDEGMHS 413
Cdd:cd19531 161 RPSPLPPLPIQYADYAVWQREWLQGEV-----LERQLAYWREQLAGAPPVLELPTDRPRPAVQSFRGARVRFTLPAELTA 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 414 RLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSGDPSFKELLNRVKQ 493
Cdd:cd19531 236 ALRALARREGATLFMTLLAAFQVLLHRYSGQDDIVVGTPVAGRNRAELEGLIGFFVNTLVLRTDLSGDPTFRELLARVRE 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 494 VNLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQNTPEATFNAPDLEASLEIQSVGSAKFDLTFEISEsnevdgT 573
Cdd:cd19531 316 TALEAYAHQDLPFEKLVEALQPERDLSRSPLFQVMFVLQNAPAAALELPGLTVEPLEVDSGTAKFDLTLSLTE------T 389
|
410 420 430
....*....|....*....|....*....|....*...
gi 1698252301 574 PNGLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNP 611
Cdd:cd19531 390 DGGLRGSLEYNTDLFDAATIERMAGHFQTLLEAIVADP 427
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
644-1151 |
3.49e-170 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 518.91 E-value: 3.49e-170
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 644 TLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPL 723
Cdd:cd17644 1 CIHQLFEEQVERTPDAVAVVFEDQQLTYEELNTKANQLAHYLQSLGVKSESLVGICVERSLEMIIGLLAILKAGGAYVPL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 724 DPDYPSDRISFMLHDAKPSCVLTNssveiecdeslkilvddvnvmeeiekyseenidemeclkplaPSHIAYVIYTSGST 803
Cdd:cd17644 81 DPNYPQERLTYILEDAQISVLLTQ------------------------------------------PENLAYVIYTSGST 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 804 GRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKV 883
Cdd:cd17644 119 GKPKGVMIEHQSLVNLSHGLIKEYGITSSDRVLQFASIAFDVAAEEIYVTLLSGATLVLRPEEMRSSLEDFVQYIQQWQL 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 884 TVLNQTPsAFYQLMQADRENEEVGQKLSLRYVVFGGEALELSRLEDWYsRHPHNAPKVINMYGITETTVHVSYIELDESI 963
Cdd:cd17644 199 TVLSLPP-AYWHLLVLELLLSTIDLPSSLRLVIVGGEAVQPELVRQWQ-KNVGNFIQLINVYGPTEATIAATVCRLTQLT 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 964 VSLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPF-GKPGTRMYRTGDLARW 1042
Cdd:cd17644 277 ERNITSVPIGRPIANTQVYILDENLQPVPVGVPGELHIGGVGLARGYLNRPELTAEKFISHPFnSSESERLYKTGDLARY 356
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1043 RQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSL 1122
Cdd:cd17644 357 LPDGNIEYLGRIDNQVKIRGFRIELGEIEAVLSQHNDVKTAVVIVREDQPGNKRLVAYIVPHYEESPSTVELRQFLKAKL 436
|
490 500
....*....|....*....|....*....
gi 1698252301 1123 PDYMVPYAFVVVNELPLTPNGKLDRKALP 1151
Cdd:cd17644 437 PDYMIPSAFVVLEELPLTPNGKIDRRALP 465
|
|
| AA-adenyl-dom |
TIGR01733 |
amino acid adenylation domain; This model represents a domain responsible for the specific ... |
670-1085 |
1.87e-169 |
|
amino acid adenylation domain; This model represents a domain responsible for the specific recognition of amino acids and activation as adenylyl amino acids. The reaction catalyzed is aa + ATP -> aa-AMP + PPi. These domains are usually found as components of multi-domain non-ribosomal peptide synthetases and are usually called "A-domains" in that context. A-domains are almost invariably followed by "T-domains" (thiolation domains, pfam00550) to which the amino acid adenylate is transferred as a thiol-ester to a bound pantetheine cofactor with the release of AMP (these are also called peptide carrier proteins, or PCPs. When the A-domain does not represent the first module (corresponding to the first amino acid in the product molecule) it is usually preceded by a "C-domain" (condensation domain, pfam00668) which catalyzes the ligation of two amino acid thiol-esters from neighboring modules. This domain is a subset of the AMP-binding domain found in Pfam (pfam00501) which also hits substrate--CoA ligases and luciferases. Sequences scoring in between trusted and noise for this model may be ambiguous as to whether they activate amino acids or other molecules lacking an alpha amino group.
Pssm-ID: 273779 [Multi-domain] Cd Length: 409 Bit Score: 514.51 E-value: 1.87e-169
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 670 TYEKLNRKANKIARFLIA-KGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNS 748
Cdd:TIGR01733 1 TYRELDERANRLARHLRAaGGVGPGDRVAVLLERSAELVVAILAVLKAGAAYVPLDPAYPAERLAFILEDAGARLLLTDS 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 749 SVEIECDESLKILVDDVNVMEEiekYSEENIDEMECLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQ 828
Cdd:TIGR01733 81 ALASRLAGLVLPVILLDPLELA---ALDDAPAPPPPDAPSGPDDLAYVIYTSGSTGRPKGVVVTHRSLVNLLAWLARRYG 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 829 FDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKE-KVTVLNQTPSAFYQLMQADREneevg 907
Cdd:TIGR01733 158 LDPDDRVLQFASLSFDASVEEIFGALLAGATLVVPPEDEERDDAALLAALIAEhPVTVLNLTPSLLALLAAALPP----- 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 908 QKLSLRYVVFGGEALELSRLEDWYSRHPhnAPKVINMYGITETTVHVSYIELDESIVSLRANSLIGCSIPDLKVYVLDNY 987
Cdd:TIGR01733 233 ALASLRLVILGGEALTPALVDRWRARGP--GARLINLYGPTETTVWSTATLVDPDDAPRESPVPIGRPLANTRLYVLDDD 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 988 LQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPF-GKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIE 1066
Cdd:TIGR01733 311 LRPVPVGVVGELYIGGPGVARGYLNRPELTAERFVPDPFaGGDGARLYRTGDLVRYLPDGNLEFLGRIDDQVKIRGYRIE 390
|
410
....*....|....*....
gi 1698252301 1067 LGEIEAVIMKHDKVEQVAV 1085
Cdd:TIGR01733 391 LGEIEAALLRHPGVREAVV 409
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
657-1151 |
3.82e-158 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 486.49 E-value: 3.82e-158
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFML 736
Cdd:cd17649 1 PDAVALVFGDQSLSYAELDARANRLAHRLRALGVGPEVRVGIALERSLEMVVALLAILKAGGAYVPLDPEYPAERLRYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 737 HDAKPSCVLTNssveiecdeslkilvddvnvmeeiekyseenidemeclkplAPSHIAYVIYTSGSTGRPKGVMIPHQNV 816
Cdd:cd17649 81 EDSGAGLLLTH-----------------------------------------HPRQLAYVIYTSGSTGTPKGVAVSHGPL 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 817 VRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQL 896
Cdd:cd17649 120 AAHCQATAERYGLTPGDRELQFASFNFDGAHEQLLPPLICGACVVLRPDELWASADELAEMVRELGVTVLDLPPAYLQQL 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 897 MQaDRENEEVGQKLSLRYVVFGGEALELSRLEDWYSRHPhnapKVINMYGITETTVHVSYIELDESIVSLRANSLIGCSI 976
Cdd:cd17649 200 AE-EADRTGDGRPPSLRLYIFGGEALSPELLRRWLKAPV----RLFNAYGPTEATVTPLVWKCEAGAARAGASMPIGRPL 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 977 PDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPGTRMYRTGDLARWRQDGTLDYIGRADH 1056
Cdd:cd17649 275 GGRSAYILDADLNPVPVGVTGELYIGGEGLARGYLGRPELTAERFVPDPFGAPGSRLYRTGDLARWRDDGVIEYLGRVDH 354
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1057 QIKIRGFRIELGEIEAVIMKHDKVEQVAVIVReDQPGDKRLVAYIV--ASNNETIDTNEMRQHASGSLPDYMVPYAFVVV 1134
Cdd:cd17649 355 QVKIRGFRIELGEIEAALLEHPGVREAAVVAL-DGAGGKQLVAYVVlrAAAAQPELRAQLRTALRASLPDYMVPAHLVFL 433
|
490
....*....|....*..
gi 1698252301 1135 NELPLTPNGKLDRKALP 1151
Cdd:cd17649 434 ARLPLTPNGKLDRKALP 450
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
645-1150 |
7.34e-156 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 480.28 E-value: 7.34e-156
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 645 LPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLD 724
Cdd:cd12115 1 LHDLVEAQAARTPDAIALVCGDESLTYAELNRRANRLAARLRAAGVGPESRVGVCLERTPDLVVALLAVLKAGAAYVPLD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 725 PDYPSDRISFMLHDAKPSCVLTNssveiecdeslkilvddvnvmeeiekyseenidemeclkplaPSHIAYVIYTSGSTG 804
Cdd:cd12115 81 PAYPPERLRFILEDAQARLVLTD------------------------------------------PDDLAYVIYTSGSTG 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 805 RPKGVMIPHQNVVRLLGATDHwfQFDADDVWTMFH--SYAFDFSVWEIWGPLLYGGRLVVVphtvsRSPKEFLQLLVKEK 882
Cdd:cd12115 119 RPKGVAIEHRNAAAFLQWAAA--AFSAEELAGVLAstSICFDLSVFELFGPLATGGKVVLA-----DNVLALPDLPAAAE 191
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 883 VTVLNQTPSAFYQLMQADreneevGQKLSLRYVVFGGEALELSRLEDWYSRHPhnAPKVINMYGITETTVHVSYIELDES 962
Cdd:cd12115 192 VTLINTVPSAAAELLRHD------ALPASVRVVNLAGEPLPRDLVQRLYARLQ--VERVVNLYGPSEDTTYSTVAPVPPG 263
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 963 ivSLRANSlIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGkPGTRMYRTGDLARW 1042
Cdd:cd12115 264 --ASGEVS-IGRPLANTQAYVLDRALQPVPLGVPGELYIGGAGVARGYLGRPGLTAERFLPDPFG-PGARLYRTGDLVRW 339
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1043 RQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSL 1122
Cdd:cd12115 340 RPDGLLEFLGRADNQVKVRGFRIELGEIEAALRSIPGVREAVVVAIGDAAGERRLVAYIVAEPGAAGLVEDLRRHLGTRL 419
|
490 500
....*....|....*....|....*...
gi 1698252301 1123 PDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd12115 420 PAYMVPSRFVRLDALPLTPNGKIDRSAL 447
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
181-1244 |
2.94e-153 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 518.95 E-value: 2.94e-153
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 181 PLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKILD------MENL 254
Cdd:PRK05691 3259 PLTPMQEGLLLHTLLEPGTGLYYMQDRYRINSALDPERFAQAWQAVVARHEALRASFSWNAGETMLQVIHkpgrtpIDYL 3338
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 255 NLEMVITNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQGD 334
Cdd:PRK05691 3339 DWRGLPEDGQEQRLQALHKQEREAGFDLLNQPPFHLRLIRVDEARYWFMMSNHHILIDAWCRSLLMNDFFEIYTALGEGR 3418
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 335 RVQLETLPvQYADYALW-QQQLLGDETtpeslistqlDFWKEELKGLPDQMELPTDyqRPVETSYRGETI-------HFH 406
Cdd:PRK05691 3419 EAQLPVPP-RYRDYIGWlQRQDLAQAR----------QWWQDNLRGFERPTPIPSD--RPFLREHAGDSGgmvvgdcYTR 3485
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 407 IDEGMHSRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDV--LSDIVGLFVNTLVLRTNTSGDP-- 482
Cdd:PRK05691 3486 LDAADGARLRELAQAHQLTVNTFAQAAWALVLRRYSGDRDVLFGVTVAGRPVSMpqMQRTVGLFINSIALRVQLPAAGqr 3565
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 483 -SFKELLNRVKQVNLAAYENQDVPferLVEVLNPVRTRNSHPLFQVMLAFQNTPEATF---NAPDLEASLEiQSVGSAKF 558
Cdd:PRK05691 3566 cSVRQWLQGLLDSNMELREYEYLP---LVAIQECSELPKGQPLFDSLFVFENAPVEVSvldRAQSLNASSD-SGRTHTNF 3641
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 559 DLTFEISESNEVdgtpnGLHglLEFSTDLYKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVAEKNTVLEKWNGGFQ 638
Cdd:PRK05691 3642 PLTAVCYPGDDL-----GLH--LSYDQRYFDAPTVERLLGEFKRLLLALVQGFHGDLSELPLLGEQERDFLLDGCNRSER 3714
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 639 IAP-EMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAG 717
Cdd:PRK05691 3715 DYPlEQSYVRLFEAQVAAHPQRIAASCLDQQWSYAELNRAANRLGHALRAAGVGVDQPVALLAERGLDLLGMIVGSFKAG 3794
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 718 AGYLPLDPDYPSDRISFMLHDAK-PSCVLTNSsveieCDESLKILVDDVN--------VMEEIEkysEENIDEMECLKPL 788
Cdd:PRK05691 3795 AGYLPLDPGLPAQRLQRIIELSRtPVLVCSAA-----CREQARALLDELGcanrprllVWEEVQ---AGEVASHNPGIYS 3866
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 789 APSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVS 868
Cdd:PRK05691 3867 GPDNLAYVIYTSGSTGLPKGVMVEQRGMLNNQLSKVPYLALSEADVIAQTASQSFDISVWQFLAAPLFGARVEIVPNAIA 3946
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 869 RSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADReneevgQKL-SLRYVVFGGEAL--ELSRleDWYSRHPHNApkVINMY 945
Cdd:PRK05691 3947 HDPQGLLAHVQAQGITVLESVPSLIQGMLAEDR------QALdGLRWMLPTGEAMppELAR--QWLQRYPQIG--LVNAY 4016
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 946 GITETTVHVSYIELDESivSLRANSL-IGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIAD 1024
Cdd:PRK05691 4017 GPAECSDDVAFFRVDLA--STRGSYLpIGSPTDNNRLYLLDEALELVPLGAVGELCVAGTGVGRGYVGDPLRTALAFVPH 4094
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1025 PFGKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGdKRLVAYIVAS 1104
Cdd:PRK05691 4095 PFGAPGERLYRTGDLARRRSDGVLEYVGRIDHQVKIRGYRIELGEIEARLHEQAEVREAAVAVQEGVNG-KHLVGYLVPH 4173
|
970 980 990 1000 1010 1020 1030 1040
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1105 NNETIDT---NEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEF--IASSSSRGPRTPQEEMLCDLFTEV 1179
Cdd:PRK05691 4174 QTVLAQGallERIKQRLRAELPDYMVPLHWLWLDRLPLNANGKLDRKALPALDIgqLQSQAYLAPRNELEQTLATIWADV 4253
|
1050 1060 1070 1080 1090 1100
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1698252301 1180 LSVSQIGIDDGFFDLGGHSLLAVQLMSRMKEALGVELNIGTLFAAPTVAGLAERLEiGNGQSALD 1244
Cdd:PRK05691 4254 LKVERVGVHDNFFELGGHSLLATQIASRVQKALQRNVPLRAMFECSTVEELAEYIE-GLAGSAID 4317
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
657-1150 |
1.03e-142 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 444.99 E-value: 1.03e-142
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFML 736
Cdd:cd17650 1 PDAIAVSDATRQLTYRELNERANQLARTLRGLGVAPGSVVGVCADRSLDAIVGLLAVLKAGGAYVPIDPDYPAERLQYML 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 737 HDAKPSCVLTNssveiecdeslkilvddvnvmeeiekyseenidemeclkplaPSHIAYVIYTSGSTGRPKGVMIPHQNV 816
Cdd:cd17650 81 EDSGAKLLLTQ------------------------------------------PEDLAYVIYTSGTTGKPKGVMVEHRNV 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 817 VRLLGATDHWFQFDADDVWTM-FHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQ 895
Cdd:cd17650 119 AHAAHAWRREYELDSFPVRLLqMASFSFDVFAGDFARSLLNGGTLVICPDEVKLDPAALYDLILKSRITLMESTPALIRP 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 896 LMQADRENEEvgqKLS-LRYVVFGGEALELSRLEDWYSRHPHNApKVINMYGITETTVHVSYIELDESIVSLRANSLIGC 974
Cdd:cd17650 199 VMAYVYRNGL---DLSaMRLLIVGSDGCKAQDFKTLAARFGQGM-RIINSYGVTEATIDSTYYEEGRDPLGDSANVPIGR 274
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 975 SIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGkPGTRMYRTGDLARWRQDGTLDYIGRA 1054
Cdd:cd17650 275 PLPNTAMYVLDERLQPQPVGVAGELYIGGAGVARGYLNRPELTAERFVENPFA-PGERMYRTGDLARWRADGNVELLGRV 353
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1055 DHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASnnETIDTNEMRQHASGSLPDYMVPYAFVVV 1134
Cdd:cd17650 354 DHQVKIRGFRIELGEIESQLARHPAIDEAVVAVREDKGGEARLCAYVVAA--ATLNTAELRAFLAKELPSYMIPSYYVQL 431
|
490
....*....|....*.
gi 1698252301 1135 NELPLTPNGKLDRKAL 1150
Cdd:cd17650 432 DALPLTPNGKVDRRAL 447
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
645-1150 |
6.78e-131 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 414.63 E-value: 6.78e-131
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 645 LPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLD 724
Cdd:cd05918 1 VHDLIEERARSQPDAPAVCAWDGSLTYAELDRLSSRLAHHLRSLGVGPGVFVPLCFEKSKWAVVAMLAVLKAGGAFVPLD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 725 PDYPSDRISFMLHDAKPSCVLTNSsveiecdeslkilvddvnvmeeiekyseenidemeclkplaPSHIAYVIYTSGSTG 804
Cdd:cd05918 81 PSHPLQRLQEILQDTGAKVVLTSS-----------------------------------------PSDAAYVIFTSGSTG 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 805 RPKGVMIPHQNVV-------RLLGATDH--WFQFdAddvwtmfhSYAFDFSVWEIWGPLLYGGrLVVVPHTVSRspKEFL 875
Cdd:cd05918 120 KPKGVVIEHRALStsalahgRALGLTSEsrVLQF-A--------SYTFDVSILEIFTTLAAGG-CLCIPSEEDR--LNDL 187
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 876 Q-LLVKEKVTVLNQTPSAFYQLmqadrENEEVgqkLSLRYVVFGGEALELSRLEDWYSRhphnaPKVINMYGITETTVHV 954
Cdd:cd05918 188 AgFINRLRVTWAFLTPSVARLL-----DPEDV---PSLRTLVLGGEALTQSDVDTWADR-----VRLINAYGPAECTIAA 254
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 955 SYieldeSIVSLRAN-SLIGCSIPDLkVYVLD--NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPF----- 1026
Cdd:cd05918 255 TV-----SPVVPSTDpRNIGRPLGAT-CWVVDpdNHDRLVPIGAVGELLIEGPILARGYLNDPEKTAAAFIEDPAwlkqe 328
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1027 -GKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKH---DKVEQVAVIVREDQPGDKRLVAYIV 1102
Cdd:cd05918 329 gSGRGRRLYRTGDLVRYNPDGSLEYVGRKDTQVKIRGQRVELGEIEHHLRQSlpgAKEVVVEVVKPKDGSSSPQLVAFVV 408
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1698252301 1103 ASNNETIDTN-----------------EMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05918 409 LDGSSSGSGDgdslflepsdefralvaELRSKLRQRLPSYMVPSVFLPLSHLPLTASGKIDRRAL 473
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
657-1151 |
9.54e-130 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 411.48 E-value: 9.54e-130
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFML 736
Cdd:cd17656 2 PDAVAVVFENQKLTYRELNERSNQLARFLREKGVKKDSIVAIMMERSAEMIVGILGILKAGGAFVPIDPEYPEERRIYIM 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 737 HDAKPSCVLTNSS--VEIECDESLKILVDDVnvmeeIEKYSEENIDEMeclkpLAPSHIAYVIYTSGSTGRPKGVMIPHQ 814
Cdd:cd17656 82 LDSGVRVVLTQRHlkSKLSFNKSTILLEDPS-----ISQEDTSNIDYI-----NNSDDLLYIIYTSGTTGKPKGVQLEHK 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 815 NVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNqTPSAFY 894
Cdd:cd17656 152 NMVNLLHFEREKTNINFSDKVLQFATCSFDVCYQEIFSTLLSGGTLYIIREETKRDVEQLFDLVKRHNIEVVF-LPVAFL 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 895 QLMQADRENEEVGQKlSLRYVVFGGEALELSRLEDWYsRHPHNApKVINMYGITETTVHVSY-IELDESIVSLRAnslIG 973
Cdd:cd17656 231 KFIFSEREFINRFPT-CVKHIITAGEQLVITNEFKEM-LHEHNV-HLHNHYGPSETHVVTTYtINPEAEIPELPP---IG 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 974 CSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgKPGTRMYRTGDLARWRQDGTLDYIGR 1053
Cdd:cd17656 305 KPISNTWIYILDQEQQLQPQGIVGELYISGASVARGYLNRQELTAEKFFPDPF-DPNERMYRTGDLARYLPDGNIEFLGR 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1054 ADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASnnETIDTNEMRQHASGSLPDYMVPYAFVV 1133
Cdd:cd17656 384 ADHQVKIRGYRIELGEIEAQLLNHPGVSEAVVLDKADDKGEKYLCAYFVME--QELNISQLREYLAKQLPEYMIPSFFVP 461
|
490
....*....|....*...
gi 1698252301 1134 VNELPLTPNGKLDRKALP 1151
Cdd:cd17656 462 LDQLPLTPNGKVDRKALP 479
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
657-1150 |
9.58e-130 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 411.28 E-value: 9.58e-130
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFML 736
Cdd:cd12114 1 PDATAVICGDGTLTYGELAERARRVAGALKAAGVRPGDLVAVTLPKGPEQVVAVLGILAAGAAYVPVDIDQPAARREAIL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 737 HDAKPSCVLTNSSVEIECDESLKILVDDVnvmeeiekySEENIDEMECLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNV 816
Cdd:cd12114 81 ADAGARLVLTDGPDAQLDVAVFDVLILDL---------DALAAPAPPPPVDVAPDDLAYVIFTSGSTGTPKGVMISHRAA 151
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 817 VRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQL 896
Cdd:cd12114 152 LNTILDINRRFAVGPDDRVLALSSLSFDLSVYDIFGALSAGATLVLPDEARRRDPAHWAELIERHGVTLWNSVPALLEML 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 897 MQADRENEEVGQklSLRYVVFGGEALELSRLEDWYSRHPHnaPKVINMYGITETTVHVSYIELDESIVSLRansligcSI 976
Cdd:cd12114 232 LDVLEAAQALLP--SLRLVLLSGDWIPLDLPARLRALAPD--ARLISLGGATEASIWSIYHPIDEVPPDWR-------SI 300
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 977 P------DLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPfgkPGTRMYRTGDLARWRQDGTLDY 1050
Cdd:cd12114 301 PygrplaNQRYRVLDPRGRDCPDWVPGELWIGGRGVALGYLGDPELTAARFVTHP---DGERLYRTGDLGRYRPDGTLEF 377
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1051 IGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVReDQPGDKRLVAYIVASN-NETIDTNEMRQHASGSLPDYMVPY 1129
Cdd:cd12114 378 LGRRDGQVKVRGYRIELGEIEAALQAHPGVARAVVVVL-GDPGGKRLAAFVVPDNdGTPIAPDALRAFLAQTLPAYMIPS 456
|
490 500
....*....|....*....|.
gi 1698252301 1130 AFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd12114 457 RVIALEALPLTANGKVDRAAL 477
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
647-1151 |
5.39e-129 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 408.10 E-value: 5.39e-129
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 647 QLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPD 726
Cdd:cd17645 2 QLFEEQVERTPDHVAVVDRGQSLTYKQLNEKANQLARHLRGKGVKPDDQVGIMLDKSLDMIAAILGVLKAGGAYVPIDPD 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 727 YPSDRISFMLHDAKPSCVLTNssveiecdeslkilvddvnvmeeiekyseenidemeclkplaPSHIAYVIYTSGSTGRP 806
Cdd:cd17645 82 YPGERIAYMLADSSAKILLTN------------------------------------------PDDLAYVIYTSGSTGLP 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 807 KGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVL 886
Cdd:cd17645 120 KGVMIEHHNLVNLCEWHRPYFGVTPADKSLVYASFSFDASAWEIFPHLTAGAALHVVPSERRLDLDALNDYFNQEGITIS 199
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 887 NQTPSAFYQLMQADREneevgqklSLRYVVFGGEALElsrledwysRHPHNAPKVINMYGITETTVHVSYIELDESivsl 966
Cdd:cd17645 200 FLPTGAAEQFMQLDNQ--------SLRVLLTGGDKLK---------KIERKGYKLVNNYGPTENTVVATSFEIDKP---- 258
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 967 RANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgKPGTRMYRTGDLARWRQDG 1046
Cdd:cd17645 259 YANIPIGKPIDNTRVYILDEALQLQPIGVAGELCIAGEGLARGYLNRPELTAEKFIVHPF-VPGERMYRTGDLAKFLPDG 337
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1047 TLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASnnETIDTNEMRQHASGSLPDYM 1126
Cdd:cd17645 338 NIEFLGRLDQQVKIRGYRIEPGEIEPFLMNHPLIELAAVLAKEDADGRKYLVAYVTAP--EEIPHEELREWLKNDLPDYM 415
|
490 500
....*....|....*....|....*
gi 1698252301 1127 VPYAFVVVNELPLTPNGKLDRKALP 1151
Cdd:cd17645 416 IPTYFVHLKALPLTANGKVDRKALP 440
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
647-1150 |
2.74e-128 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 405.54 E-value: 2.74e-128
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 647 QLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPD 726
Cdd:cd17653 1 DAFERIAAAHPDAVAVESLGGSLTYGELDAASNALANRLLQLGVVPGDVVPLLSDRSLEMLVAILAILKAGAAYVPLDAK 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 727 YPSDRISFMLHDAKPSCVLTNSSVeiecdeslkilvDDVnvmeeiekyseenidemeclkplapshiAYVIYTSGSTGRP 806
Cdd:cd17653 81 LPSARIQAILRTSGATLLLTTDSP------------DDL----------------------------AYIIFTSGSTGIP 120
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 807 KGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVvphtvsRSPKEFLQLLVKEkVTVL 886
Cdd:cd17653 121 KGVMVPHRGVLNYVSQPPARLDVGPGSRVAQVLSIAFDACIGEIFSTLCNGGTLVL------ADPSDPFAHVART-VDAL 193
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 887 NQTPSAFYQLMQADRENeevgqklsLRYVVFGGEALELSRLEDWYSRhphnaPKVINMYGITETTVHVSYIELdesivSL 966
Cdd:cd17653 194 MSTPSILSTLSPQDFPN--------LKTIFLGGEAVPPSLLDRWSPG-----RRLYNAYGPTECTISSTMTEL-----LP 255
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 967 RANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGkPGTRMYRTGDLARWRQDG 1046
Cdd:cd17653 256 GQPVTIGKPIPNSTCYILDADLQPVPEGVVGEICISGVQVARGYLGNPALTASKFVPDPFW-PGSRMYRTGDYGRWTEDG 334
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1047 TLDYIGRADHQIKIRGFRIELGEIEAVIMKHD-KVEQVAVIVREDqpgdkRLVAYIVAsnnETIDTNEMRQHASGSLPDY 1125
Cdd:cd17653 335 GLEFLGREDNQVKVRGFRINLEEIEEVVLQSQpEVTQAAAIVVNG-----RLVAFVTP---ETVDVDGLRSELAKHLPSY 406
|
490 500
....*....|....*....|....*
gi 1698252301 1126 MVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd17653 407 AVPDRIIALDSFPLTANGKVDRKAL 431
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
657-1151 |
6.42e-127 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 402.93 E-value: 6.42e-127
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVG-PDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFM 735
Cdd:cd17648 1 PDRVAVVYGDKRLTYRELNERANRLAHYLLSVAEIrPDDLVGLVLDKSELMIIAILAVWKAGAAYVPIDPSYPDERIQFI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 736 LHDAKPSCVLTNssveiecdeslkilvddvnvmeeiekyseenidemeclkplaPSHIAYVIYTSGSTGRPKGVMIPHQN 815
Cdd:cd17648 81 LEDTGARVVITN------------------------------------------STDLAYAIYTSGTTGKPKGVLVEHGS 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 816 VVRLLGATDHWFQFDA--DDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAF 893
Cdd:cd17648 119 VVNLRTSLSERYFGRDngDEAVLFFSNYVFDFFVEQMTLALLNGQKLVVPPDEMRFDPDRFYAYINREKVTYLSGTPSVL 198
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 894 YQLmqadreneEVGQKLSLRYVVFGGEALELSRLEDWYSRHPHnapKVINMYGITETTV--HVSYIELDEsivslRANSL 971
Cdd:cd17648 199 QQY--------DLARLPHLKRVDAAGEEFTAPVFEKLRSRFAG---LIINAYGPTETTVtnHKRFFPGDQ-----RFDKS 262
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 972 IGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPG-------TRMYRTGDLARWRQ 1044
Cdd:cd17648 263 LGRPVRNTKCYVLNDAMKRVPVGAVGELYLGGDGVARGYLNRPELTAERFLPNPFQTEQerargrnARLYKTGDLVRWLP 342
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1045 DGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVRED-----QPGDKRLVAYIVaSNNETIDTNEMRQHAS 1119
Cdd:cd17648 343 SGELEYLGRNDFQVKIRGQRIEPGEVEAALASYPGVRECAVVAKEDasqaqSRIQKYLVGYYL-PEPGHVPESDLLSFLR 421
|
490 500 510
....*....|....*....|....*....|..
gi 1698252301 1120 GSLPDYMVPYAFVVVNELPLTPNGKLDRKALP 1151
Cdd:cd17648 422 AKLPRYMVPARLVRLEGIPVTINGKLDVRALP 453
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
656-1150 |
2.40e-124 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 395.46 E-value: 2.40e-124
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 656 NPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFM 735
Cdd:cd05945 4 NPDRPAVVEGGRTLTYRELKERADALAAALASLGLDAGDPVVVYGHKSPDAIAAFLAALKAGHAYVPLDASSPAERIREI 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 736 LHDAKPSCVLTnssveiecdeslkilvddvnvmeeiekyseenidemeclkplAPSHIAYVIYTSGSTGRPKGVMIPHQN 815
Cdd:cd05945 84 LDAAKPALLIA------------------------------------------DGDDNAYIIFTSGSTGRPKGVQISHDN 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 816 VVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQ 895
Cdd:cd05945 122 LVSFTNWMLSDFPLGPGDVFLNQAPFSFDLSVMDLYPALASGATLVPVPRDATADPKQLFRFLAEHGITVWVSTPSFAAM 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 896 LMQADRENEEVGQklSLRYVVFGGEALELSRLEDWYSRHPhnAPKVINMYGITETTVHVSYIELDESIVSlRANSL-IGC 974
Cdd:cd05945 202 CLLSPTFTPESLP--SLRHFLFCGEVLPHKTARALQQRFP--DARIYNTYGPTEATVAVTYIEVTPEVLD-GYDRLpIGY 276
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 975 SIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFiadpFGKPGTRMYRTGDLARWRQDGTLDYIGRA 1054
Cdd:cd05945 277 AKPGAKLVILDEDGRPVPPGEKGELVISGPSVSKGYLNNPEKTAAAF----FPDEGQRAYRTGDLVRLEADGLLFYRGRL 352
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1055 DHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNN-ETIDTNEMRQHASGSLPDYMVPYAFVV 1133
Cdd:cd05945 353 DFQVKLNGYRIELEEIEAALRQVPGVKEAVVVPKYKGEKVTELIAFVVPKPGaEAGLTKAIKAELAERLPPYMIPRRFVY 432
|
490
....*....|....*..
gi 1698252301 1134 VNELPLTPNGKLDRKAL 1150
Cdd:cd05945 433 LDELPLNANGKIDRKAL 449
|
|
| AMP-binding |
pfam00501 |
AMP-binding enzyme; |
649-1061 |
4.32e-123 |
|
AMP-binding enzyme;
Pssm-ID: 459834 [Multi-domain] Cd Length: 417 Bit Score: 390.91 E-value: 4.32e-123
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 649 FEKQAHINPNSIAV-VFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDY 727
Cdd:pfam00501 1 LERQAARTPDKTALeVGEGRRLTYRELDERANRLAAGLRALGVGKGDRVAILLPNSPEWVVAFLACLKAGAVYVPLNPRL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 728 PSDRISFMLHDAKPSCVLTNSSVEIE---------CDESLKILVDDVNVMEEIEKYSEENIDEM--ECLKPLAPSHIAYV 796
Cdd:pfam00501 81 PAEELAYILEDSGAKVLITDDALKLEellealgklEVVKLVLVLDRDPVLKEEPLPEEAKPADVppPPPPPPDPDDLAYI 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 797 IYTSGSTGRPKGVMIPHQNVVRLLGA----TDHWFQFDADDVWTMFHSYAFDFSV-WEIWGPLLYGGRLVVVPHTVSRSP 871
Cdd:pfam00501 161 IYTSGTTGKPKGVMLTHRNLVANVLSikrvRPRGFGLGPDDRVLSTLPLFHDFGLsLGLLGPLLAGATVVLPPGFPALDP 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 872 KEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEvgQKLSLRYVVFGGEALELSRLEDWYSRHPhnaPKVINMYGITETT 951
Cdd:pfam00501 241 AALLELIERYKVTVLYGVPTLLNMLLEAGAPKRA--LLSSLRLVLSGGAPLPPELARRFRELFG---GALVNGYGLTETT 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 952 VHVSYIELDEsiVSLRANSLIGCSIPDLKVYVLD-NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADpfgkpg 1030
Cdd:pfam00501 316 GVVTTPLPLD--EDLRSLGSVGRPLPGTEVKIVDdETGEPVPPGEPGELCVRGPGVMKGYLNDPELTAEAFDED------ 387
|
410 420 430
....*....|....*....|....*....|.
gi 1698252301 1031 tRMYRTGDLARWRQDGTLDYIGRADHQIKIR 1061
Cdd:pfam00501 388 -GWYRTGDLGRRDEDGYLEIVGRKKDQIKLG 417
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
645-1152 |
2.02e-119 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 382.24 E-value: 2.02e-119
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 645 LPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLD 724
Cdd:COG0318 1 LADLLRRAAARHPDRPALVFGGRRLTYAELDARARRLAAALRALGVGPGDRVALLLPNSPEFVVAFLAALRAGAVVVPLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 725 PDYPSDRISFMLHDAKPSCVLTnssveiecdeslkilvddvnvmeeiekyseenidemeclkplapshiAYVIYTSGSTG 804
Cdd:COG0318 81 PRLTAEELAYILEDSGARALVT-----------------------------------------------ALILYTSGTTG 113
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 805 RPKGVMIPHQNVVRLLGATDHWFQFDADDVW----TMFHSYAFdfsVWEIWGPLLYGGRLVVVPHtvsRSPKEFLQLLVK 880
Cdd:COG0318 114 RPKGVMLTHRNLLANAAAIAAALGLTPGDVVlvalPLFHVFGL---TVGLLAPLLAGATLVLLPR---FDPERVLELIER 187
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 881 EKVTVLNQTPSAFYQLMQADRENEEvgqKLS-LRYVVFGGEALELSRLEDWYSRHphnAPKVINMYGITETTVHVSYIEL 959
Cdd:COG0318 188 ERVTVLFGVPTMLARLLRHPEFARY---DLSsLRLVVSGGAPLPPELLERFEERF---GVRIVEGYGLTETSPVVTVNPE 261
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 960 DESivsLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFiADPFgkpgtrmYRTGDL 1039
Cdd:COG0318 262 DPG---ERRPGSVGRPLPGVEVRIVDEDGRELPPGEVGEIVVRGPNVMKGYWNDPEATAEAF-RDGW-------LRTGDL 330
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1040 ARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHAS 1119
Cdd:COG0318 331 GRLDEDGYLYIVGRKKDMIISGGENVYPAEVEEVLAAHPGVAEAAVVGVPDEKWGERVVAFVVLRPGAELDAEELRAFLR 410
|
490 500 510
....*....|....*....|....*....|...
gi 1698252301 1120 GSLPDYMVPYAFVVVNELPLTPNGKLDRKALPA 1152
Cdd:COG0318 411 ERLARYKVPRRVEFVDELPRTASGKIDRRALRE 443
|
|
| EntF2 |
COG3319 |
Thioesterase domain of type I polyketide synthase or non-ribosomal peptide synthetase ... |
689-1501 |
2.55e-118 |
|
Thioesterase domain of type I polyketide synthase or non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442548 [Multi-domain] Cd Length: 855 Bit Score: 392.91 E-value: 2.55e-118
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 689 GVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTnssVEIECDESLKILVDDVNVM 768
Cdd:COG3319 47 LVALAALALAALALAALLAVALLAAALALAALAALAALALALAAAAAALLLAALALLL---ALLAALALALLALLLAALL 123
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 769 EEIEKYSEENIDEMECLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVW 848
Cdd:COG3319 124 LALAALAAAAAAAALAAAAAAAAALAAAAGLGGGGGGAGVLVLVLAALLALLLAALLALALALAALLLLALAAALALALL 203
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 849 EIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVkekvtvlnqTPSAFYQLMQADRENEEVGQKLSLRYVVFGGEALELSRLE 928
Cdd:COG3319 204 LLLALLLLLLLLLALLLLLLLALLAAAALLA---------LLLALLLLLLAALLLLLALALLLLLALLLLLGLLALLLAL 274
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 929 DWYSRHPHNAPKVINMYGITETTVHVSYIELDESIVSLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLAR 1008
Cdd:COG3319 275 LLLLALLLLAAAAALAAGGTATTAAVTTTAAAAAPGVAGALGPIGGGPGLLVLLVLLVLLLPLLLGVGGGGGGGGGGGGA 354
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1009 GYLGRAGLTAERFIADPFGKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVR 1088
Cdd:COG3319 355 GGLAGRGLRAAAALRDPAGAGARGRLRRGGDRGRRLGGGLLLGLGRLRLQRLRRGLREELEEAEAALAEAAAVAAAVAAA 434
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1089 EDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEFIASSSSRGPRTPQ 1168
Cdd:COG3319 435 AAAAAAAAALAAAVVAAAALAAAALLLLLLLLLLPPPLPPALLLLLLLLLLLLLAALLLAAAAPAAAAAAAAAPAPAAAL 514
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1169 EEMLCDLFTEVLSVSQIGIDDGFFDLGGHSLLAVQLMSRMKEALGVELNIGTLFAAPTVAGLAERLEIGNGQSALDVLLP 1248
Cdd:COG3319 515 ELALALLLLLLLGLGLVGDDDDFFGGGGGSLLALLLLLLLLALLLRLLLLLALLLAPTLAALAAALAAAAAAAALSPLVP 594
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1249 LRASGDQLPLFCVHPAGGLSWCYAGLMKSLGTDYPIYGVQARGIAENEELPKSLEEMAADYLKHVREIQPHGPYRLLGWS 1328
Cdd:COG3319 595 LRAGGSGPPLFCVHPAGGNVLCYRPLARALGPDRPVYGLQAPGLDGGEPPPASVEEMAARYVEAIRAVQPEGPYHLLGWS 674
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1329 LGGNVVHAMAAQLQNEGEEVELLVMLDSY-PGHFLPNTEAPTEEEALIALLALGGYDPDNMDGKPLT----MESAVEILR 1403
Cdd:COG3319 675 FGGLVAYEMARQLEAQGEEVALLVLLDSYaPGALARLDEAELLAALLRDLARGVDLPLDAEELRALDpeerLARLLERLR 754
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1404 KDGsALASLEEETILNLKETYVNSVGLLGKYVPKVYNGDILFFRSTVIPDWFDPISPNTWLNYLDGDIVQHDIDCRHKDL 1483
Cdd:COG3319 755 EAG-LPAGLDAERLRRLLRVFRANLRALRRYRPRPYDGPVLLFRAEEDPPGRADDPALGWRPLVAGGLEVHDVPGDHFSM 833
|
810
....*....|....*...
gi 1698252301 1484 CQPGPLTEIGQVLAKYLQ 1501
Cdd:COG3319 834 LREPHVAELAAALRAALA 851
|
|
| X-Domain_NRPS |
cd19546 |
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to ... |
176-611 |
5.82e-118 |
|
X-domain is a catalytically inactive Condensation-like domain shown to recruit oxygenases to the non-ribosomal peptide synthetase (NRPS); The X-domain is a catalytically inactive member of the Condensation (C) domain family of non-ribosomal peptide synthetase (NRPS). It has been shown to recruit oxygenases to the NRPS to perform side-chain crosslinking in the production of glycopeptide antibiotics. C-domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as this X-domain, the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, and dual E/C (epimerization and condensation) domains. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity; members of this X-domain subfamily lack the second H of this motif.
Pssm-ID: 380468 [Multi-domain] Cd Length: 440 Bit Score: 377.98 E-value: 5.82e-118
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 176 RPNEVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKILDMENLN 255
Cdd:cd19546 1 RPDEVPATAGQLRTWLLARLDEETRGRHLSVALRLRGRLDRDALEAALGDVAARHEILRTTFPGDGGDVHQRILDADAAR 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 256 LEMVITNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQGDR 335
Cdd:cd19546 81 PELPVVPATEEELPALLADRAAHLFDLTRETPWRCTLFALSDTEHVLLLVVHRIAADDESLDVLVRDLAAAYGARREGRA 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 336 VQLETLPVQYADYALWQQQLLGDETTPESLISTQLDFWKEELKGLPDQMELPTDYQRPVETSYRGETIHFHIDEGMHSRL 415
Cdd:cd19546 161 PERAPLPLQFADYALWERELLAGEDDRDSLIGDQIAYWRDALAGAPDELELPTDRPRPVLPSRRAGAVPLRLDAEVHARL 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 416 VELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDV-LSDIVGLFVNTLVLRTNTSGDPSFKELLNRVKQV 494
Cdd:cd19546 241 MEAAESAGATMFTVVQAALAMLLTRLGAGTDVTVGTVLPRDDEEGdLEGMVGPFARPLALRTDLSGDPTFRELLGRVREA 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 495 NLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQ---NTPEATFNAPDLEASLEIQSVGSAKFDLTFEISESNEVD 571
Cdd:cd19546 321 VREARRHQDVPFERLAELLALPPSADRHPVFQVALDVRdddNDPWDAPELPGLRTSPVPLGTEAMELDLSLALTERRNDD 400
|
410 420 430 440
....*....|....*....|....*....|....*....|
gi 1698252301 572 GTPNGLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNP 611
Cdd:cd19546 401 GDPDGLDGSLRYAADLFDRATAAALARRLVRVLEQVAADP 440
|
|
| SgcC5_NRPS-like |
cd19539 |
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- ... |
179-611 |
8.23e-107 |
|
SgcC5 is a non-ribosomal peptide synthetase (NRPS) condensation enzyme with ester- and amide- bond forming activity and similar C-domains of modular NRPSs; SgcC5 is a free-standing NRPS condensation enzyme (rather than a modular NRPS), which catalyzes the condensation between the SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and (R)-1phenyl-1,2-ethanediol, forming an ester bond, during the synthesis of the chromoprotein enediyne antitumor antibiotic C-1027. It has some acceptor substrate promiscuity as it has been shown to also catalyze the formation of an amide bond between SgcC2-tethered (S)-3-chloro-5-hydroxy-beta-tyrosine and a mimic of the enediyne core acceptor substrate having an amine at its C-2 position. This subfamily also includes similar C-domains of modular NRPSs such as Penicillium chrysogenum N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase PCBAB. Condensation (C) domains of NRPSs normally catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380462 [Multi-domain] Cd Length: 427 Bit Score: 346.67 E-value: 8.23e-107
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 179 EVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIF-PNVLGSSYQKILDMENLNLE 257
Cdd:cd19539 1 RIPLSFAQERLWFIDQGEDGGPAYNIPGAWRLTGPLDVEALREALRDVVARHEALRTLLvRDDGGVPRQEILPPGPAPLE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 258 MVITNTCKDELES----VLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQG 333
Cdd:cd19539 81 VRDLSDPDSDRERrleeLLRERESRGFDLDEEPPIRAVLGRFDPDDHVLVLVAHHTAFDAWSLDVFARDLAALYAARRKG 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 334 DRVQLETLPVQYADYALWQQQLLGDETTPESListqlDFWKEELKGLpDQMELPTDYQRPVETSYRGETIHFHIDEGMHS 413
Cdd:cd19539 161 PAAPLPELRQQYKEYAAWQREALAAPRAAELL-----DFWRRRLRGA-EPTALPTDRPRPAGFPYPGADLRFELDAELVA 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 414 RLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSGDPSFKELLNRVKQ 493
Cdd:cd19539 235 ALRELAKRARSSLFMVLLAAYCVLLRRYTGQTDIVVGTPVAGRNHPRFESTVGFFVNLLPLRVDVSDCATFRDLIARVRK 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 494 VNLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQNTPEATFNAPDLEASLEIQSV-GSAKFDLTFEISEsnevdg 572
Cdd:cd19539 315 ALVDAQRHQELPFQQLVAELPVDRDAGRHPLVQIVFQVTNAPAGELELAGGLSYTEGSDIpDGAKFDLNLTVTE------ 388
|
410 420 430
....*....|....*....|....*....|....*....
gi 1698252301 573 TPNGLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNP 611
Cdd:cd19539 389 EGTGLRGSLGYATSLFDEETIQGFLADYLQVLRQLLANP 427
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
372-1235 |
1.93e-106 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 370.93 E-value: 1.93e-106
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 372 FWKEELKGLPDQMeLPTDYQRPVETSYRGETIHFHIDEgmhsrlVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGS 451
Cdd:TIGR03443 1 RWSERLDNPTLSV-LPHDYLRPANNRLVEATYSLQLPS------AEVTAGGGSTPFIILLAAFAALVYRLTGDEDIVLGT 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 452 piAGRNDDvlsdivglfvNTLVLRTNTSGDPSFKELLNRVKQVNLAAYENQDVPFERLVEVLNPVRTRNSHP-LFQvmLA 530
Cdd:TIGR03443 74 --SSNKSG----------RPFVLRLNITPELSFLQLYAKVSEEEKEGASDIGVPFDELSEHIQAAKKLERTPpLFR--LA 139
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 531 FQNTPEAtfnapdleaSLEIQSVGSAKfDLTFEISESN---EVDGTPNGLhgllefstdLYKRETVQKLIERFILLLDDA 607
Cdd:TIGR03443 140 FQDAPDN---------QQTTYSTGSTT-DLTVFLTPSSpelELSIYYNSL---------LFSSDRITIVADQLAQLLSAA 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 608 ATNPNQSIGRLEILTVAEKN-----TVLEKWnGGFQIApemtLPQLFEKQAHINPNSIAVV----FED-----KKLTYEK 673
Cdd:TIGR03443 201 SSNPDEPIGKVSLITPSQKSllpdpTKDLDW-SGFRGA----IHDIFADNAEKHPDRTCVVetpsFLDpssktRSFTYKQ 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 674 LNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLT------- 746
Cdd:TIGR03443 276 INEASNILAHYLLKTGIKRGDVVMIYAYRGVDLVVAVMGVLKAGATFSVIDPAYPPARQTIYLSVAKPRALIViekagtl 355
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 747 NSSVEIECDESLKI--------LVDDVNVMEeiekySEENIDEMECLKP------------LAPSHIAYVIYTSGSTGRP 806
Cdd:TIGR03443 356 DQLVRDYIDKELELrteipalaLQDDGSLVG-----GSLEGGETDVLAPyqalkdtptgvvVGPDSNPTLSFTSGSEGIP 430
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 807 KGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVL 886
Cdd:TIGR03443 431 KGVLGRHFSLAYYFPWMAKRFGLSENDKFTMLSGIAHDPIQRDMFTPLFLGAQLLVPTADDIGTPGRLAEWMAKYGATVT 510
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 887 NQTPsAFYQLMQAdrenEEVGQKLSLRYVVFGGEAL---ELSRLEDWysrhphnAPKV--INMYGITETTVHVSYIElde 961
Cdd:TIGR03443 511 HLTP-AMGQLLSA----QATTPIPSLHHAFFVGDILtkrDCLRLQTL-------AENVciVNMYGTTETQRAVSYFE--- 575
|
650 660 670 680 690 700 710 720
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 962 sIVSLRANSLI----------GCSIPDLKVYVLDNY--LQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKP 1029
Cdd:TIGR03443 576 -IPSRSSDSTFlknlkdvmpaGKGMKNVQLLVVNRNdrTQTCGVGEVGEIYVRAGGLAEGYLGLPELNAEKFVNNWFVDP 654
|
730 740 750 760 770 780 790 800
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1030 GT---------------------RMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVR 1088
Cdd:TIGR03443 655 SHwidldkennkperefwlgprdRLYRTGDLGRYLPDGNVECCGRADDQVKIRGFRIELGEIDTHLSQHPLVRENVTLVR 734
|
810 820 830 840 850 860 870 880
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1089 EDQPGDKRLVAYIVASNN------------ETIDTNEM--------------RQHASGSLPDYMVPYAFVVVNELPLTPN 1142
Cdd:TIGR03443 735 RDKDEEPTLVSYIVPQDKsdeleefksevdDEESSDPVvkglikyrklikdiREYLKKKLPSYAIPTVIVPLKKLPLNPN 814
|
890 900 910 920 930 940 950 960
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1143 GKLDRKALPAP-----EFIASSSSRGPR----TPQEEMLCDLFTEVL--SVSQIGIDDGFFDLGGHSLLAVQLMSRMKEA 1211
Cdd:TIGR03443 815 GKVDKPALPFPdtaqlAAVAKNRSASAAdeefTETEREIRDLWLELLpnRPATISPDDSFFDLGGHSILATRMIFELRKK 894
|
970 980
....*....|....*....|....
gi 1698252301 1212 LGVELNIGTLFAAPTVAGLAERLE 1235
Cdd:TIGR03443 895 LNVELPLGLIFKSPTIKGFAKEVD 918
|
|
| C_NRPS-like |
cd19066 |
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of ... |
179-611 |
7.48e-105 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long, with various activities such as antibiotic, antifungal, antitumor and immunosuppression. There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380453 [Multi-domain] Cd Length: 427 Bit Score: 341.31 E-value: 7.48e-105
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 179 EVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKILDMENLNLEM 258
Cdd:cd19066 1 KIPLSPMQRGMWFLKKLATDPSAFNVAIEMFLTGSLDLARLKQALDAVMERHDVLRTRFCEEAGRYEQVVLDKTVRFRIE 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 259 VI----TNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQGD 334
Cdd:cd19066 81 IIdlrnLADPEARLLELIDQIQQTIYDLERGPLVRVALFRLADERDVLVVAIHHIIVDGGSFQILFEDISSVYDAAERQK 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 335 RVqLETLPVQYADYALWQQQLLGDEttpesLISTQLDFWKEELKGLPDQMELPTDYQRPVETSYRGETIHFHIDEGMHSR 414
Cdd:cd19066 161 PT-LPPPVGSYADYAAWLEKQLESE-----AAQADLAYWTSYLHGLPPPLPLPKAKRPSQVASYEVLTLEFFLRSEETKR 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 415 LVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSGDPSFKELLNRVKQV 494
Cdd:cd19066 235 LREVARESGTTPTQLLLAAFALALKRLTASIDVVIGLTFLNRPDEAVEDTIGLFLNLLPLRIDTSPDATFPELLKRTKEQ 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 495 NLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQNTPEATFNAPDLEAS-LEIQSVGSAKFDLTFEISEsnEVDGt 573
Cdd:cd19066 315 SREAIEHQRVPFIELVRHLGVVPEAPKHPLFEPVFTFKNNQQQLGKTGGFIFTtPVYTSSEGTVFDLDLEASE--DPDG- 391
|
410 420 430
....*....|....*....|....*....|....*...
gi 1698252301 574 pnGLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNP 611
Cdd:cd19066 392 --DLLLRLEYSRGVYDERTIDRFAERYMTALRQLIENP 427
|
|
| Condensation |
pfam00668 |
Condensation domain; This domain is found in many multi-domain enzymes which synthesize ... |
178-626 |
2.02e-104 |
|
Condensation domain; This domain is found in many multi-domain enzymes which synthesize peptide antibiotics. This domain catalyzes a condensation reaction to form peptide bonds in non- ribosomal peptide biosynthesis. It is usually found to the carboxy side of a phosphopantetheine binding domain (pfam00550). It has been shown that mutations in the HHXXXDG motif abolish activity suggesting this is part of the active site.
Pssm-ID: 395541 [Multi-domain] Cd Length: 454 Bit Score: 340.85 E-value: 2.02e-104
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 178 NEVPLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFP-NVLGSSYQKILDMENLNL 256
Cdd:pfam00668 3 DEYPLSPAQKRMWFLEKLEPHSSAYNMPAVLKLTGELDPERLEKALQELINRHDALRTVFIrQENGEPVQVILEERPFEL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 257 EMV-ITNTCKDELESVLSEAVR----YSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARC 331
Cdd:pfam00668 83 EIIdISDLSESEEEEAIEAFIQrdlqSPFDLEKGPLFRAGLFRIAENRHHLLLSMHHIIVDGVSLGILLRDLADLYQQLL 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 332 QGDrvQLETLPVQ-YADYALWQQQLLGDEttpesLISTQLDFWKEELKGLPDQMELPTDYQRPVETSYRGETIHFHIDEG 410
Cdd:pfam00668 163 KGE--PLPLPPKTpYKDYAEWLQQYLQSE-----DYQKDAAYWLEQLEGELPVLQLPKDYARPADRSFKGDRLSFTLDED 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 411 MHSRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSGDPSFKELLNR 490
Cdd:pfam00668 236 TEELLRKLAKAHGTTLNDVLLAAYGLLLSRYTGQDDIVVGTPGSGRPSPDIERMVGMFVNTLPLRIDPKGGKTFSELIKR 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 491 VKQVNLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQNTP----EATFNAPD-LEASLEIQSVGSAKFDLTFEIS 565
Cdd:pfam00668 316 VQEDLLSAEPHQGYPFGDLVNDLRLPRDLSRHPLFDPMFSFQNYLgqdsQEEEFQLSeLDLSVSSVIEEEAKYDLSLTAS 395
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1698252301 566 ESNEvdgtpnGLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNPNQSIGRLEILTVAEK 626
Cdd:pfam00668 396 ERGG------GLTIKIDYNTSLFDEETIERFAEHFKELLEQAIAHPSQPLSELDLLSDAEK 450
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
643-1150 |
5.72e-86 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 290.64 E-value: 5.72e-86
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 643 MTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLP 722
Cdd:PRK04813 2 MDIIETIEEFAQTQPDFPAYDYLGEKLTYGQLKEDSDALAAFIDSLKLPDKSPIIVFGHMSPEMLATFLGAVKAGHAYIP 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 723 LDPDYPSDRISFMLHDAKPSCVLTNSSVEIEcDESLKILVDDvNVMEEIEKYSEENIDemeclKPLAPSHIAYVIYTSGS 802
Cdd:PRK04813 82 VDVSSPAERIEMIIEVAKPSLIIATEELPLE-ILGIPVITLD-ELKDIFATGNPYDFD-----HAVKGDDNYYIIFTSGT 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 803 TGRPKGVMIPHQNvvrLLGATDhW----FQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLL 878
Cdd:PRK04813 155 TGKPKGVQISHDN---LVSFTN-WmledFALPEGPQFLNQAPYSFDLSVMDLYPTLASGGTLVALPKDMTANFKQLFETL 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 879 VKEKVTVLNQTPSaFYQLMQADRE-NEEvgQKLSLRYVVFGGEALELSRLEDWYSRHPhNApKVINMYGITETTVHVSYI 957
Cdd:PRK04813 231 PQLPINVWVSTPS-FADMCLLDPSfNEE--HLPNLTHFLFCGEELPHKTAKKLLERFP-SA-TIYNTYGPTEATVAVTSI 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 958 ELDESIVSlRANSL-IGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFiadpFGKPGTRMYRT 1036
Cdd:PRK04813 306 EITDEMLD-QYKRLpIGYAKPDSPLLIIDEEGTKLPDGEQGEIVISGPSVSKGYLNNPEKTAEAF----FTFDGQPAYHT 380
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1037 GDLARWrQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQvAVIVredqPGDK-----RLVAYIVASNNETID- 1110
Cdd:PRK04813 381 GDAGYL-EDGLLFYQGRIDFQIKLNGYRIELEEIEQNLRQSSYVES-AVVV----PYNKdhkvqYLIAYVVPKEEDFERe 454
|
490 500 510 520
....*....|....*....|....*....|....*....|...
gi 1698252301 1111 ---TNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK04813 455 felTKAIKKELKERLMEYMIPRKFIYRDSLPLTPNGKIDRKAL 497
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
792-1146 |
3.61e-81 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 270.70 E-value: 3.61e-81
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 792 HIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPhtvSRSP 871
Cdd:cd04433 1 DPALILYTSGTTGKPKGVVLSHRNLLAAAAALAASGGLTEGDVFLSTLPLFHIGGLFGLLGALLAGGTVVLLP---KFDP 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 872 KEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEvgQKLSLRYVVFGGEALELSRLEDWYSRHPhnaPKVINMYGITETT 951
Cdd:cd04433 78 EAALELIEREKVTILLGVPTLLARLLKAPESAGY--DLSSLRALVSGGAPLPPELLERFEEAPG---IKLVNGYGLTETG 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 952 VHVSYIELDEsiVSLRANSlIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFiadpfgkpGT 1031
Cdd:cd04433 153 GTVATGPPDD--DARKPGS-VGRPVPGVEVRIVDPDGGELPPGEIGELVVRGPSVMKGYWNNPEATAAVD--------ED 221
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1032 RMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDT 1111
Cdd:cd04433 222 GWYRTGDLGRLDEDGYLYIVGRLKDMIKSGGENVYPAEVEAVLLGHPGVAEAAVVGVPDPEWGERVVAVVVLRPGADLDA 301
|
330 340 350
....*....|....*....|....*....|....*
gi 1698252301 1112 NEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLD 1146
Cdd:cd04433 302 EELRAHVRERLAPYKVPRRVVFVDALPRTASGKID 336
|
|
| C_PKS-NRPS |
cd19532 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
179-611 |
2.99e-76 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHxxxD motif, a few such as Monascus pilosus lovastatin nonaketide synthase MokA have a non-canonical HRxxxD motif in the C-domain and are unable to catalyze amide-bond formation. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380455 [Multi-domain] Cd Length: 421 Bit Score: 259.70 E-value: 2.99e-76
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 179 EVPLSFAQRRLWFLNC-LEGPSpTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSS--YQKILDMENLN 255
Cdd:cd19532 1 TEPMSFGQSRFWFLQQyLEDPT-TFNVTFSYRLTGPLDVARLERAVRAVGQRHEALRTCFFTDPEDGepMQGVLASSPLR 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 256 LEMViTNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYkarcqgDR 335
Cdd:cd19532 80 LEHV-QISDEAEVEEEFERLKNHVYDLESGETMRIVLLSLSPTEHYLIFGYHHIAMDGVSFQIFLRDLERAY------NG 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 336 VQLETLPVQYADYALWQQQLLGDETTpesliSTQLDFWKEELKGLPDQMEL------PTdyqRPVETSYRGETIHFHIDE 409
Cdd:cd19532 153 QPLLPPPLQYLDFAARQRQDYESGAL-----DEDLAYWKSEFSTLPEPLPLlpfakvKS---RPPLTRYDTHTAERRLDA 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 410 GMHSRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGspI--AGRNDDVLSDIVGLFVNTLVLRTNTSGDPSFKEL 487
Cdd:cd19532 225 ALAARIKEASRKLRVTPFHFYLAALQVLLARLLDVDDICIG--IadANRTDEDFMETIGFFLNLLPLRFRRDPSQTFADV 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 488 LNRVKQVNLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVMLAF-QNTPE-ATFnaPDLEASLEIQSVGSAKFDLTFEIS 565
Cdd:cd19532 303 LKETRDKAYAALAHSRVPFDVLLDELGVPRSATHSPLFQVFINYrQGVAEsRPF--GDCELEGEEFEDARTPYDLSLDII 380
|
410 420 430 440
....*....|....*....|....*....|....*....|....*...
gi 1698252301 566 ESneVDGTPnglhgLLEFST--DLYKRETVQKLIERFILLLDDAATNP 611
Cdd:cd19532 381 DN--PDGDC-----LLTLKVqsSLYSEEDAELLLDSYVNLLEAFARDP 421
|
|
| Acs |
COG0365 |
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism]; |
648-1150 |
3.01e-74 |
|
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism];
Pssm-ID: 440134 [Multi-domain] Cd Length: 565 Bit Score: 258.89 E-value: 3.01e-74
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 648 LFEKQAHINPNSIAVVFED-----KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLP 722
Cdd:COG0365 14 CLDRHAEGRGDKVALIWEGedgeeRTLTYAELRREVNRFANALRALGVKKGDRVAIYLPNIPEAVIAMLACARIGAVHSP 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 723 LDPDYPSDRISFMLHDAKPSCVLTNSS----------------VEIECDESLKILV-----------DDVNVMEEIEKYS 775
Cdd:COG0365 94 VFPGFGAEALADRIEDAEAKVLITADGglrggkvidlkekvdeALEELPSLEHVIVvgrtgadvpmeGDLDWDELLAAAS 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 776 eeniDEMEClKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNV-VRLLGATDHWFQFDADDV--------WTMFHSYAfdfs 846
Cdd:COG0365 174 ----AEFEP-EPTDADDPLFILYTSGTTGKPKGVVHTHGGYlVHAATTAKYVLDLKPGDVfwctadigWATGHSYI---- 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 847 vweIWGPLLYGGRLVV---VPHTvsRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADrenEEVGQKL---SLRYVVFGGE 920
Cdd:COG0365 245 ---VYGPLLNGATVVLyegRPDF--PDPGRLWELIEKYGVTVFFTAPTAIRALMKAG---DEPLKKYdlsSLRLLGSAGE 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 921 AL--ELSRledWYSRH---PhnapkVINMYGITETTVH-VSYIELDEsivsLRANSlIGCSIPDLKVYVLDNYLQPVPPG 994
Cdd:COG0365 317 PLnpEVWE---WWYEAvgvP-----IVDGWGQTETGGIfISNLPGLP----VKPGS-MGKPVPGYDVAVVDEDGNPVPPG 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 995 VVGEMYVAGA--GLARGYLGRAgltaERFIADPFGK-PGtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIE 1071
Cdd:COG0365 384 EEGELVIKGPwpGMFRGYWNDP----ERYRETYFGRfPG--WYRTGDGARRDEDGYFWILGRSDDVINVSGHRIGTAEIE 457
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1072 AVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETID---TNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRK 1148
Cdd:COG0365 458 SALVSHPAVAEAAVVGVPDEIRGQVVKAFVVLKPGVEPSdelAKELQAHVREELGPYAYPREIEFVDELPKTRSGKIMRR 537
|
..
gi 1698252301 1149 AL 1150
Cdd:COG0365 538 LL 539
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
643-1150 |
5.59e-73 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 253.96 E-value: 5.59e-73
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 643 MTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLP 722
Cdd:PRK06187 6 LTIGRILRHGARKHPDKEAVYFDGRRTTYAELDERVNRLANALRALGVKKGDRVAVFDWNSHEYLEAYFAVPKIGAVLHP 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 723 LDPDYPSDRISFMLHDAKPSCVLTNSSVE-----------------IECDESLKILVDDVNVMEEI-----EKYSEENID 780
Cdd:PRK06187 86 INIRLKPEEIAYILNDAEDRVVLVDSEFVpllaailpqlptvrtviVEGDGPAAPLAPEVGEYEELlaaasDTFDFPDID 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 781 EMEclkplapshIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWT----MFHSYAfdfsvweiWG---- 852
Cdd:PRK06187 166 END---------AAAMLYTSGTTGHPKGVVLSHRNLFLHSLAVCAWLKLSRDDVYLvivpMFHVHA--------WGlpyl 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 853 PLLYGGRLVVVPHTvsrSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENeevGQKLS-LRYVVFGGEALELSRLEDWY 931
Cdd:PRK06187 229 ALMAGAKQVIPRRF---DPENLLDLIETERVTFFFAVPTIWQMLLKAPRAY---FVDFSsLRLVIYGGAALPPALLREFK 302
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 932 SRhpHNApKVINMYGITET--TVHVSYIELDESIVSLRANSlIGCSIPDLKVYVLDNYLQPVPP--GVVGEMYVAGAGLA 1007
Cdd:PRK06187 303 EK--FGI-DLVQGYGMTETspVVSVLPPEDQLPGQWTKRRS-AGRPLPGVEARIVDDDGDELPPdgGEVGEIIVRGPWLM 378
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1008 RGYLGRAGLTAERFIADpfgkpgtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIV 1087
Cdd:PRK06187 379 QGYWNRPEATAETIDGG--------WLHTGDVGYIDEDGYLYITDRIKDVIISGGENIYPRELEDALYGHPAVAEVAVIG 450
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1698252301 1088 REDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK06187 451 VPDEKWGERPVAVVVLKPGATLDAKELRAFLRGRLAKFKLPKRIAFVDELPRTSVGKILKRVL 513
|
|
| FC-FACS_FadD_like |
cd05936 |
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This ... |
645-1150 |
6.62e-73 |
|
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This subfamily of the AMP-forming adenylation family contains Escherichia coli FadD and similar prokaryotic fatty acid CoA synthetases. FadD was characterized as a long-chain fatty acid CoA synthetase. The gene fadD is regulated by the fatty acid regulatory protein FadR. Fatty acid CoA synthetase catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341259 [Multi-domain] Cd Length: 468 Bit Score: 251.71 E-value: 6.62e-73
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 645 LPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLD 724
Cdd:cd05936 1 LADLLEEAARRFPDKTALIFMGRKLTYRELDALAEAFAAGLQNLGVQPGDRVALMLPNCPQFPIAYFGALKAGAVVVPLN 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 725 PDYPSDRISFMLHDAKPSCvltnssveIECDESLKilvddvNVMEEIEKYSEEnidemeclKPLAPSHIAYVIYTSGSTG 804
Cdd:cd05936 81 PLYTPRELEHILNDSGAKA--------LIVAVSFT------DLLAAGAPLGER--------VALTPEDVAVLQYTSGTTG 138
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 805 RPKGVMIPHQNVVRLLGATDHWFQF--DADDVWT----MFHSYAFDFSVWEiwgPLLYGGRLVVVPhtvSRSPKEFLQLL 878
Cdd:cd05936 139 VPKGAMLTHRNLVANALQIKAWLEDllEGDDVVLaalpLFHVFGLTVALLL---PLALGATIVLIP---RFRPIGVLKEI 212
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 879 VKEKVTVLNQTPSAFYQLMQAdrenEEVGQKL--SLRYVVFGGEALELSRLEDWysrHPHNAPKVINMYGITET--TVHV 954
Cdd:cd05936 213 RKHRVTIFPGVPTMYIALLNA----PEFKKRDfsSLRLCISGGAPLPVEVAERF---EELTGVPIVEGYGLTETspVVAV 285
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 955 SYIEldesiVSLRANSlIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmy 1034
Cdd:cd05936 286 NPLD-----GPRKPGS-IGIPLPGTEVKIVDDDGEELPPGEVGELWVRGPQVMKGYWNRPEETAEAFVDGWL-------- 351
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1035 RTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEM 1114
Cdd:cd05936 352 RTGDIGYMDEDGYFFIVDRKKDMIIVGGFNVYPREVEEVLYEHPAVAEAAVVGVPDPYSGEAVKAFVVLKEGASLTEEEI 431
|
490 500 510
....*....|....*....|....*....|....*.
gi 1698252301 1115 RQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05936 432 IAFCREQLAGYKVPRQVEFRDELPKSAVGKILRREL 467
|
|
| A_NRPS_acs4 |
cd17654 |
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal ... |
669-1150 |
3.17e-72 |
|
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains acyl-CoA synthethase family member 4, also known as 2-aminoadipic 6-semialdehyde dehydrogenase or aminoadipate-semialdehyde dehydrogenase, most of which are uncharacterized. Acyl-CoA synthetase catalyzes the initial reaction in fatty acid metabolism, by forming a thioester with CoA. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341309 [Multi-domain] Cd Length: 449 Bit Score: 249.31 E-value: 3.17e-72
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNs 748
Cdd:cd17654 17 VSYADLAEKISNLSNFLRKKFQTEERAIGLRCDRGTESPVAILAILFLGAAYAPIDPASPEQRSLTVMKKCHVSYLLQN- 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 749 sveiecdeslkilvddvnvmEEIEKYSEENIDEMECLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQ 828
Cdd:cd17654 96 --------------------KELDNAPLSFTPEHRHFNIRTDECLAYVIHTSGTTGTPKIVAVPHKCILPNIQHFRSLFN 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 829 FDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKE-KVTVLNQTPSAFYQLMQADRENEEVG 907
Cdd:cd17654 156 ITSEDILFLTSPLTFDPSVVEIFLSLSSGATLLIVPTSVKVLPSKLADILFKRhRITVLQATPTLFRRFGSQSIKSTVLS 235
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 908 QKLSLRYVVFGGEAL-ELSRLEDWysRHPHNAPKVINMYGITETTVHVSYIEldesIVSLRANSLIGCSIPDLKVYVLDN 986
Cdd:cd17654 236 ATSSLRVLALGGEPFpSLVILSSW--RGKGNRTRIFNIYGITEVSCWALAYK----VPEEDSPVQLGSPLLGTVIEVRDQ 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 987 ylqpvpPGVVGEMYVAGAGLARGYlgragltaerFIADPFGKPGTRMYRTGDLARwRQDGTLDYIGRADHQIKIRGFRIE 1066
Cdd:cd17654 310 ------NGSEGTGQVFLGGLNRVC----------ILDDEVTVPKGTMRATGDFVT-VKDGELFFLGRKDSQIKRRGKRIN 372
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1067 LGEIEAVIMKHDKVEQVAVIVREDQpgdkRLVAYIVASNNETIDTNEMRQH--ASGSLPDYmvpyaFVVVNELPLTPNGK 1144
Cdd:cd17654 373 LDLIQQVIESCLGVESCAVTLSDQQ----RLIAFIVGESSSSRIHKELQLTllSSHAIPDT-----FVQIDKLPLTSHGK 443
|
....*.
gi 1698252301 1145 LDRKAL 1150
Cdd:cd17654 444 VDKSEL 449
|
|
| COG4908 |
COG4908 |
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General ... |
182-427 |
9.92e-69 |
|
Uncharacterized conserved protein, contains a NRPS condensation (elongation) domain [General function prediction only];
Pssm-ID: 443936 [Multi-domain] Cd Length: 243 Bit Score: 231.47 E-value: 9.92e-69
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 182 LSFAQRRLWFLnclEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKILDMENLNLEMV-- 259
Cdd:COG4908 1 LSPAQKRFLFL---EPGSNAYNIPAVLRLEGPLDVEALERALRELVRRHPALRTRFVEEDGEPVQRIDPDADLPLEVVdl 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 260 ---ITNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQGDRV 336
Cdd:COG4908 78 salPEPEREAELEELVAEEASRPFDLARGPLLRAALIRLGEDEHVLLLTIHHIISDGWSLGILLRELAALYAALLEGEPP 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 337 QLETLPVQYADYALWQQQLLGDETtpeslISTQLDFWKEELKGLPDQMELPTDYQRPVETSYRGETIHFHIDEGMHSRLV 416
Cdd:COG4908 158 PLPELPIQYADYAAWQRAWLQSEA-----LEKQLEYWRQQLAGAPPVLELPTDRPRPAVQTFRGATLSFTLPAELTEALK 232
|
250
....*....|.
gi 1698252301 417 ELGRKNGVSLF 427
Cdd:COG4908 233 ALAKAHGATVN 243
|
|
| C_PKS-NRPS |
cd20483 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
179-607 |
7.41e-65 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Most members of this subfamily have the typical C-domain HHXXXD motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380471 [Multi-domain] Cd Length: 430 Bit Score: 227.14 E-value: 7.41e-65
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 179 EVPLSFAQRRLWFLNC-LEGPSpTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKILDMENLNLE 257
Cdd:cd20483 1 PRPMSTFQRRLWFLHNfLEDKT-FLNLLLVCHIKGKPDVNLLQKALSELVRRHEVLRTAYFEGDDFGEQQVLDDPSFHLI 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 258 MVITNTCKD---ELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKA-RCQG 333
Cdd:cd20483 80 VIDLSEAADpeaALDQLVRNLRRQELDIEEGEVIRGWLVKLPDEEFALVLASHHIAWDRGSSKSIFEQFTALYDAlRAGR 159
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 334 DRVQLETLPVQYADYALWQQQLLGDETTPESListqlDFWKEELKGLPDQME-LPTDYQ-RPVETSYRGETIHFHIDEGM 411
Cdd:cd20483 160 DLATVPPPPVQYIDFTLWHNALLQSPLVQPLL-----DFWKEKLEGIPDASKlLPFAKAeRPPVKDYERSTVEATLDKEL 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 412 HSRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSGDPSFKELLNRV 491
Cdd:cd20483 235 LARMKRICAQHAVTPFMFLLAAFRAFLYRYTEDEDLTIGMVDGDRPHPDFDDLVGFFVNMLPIRCRMDCDMSFDDLLEST 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 492 KQVNLAAYENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQ---NTPEATFnapdleASLEIQSVGS----AKFDLTFEI 564
Cdd:cd20483 315 KTTCLEAYEHSAVPFDYIVDALDVPRSTSHFPIGQIAVNYQvhgKFPEYDT------GDFKFTDYDHydipTACDIALEA 388
|
410 420 430 440
....*....|....*....|....*....|....*....|...
gi 1698252301 565 SESNEvdgtpNGLHGLLEFSTDLYKRETVQKLIERFILLLDDA 607
Cdd:cd20483 389 EEDPD-----GGLDLRLEFSTTLYDSADMERFLDNFVTFLTSV 426
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
667-1153 |
5.02e-64 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 227.79 E-value: 5.02e-64
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 667 KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVlt 746
Cdd:cd17647 19 RSFTYRDINEASNIVAHYLIKTGIKRGDVVMIYSYRGVDLMVAVMGVLKAGATFSVIDPAYPPARQNIYLGVAKPRGL-- 96
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 747 nssveiecdeslkILVDDVNVMeeiekyseenidemeclkpLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHW 826
Cdd:cd17647 97 -------------IVIRAAGVV-------------------VGPDSNPTLSFTSGSEGIPKGVLGRHFSLAYYFPWMAKR 144
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 827 FQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQTPsAFYQLMQADreneEV 906
Cdd:cd17647 145 FNLSENDKFTMLSGIAHDPIQRDMFTPLFLGAQLLVPTQDDIGTPGRLAEWMAKYGATVTHLTP-AMGQLLTAQ----AT 219
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 907 GQKLSLRYVVFGGEAL---ELSRLEDWysrhpHNAPKVINMYGITETTVHVSYIEL-----DESIV-SLRANSLIGCSIP 977
Cdd:cd17647 220 TPFPKLHHAFFVGDILtkrDCLRLQTL-----AENVRIVNMYGTTETQRAVSYFEVpsrssDPTFLkNLKDVMPAGRGML 294
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 978 DLKVYVLDNY--LQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPG---------------------TRMY 1034
Cdd:cd17647 295 NVQLLVVNRNdrTQICGIGEVGEIYVRAGGLAEGYRGLPELNKEKFVNNWFVEPDhwnyldkdnnepwrqfwlgprDRLY 374
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1035 RTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNE- 1113
Cdd:cd17647 375 RTGDLGRYLPNGDCECCGRADDQVKIRGFRIELGEIDTHISQHPLVRENITLVRRDKDEEPTLVSYIVPRFDKPDDESFa 454
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 1114 --------------------------MRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAP 1153
Cdd:cd17647 455 qedvpkevstdpivkgligyrklikdIREFLKKRLASYAIPSLIVVLDKLPLNPNGKVDKPKLQFP 520
|
|
| PRK07656 |
PRK07656 |
long-chain-fatty-acid--CoA ligase; Validated |
643-1150 |
8.29e-64 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236072 [Multi-domain] Cd Length: 513 Bit Score: 226.71 E-value: 8.29e-64
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 643 MTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLP 722
Cdd:PRK07656 5 MTLPELLARAARRFGDKEAYVFGDQRLTYAELNARVRRAAAALAALGIGKGDRVAIWAPNSPHWVIAALGALKAGAVVVP 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 723 LDPDYPSDRISFMLHDAKPSCV------LTNSSVEIECDESLKILV-----DDVNVMEEIEKYSE--ENIDEMECLKPLA 789
Cdd:PRK07656 85 LNTRYTADEAAYILARGDAKALfvlglfLGVDYSATTRLPALEHVViceteEDDPHTEKMKTFTDflAAGDPAERAPEVD 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 790 PSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADD----VWTMFHsyAFDFSVwEIWGPLLYGGRLVVVPH 865
Cdd:PRK07656 165 PDDVADILFTSGTTGRPKGAMLTHRQLLSNAADWAEYLGLTEGDrylaANPFFH--VFGYKA-GVNAPLMRGATILPLPV 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 866 TvsrSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEvgqKL-SLRYVVFGGEALELSRLEDWYSRHPhnAPKVINM 944
Cdd:PRK07656 242 F---DPDEVFRLIETERITVLPGPPTMYNSLLQHPDRSAE---DLsSLRLAVTGAASMPVALLERFESELG--VDIVLTG 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 945 YGITETTVHVSYIELDESIVSLrANSlIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIAD 1024
Cdd:PRK07656 314 YGLSEASGVTTFNRLDDDRKTV-AGT-IGTAIAGVENKIVNELGEEVPVGEVGELLVRGPNVMKGYYDDPEATAAAIDAD 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1025 PFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIvredqpG--DKRL----V 1098
Cdd:PRK07656 392 GW-------LHTGDLGRLDEEGYLYIVDRKKDMFIVGGFNVYPAEVEEVLYEHPAVAEAAVI------GvpDERLgevgK 458
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 1698252301 1099 AYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK07656 459 AYVVLKPGAELTEEELIAYCREHLAKYKVPRSIEFLDELPKNATGKVLKRAL 510
|
|
| ligase_PEP_1 |
TIGR03098 |
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an ... |
644-1152 |
6.59e-63 |
|
acyl-CoA ligase (AMP-forming), exosortase A-associated; This group of proteins contains an AMP-binding domain (pfam00501) associated with acyl CoA-ligases. These proteins are generally found in genomes containing the exosortase/PEP-CTERM protein expoert system, specifically the type 1 variant of this system described by the Genome Property GenProp0652. When found in this context they are invariably present next to a decarboxylase enzyme. A number of sequences from Burkholderia species also hit this model, but the genomic context is obviously different. The hypothesis of a constant substrate for this family is only strong where the exosortase context is present.
Pssm-ID: 211788 [Multi-domain] Cd Length: 517 Bit Score: 224.28 E-value: 6.59e-63
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 644 TLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPL 723
Cdd:TIGR03098 1 LLHHLLEDAAARLPDATALVHHDRTLTYAALSERVLALASGLRGLGLARGERVAIYLDKRLETVTAMFGAALAGGVFVPI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 724 DPDYPSDRISFMLHDAKPSCVLTNSS-------VEIEC-DESLKILVDDVNvmEEIEKYSEENI---DEMECLKPLAPSH 792
Cdd:TIGR03098 81 NPLLKAEQVAHILADCNVRLLVTSSErldllhpALPGChDLRTLIIVGDPA--HASEGHPGEEPaswPKLLALGDADPPH 158
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 793 ------IAYVIYTSGSTGRPKGVMIPHQNVVrlLGA--TDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVP 864
Cdd:TIGR03098 159 pvidsdMAAILYTSGSTGRPKGVVLSHRNLV--AGAqsVATYLENRPDDRLLAVLPLSFDYGFNQLTTAFYVGATVVLHD 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 865 HTVsrsPKEFLQLLVKEKVTVLNQTPSAFYQLMQADREnEEVGQklSLRYVVFGGEALELSRLEDWYSRHPHNapKVINM 944
Cdd:TIGR03098 237 YLL---PRDVLKALEKHGITGLAAVPPLWAQLAQLDWP-ESAAP--SLRYLTNSGGAMPRATLSRLRSFLPNA--RLFLM 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 945 YGITEtTVHVSYieLDESIVSLRANSlIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIAD 1024
Cdd:TIGR03098 309 YGLTE-AFRSTY--LPPEEVDRRPDS-IGKAIPNAEVLVLREDGSECAPGEEGELVHRGALVAMGYWNDPEKTAERFRPL 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1025 P-----FGKPGTRMYrTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVI-VREDQPGDkRLV 1098
Cdd:TIGR03098 385 PpfpgeLHLPELAVW-SGDTVRRDEEGFLYFVGRRDEMIKTSGYRVSPTEVEEVAYATGLVAEAVAFgVPDPTLGQ-AIV 462
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 1099 AYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPA 1152
Cdd:TIGR03098 463 LVVTPPGGEELDRAALLAECRARLPNYMVPALIHVRQALPRNANGKIDRKALAK 516
|
|
| FACL_FadD13-like |
cd17631 |
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, ... |
649-1147 |
1.95e-61 |
|
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, including Mycobacterium tuberculosis acid-induced operon MymA encoding the fatty acyl-CoA synthetase FadD13 which is essential for virulence and intracellular growth of the pathogen. The fatty acyl-CoA synthetase activates lipids before entering into the metabolic pathways and is also involved in transmembrane lipid transport. However, unlike soluble fatty acyl-CoA synthetases, but like the mammalian integral-membrane very-long-chain acyl-CoA synthetases, FadD13 accepts lipid substrates up to the maximum length of C26, and this is facilitated by an extensive hydrophobic tunnel from the active site to a positively charged patch. Also included is feruloyl-CoA synthetase (Fcs) in Rhodococcus strains where it is involved in biotechnological vanillin production from eugenol and ferulic acid via a non-beta-oxidative pathway.
Pssm-ID: 341286 [Multi-domain] Cd Length: 435 Bit Score: 217.48 E-value: 1.95e-61
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 649 FEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYP 728
Cdd:cd17631 1 LRRRARRHPDRTALVFGGRSLTYAELDERVNRLAHALRALGVAKGDRVAVLSKNSPEFLELLFAAARLGAVFVPLNFRLT 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 729 SDRISFMLHDAKPscvltnssveiecdeslKILVDDvnvmeeiekyseenidemeclkplapshIAYVIYTSGSTGRPKG 808
Cdd:cd17631 81 PPEVAYILADSGA-----------------KVLFDD----------------------------LALLMYTSGTTGRPKG 115
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 809 VMIPHQNVV-RLLGATDHWFqFDADDVWT----MFHSYAFDFsvweIWGPLLY-GGRLVVVPHTvsrSPKEFLQLLVKEK 882
Cdd:cd17631 116 AMLTHRNLLwNAVNALAALD-LGPDDVLLvvapLFHIGGLGV----FTLPTLLrGGTVVILRKF---DPETVLDLIERHR 187
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 883 VTVLNQTPSAFYQLMQADRENEevgQKLS-LRYVVFGGEALELSRLEDWYSRHphnaPKVINMYGITETTVHVSYIELDE 961
Cdd:cd17631 188 VTSFFLVPTMIQALLQHPRFAT---TDLSsLRAVIYGGAPMPERLLRALQARG----VKFVQGYGMTETSPGVTFLSPED 260
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 962 SIVSLRAnslIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAErFIADPFgkpgtrmYRTGDLAR 1041
Cdd:cd17631 261 HRRKLGS---AGRPVFFVEVRIVDPDGREVPPGEVGEIVVRGPHVMAGYWNRPEATAA-AFRDGW-------FHTGDLGR 329
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1042 WRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGS 1121
Cdd:cd17631 330 LDEDGYLYIVDRKKDMIISGGENVYPAEVEDVLYEHPAVAEVAVIGVPDEKWGEAVVAVVVPRPGAELDEDELIAHCRER 409
|
490 500
....*....|....*....|....*.
gi 1698252301 1122 LPDYMVPYAFVVVNELPLTPNGKLDR 1147
Cdd:cd17631 410 LARYKIPKSVEFVDALPRNATGKILK 435
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1-596 |
1.82e-59 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 227.15 E-value: 1.82e-59
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRpndkRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPAP 80
Cdd:PRK12316 3466 LLEHPWVREAVVLAVDGR----QLVAYVVPEDEAGDLREALKAHLKASLPEYMVPAHLLFLERMPLTPNGKLDRKALPRP 3541
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 81 DFNGMNNERVA-RNPKEEILCDLFAEVLGVSRINIDDNFFEMGGHSLLASRLMARIREtLSVELGIGKLFESPTVAELAK 159
Cdd:PRK12316 3542 DAALLQQDYVApVNELERRLAAIWADVLKLEQVGLTDNFFELGGDSIISLQVVSRARQ-AGIRFTPKDLFQHQTIQGLAR 3620
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 160 --------QLNHAKSARPAIQKASRPNEVPLSFAQRRLWFLNCLEGPSptyniplvirmnGILNRQALQGAFYDVVEKHE 231
Cdd:PRK12316 3621 varvgggvAVDQGPVSGETLLLPIQQQFFEEPVPERHHWNQSLLLKPR------------EALDAAALEAALQALVEHHD 3688
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 232 TLRTIFPNVLG---SSYQKILDMENLNLEMVITNTckDELESVLSEAVRySFNLDFEPAVRLQLFTVSENEHVLLILLHH 308
Cdd:PRK12316 3689 ALRLRFVEDAGgwtAEHLPVELGGALLWRAELDDA--EELERLGEEAQR-SLDLADGPLLRALLATLADGSQRLLLVIHH 3765
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 309 IVGDGWSLQPLTRDFTAAYKARCQGDRVQLETLPVQYADYALWQQQLLGDETtpeslISTQLDFWKEELKGLPDqmELPT 388
Cdd:PRK12316 3766 LVVDGVSWRILLEDLQQAYQQLLQGEAPRLPAKTSSFKAWAERLQEHARGEA-----LKAELAYWQEQLQGVSS--ELPC 3838
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 389 DYQRPVETSYRGETIHFHIDEGMHSRLV-ELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRND---DV-LSD 463
Cdd:PRK12316 3839 DHPQGALQNRHAASVQTRLDRELTRRLLqQAPAAYRTQVNDLLLTALARVVCRWTGEASALVQLEGHGREDlfaDIdLSR 3918
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 464 IVGLFVNTLVLRTNTSGDpsFKELLNRVKQvNLAAYENQDVPFERLvevlnpvRTRNSHPLFQVmLAFQNTPEATFN--- 540
Cdd:PRK12316 3919 TVGWFTSLFPVRLSPVED--LGASIKAIKE-QLRAIPNKGIGFGLL-------RYLGDEESRRT-LAGLPVPRITFNylg 3987
|
570 580 590 600 610 620
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 541 ----APDLEASLEIQSVGSAKFDLTFEISESNEVDGTPNGLHGLLE----FSTDLYKRETVQKL 596
Cdd:PRK12316 3988 qfdgSFDEEMALFVPAGESAGAEQSPDAPLDNWLSLNGRVYGGELSldwtFSREMFEEATIQRL 4051
|
|
| Firefly_Luc_like |
cd05911 |
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family ... |
665-1145 |
2.95e-59 |
|
Firefly luciferase of light emitting insects and 4-Coumarate-CoA Ligase (4CL); This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341237 [Multi-domain] Cd Length: 486 Bit Score: 212.84 E-value: 2.95e-59
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 665 EDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCV 744
Cdd:cd05911 7 TGKELTYAQLRTLSRRLAAGLRKLGLKKGDVVGIISPNSTYYPPVFLGCLFAGGIFSAANPIYTADELAHQLKISKPKVI 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 745 LTNSSVEIECDESLKILVDDVNV---------MEEIEKY-SEENIDEMECLKP---LAPSHIAYVIYTSGSTGRPKGVMI 811
Cdd:cd05911 87 FTDPDGLEKVKEAAKELGPKDKIivlddkpdgVLSIEDLlSPTLGEEDEDLPPplkDGKDDTAAILYSSGTTGLPKGVCL 166
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 812 PHQNVV-RLLGATDHWF-QFDADDVW----TMFHSYAFDFSVWEiwgpLLYGGRLVVVPHTvsrSPKEFLQLLVKEKVTV 885
Cdd:cd05911 167 SHRNLIaNLSQVQTFLYgNDGSNDVIlgflPLYHIYGLFTTLAS----LLNGATVIIMPKF---DSELFLDLIEKYKITF 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 886 LNQTPSAFYQLMQADRENEEvgqKL-SLRYVVFGGEALeLSRLEDWYSRHPHNApKVINMYGITETTVHVSY-IELDESI 963
Cdd:cd05911 240 LYLVPPIAAALAKSPLLDKY---DLsSLRVILSGGAPL-SKELQELLAKRFPNA-TIKQGYGMTETGGILTVnPDGDDKP 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 964 VSlranslIGCSIPDLKVYVLD-NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLARW 1042
Cdd:cd05911 315 GS------VGRLLPNVEAKIVDdDGKDSLGPNEPGEICVRGPQVMKGYYNNPEATKETFDEDGW-------LHTGDIGYF 381
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1043 RQDGTLdYI-GRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGS 1121
Cdd:cd05911 382 DEDGYL-YIvDRKKELIKYKGFQVAPAELEAVLLEHPGVADAAVIGIPDEVSGELPRAYVVRKPGEKLTEKEVKDYVAKK 460
|
490 500
....*....|....*....|....*...
gi 1698252301 1122 LPDYmvpYAF----VVVNELPLTPNGKL 1145
Cdd:cd05911 461 VASY---KQLrggvVFVDEIPKSASGKI 485
|
|
| DCL_NRPS |
cd19543 |
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the ... |
181-611 |
1.49e-56 |
|
DCL-type Condensation domain of nonribosomal peptide synthetases (NRPSs), which catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor; The DCL-type Condensation (C) domain catalyzes the condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. This domain is D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L)); this is in contrast with the standard LCL domains which catalyze peptide bond formation between two L-amino acids, and the restriction of ribosomes to use only L-amino acids. C domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains in addition to the LCL- and DCL-types such as starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380465 [Multi-domain] Cd Length: 423 Bit Score: 202.82 E-value: 1.49e-56
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 181 PLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIF-PNVLGSSYQKI-----LDMENL 254
Cdd:cd19543 3 PLSPMQEGMLFHSLLDPGSGAYVEQMVITLEGPLDPDRFRAAWQAVVDRHPILRTSFvWEGLGEPLQVVlkdrkLPWREL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 255 NLEMVITNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQGD 334
Cdd:cd19543 83 DLSHLSEAEQEAELEALAEEDRERGFDLARAPLMRLTLIRLGDDRYRLVWSFHHILLDGWSLPILLKELFAIYAALGEGQ 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 335 RVQLETlPVQYADYALWQQQLLGDETtpeslistqLDFWKEELKGLPDQMELPTDYQRPVETSYRGETIHFHIDEGMHSR 414
Cdd:cd19543 163 PPSLPP-VRPYRDYIAWLQRQDKEAA---------EAYWREYLAGFEEPTPLPKELPADADGSYEPGEVSFELSAELTAR 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 415 LVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDV--LSDIVGLFVNTLVLRTNTSGDPSFKELLNRVK 492
Cdd:cd19543 233 LQELARQHGVTLNTVVQGAWALLLSRYSGRDDVVFGTTVSGRPAELpgIETMVGLFINTLPVRVRLDPDQTVLELLKDLQ 312
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 493 QVNLAAYENQDVPferLVEVLNpvRTRNSHPLFQVMLAFQNTP-EATFNAPDLEASLEIQSVGSAK---FDLTFEISESN 568
Cdd:cd19543 313 AQQLELREHEYVP---LYEIQA--WSEGKQALFDHLLVFENYPvDESLEEEQDEDGLRITDVSAEEqtnYPLTVVAIPGE 387
|
410 420 430 440
....*....|....*....|....*....|....*....|...
gi 1698252301 569 EvdgtpngLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNP 611
Cdd:cd19543 388 E-------LTIKLSYDAEVFDEATIERLLGHLRRVLEQVAANP 423
|
|
| C_PKS-NRPS_PksJ-like |
cd20484 |
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS ... |
181-611 |
1.20e-54 |
|
Condensation domain of hybrid polyketide synthetase/nonribosomal peptide synthetases (PKS/NRPSs), similar to Bacillus subtilis PksJ; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Hybrid PKS/NRPS create polymers containing both polyketide and amide linkages. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily have the typical C-domain HHxxxD motif. PksJ is involved in some intermediate steps for the synthesis of the antibiotic polyketide bacillaene which is important in secondary metabolism. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380472 [Multi-domain] Cd Length: 430 Bit Score: 197.54 E-value: 1.20e-54
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 181 PLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKILDMENLNLEMV- 259
Cdd:cd20484 3 PLSEGQKGLWMLQKMSPEMSAYNVPLCFRFSSKLDVEKFKQACQFVLEQHPILKSVIEEEDGVPFQKIEPSKPLSFQEEd 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 260 ITNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQGDRVQLE 339
Cdd:cd20484 83 ISSLKESEIIAYLREKAKEPFVLENGPLMRVHLFSRSEQEHFVLITIHHIIFDGSSSLTLIHSLLDAYQALLQGKQPTLA 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 340 TLPVQYADYALWQQQLLGDETTPEslistQLDFWKEELKG-LPDqMELPTDYQRPVETSYRGETIHFHIDEGMHSRLVEL 418
Cdd:cd20484 163 SSPASYYDFVAWEQDMLAGAEGEE-----HRAYWKQQLSGtLPI-LELPADRPRSSAPSFEGQTYTRRLPSELSNQIKSF 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 419 GRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSGDPSFKELLNRVKQVNLAA 498
Cdd:cd20484 237 ARSQSINLSTVFLGIFKLLLHRYTGQEDIIVGMPTMGRPEERFDSLIGYFINMLPIRSRILGEETFSDFIRKLQLTVLDG 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 499 YENQDVPFERLVEVLNPVRTRNSHPLFQVMLAFQNTPEAT----FNAPD-----LEASLEIQSVGsaKFDLTFEISESNE 569
Cdd:cd20484 317 LDHAAYPFPAMVRDLNIPRSQANSPVFQVAFFYQNFLQSTslqqFLAEYqdvlsIEFVEGIHQEG--EYELVLEVYEQED 394
|
410 420 430 440
....*....|....*....|....*....|....*....|..
gi 1698252301 570 vDGTPNglhglLEFSTDLYKRETVQKLIERFILLLDDAATNP 611
Cdd:cd20484 395 -RFTLN-----IKYNPDLFDASTIERMMEHYVKLAEELIANP 430
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
676-1150 |
4.05e-54 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 196.89 E-value: 4.05e-54
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 676 RKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAG----YLPLDPDYPSDRISFMLHDAKPSCVLtnssve 751
Cdd:cd05922 1 LGVSAAASALLEAGGVRGERVVLILPNRFTYIELSFAVAYAGGRlglvFVPLNPTLKESVLRYLVADAGGRIVL------ 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 752 ieCDESLKILVDDVNVM--EEIEKYSEENIDEMECLK---PLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHW 826
Cdd:cd05922 75 --ADAGAADRLRDALPAspDPGTVLDADGIRAARASApahEVSHEDLALLLYTSGSTGSPKLVRLSHQNLLANARSIAEY 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 827 FQFDADDVW--TMFHSYAFDFSVWEIwgPLLYGGRLVVvpHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENE 904
Cdd:cd05922 153 LGITADDRAltVLPLSYDYGLSVLNT--HLLRGATLVL--TNDGVLDDAFWEDLREHGATGLAGVPSTYAMLTRLGFDPA 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 905 EVGqklSLRYVVFGGEALELSRLEDWYSRHPhnAPKVINMYGITETTVHVSYIELDESivsLRANSLIGCSIPDLKVYVL 984
Cdd:cd05922 229 KLP---SLRYLTQAGGRLPQETIARLRELLP--GAQVYVMYGQTEATRRMTYLPPERI---LEKPGSIGLAIPGGEFEIL 300
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 985 DNYLQPVPPGVVGEMYVAGAGLARGYLGRagltaERFIADPfGKPGTRMYrTGDLARWRQDGTLDYIGRADHQIKIRGFR 1064
Cdd:cd05922 301 DDDGTPTPPGEPGEIVHRGPNVMKGYWND-----PPYRRKE-GRGGGVLH-TGDLARRDEDGFLFIVGRRDRMIKLFGNR 373
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1065 IELGEIEAVIMKHDKVEQVAVIVREDQPGDkRLVAYIVASNNetIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGK 1144
Cdd:cd05922 374 ISPTEIEAAARSIGLIIEAAAVGLPDPLGE-KLALFVTAPDK--IDPKDVLRSLAERLPPYKVPATVRVVDELPLTASGK 450
|
....*.
gi 1698252301 1145 LDRKAL 1150
Cdd:cd05922 451 VDYAAL 456
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
659-1150 |
1.45e-52 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 193.30 E-value: 1.45e-52
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 659 SIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHD 738
Cdd:cd05926 5 ALVVPGSTPALTYADLAELVDDLARQLAALGIKKGDRVAIALPNGLEFVVAFLAAARAGAVVAPLNPAYKKAEFEFYLAD 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 739 AKPSCVLTNSSVEIECDES---LKILVDDVnvmeEIEKYSEENIDEMECLKPLAPSH-------------IAYVIYTSGS 802
Cdd:cd05926 85 LGSKLVLTPKGELGPASRAaskLGLAILEL----ALDVGVLIRAPSAESLSNLLADKknaksegvplpddLALILHTSGT 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 803 TGRPKGVMIPHQNVVRLLGATDHWFQFDADD----VWTMFHSYAFdfsVWEIWGPLLYGGRlVVVPHtvSRSPKEFLQLL 878
Cdd:cd05926 161 TGRPKGVPLTHRNLAASATNITNTYKLTPDDrtlvVMPLFHVHGL---VASLLSTLAAGGS-VVLPP--RFSASTFWPDV 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 879 VKEKVTVLNQTPSaFYQLMQADRENEEVGQKLSLRYVVFGGEALE---LSRLEDWYsrhphNAPkVINMYGITETTVHVS 955
Cdd:cd05926 235 RDYNATWYTAVPT-IHQILLNRPEPNPESPPPKLRFIRSCSASLPpavLEALEATF-----GAP-VLEAYGMTEAAHQMT 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 956 YIELDESIvslRANSLIGcsIPD-LKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmY 1034
Cdd:cd05926 308 SNPLPPGP---RKPGSVG--KPVgVEVRILDEDGEILPPGVVGEICLRGPNVTRGYLNNPEANAEAAFKDGW-------F 375
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1035 RTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEM 1114
Cdd:cd05926 376 RTGDLGYLDADGYLFLTGRIKELINRGGEKISPLEVDGVLLSHPAVLEAVAFGVPDEKYGEEVAAAVVLREGASVTEEEL 455
|
490 500 510
....*....|....*....|....*....|....*.
gi 1698252301 1115 RQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05926 456 RAFCRKHLAAFKVPKKVYFVDELPKTATGKIQRRKV 491
|
|
| MCS |
cd05941 |
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step ... |
658-1150 |
9.08e-52 |
|
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step reaction consisting of the adenylation of malonate with ATP, followed by malonyl transfer from malonyl-AMP to CoA. Malonic acid and its derivatives are the building blocks of polyketides and malonyl-CoA serves as the substrate of polyketide synthases. Malonyl-CoA synthetase has broad substrate tolerance and can activate a variety of malonyl acid derivatives. MCS may play an important role in biosynthesis of polyketides, the important secondary metabolites with therapeutic and agrochemical utility.
Pssm-ID: 341264 [Multi-domain] Cd Length: 442 Bit Score: 189.42 E-value: 9.08e-52
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 658 NSIAVVFEDKKLTYEKLNRKANKIARFLIAKG-VGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFML 736
Cdd:cd05941 1 DRIAIVDDGDSITYADLVARAARLANRLLALGkDLRGDRVAFLAPPSAEYVVAQLAIWRAGGVAVPLNPSYPLAELEYVI 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 737 HDAKPScvltnssveiecdeslkILVDDvnvmeeiekyseenidemeclkplapshiAYVIYTSGSTGRPKGVMIPHQNV 816
Cdd:cd05941 81 TDSEPS-----------------LVLDP-----------------------------ALILYTSGTTGRPKGVVLTHANL 114
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 817 ---VRLLgaTDHWfQFDADDVWT----MFHSYAFdfsVWEIWGPLLYGGRLVVVPHTvsrSPKEFLQLLVKEKVTVLNQT 889
Cdd:cd05941 115 aanVRAL--VDAW-RWTEDDVLLhvlpLHHVHGL---VNALLCPLFAGASVEFLPKF---DPKEVAISRLMPSITVFMGV 185
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 890 PSAFYQLMQADRENEEVGQKLS------LRYVVFGGEALELSRLEDWYSRHPHnapKVINMYGITETTVHVSyIELDESi 963
Cdd:cd05941 186 PTIYTRLLQYYEAHFTDPQFARaaaaerLRLMVSGSAALPVPTLEEWEAITGH---TLLERYGMTEIGMALS-NPLDGE- 260
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 964 vslRANSLIGCSIPDLKVYVLD-NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLARW 1042
Cdd:cd05941 261 ---RRPGTVGMPLPGVQARIVDeETGEPLPRGEVGEIQVRGPSVFKEYWNKPEATKEEFTDDGW-------FKTGDLGVV 330
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1043 RQDGTLDYIGR-ADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNN-ETIDTNEMRQHASG 1120
Cdd:cd05941 331 DEDGYYWILGRsSVDIIKSGGYKVSALEIERVLLAHPGVSECAVIGVPDPDWGERVVAVVVLRAGaAALSLEELKEWAKQ 410
|
490 500 510
....*....|....*....|....*....|
gi 1698252301 1121 SLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05941 411 RLAPYKRPRRLILVDELPRNAMGKVNKKEL 440
|
|
| FACL_DitJ_like |
cd05934 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
670-1151 |
1.40e-51 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Members of this family include DitJ from Pseudomonas and similar proteins.
Pssm-ID: 341257 [Multi-domain] Cd Length: 422 Bit Score: 188.27 E-value: 1.40e-51
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 670 TYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNss 749
Cdd:cd05934 5 TYAELLRESARIAAALAALGIRPGDRVALMLDNCPEFLFAWFALAKLGAVLVPINTALRGDELAYIIDHSGAQLVVVD-- 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 750 veiecdeslkilvddvnvmeeiekyseenidemeclkplapshIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQF 829
Cdd:cd05934 83 -------------------------------------------PASILYTSGTTGPPKGVVITHANLTFAGYYSARRFGL 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 830 DADDVW--TM--FHSYAfdfSVWEIWGPLLYGGRLVVVPHTvsrSPKEFLQLLVKEKVTVLNQTPSAFYQLM-QADRENE 904
Cdd:cd05934 120 GEDDVYltVLplFHINA---QAVSVLAALSVGATLVLLPRF---SASRFWSDVRRYGATVTNYLGAMLSYLLaQPPSPDD 193
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 905 EVGQklsLRyVVFGGEALElSRLEDWYSRHphnAPKVINMYGITETTVHVSyIELDESivslRANSLIGCSIPDLKVYVL 984
Cdd:cd05934 194 RAHR---LR-AAYGAPNPP-ELHEEFEERF---GVRLLEGYGMTETIVGVI-GPRDEP----RRPGSIGRPAPGYEVRIV 260
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 985 DNYLQPVPPGVVGEMYVAGA---GLARGYLGRAGLTAERFiadPFGkpgtrMYRTGDLARWRQDGTLDYIGRADHQIKIR 1061
Cdd:cd05934 261 DDDGQELPAGEPGELVIRGLrgwGFFKGYYNMPEATAEAM---RNG-----WFHTGDLGYRDADGFFYFVDRKKDMIRRR 332
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1062 GFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTP 1141
Cdd:cd05934 333 GENISSAEVERAILRHPAVREAAVVAVPDEVGEDEVKAVVVLRPGETLDPEELFAFCEGQLAYFKVPRYIRFVDDLPKTP 412
|
490
....*....|
gi 1698252301 1142 NGKLDRKALP 1151
Cdd:cd05934 413 TEKVAKAQLR 422
|
|
| BCL_4HBCL |
cd05959 |
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate ... |
657-1150 |
1.22e-49 |
|
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate CoA ligase and 4-hydroxybenzoate-coenzyme A ligase catalyze the first activating step for benzoate and 4-hydroxybenzoate catabolic pathways, respectively. Although these two enzymes share very high sequence homology, they have their own substrate preference. The reaction proceeds via a two-step process; the first ATP-dependent step forms the substrate-AMP intermediate, while the second step forms the acyl-CoA ester, releasing the AMP. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Some bacteria can use benzoic acid or benzenoid compounds as the sole source of carbon and energy through degradation. Benzoate CoA ligase and 4-hydroxybenzoate-Coenzyme A ligase are key enzymes of this process.
Pssm-ID: 341269 [Multi-domain] Cd Length: 508 Bit Score: 184.88 E-value: 1.22e-49
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFML 736
Cdd:cd05959 18 GDKTAFIDDAGSLTYAELEAEARRVAGALRALGVKREERVLLIMLDTVDFPTAFLGAIRAGIVPVPVNTLLTPDDYAYYL 97
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 737 HDAKPSCVLTNSSV------EIECDESLKILVDDVNVMEEIEKYS--EENIDEMECLKPLAPSH---IAYVIYTSGSTGR 805
Cdd:cd05959 98 EDSRARVVVVSGELapvlaaALTKSEHTLVVLIVSGGAGPEAGALllAELVAAEAEQLKPAATHaddPAFWLYSSGSTGR 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 806 PKGVMIPHQNVV--------RLLGATDhwfqfdaDDVW----TMFHSYAFDFSVWeiwGPLLYGGRLVVVPHTVSrsPKE 873
Cdd:cd05959 178 PKGVVHLHADIYwtaelyarNVLGIRE-------DDVCfsaaKLFFAYGLGNSLT---FPLSVGATTVLMPERPT--PAA 245
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 874 FLQLLVKEKVTVLNQTPsAFYQLMQADRENEEVGQKlSLRYVVFGGEALELSRLEDWYSRHPHNapkVINMYGITEttvh 953
Cdd:cd05959 246 VFKRIRRYRPTVFFGVP-TLYAAMLAAPNLPSRDLS-SLRLCVSAGEALPAEVGERWKARFGLD---ILDGIGSTE---- 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 954 VSYIELDESIVSLRANSlIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADpfgkpgtrM 1033
Cdd:cd05959 317 MLHIFLSNRPGRVRYGT-TGKPVPGYEVELRDEDGGDVADGEPGELYVRGPSSATMYWNNRDKTRDTFQGE--------W 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1034 YRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIV---ASNNETID 1110
Cdd:cd05959 388 TRTGDKYVRDDDGFYTYAGRADDMLKVSGIWVSPFEVESALVQHPAVLEAAVVGVEDEDGLTKPKAFVVlrpGYEDSEAL 467
|
490 500 510 520
....*....|....*....|....*....|....*....|
gi 1698252301 1111 TNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05959 468 EEELKEFVKDRLAPYKYPRWIVFVDELPKTATGKIQRFKL 507
|
|
| CHC_CoA_lg |
cd05903 |
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); ... |
669-1145 |
9.60e-49 |
|
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); Cyclohexanecarboxylate-CoA ligase activates the aliphatic ring compound, cyclohexanecarboxylate, for degradation. It catalyzes the synthesis of cyclohexanecarboxylate-CoA thioesters in a two-step reaction involving the formation of cyclohexanecarboxylate-AMP anhydride, followed by the nucleophilic substitution of AMP by CoA.
Pssm-ID: 341229 [Multi-domain] Cd Length: 437 Bit Score: 180.65 E-value: 9.60e-49
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPscvltns 748
Cdd:cd05903 2 LTYSELDTRADRLAAGLAALGVGPGDVVAFQLPNWWEFAVLYLACLRIGAVTNPILPFFREHELAFILRRAKA------- 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 749 sveiecdeslKILVddvnVMEEiekYSEENIDEMeclkplaPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGA-TDHWF 827
Cdd:cd05903 75 ----------KVFV----VPER---FRQFDPAAM-------PDAVALLLFTSGTTGEPKGVMHSHNTLSASIRQyAERLG 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 828 QFDADDVWT---MFHSYAFdfsVWEIWGPLLYGGRLVVVPhtvSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADrenE 904
Cdd:cd05903 131 LGPGDVFLVaspMAHQTGF---VYGFTLPLLLGAPVVLQD---IWDPDKALALMREHGVTFMMGATPFLTDLLNAV---E 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 905 EVGQKLS-LRYVVFGGEALELSRLEDWYSRhphNAPKVINMYGITETTVHVSYIELDESIVSLRANsliGCSIPDLKVYV 983
Cdd:cd05903 202 EAGEPLSrLRTFVCGGATVPRSLARRAAEL---LGAKVCSAYGSTECPGAVTSITPAPEDRRLYTD---GRPLPGVEIKV 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 984 LDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAErfiADPFGkpgtrMYRTGDLARWRQDGTLDYIGRADHQIkIR-G 1062
Cdd:cd05903 276 VDDTGATLAPGVEGELLSRGPSVFLGYLDRPDLTAD---AAPEG-----WFRTGDLARLDEDGYLRITGRSKDII-IRgG 346
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1063 FRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGS-LPDYMVPYAFVVVNELPLTP 1141
Cdd:cd05903 347 ENIPVLEVEDLLLGHPGVIEAAVVALPDERLGERACAVVVTKSGALLTFDELVAYLDRQgVAKQYWPERLVHVDDLPRTP 426
|
....
gi 1698252301 1142 NGKL 1145
Cdd:cd05903 427 SGKV 430
|
|
| menE |
TIGR01923 |
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, ... |
670-1150 |
1.59e-48 |
|
O-succinylbenzoate-CoA ligase; This model represents an enzyme, O-succinylbenzoate-CoA ligase, which is involved in the fourth step of the menaquinone biosynthesis pathway. O-succinylbenzoate-CoA ligase, together with menB - naphtoate synthase, take 2-succinylbenzoate and convert it into 1,4-di-hydroxy-2- naphtoate. [Biosynthesis of cofactors, prosthetic groups, and carriers, Menaquinone and ubiquinone]
Pssm-ID: 162605 [Multi-domain] Cd Length: 436 Bit Score: 179.95 E-value: 1.59e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 670 TYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNSS 749
Cdd:TIGR01923 1 TWQDLDCEAAHLAKALKAQGIRSGSRVALVGQNSIEMVLLLHACLLLGAEIAMLNTRLTENERTNQLEDLDVQLLLTDSL 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 750 VEIEcdeslKILVDDVNvmeEIEKYSEENIdEMECLKPLapSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQF 829
Cdd:TIGR01923 81 LEEK-----DFQADSLD---RIEAAGRYET-SLSASFNM--DQIATLMFTSGTTGKPKAVPHTFRNHYASAVGSKENLGF 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 830 DADDVW----TMFHSYAFdfSVweIWGPLLYGGRLVVVphtvsrSPK-EFLQLLVKEKVTVLNQTPSAFYQLMQADRENE 904
Cdd:TIGR01923 150 TEDDNWllslPLYHISGL--SI--LFRWLIEGATLRIV------DKFnQLLEMIANERVTHISLVPTQLNRLLDEGGHNE 219
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 905 evgqklSLRYVVFGGEALELSRLEDWYSRhphNAPkVINMYGITETTVHVSYIELDESIVSLRANS-LIGCSIpdlKVYV 983
Cdd:TIGR01923 220 ------NLRKILLGGSAIPAPLIEEAQQY---GLP-IYLSYGMTETCSQVTTATPEMLHARPDVGRpLAGREI---KIKV 286
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 984 lDNYLQpvppgvVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmyRTGDLARWRQDGTLDYIGRADHQIKIRGF 1063
Cdd:TIGR01923 287 -DNKEG------HGEIMVKGANLMKGYLYQGELTPAFEQQGWF--------NTGDIGELDGEGFLYVLGRRDDLIISGGE 351
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1064 RIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVAsnNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNG 1143
Cdd:TIGR01923 352 NIYPEEIETVLYQHPGIQEAVVVPKPDAEWGQVPVAYIVS--ESDISQAKLIAYLTEKLAKYKVPIAFEKLDELPYNASG 429
|
....*..
gi 1698252301 1144 KLDRKAL 1150
Cdd:TIGR01923 430 KILRNQL 436
|
|
| PRK03640 |
PRK03640 |
o-succinylbenzoate--CoA ligase; |
643-1150 |
1.71e-48 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 235146 [Multi-domain] Cd Length: 483 Bit Score: 180.93 E-value: 1.71e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 643 MTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLP 722
Cdd:PRK03640 2 ETMPNWLKQRAFLTPDRTAIEFEEKKVTFMELHEAVVSVAGKLAALGVKKGDRVALLMKNGMEMILVIHALQQLGAVAVL 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 723 LDPDYPSDRISFMLHDAKPSCVLTNSSVEIECDESLKILVDDVNVMEEIEKYSEENIDEMEclkplapshIAYVIYTSGS 802
Cdd:PRK03640 82 LNTRLSREELLWQLDDAEVKCLITDDDFEAKLIPGISVKFAELMNGPKEEAEIQEEFDLDE---------VATIMYTSGT 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 803 TGRPKGVMIPHQNvvrllgatdHWFQ---------FDADDVW----TMFHsyafdfsvweIWG------PLLYGGRLVVV 863
Cdd:PRK03640 153 TGKPKGVIQTYGN---------HWWSavgsalnlgLTEDDCWlaavPIFH----------ISGlsilmrSVIYGMRVVLV 213
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 864 PHTvsrSPKEFLQLLVKEKVTVLNQTPSAFYQLMQadrENEEVGQKLSLRYVVFGGEALELSRLEDwySRHpHNAPkVIN 943
Cdd:PRK03640 214 EKF---DAEKINKLLQTGGVTIISVVSTMLQRLLE---RLGEGTYPSSFRCMLLGGGPAPKPLLEQ--CKE-KGIP-VYQ 283
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 944 MYGITETTVHVSYIELDESIVSLRA--NSLIGCSIPdlkvyVLDNyLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERF 1021
Cdd:PRK03640 284 SYGMTETASQIVTLSPEDALTKLGSagKPLFPCELK-----IEKD-GVVVPPFEEGEIVVKGPNVTKGYLNREDATRETF 357
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1022 IADPFgkpgtrmyRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYI 1101
Cdd:PRK03640 358 QDGWF--------KTGDIGYLDEEGFLYVLDRRSDLIISGGENIYPAEIEEVLLSHPGVAEAGVVGVPDDKWGQVPVAFV 429
|
490 500 510 520
....*....|....*....|....*....|....*....|....*....
gi 1698252301 1102 VASnnETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK03640 430 VKS--GEVTEEELRHFCEEKLAKYKVPKRFYFVEELPRNASGKLLRHEL 476
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
661-1150 |
5.67e-48 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 178.04 E-value: 5.67e-48
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 661 AVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAK 740
Cdd:cd05919 3 AFYAADRSVTYGQLHDGANRLGSALRNLGVSSGDRVLLLMLDSPELVQLFLGCLARGAIAVVINPLLHPDDYAYIARDCE 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 741 PSCVLTNSsveiecdeslkilvDDvnvmeeiekyseenidemeclkplapshIAYVIYTSGSTGRPKGVMIPHQNvvrLL 820
Cdd:cd05919 83 ARLVVTSA--------------DD----------------------------IAYLLYSSGTTGPPKGVMHAHRD---PL 117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 821 GATDHW----FQFDADDVW----TMFHSYAFDFSVWeiwGPLLYGGRLVVVPhtVSRSPKEFLQLLVKEKVTVLNQTPSA 892
Cdd:cd05919 118 LFADAMareaLGLTPGDRVfssaKMFFGYGLGNSLW---FPLAVGASAVLNP--GWPTAERVLATLARFRPTVLYGVPTF 192
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 893 FYQLM-QADRENEEVGqklSLRYVVFGGEALELSRLEDWYSrhpHNAPKVINMYGITEttvhVSYIELDESIVSLRANSL 971
Cdd:cd05919 193 YANLLdSCAGSPDALR---SLRLCVSAGEALPRGLGERWME---HFGGPILDGIGATE----VGHIFLSNRPGAWRLGST 262
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 972 iGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADpfgkpgtrMYRTGDLARWRQDGTLDYI 1051
Cdd:cd05919 263 -GRPVPGYEIRLVDEEGHTIPPGEEGDLLVRGPSAAVGYWNNPEKSRATFNGG--------WYRTGDKFCRDADGWYTHA 333
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1052 GRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMR---QHASGSLPDYMVP 1128
Cdd:cd05919 334 GRADDMLKVGGQWVSPVEVESLIIQHPAVAEAAVVAVPESTGLSRLTAFVVLKSPAAPQESLARdihRHLLERLSAHKVP 413
|
490 500
....*....|....*....|..
gi 1698252301 1129 YAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05919 414 RRIAFVDELPRTATGKLQRFKL 435
|
|
| MACS_like |
cd05972 |
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of ... |
669-1150 |
4.72e-47 |
|
Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes.
Pssm-ID: 341276 [Multi-domain] Cd Length: 428 Bit Score: 175.22 E-value: 4.72e-47
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNS 748
Cdd:cd05972 1 WSFRELKRESAKAANVLAKLGLRKGDRVAVLLPRVPELWAVILAVIKLGAVYVPLTTLLGPKDIEYRLEAAGAKAIVTDA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 749 sveiecdeslkilvDDvnvmeeiekyseenidemeclkplapshIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQ 828
Cdd:cd05972 81 --------------ED----------------------------PALIYFTSGTTGLPKGVLHTHSYPLGHIPTAAYWLG 118
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 829 FDADDV-WTMfHSYAFDFSVW-EIWGPLLYGgrLVVVPHTVSR-SPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENee 905
Cdd:cd05972 119 LRPDDIhWNI-ADPGWAKGAWsSFFGPWLLG--ATVFVYEGPRfDAERILELLERYGVTSFCGPPTAYRMLIKQDLSS-- 193
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 906 vGQKLSLRYVVFGGEALELSRLEDWYSrhpHNAPKVINMYGITETTVHVSyielDESIVSLRANSlIGCSIPDLKVYVLD 985
Cdd:cd05972 194 -YKFSHLRLVVSAGEPLNPEVIEWWRA---ATGLPIRDGYGQTETGLTVG----NFPDMPVKPGS-MGRPTPGYDVAIID 264
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 986 NYLQPVPPGVVGEMYV--AGAGLARGYLGRAGLTAERFIADpfgkpgtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGF 1063
Cdd:cd05972 265 DDGRELPPGEEGDIAIklPPPGLFLGYVGDPEKTEASIRGD--------YYLTGDRAYRDEDGYFWFVGRADDIIKSSGY 336
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1064 RIELGEIEAVIMKHDKVEQVAVIVREDqPGDKRLV-AYIVASNNET---IDTNEMRQHASGSLPDYMVPYAFVVVNELPL 1139
Cdd:cd05972 337 RIGPFEVESALLEHPAVAEAAVVGSPD-PVRGEVVkAFVVLTSGYEpseELAEELQGHVKKVLAPYKYPREIEFVEELPK 415
|
490
....*....|.
gi 1698252301 1140 TPNGKLDRKAL 1150
Cdd:cd05972 416 TISGKIRRVEL 426
|
|
| MACS_like_4 |
cd05969 |
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most ... |
669-1154 |
3.27e-45 |
|
Uncharacterized subfamily of Acetyl-CoA synthetase like family (ACS); This family is most similar to acetyl-CoA synthetase. Acetyl-CoA synthetase (ACS) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is only present in bacteria.
Pssm-ID: 341273 [Multi-domain] Cd Length: 442 Bit Score: 170.38 E-value: 3.27e-45
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTns 748
Cdd:cd05969 1 YTFAQLKVLSARFANVLKSLGVGKGDRVFVLSPRSPELYFSMLGIGKIGAVICPLFSAFGPEAIRDRLENSEAKVLIT-- 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 749 sveiecdeslkilvddvnvmeeiekySEENIDEMEclkplaPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQ 828
Cdd:cd05969 79 --------------------------TEELYERTD------PEDPTLLHYTSGTTGTPKGVLHVHDAMIFYYFTGKYVLD 126
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 829 FDADDV--------WTMFHSYAfdfsvweIWGPLLYGGRLVVVPHTVSrsPKEFLQLLVKEKVTVLNQTPSAFYQLMQAD 900
Cdd:cd05969 127 LHPDDIywctadpgWVTGTVYG-------IWAPWLNGVTNVVYEGRFD--AESWYGIIERVKVTVWYTAPTAIRMLMKEG 197
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 901 RENEEVGQKLSLRYVVFGGEAL--ELSRledwYSRHPHNAPkVINMYGITETTVHV--SYIELDESIVSLransliGCSI 976
Cdd:cd05969 198 DELARKYDLSSLRFIHSVGEPLnpEAIR----WGMEVFGVP-IHDTWWQTETGSIMiaNYPCMPIKPGSM------GKPL 266
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 977 PDLKVYVLDNYLQPVPPGVVGEMYVAGA--GLARGYLGRAGLTAERFIadpfgkpgTRMYRTGDLARWRQDGTLDYIGRA 1054
Cdd:cd05969 267 PGVKAAVVDENGNELPPGTKGILALKPGwpSMFRGIWNDEERYKNSFI--------DGWYLTGDLAYRDEDGYFWFVGRA 338
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1055 DHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIV-ASNNETIDT--NEMRQHASGSLPDYMVPYAF 1131
Cdd:cd05969 339 DDIIKTSGHRVGPFEVESALMEHPAVAEAGVIGKPDPLRGEIIKAFISlKEGFEPSDElkEEIINFVRQKLGAHVAPREI 418
|
490 500
....*....|....*....|...
gi 1698252301 1132 VVVNELPLTPNGKLDRKALPAPE 1154
Cdd:cd05969 419 EFVDNLPKTRSGKIMRRVLKAKE 441
|
|
| MACS_like_3 |
cd05971 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
667-1150 |
3.50e-45 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341275 [Multi-domain] Cd Length: 439 Bit Score: 169.92 E-value: 3.50e-45
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 667 KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLT 746
Cdd:cd05971 5 EKVTFKELKTASNRFANVLKEIGLEKGDRVGVFLSQGPECAIAHIAILRSGAIAVPLFALFGPEALEYRLSNSGASALVT 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 747 nssveiecDESlkilvDDvnvmeeiekyseenidemeclkplapshIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHW 826
Cdd:cd05971 85 --------DGS-----DD----------------------------PALIIYTSGTTGPPKGALHAHRVLLGHLPGVQFP 123
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 827 FQF---DADDVWTMfHSYAFDFSVWEIWGPLLYGGrLVVVPHTVSR-SPKEFLQLLVKEKVTVLNQTPSAFyQLMQADRE 902
Cdd:cd05971 124 FNLfprDGDLYWTP-ADWAWIGGLLDVLLPSLYFG-VPVLAHRMTKfDPKAALDLMSRYGVTTAFLPPTAL-KMMRQQGE 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 903 NEEVGQkLSLRYVVFGGEALElSRLEDWYSRHPHNApkVINMYGITETTVHVSyielDESIVSLRANSLIGCSIPDLKVY 982
Cdd:cd05971 201 QLKHAQ-VKLRAIATGGESLG-EELLGWAREQFGVE--VNEFYGQTECNLVIG----NCSALFPIKPGSMGKPIPGHRVA 272
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 983 VLDNYLQPVPPGVVGEMYV----AGAGLarGYLGRAGLTAERFIADPFgkpgtrmyRTGDLARWRQDGTLDYIGRADHQI 1058
Cdd:cd05971 273 IVDDNGTPLPPGEVGEIAVelpdPVAFL--GYWNNPSATEKKMAGDWL--------LTGDLGRKDSDGYFWYVGRDDDVI 342
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1059 KIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETID---TNEMRQHASGSLPDYMVPYAFVVVN 1135
Cdd:cd05971 343 TSSGYRIGPAEIEECLLKHPAVLMAAVVGIPDPIRGEIVKAFVVLNPGETPSdalAREIQELVKTRLAAHEYPREIEFVN 422
|
490
....*....|....*
gi 1698252301 1136 ELPLTPNGKLDRKAL 1150
Cdd:cd05971 423 ELPRTATGKIRRREL 437
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1-389 |
6.65e-44 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 176.30 E-value: 6.65e-44
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDrpndKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPAP 80
Cdd:PRK12316 928 LLEHPWVREAAVLAVDG----KQLVGYVVLESEGGDWREALKAHLAASLPEYMVPAQWLALERLPLTPNGKLDRKALPAP 1003
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 81 DFNGMNNERVA-RNPKEEILCDLFAEVLGVSRINIDDNFFEMGGHSLLASRLMARIRETlSVELGIGKLFESPTVAELAk 159
Cdd:PRK12316 1004 EASVAQQGYVApRNALERTLAAIWQDVLGVERVGLDDNFFELGGDSIVSIQVVSRARQA-GIQLSPRDLFQHQTIRSLA- 1081
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 160 QLNHAKSArPAIQKASRPNEVPLSFAQRrlWFlncLEGPSPT---YNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTI 236
Cdd:PRK12316 1082 LVAKAGQA-TAADQGPASGEVALAPVQR--WF---FEQAIPQrqhWNQSLLLQARQPLDPDRLGRALERLVAHHDALRLR 1155
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 237 FPNVLGSSYQKILDMENLNLEMVITNTCKDELESVLSEAVRySFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSL 316
Cdd:PRK12316 1156 FREEDGGWQQAYAAPQAGEVLWQRQAASEEELLALCEEAQR-SLDLEQGPLLRALLVDMADGSQRLLLVIHHLVVDGVSW 1234
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1698252301 317 QPLTRDFTAAYkarcqgdRVQLETLPVQYADYALWQQQLLGDETTpeslISTQLDFWKEELKGLPDqmELPTD 389
Cdd:PRK12316 1235 RILLEDLQRAY-------ADLDADLPARTSSYQAWARRLHEHAGA----RAEELDYWQAQLEDAPH--ELPCE 1294
|
|
| EntE |
COG1021 |
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase ... |
644-1150 |
1.03e-43 |
|
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440644 [Multi-domain] Cd Length: 533 Bit Score: 168.02 E-value: 1.03e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 644 TLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAgyLPL 723
Cdd:COG1021 26 TLGDLLRRRAERHPDRIAVVDGERRLSYAELDRRADRLAAGLLALGLRPGDRVVVQLPNVAEFVIVFFALFRAGA--IPV 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 724 DPdYPSDR---ISFMLHDAKPSCVLTNSSVE-----------IECDESLK--ILVDDVNVMEEIEKYSEENIDEMEClkP 787
Cdd:COG1021 104 FA-LPAHRraeISHFAEQSEAVAYIIPDRHRgfdyralarelQAEVPSLRhvLVVGDAGEFTSLDALLAAPADLSEP--R 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 788 LAPSHIAYVIYTSGSTGRPKgvMIP--HQ----NV---VRLLGatdhwfqFDADDVW----TMFHSYAFdfSVWEIWGPL 854
Cdd:COG1021 181 PDPDDVAFFQLSGGTTGLPK--LIPrtHDdylySVrasAEICG-------LDADTVYlaalPAAHNFPL--SSPGVLGVL 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 855 LYGGRLVVVPhtvSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQA-DRENEEVGqklSLRYVVFGGealelSRLEdwysr 933
Cdd:COG1021 250 YAGGTVVLAP---DPSPDTAFPLIERERVTVTALVPPLALLWLDAaERSRYDLS---SLRVLQVGG-----AKLS----- 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 934 hPHNAPKVINMYGITETTVH------VSYIELDESiVSLRANSlIGCSI-PDLKVYVLDNYLQPVPPGVVGEMYVAGAGL 1006
Cdd:COG1021 314 -PELARRVRPALGCTLQQVFgmaeglVNYTRLDDP-EEVILTT-QGRPIsPDDEVRIVDEDGNPVPPGEVGELLTRGPYT 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1007 ARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIkIRGfrielGE------IEAVIMKHDKV 1080
Cdd:COG1021 391 IRGYYRAPEHNARAFTPDGF-------YRTGDLVRRTPDGYLVVEGRAKDQI-NRG-----GEkiaaeeVENLLLAHPAV 457
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1698252301 1081 EQVAVIVREDQPGDKRLVAYIVAsNNETIDTNEMRQH--ASGsLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:COG1021 458 HDAAVVAMPDEYLGERSCAFVVP-RGEPLTLAELRRFlrERG-LAAFKLPDRLEFVDALPLTAVGKIDKKAL 527
|
|
| 4CL |
cd05904 |
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the ... |
669-1150 |
1.17e-43 |
|
4-Coumarate-CoA Ligase (4CL); 4-Coumarate:coenzyme A ligase is a key enzyme in the phenylpropanoid metabolic pathway for monolignol and flavonoid biosynthesis. It catalyzes the synthesis of hydroxycinnamate-CoA thioesters in a two-step reaction, involving the formation of hydroxycinnamate-AMP anhydride and the nucleophilic substitution of AMP by CoA. The phenylpropanoid pathway is one of the most important secondary metabolism pathways in plants and hydroxycinnamate-CoA thioesters are the precursors of lignin and other important phenylpropanoids.
Pssm-ID: 341230 [Multi-domain] Cd Length: 505 Bit Score: 167.41 E-value: 1.17e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNS 748
Cdd:cd05904 33 LTYAELERRVRRLAAGLAKRGGRKGDVVLLLSPNSIEFPVAFLAVLSLGAVVTTANPLSTPAEIAKQVKDSGAKLAFTTA 112
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 749 SVEiecdESLKILVDDVNVMEEIEKYSEENIDEMECLKPLAP-------SHIAYVIYTSGSTGRPKGVMIPHQNVVRLLg 821
Cdd:cd05904 113 ELA----EKLASLALPVVLLDSAEFDSLSFSDLLFEADEAEPpvvvikqDDVAALLYSSGTTGRSKGVMLTHRNLIAMV- 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 822 ATDHWF---QFDADDVW----TMFHSYAFdfsVWEIWGPLLYGGRLVVVPHTVSRspkEFLQLLVKEKVTVLNQTPSAFY 894
Cdd:cd05904 188 AQFVAGegsNSDSEDVFlcvlPMFHIYGL---SSFALGLLRLGATVVVMPRFDLE---ELLAAIERYKVTHLPVVPPIVL 261
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 895 QLmqADRENEEVGQKLSLRYVVFGGEALELSRLEDWYSRHPHnaPKVINMYGITETTVHVSYIELDESiVSLRANSlIGC 974
Cdd:cd05904 262 AL--VKSPIVDKYDLSSLRQIMSGAAPLGKELIEAFRAKFPN--VDLGQGYGMTESTGVVAMCFAPEK-DRAKYGS-VGR 335
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 975 SIPDLKVYVLD-NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGR 1053
Cdd:cd05904 336 LVPNVEAKIVDpETGESLPPNQTGELWIRGPSIMKGYLNNPEATAATIDKEGW-------LHTGDLCYIDEDGYLFIVDR 408
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1054 ADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLpdymVPY---- 1129
Cdd:cd05904 409 LKELIKYKGFQVAPAELEALLLSHPEILDAAVIPYPDEEAGEVPMAFVVRKPGSSLTEDEIMDFVAKQV----APYkkvr 484
|
490 500
....*....|....*....|...
gi 1698252301 1130 --AFvvVNELPLTPNGKLDRKAL 1150
Cdd:cd05904 485 kvAF--VDAIPKSPSGKILRKEL 505
|
|
| 23DHB-AMP_lg |
cd05920 |
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2, ... |
644-1150 |
3.31e-43 |
|
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2,3-dihydroxybenzoate (DHB) by ligation of AMP from ATP with the release of pyrophosphate. However, it can also catalyze the ATP-PPi exchange for 2,3-DHB analogs, such as salicyclic acid (o-hydrobenzoate), as well as 2,4-DHB and 2,5-DHB, but with less efficiency. Proteins in this family are the stand-alone adenylation components of non-ribosomal peptide synthases (NRPSs) involved in the biosynthesis of siderophores, which are low molecular weight iron-chelating compounds synthesized by many bacteria to aid in the acquisition of this vital trace elements. In Escherichia coli, the 2,3-dihydroxybenzoate-AMP ligase is called EntE, the adenylation component of the enterobactin NRPS system.
Pssm-ID: 341244 [Multi-domain] Cd Length: 482 Bit Score: 165.19 E-value: 3.31e-43
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 644 TLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAgyLPL 723
Cdd:cd05920 16 PLGDLLARSAARHPDRIAVVDGDRRLTYRELDRRADRLAAGLRGLGIRPGDRVVVQLPNVAEFVVLFFALLRLGA--VPV 93
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 724 DPdYPSDRISFMLHDAKPScvltnssveiecdESLKILVDDVNvmeeiekyseENIDEMECLKPLAPSH--IAYVIYTSG 801
Cdd:cd05920 94 LA-LPSHRRSELSAFCAHA-------------EAVAYIVPDRH----------AGFDHRALARELAESIpeVALFLLSGG 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 802 STGRPKgvMIP--HQNVVRLLGATDHWFQFDADDVWTMFHSYAFDF--SVWEIWGPLLYGGRLVVVPhtvSRSPKEFLQL 877
Cdd:cd05920 150 TTGTPK--LIPrtHNDYAYNVRASAEVCGLDQDTVYLAVLPAAHNFplACPGVLGTLLAGGRVVLAP---DPSPDAAFPL 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 878 LVKEKVTVLNQTPSAFYQLMQAdrENEEVGQKLSLRYVVFGGealelSRLEDWYSR--HPHNAPKVINMYGITETTVhvS 955
Cdd:cd05920 225 IEREGVTVTALVPALVSLWLDA--AASRRADLSSLRLLQVGG-----ARLSPALARrvPPVLGCTLQQVFGMAEGLL--N 295
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 956 YIELDES---IVSLRANSLIgcsiPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtr 1032
Cdd:cd05920 296 YTRLDDPdevIIHTQGRPMS----PDDEIRVVDEEGNPVPPGEEGELLTRGPYTIRGYYRAPEHNARAFTPDGF------ 365
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1033 mYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVAsNNETIDTN 1112
Cdd:cd05920 366 -YRTGDLVRRTPDGYLVVEGRIKDQINRGGEKIAAEEVENLLLRHPAVHDAAVVAMPDELLGERSCAFVVL-RDPPPSAA 443
|
490 500 510
....*....|....*....|....*....|....*....
gi 1698252301 1113 EMRQHASG-SLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05920 444 QLRRFLRErGLAAYKLPDRIEFVDSLPLTAVGKIDKKAL 482
|
|
| entF |
PRK10252 |
enterobactin non-ribosomal peptide synthetase EntF; |
1-162 |
1.12e-42 |
|
enterobactin non-ribosomal peptide synthetase EntF;
Pssm-ID: 236668 [Multi-domain] Cd Length: 1296 Bit Score: 171.38 E-value: 1.12e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPND------KRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDR 74
Cdd:PRK10252 879 MQALPDVEQAVTHACVINQAAatggdaRQLVGYLVSQSGLPLDTSALQAQLRERLPPHMVPVVLLQLDQLPLSANGKLDR 958
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 75 KKLPAPDFNGMNNERVARNPKEEILCDLFAEVLGVSRINIDDNFFEMGGHSLLASRLMARIRETLSVELGIGKLFESPTV 154
Cdd:PRK10252 959 KALPLPELKAQVPGRAPKTGTETIIAAAFSSLLGCDVVDADADFFALGGHSLLAMKLAAQLSRQFARQVTPGQVMVASTV 1038
|
....*...
gi 1698252301 155 AELAKQLN 162
Cdd:PRK10252 1039 AKLATLLD 1046
|
|
| PRK12467 |
PRK12467 |
peptide synthase; Provisional |
1-355 |
1.13e-42 |
|
peptide synthase; Provisional
Pssm-ID: 237108 [Multi-domain] Cd Length: 3956 Bit Score: 172.27 E-value: 1.13e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVReDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPAP 80
Cdd:PRK12467 3513 LLQHPSVREAVVLAR-DGAGGKQLVAYVVPADPQGDWRETLRDHLAASLPDYMVPAQLLVLAAMPLGPNGKVDRKALPDP 3591
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 81 DFNGMNNERVARNPKEEILCDLFAEVLGVSRINIDDNFFEMGGHSLLASRLMARIRETLSVELGIGKLFESPTVAELAkq 160
Cdd:PRK12467 3592 DAKGSREYVAPRSEVEQQLAAIWADVLGVEQVGVTDNFFELGGDSLLALQVLSRIRQSLGLKLSLRDLMSAPTIAELA-- 3669
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 161 lnhaksarpaiqkasrpnevplsfaqrrlwflncleGPSPTYNIPLvirmNGILNRQALQGAFYDVVEKHETLRTIFpnv 240
Cdd:PRK12467 3670 ------------------------------------GYSPLGDVPV----NLLLDLNRLETGFPALFCRHEGLGTVF--- 3706
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 241 lgssyqkildmenlnlemvitntckdelesvlseavrysfnlDFEPAVRLqlftVSENEHVLLILLHHIVGDGWSlqplt 320
Cdd:PRK12467 3707 ------------------------------------------DYEPLAVI----LEGDRHVLGLTCRHLLDDGWQ----- 3735
|
330 340 350
....*....|....*....|....*....|....*
gi 1698252301 321 rdftaaykarcqgdRVQLETLPVQYADYALWQQQL 355
Cdd:PRK12467 3736 --------------DTSLQAMAVQYADYILWQQAK 3756
|
|
| starter-C_NRPS |
cd19533 |
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases ... |
181-611 |
1.36e-42 |
|
Starter Condensation domains, found in the first module of nonribosomal peptide synthetases (NRPSs); Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. While standard C-domains catalyze peptide bond formation between two amino acids, an initial, ('starter') C-domain may instead acylate an amino acid with a fatty acid. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380456 [Multi-domain] Cd Length: 419 Bit Score: 161.77 E-value: 1.36e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 181 PLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKILDMENLNLEMVI 260
Cdd:cd19533 3 PLTSAQRGVWFAEQLDPEGSIYNLAEYLEITGPVDLAVLERALRQVIAEAETLRLRFTEEEGEPYQWIDPYTPVPIRHID 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 261 TNTCKDELESVLS---EAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQGDRVQ 337
Cdd:cd19533 83 LSGDPDPEGAAQQwmqEDLRKPLPLDNDPLFRHALFTLGDNRHFWYQRVHHIVMDGFSFALFGQRVAEIYTALLKGRPAP 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 338 LETLPvQYADYALWQQQLLGDEttpesliSTQLD--FWKEELKGLPDQMELPTDYQRPVeTSYRGETIHFhiDEGMHSRL 415
Cdd:cd19533 163 PAPFG-SFLDLVEEEQAYRQSE-------RFERDraFWTEQFEDLPEPVSLARRAPGRS-LAFLRRTAEL--PPELTRTL 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 416 VELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLRTNTSGDPSFKELLNRVKQVN 495
Cdd:cd19533 232 LEAAEAHGASWPSFFIALVAAYLHRLTGANDVVLGVPVMGRLGAAARQTPGMVANTLPLRLTVDPQQTFAELVAQVSREL 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 496 LAAYENQDVPFERLVEVLNpvRTRNSHPLFQVMLAFQnTPEATFNAPDLEASLEIQSVGSAKfDLTFEISEsnevDGTPN 575
Cdd:cd19533 312 RSLLRHQRYRYEDLRRDLG--LTGELHPLFGPTVNYM-PFDYGLDFGGVVGLTHNLSSGPTN-DLSIFVYD----RDDES 383
|
410 420 430
....*....|....*....|....*....|....*.
gi 1698252301 576 GLHGLLEFSTDLYKRETVQKLIERFILLLDDAATNP 611
Cdd:cd19533 384 GLRIDFDANPALYSGEDLARHQERLLRLLEEAAADP 419
|
|
| LC_FACS_like |
cd05935 |
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain ... |
669-1150 |
2.54e-42 |
|
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain fatty acyl-CoA synthetases, which catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters.
Pssm-ID: 341258 [Multi-domain] Cd Length: 430 Bit Score: 161.49 E-value: 2.54e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNS 748
Cdd:cd05935 2 LTYLELLEVVKKLASFLSNKGVRKGDRVGICLQNSPQYVIAYFAIWRANAVVVPINPMLKERELEYILNDSGAKVAVVGS 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 749 SVEiecdeslkilvddvnvmeeiekyseenidemeclkplapsHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQ 828
Cdd:cd05935 82 ELD----------------------------------------DLALIPYTSGTTGLPKGCMHTHFSAAANALQSAVWTG 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 829 FDADDVWT----MFHSYAFDFSVWeiwGPLLYGGRLVVVphtvSRSPKEFL-QLLVKEKVTVLNQTPSAFYQLMqADREN 903
Cdd:cd05935 122 LTPSDVILaclpLFHVTGFVGSLN---TAVYVGGTYVLM----ARWDRETAlELIEKYKVTFWTNIPTMLVDLL-ATPEF 193
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 904 EEVGQKlSLRYVVFGGEALELSRLEDWYSRhphNAPKVINMYGITETtvhvsyieLDESIVSLRANSLIGC-SIP----D 978
Cdd:cd05935 194 KTRDLS-SLKVLTGGGAPMPPAVAEKLLKL---TGLRFVEGYGLTET--------MSQTHTNPPLRPKLQClGIP*fgvD 261
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 979 LKVYVLDNyLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPfgkpGTRMYRTGDLARWRQDGTLDYIGRADHQI 1058
Cdd:cd05935 262 ARVIDIET-GRELPPNEVGEIVVRGPQIFKGYWNRPEETEESFIEIK----GRRFFRTGDLGYMDEEGYFFFVDRVKRMI 336
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1059 KIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIV--ASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNE 1136
Cdd:cd05935 337 NVSGFKVWPAEVEAKLYKHPAI*EVCVISVPDERVGEEVKAFIVlrPEYRGKVTEEDIIEWAREQMAAYKYPREVEFVDE 416
|
490
....*....|....
gi 1698252301 1137 LPLTPNGKLDRKAL 1150
Cdd:cd05935 417 LPRSASGKILWRLL 430
|
|
| CBAL |
cd05923 |
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) ... |
656-1150 |
3.10e-42 |
|
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) to 4-chlorobenzoyl-coenzyme A (4-CB-CoA) by the two-step adenylation and thioester-forming reactions. 4-Chlorobenzoate (4-CBA) is an environmental pollutant derived from microbial breakdown of aromatic pollutants, such as polychlorinated biphenyls (PCBs), DDT, and certain herbicides. The 4-CBA degrading pathway converts 4-CBA to the metabolite 4-hydroxybezoate (4-HBA), allowing some soil-dwelling microbes to utilize 4-CBA as an alternate carbon source. This pathway consists of three chemical steps catalyzed by 4-CBA-CoA ligase, 4-CBA-CoA dehalogenase, and 4HBA-CoA thioesterase in sequential reactions.
Pssm-ID: 341247 [Multi-domain] Cd Length: 493 Bit Score: 162.68 E-value: 3.10e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 656 NPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFM 735
Cdd:cd05923 16 DACAIADPARGLRLTYSELRARIEAVAARLHARGLRPGQRVAVVLPNSVEAVIALLALHRLGAVPALINPRLKAAELAEL 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 736 LHDAK-PSCVLTNSS--VEIECDESLKILVDDVNV-MEEIEKYSEENIDemeclKPLAPSHIAYVIYTSGSTGRPKGVMI 811
Cdd:cd05923 96 IERGEmTAAVIAVDAqvMDAIFQSGVRVLALSDLVgLGEPESAGPLIED-----PPREPEQPAFVFYTSGTTGLPKGAVI 170
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 812 PHQNVVR--LLGATDHWFQFDADDV----WTMFHSYAFdFSVweIWGPLLYGGRLVVVPHTvsrSPKEFLQLLVKEKVTV 885
Cdd:cd05923 171 PQRAAESrvLFMSTQAGLRHGRHNVvlglMPLYHVIGF-FAV--LVAALALDGTYVVVEEF---DPADALKLIEQERVTS 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 886 LNQTPSAFYQLMQADrenEEVGQKL-SLRYVVFGGEALELSRLEdwySRHPHNAPKVINMYGITETtVHVSYIELDESIV 964
Cdd:cd05923 245 LFATPTHLDALAAAA---EFAGLKLsSLRHVTFAGATMPDAVLE---RVNQHLPGEKVNIYGTTEA-MNSLYMRDARTGT 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 965 SLRANSLIGCSIpdlkVYVLDNYLQPVPPGVVGEMYVAGAGLA--RGYLGRAGLTAERFIadpFGKpgtrmYRTGDLARW 1042
Cdd:cd05923 318 EMRPGFFSEVRI----VRIGGSPDEALANGEEGELIVAAAADAafTGYLNQPEATAKKLQ---DGW-----YRTGDVGYV 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1043 RQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVAsNNETIDTNEMRQHASGS- 1121
Cdd:cd05923 386 DPSGDVRILGRVDDMIISGGENIHPSEIERVLSRHPGVTEVVVIGVADERWGQSVTACVVP-REGTLSADELDQFCRASe 464
|
490 500
....*....|....*....|....*....
gi 1698252301 1122 LPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05923 465 LADFKRPRRYFFLDELPKNAMNKVLRRQL 493
|
|
| PRK05605 |
PRK05605 |
long-chain-fatty-acid--CoA ligase; Validated |
641-1148 |
3.16e-42 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235531 [Multi-domain] Cd Length: 573 Bit Score: 164.40 E-value: 3.16e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 641 PEMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGY 720
Cdd:PRK05605 30 GDTTLVDLYDNAVARFGDRPALDFFGATTTYAELGKQVRRAAAGLRALGVRPGDRVAIVLPNCPQHIVAFYAVLRLGAVV 109
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 721 LPLDPDYPSDRISFML--HDAKPSCVLTNSSVEIECdeslkiLVDDVNVmEEIekYSEENIDEMECLKPLA--------- 789
Cdd:PRK05605 110 VEHNPLYTAHELEHPFedHGARVAIVWDKVAPTVER------LRRTTPL-ETI--VSVNMIAAMPLLQRLAlrlpipalr 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 790 -------------------------------------PSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDAD 832
Cdd:PRK05605 181 karaaltgpapgtvpwetlvdaaiggdgsdvshprptPDDVALILYTSGTTGKPKGAQLTHRNLFANAAQGKAWVPGLGD 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 833 D------VWTMFHSY------AFDFSVweiwgpllyGGRLVVVPhtvSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQAD 900
Cdd:PRK05605 261 GpervlaALPMFHAYgltlclTLAVSI---------GGELVLLP---APDIDLILDAMKKHPPTWLPGVPPLYEKIAEAA 328
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 901 RENeevGQKLS-LRYVVFGGEALELSRLEDWYSrhpHNAPKVINMYGITETtvhvSYIELDESIVSLRANSLIGCSIPDL 979
Cdd:PRK05605 329 EER---GVDLSgVRNAFSGAMALPVSTVELWEK---LTGGLLVEGYGLTET----SPIIVGNPMSDDRRPGYVGVPFPDT 398
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 980 KVYVLD--NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADpfgkpgtrMYRTGDLARWRQDGTLDYIGRADHQ 1057
Cdd:PRK05605 399 EVRIVDpeDPDETMPDGEEGELLVRGPQVFKGYWNRPEETAKSFLDG--------WFRTGDVVVMEEDGFIRIVDRIKEL 470
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1058 IKIRGFRIELGEIEAVIMKHDKVEQVAV--IVREDqpGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVN 1135
Cdd:PRK05605 471 IITGGFNVYPAEVEEVLREHPGVEDAAVvgLPRED--GSEEVVAAVVLEPGAALDPEGLRAYCREHLTRYKVPRRFYHVD 548
|
570
....*....|...
gi 1698252301 1136 ELPLTPNGKLDRK 1148
Cdd:PRK05605 549 ELPRDQLGKVRRR 561
|
|
| PRK06145 |
PRK06145 |
acyl-CoA synthetase; Validated |
653-1150 |
4.05e-42 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 102207 [Multi-domain] Cd Length: 497 Bit Score: 162.36 E-value: 4.05e-42
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 653 AHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRI 732
Cdd:PRK06145 12 ARRTPDRAALVYRDQEISYAEFHQRILQAAGMLHARGIGQGDVVALLMKNSAAFLELAFAASYLGAVFLPINYRLAADEV 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 733 SFMLHDAKPSCVLTNSSVEIECDESLKILVDDVNVMEEIEKYSE--ENIDEMEclkPLAPSHIAYVIYTSGSTGRPKGVM 810
Cdd:PRK06145 92 AYILGDAGAKLLLVDEEFDAIVALETPKIVIDAAAQADSRRLAQggLEIPPQA---AVAPTDLVRLMYTSGTTDRPKGVM 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 811 IPHQNVvrllgatdHWFQFD--------ADD----VWTMFHSYAFDFSVWEIwgpLLYGGRLVVVPHTvsrSPKEFLQLL 878
Cdd:PRK06145 169 HSYGNL--------HWKSIDhvialgltASErllvVGPLYHVGAFDLPGIAV---LWVGGTLRIHREF---DPEAVLAAI 234
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 879 VKEKVTVLNQTPSAFYQLMQA-DRENEEVGqklSLRYVVFGGEALELSRLEDwYSRHPHNApKVINMYGITETTVHVSYI 957
Cdd:PRK06145 235 ERHRLTCAWMAPVMLSRVLTVpDRDRFDLD---SLAWCIGGGEKTPESRIRD-FTRVFTRA-RYIDAYGLTETCSGDTLM 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 958 ELDESIVSLRANsliGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmyRTG 1037
Cdd:PRK06145 310 EAGREIEKIGST---GRALAHVEIRIADGAGRWLPPNMKGEICMRGPKVTKGYWKDPEKTAEAFYGDWF--------RSG 378
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1038 DLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQH 1117
Cdd:PRK06145 379 DVGYLDEEGFLYLTDRKKDMIISGGENIASSEVERVIYELPEVAEAAVIGVHDDRWGERITAVVVLNPGATLTLEALDRH 458
|
490 500 510
....*....|....*....|....*....|...
gi 1698252301 1118 ASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK06145 459 CRQRLASFKVPRQLKVRDELPRNPSGKVLKRVL 491
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1-389 |
5.03e-41 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 166.88 E-value: 5.03e-41
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVReDRPNDKRIIAYIVAE-----EKEPINLSE-IRSYVSESLANYMIPSAFVVLEELPLTPNGKVDR 74
Cdd:PRK05691 2610 LLEHPAVREAVVLAL-DTPSGKQLAGYLVSAvagqdDEAQAALREaLKAHLKQQLPDYMVPAHLILLDSLPLTANGKLDR 2688
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 75 KKLPAPDFNGMNNERVA-RNPKEEILCDLFAEVLGVSRINIDDNFFEMGGHSLLASRLMARIREtLSVELGIGKLFESPT 153
Cdd:PRK05691 2689 RALPAPDPELNRQAYQApRSELEQQLAQIWREVLNVERVGLGDNFFELGGDSILSIQVVSRARQ-LGIHFSPRDLFQHQT 2767
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 154 VAELAKQLNHakSARPAIQKASRPNEVPLSFAQRrlWFLNcLEGPSPT-YNIPLVIRMNGILNRQALQGAFYDVVEKHET 232
Cdd:PRK05691 2768 VQTLAAVATH--SEAAQAEQGPLQGASGLTPIQH--WFFD-SPVPQPQhWNQALLLEPRQALDPALLEQALQALVEHHDA 2842
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 233 LRTIFPNVLG---SSYQKILDMEnlnLEMVITNTCKDELESVLSEAVRySFNLDFEPAVRLQLFTVSENEHVLLILLHHI 309
Cdd:PRK05691 2843 LRLRFSQADGrwqAEYRAVTAQE---LLWQVTVADFAECAALFADAQR-SLDLQQGPLLRALLVDGPQGQQRLLLAIHHL 2918
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 310 VGDGWSLQPLTRDFTAAYKARCQGDRVQLETLPVQYADYALWQQQLLGDETTPEslistQLDFWKEELKGLPdqMELPTD 389
Cdd:PRK05691 2919 VVDGVSWRVLLEDLQALYRQLSAGAEPALPAKTSAFRDWAARLQAYAGSESLRE-----ELGWWQAQLGGPR--AELPCD 2991
|
|
| FAAL |
cd05931 |
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and ... |
657-1149 |
7.27e-40 |
|
Fatty acyl-AMP ligase (FAAL); FAAL belongs to the class I adenylate forming enzyme family and is homologous to fatty acyl-coenzyme A (CoA) ligases (FACLs). However, FAALs produce only the acyl adenylate and are unable to perform the thioester-forming reaction, while FACLs perform a two-step catalytic reaction; AMP ligation followed by CoA ligation using ATP and CoA as cofactors. FAALs have insertion motifs between the N-terminal and C-terminal subdomains that distinguish them from the FACLs. This insertion motif precludes the binding of CoA, thus preventing CoA ligation. It has been suggested that the acyl adenylates serve as substrates for multifunctional polyketide synthases to permit synthesis of complex lipids such as phthiocerol dimycocerosate, sulfolipids, mycolic acids, and mycobactin.
Pssm-ID: 341254 [Multi-domain] Cd Length: 547 Bit Score: 157.02 E-value: 7.27e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVF------EDKKLTYEKLNRKANKIARFLIAKGvGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPS- 729
Cdd:cd05931 7 PDRPAYTFlddeggREETLTYAELDRRARAIAARLQAVG-KPGDRVLLLAPPGLDFVAAFLGCLYAGAIAVPLPPPTPGr 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 730 --DRISFMLHDAKPSCVLTNSSV---------EIECDESLKILVDDVnvmeeiekySEENIDEMECLKPLAPSHIAYVIY 798
Cdd:cd05931 86 haERLAAILADAGPRVVLTTAAAlaavrafaaSRPAAGTPRLLVVDL---------LPDTSAADWPPPSPDPDDIAYLQY 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 799 TSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWT----MFHSYAFDFSvweIWGPLLYGGRLVVV-PHTVSRSPKE 873
Cdd:cd05931 157 TSGSTGTPKGVVVTHRNLLANVRQIRRAYGLDPGDVVVswlpLYHDMGLIGG---LLTPLYSGGPSVLMsPAAFLRRPLR 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 874 FLQLLVKEKVTVlnqtpSA---F-YQLMqADRENEEVGQKL---SLRYVVFGGEALELSRLEDWYSRH-PHN-APKVIN- 943
Cdd:cd05931 234 WLRLISRYRATI-----SAapnFaYDLC-VRRVRDEDLEGLdlsSWRVALNGAEPVRPATLRRFAEAFaPFGfRPEAFRp 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 944 MYGITETTVHVSYIELDESIVSLR-------------------ANSLIGC--SIPDLKVYVLD-NYLQPVPPGVVGEMYV 1001
Cdd:cd05931 308 SYGLAEATLFVSGGPPGTGPVVLRvdrdalagravavaaddpaARELVSCgrPLPDQEVRIVDpETGRELPDGEVGEIWV 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1002 AGAGLARGYLGRAGLTAERFIADPfGKPGTRMYRTGDLARwRQDGTLdYI-GRADHQIKIRGFRIELGEIEAVIMKHDKV 1080
Cdd:cd05931 388 RGPSVASGYWGRPEATAETFGALA-ATDEGGWLRTGDLGF-LHDGEL-YItGRLKDLIIVRGRNHYPQDIEATAEEAHPA 464
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 1081 EQ---VAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDY--MVPYAFVVV--NELPLTPNGKLDRKA 1149
Cdd:cd05931 465 LRpgcVAAFSVPDDGEERLVVVAEVERGADPADLAAIAAAIRAAVAREhgVAPADVVLVrpGSIPRTSSGKIQRRA 540
|
|
| ttLC_FACS_AlkK_like |
cd12119 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
670-1150 |
7.57e-40 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family catalyzes the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified from Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes uncharacterized FACS proteins.
Pssm-ID: 341284 [Multi-domain] Cd Length: 518 Bit Score: 156.25 E-value: 7.57e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 670 TYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNSS 749
Cdd:cd12119 27 TYAEVAERARRLANALRRLGVKPGDRVATLAWNTHRHLELYYAVPGMGAVLHTINPRLFPEQIAYIINHAEDRVVFVDRD 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 750 VE--IE-CDESLK-----ILVDDVNVMEE-----IEKYsEENID--EMECLKPLAPSHIAYVI-YTSGSTGRPKGVMIPH 813
Cdd:cd12119 107 FLplLEaIAPRLPtvehvVVMTDDAAMPEpagvgVLAY-EELLAaeSPEYDWPDFDENTAAAIcYTSGTTGNPKGVVYSH 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 814 QNVV--RLLGATDHWFQFDADDVWT----MFHSYAfdfsvweiWG-P---LLYGGRLVVV-PHTvsrSPKEFLQLLVKEK 882
Cdd:cd12119 186 RSLVlhAMAALLTDGLGLSESDVVLpvvpMFHVNA--------WGlPyaaAMVGAKLVLPgPYL---DPASLAELIEREG 254
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 883 VTVLNQTPSAFYQLMQA-DRENEEVgqkLSLRYVVFGGEALELSRLEDWYSRHPhnapKVINMYGITETT--VHVSYI-- 957
Cdd:cd12119 255 VTFAAGVPTVWQGLLDHlEANGRDL---SSLRRVVIGGSAVPRSLIEAFEERGV----RVIHAWGMTETSplGTVARPps 327
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 958 ---ELD-ESIVSLRANSliGCSIPDLKVYVLDNYLQPVP--PGVVGEMYVAGAGLARGYLGRAGlTAERFIADPFgkpgt 1031
Cdd:cd12119 328 ehsNLSeDEQLALRAKQ--GRPVPGVELRIVDDDGRELPwdGKAVGELQVRGPWVTKSYYKNDE-ESEALTEDGW----- 399
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1032 rmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDT 1111
Cdd:cd12119 400 --LRTGDVATIDEDGYLTITDRSKDVIKSGGEWISSVELENAIMAHPAVAEAAVIGVPHPKWGERPLAVVVLKEGATVTA 477
|
490 500 510
....*....|....*....|....*....|....*....
gi 1698252301 1112 NEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd12119 478 EELLEFLADKVAKWWLPDDVVFVDEIPKTSTGKIDKKAL 516
|
|
| PRK06839 |
PRK06839 |
o-succinylbenzoate--CoA ligase; |
650-1150 |
8.74e-40 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 168698 [Multi-domain] Cd Length: 496 Bit Score: 155.40 E-value: 8.74e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 650 EKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAK-GVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYP 728
Cdd:PRK06839 9 EKRAYLHPDRIAIITEEEEMTYKQLHEYVSKVAAYLIYElNVKKGERIAILSQNSLEYIVLLFAIAKVECIAVPLNIRLT 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 729 SDRISFMLHDAKPSCVL-----TNSSVEIECDESLKILVDdVNVMEEIEKYSEENIDEMECLKPLapshiaYVIYTSGST 803
Cdd:PRK06839 89 ENELIFQLKDSGTTVLFvektfQNMALSMQKVSYVQRVIS-ITSLKEIEDRKIDNFVEKNESASF------IICYTSGTT 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 804 GRPKGVMIPHQNVvrLLGATDHWFQFD--ADDV----WTMFHS-----YAFdfsvweiwgPLLYGGRLVVVPHTVSrsPK 872
Cdd:PRK06839 162 GKPKGAVLTQENM--FWNALNNTFAIDltMHDRsivlLPLFHIggiglFAF---------PTLFAGGVIIVPRKFE--PT 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 873 EFLQLLVKEKVTVLNQTPSAFYQLMQA-DRENEEVGqklSLRYVVFGGEALELSRLEDWYSRhphnAPKVINMYGITETT 951
Cdd:PRK06839 229 KALSMIEKHKVTVVMGVPTIHQALINCsKFETTNLQ---SVRWFYNGGAPCPEELMREFIDR----GFLFGQGFGMTETS 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 952 VHVSYIELDESivsLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERfIADPFgkpgt 1031
Cdd:PRK06839 302 PTVFMLSEEDA---RRKVGSIGKPVLFCDYELIDENKNKVEVGEVGELLIRGPNVMKEYWNRPDATEET-IQDGW----- 372
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1032 rmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDT 1111
Cdd:PRK06839 373 --LCTGDLARVDEDGFVYIVGRKKEMIISGGENIYPLEVEQVINKLSDVYEVAVVGRQHVKWGEIPIAFIVKKSSSVLIE 450
|
490 500 510
....*....|....*....|....*....|....*....
gi 1698252301 1112 NEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK06839 451 KDVIEHCRLFLAKYKIPKEIVFLKELPKNATGKIQKAQL 489
|
|
| PRK07787 |
PRK07787 |
acyl-CoA synthetase; Validated |
661-1154 |
8.79e-40 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236096 [Multi-domain] Cd Length: 471 Bit Score: 155.15 E-value: 8.79e-40
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 661 AVVFEDKKLTYEKLNRKANKIARfliakGVGPDQLVA-LAMPrSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDA 739
Cdd:PRK07787 18 AVRIGGRVLSRSDLAGAATAVAE-----RVAGARRVAvLATP-TLATVLAVVGALIAGVPVVPVPPDSGVAERRHILADS 91
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 740 KPSCVLTNSSveiecDESLKILVDDVNVMEEI-EKYSEENidemeclkplaPSHIAYVIYTSGSTGRPKGVMIPHQNVVR 818
Cdd:PRK07787 92 GAQAWLGPAP-----DDPAGLPHVPVRLHARSwHRYPEPD-----------PDAPALIVYTSGTTGPPKGVVLSRRAIAA 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 819 LLGA-TDHWfQFDADDVWT----MFHSYAFdfsVWEIWGPLLYGGRLVvvpHTVSRSPKEFLQLLvKEKVTVLNQTPSAF 893
Cdd:PRK07787 156 DLDAlAEAW-QWTADDVLVhglpLFHVHGL---VLGVLGPLRIGNRFV---HTGRPTPEAYAQAL-SEGGTLYFGVPTVW 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 894 YQLMqadrENEEVGQKLS-LRYVVFGGEALELSRLEDWYSRHPHnapKVINMYGITETTVhvsyieldesIVSLRANS-- 970
Cdd:PRK07787 228 SRIA----ADPEAARALRgARLLVSGSAALPVPVFDRLAALTGH---RPVERYGMTETLI----------TLSTRADGer 290
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 971 ---LIGCSIPDLKVYVLDNYLQPVP--PGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLARWRQD 1045
Cdd:PRK07787 291 rpgWVGLPLAGVETRLVDEDGGPVPhdGETVGELQVRGPTLFDGYLNRPDATAAAFTADGW-------FRTGDVAVVDPD 363
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1046 GTLDYIGR-ADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASnnETIDTNEMRQHASGSLPD 1124
Cdd:PRK07787 364 GMHRIVGReSTDLIKSGGYRIGAGEIETALLGHPGVREAAVVGVPDDDLGQRIVAYVVGA--DDVAADELIDFVAQQLSV 441
|
490 500 510
....*....|....*....|....*....|
gi 1698252301 1125 YMVPYAFVVVNELPLTPNGKLDRKALPAPE 1154
Cdd:PRK07787 442 HKRPREVRFVDALPRNAMGKVLKKQLLSEG 471
|
|
| C_NRPS-like |
cd19537 |
Condensation family domain with an atypical active site motif; Condensation (C) domains of ... |
181-603 |
2.78e-39 |
|
Condensation family domain with an atypical active site motif; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. Members of this subfamily typically have a non-canonical conserved SHXXXDX(14)Y motif. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380460 [Multi-domain] Cd Length: 395 Bit Score: 151.57 E-value: 2.78e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 181 PLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIF---PN----VLGSSYQKILDMEN 253
Cdd:cd19537 3 ALSPIEREWWHKYQLSTGTSSFNVSFACRLSGDVDRDRLASAWNTVLARHRILRSRYvprDGglrrSYSSSPPRVQRVDT 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 254 LNLemvitntckdelesvlSEAVRYSFNLDFEPAVRLqlfTVSENEhvLLILLHHIVGDGWSLQPLTRDFTAAYKARcqg 333
Cdd:cd19537 83 LDV----------------WKEINRPFDLEREDPIRV---FISPDT--LLVVMSHIICDLTTLQLLLREVSAAYNGK--- 138
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 334 drvQLETLPVQYADYALWQQQLlgdetTPEslistQLDFWKEELKGLPdQMELPTdyqRPVETSYRGETIHFHIDEGMHS 413
Cdd:cd19537 139 ---LLPPVRREYLDSTAWSRPA-----SPE-----DLDFWSEYLSGLP-LLNLPR---RTSSKSYRGTSRVFQLPGSLYR 201
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 414 RLVELGRKNGVSLfmvLQAGLSALFTRLGA---GTDIPIGSPIAGRNDDVLSDIVGLFVNTLVLR--TNTSGDPSFKELL 488
Cdd:cd19537 202 SLLQFSTSSGITL---HQLALAAVALALQDlsdRTDIVLGAPYLNRTSEEDMETVGLFLEPLPIRirFPSSSDASAADFL 278
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 489 NRVKQVNLAAYENQdVPFERLVEVLNPVRTRNSHPLFQVMLAFQN--TPEATFNAPDLEaSLEIQSVGsAKFDLTFEISE 566
Cdd:cd19537 279 RAVRRSSQAALAHA-IPWHQLLEHLGLPPDSPNHPLFDVMVTFHDdrGVSLALPIPGVE-PLYTWAEG-AKFPLMFEFTA 355
|
410 420 430
....*....|....*....|....*....|....*..
gi 1698252301 567 SNEvDGTpnGLHglLEFSTDLYKRETVQkLIERFILL 603
Cdd:cd19537 356 LSD-DSL--LLR--LEYDTDCFSEEEID-RIESLILA 386
|
|
| PRK06188 |
PRK06188 |
acyl-CoA synthetase; Validated |
656-1153 |
4.47e-39 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235731 [Multi-domain] Cd Length: 524 Bit Score: 153.99 E-value: 4.47e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 656 NPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFM 735
Cdd:PRK06188 25 YPDRPALVLGDTRLTYGQLADRISRYIQAFEALGLGTGDAVALLSLNRPEVLMAIGAAQLAGLRRTALHPLGSLDDHAYV 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 736 LHDAKPSCVLTNSSVEIE--------CDESLKIL----VDD-VNVMEEIEKYSEenidemeclKPL----APSHIAYVIY 798
Cdd:PRK06188 105 LEDAGISTLIVDPAPFVEralallarVPSLKHVLtlgpVPDgVDLLAAAAKFGP---------APLvaaaLPPDIAGLAY 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 799 TSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADD----VWTMFHSYAFDFSvweiwgP-LLYGGRLVVVPhtvSRSPKE 873
Cdd:PRK06188 176 TGGTTGKPKGVMGTHRSIATMAQIQLAEWEWPADPrflmCTPLSHAGGAFFL------PtLLRGGTVIVLA---KFDPAE 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 874 FLQLLVKEKVTVLNQTPSAFYQLMQADRENEevgQKLS-LRYVVFGGEALELSRLEDWYSRHphnAPKVINMYGITETTV 952
Cdd:PRK06188 247 VLRAIEEQRITATFLVPTMIYALLDHPDLRT---RDLSsLETVYYGASPMSPVRLAEAIERF---GPIFAQYYGQTEAPM 320
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 953 HVSYI---ELDESIVSLRANSliGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFiadpfgKP 1029
Cdd:PRK06188 321 VITYLrkrDHDPDDPKRLTSC--GRPTPGLRVALLDEDGREVAQGEVGEICVRGPLVMDGYWNRPEETAEAF------RD 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1030 GtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVI-VREDQPGDKrLVAYIVASNNET 1108
Cdd:PRK06188 393 G--WLHTGDVAREDEDGFYYIVDRKKDMIVTGGFNVFPREVEDVLAEHPAVAQVAVIgVPDEKWGEA-VTAVVVLRPGAA 469
|
490 500 510 520
....*....|....*....|....*....|....*....|....*...
gi 1698252301 1109 IDTNEMRQH---ASGSLpdyMVPYAFVVVNELPLTPNGKLDRKALPAP 1153
Cdd:PRK06188 470 VDAAELQAHvkeRKGSV---HAPKQVDFVDSLPLTALGKPDKKALRAR 514
|
|
| PRK06087 |
PRK06087 |
medium-chain fatty-acid--CoA ligase; |
642-1150 |
8.98e-39 |
|
medium-chain fatty-acid--CoA ligase;
Pssm-ID: 180393 [Multi-domain] Cd Length: 547 Bit Score: 153.75 E-value: 8.98e-39
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 642 EMTLPQLFEKQAHINPNSIAVVFE-DKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGY 720
Cdd:PRK06087 22 DASLADYWQQTARAMPDKIAVVDNhGASYTYSALDHAASRLANWLLAKGIEPGDRVAFQLPGWCEFTIIYLACLKVGAVS 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 721 LPLDPDYPSDRISFMLHDAK------PSCVLTNSSVE--IECDESLKILVDDVNVMEEIEKYSE----ENIDEMECLKPL 788
Cdd:PRK06087 102 VPLLPSWREAELVWVLNKCQakmffaPTLFKQTRPVDliLPLQNQLPQLQQIVGVDKLAPATSSlslsQIIADYEPLTTA 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 789 APSH---IAYVIYTSGSTGRPKGVMIPHQNVV---RLLGATDHwfqFDADDVWTM----FHSYAFDFSVweiWGPLLYGG 858
Cdd:PRK06087 182 ITTHgdeLAAVLFTSGTEGLPKGVMLTHNNILaseRAYCARLN---LTWQDVFMMpaplGHATGFLHGV---TAPFLIGA 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 859 RLVVVPHTvsrSPKEFLQLLVKEKVT-VLNQTPSAFYQLMQADRENEEVGqklSLRYVVFGGEALELSRLEDWYSRHphn 937
Cdd:PRK06087 256 RSVLLDIF---TPDACLALLEQQRCTcMLGATPFIYDLLNLLEKQPADLS---ALRFFLCGGTTIPKKVARECQQRG--- 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 938 aPKVINMYGITETTVHVsYIELDESIVSLRANSliGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLT 1017
Cdd:PRK06087 327 -IKLLSVYGSTESSPHA-VVNLDDPLSRFMHTD--GYAAAGVEIKVVDEARKTLPPGCEGEEASRGPNVFMGYLDEPELT 402
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1018 AERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRaDHQIKIRGFR-IELGEIEAVIMKHDKVEQVAVIVREDQPGDKR 1096
Cdd:PRK06087 403 ARALDEEGW-------YYSGDLCRMDEAGYIKITGR-KKDIIVRGGEnISSREVEDILLQHPKIHDACVVAMPDERLGER 474
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 1097 LVAYIVASNNE-TIDTNEMRQH-ASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK06087 475 SCAYVVLKAPHhSLTLEEVVAFfSRKRVAKYKYPEHIVVIDKLPRTASGKIQKFLL 530
|
|
| ACS-like |
cd17634 |
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the ... |
656-1145 |
1.60e-38 |
|
acetate-CoA ligase; This family includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases. The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341289 [Multi-domain] Cd Length: 587 Bit Score: 153.50 E-value: 1.60e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 656 NPNSIAVVFED------KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPS 729
Cdd:cd17634 66 NGDRTAIIYEGddtsqsRTISYRELHREVCRFAGTLLDLGVKKGDRVAIYMPMIPEAAVAMLACARIGAVHSVIFGGFAP 145
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 730 DRISFMLHDAKPSCVLTNS-------SVEIE--CDESLK---------ILVD------------DVNVMEEIEKYSEENI 779
Cdd:cd17634 146 EAVAGRIIDSSSRLLITADggvragrSVPLKknVDDALNpnvtsvehvIVLKrtgsdidwqegrDLWWRDLIAKASPEHQ 225
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 780 DEmeclkPLAPSHIAYVIYTSGSTGRPKGVMipHQNVVRLLGAT---DHWFQFDADDV--------WTMFHSyafdfsvW 848
Cdd:cd17634 226 PE-----AMNAEDPLFILYTSGTTGKPKGVL--HTTGGYLVYAAttmKYVFDYGPGDIywctadvgWVTGHS-------Y 291
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 849 EIWGPLLYGGRLVV---VPhtVSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLSLRYVVFGGEALELS 925
Cdd:cd17634 292 LLYGPLACGATTLLyegVP--NWPTPARMWQVVDKHGVNILYTAPTAIRALMAAGDDAIEGTDRSSLRILGSVGEPINPE 369
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 926 RLEdWYSRH--PHNAPkVINMYGITETTVHVSyieldeSIVSLRANSLIGCS---IPDLKVYVLDNYLQPVPPGVVGEMY 1000
Cdd:cd17634 370 AYE-WYWKKigKEKCP-VVDTWWQTETGGFMI------TPLPGAIELKAGSAtrpVFGVQPAVVDNEGHPQPGGTEGNLV 441
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1001 VAGA--GLARGYLGRAGLTAERFIADPFGkpgtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHD 1078
Cdd:cd17634 442 ITDPwpGQTRTLFGDHERFEQTYFSTFKG-----MYFSGDGARRDEDGYYWITGRSDDVINVAGHRLGTAEIESVLVAHP 516
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1079 KVEQVAVIVREDQPGDKRLVAYIVASNNETID---TNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKL 1145
Cdd:cd17634 517 KVAEAAVVGIPHAIKGQAPYAYVVLNHGVEPSpelYAELRNWVRKEIGPLATPDVVHWVDSLPKTRSGKI 586
|
|
| PRK07798 |
PRK07798 |
acyl-CoA synthetase; Validated |
642-1146 |
6.00e-38 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236100 [Multi-domain] Cd Length: 533 Bit Score: 150.81 E-value: 6.00e-38
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 642 EMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYL 721
Cdd:PRK07798 2 AWNIADLFEAVADAVPDRVALVCGDRRLTYAELEERANRLAHYLIAQGLGPGDHVGIYARNRIEYVEAMLGAFKARAVPV 81
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 722 PLDPDYPSDRISFMLHDAKPSCVLTNSS------------------VEIECDESLKILVDDVNVMEEIEKYSEEnideme 783
Cdd:PRK07798 82 NVNYRYVEDELRYLLDDSDAVALVYEREfaprvaevlprlpklrtlVVVEDGSGNDLLPGAVDYEDALAAGSPE------ 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 784 clkPLAPSHIA---YVIYTSGSTGRPKGVMIPHQNVVR-LLGATDHWFQFDADDVWT------------------MFHSY 841
Cdd:PRK07798 156 ---RDFGERSPddlYLLYTGGTTGMPKGVMWRQEDIFRvLLGGRDFATGEPIEDEEElakraaagpgmrrfpappLMHGA 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 842 AFdfsvWEIWGPLLYGGRLVVVPHtVSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLSLRYVVFGGEA 921
Cdd:PRK07798 233 GQ----WAAFAALFSGQTVVLLPD-VRFDADEVWRTIEREKVNVITIVGDAMARPLLDALEARGPYDLSSLFAIASGGAL 307
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 922 LELSRLEDWYSRHPHNApkVINMYGITET----TVHVS---------YIELDESIVslransligcsipdlkvyVLDNYL 988
Cdd:PRK07798 308 FSPSVKEALLELLPNVV--LTDSIGSSETgfggSGTVAkgavhtggpRFTIGPRTV------------------VLDEDG 367
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 989 QPVPPGVVGEMYVAGAG-LARGYLGRAGLTAERF-IADpfgkpGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIE 1066
Cdd:PRK07798 368 NPVEPGSGEIGWIARRGhIPLGYYKDPEKTAETFpTID-----GVRYAIPGDRARVEADGTITLLGRGSVCINTGGEKVF 442
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1067 LGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLD 1146
Cdd:PRK07798 443 PEEVEEALKAHPDVADALVVGVPDERWGQEVVAVVQLREGARPDLAELRAHCRSSLAGYKVPRAIWFVDEVQRSPAGKAD 522
|
|
| CT_NRPS-like |
cd19542 |
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike ... |
191-611 |
2.89e-37 |
|
Terminal Condensation (CT)-like domains of nonribosomal peptide synthetases (NRPSs); Unlike bacterial NRPS, which typically have specialized terminal thioesterase (TE) domains to cyclize peptide products, many fungal NRPSs employ a terminal condensation-like (CT) domain to produce macrocyclic peptidyl products (e.g. cyclosporine and echinocandin). Domains in this subfamily (which includes both terminal and non-terminal domains) typically have a non-canonical conserved [SN]HxxxDx(14)Y motif at their active site compared to the standard Condensation (C) domain active site motif (HHxxxD). C-domains of NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380464 [Multi-domain] Cd Length: 401 Bit Score: 145.91 E-value: 2.89e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 191 FLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIF--PNVLGSSYQKILDmeNLNLEMVITNTCKDEL 268
Cdd:cd19542 11 MLLSQLRSPGLYFNHFVFDLDSSVDVERLRNAWRQLVQRHDILRTVFveSSAEGTFLQVVLK--SLDPPIEEVETDEDSL 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 269 ESVLSEAVRYSFnLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKArcqgdrvQLETLPVQYADY 348
Cdd:cd19542 89 DALTRDLLDDPT-LFGQPPHRLTLLETSSGEVYLVLRISHALYDGVSLPIILRDLAAAYNG-------QLLPPAPPFSDY 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 349 ALWQQQLLGDETtpeslistqLDFWKEELKGLPDQMElptdyqrPVETSYRGETIHFHIDEGMHSRLVELGRKNGVSLFM 428
Cdd:cd19542 161 ISYLQSQSQEES---------LQYWRKYLQGASPCAF-------PSLSPKRPAERSLSSTRRSLAKLEAFCASLGVTLAS 224
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 429 VLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLS--DIVGLFVNTLVLRTNTSGDPSFKELLNRVKQVNLAAYENQDVPF 506
Cdd:cd19542 225 LFQAAWALVLARYTGSRDVVFGYVVSGRDLPVPGidDIVGPCINTLPVRVKLDPDWTVLDLLRQLQQQYLRSLPHQHLSL 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 507 ERLVEVLNPVRTRnshPLFQVMLAFQNTPEATFNAPDLEASLEIQSVGSA-KFDLTFEISESnevdgtPNGLHGLLEFST 585
Cdd:cd19542 305 REIQRALGLWPSG---TLFNTLVSYQNFEASPESELSGSSVFELSAAEDPtEYPVAVEVEPS------GDSLKVSLAYST 375
|
410 420
....*....|....*....|....*.
gi 1698252301 586 DLYKRETVQKLIERFILLLDDAATNP 611
Cdd:cd19542 376 SVLSEEQAEELLEQFDDILEALLANP 401
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
644-1257 |
9.42e-37 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 153.01 E-value: 9.42e-37
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 644 TLPQLFEKQAHINPNSIAVVF------EDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALaMPRSLNMVVSLLAVLKAG 717
Cdd:PRK05691 10 TLVQALQRRAAQTPDRLALRFladdpgEGVVLSYRDLDLRARTIAAALQARASFGDRAVLL-FPSGPDYVAAFFGCLYAG 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 718 AGYLPLDPDYPS-----DRISFMLHDAKPSCVLTNSSVEiecdESLkilvddvnvmEEIEKYSEENIDEMEC---LKP-- 787
Cdd:PRK05691 89 VIAVPAYPPESArrhhqERLLSIIADAEPRLLLTVADLR----DSL----------LQMEELAAANAPELLCvdtLDPal 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 788 --------LAPSHIAYVIYTSGSTGRPKGVMIPHQNVVrllgatdhwfqfdADDvWTMFHSYAFDFS---VWEIWGPL-- 854
Cdd:PRK05691 155 aeawqepaLQPDDIAFLQYTSGSTALPKGVQVSHGNLV-------------ANE-QLIRHGFGIDLNpddVIVSWLPLyh 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 855 ---LYGGRLVV----VPhTVSRSPKEFLQLLVK--EKVTVLNQT----PSAFYQLMqADRENEEVGQKLSL---RYVVFG 918
Cdd:PRK05691 221 dmgLIGGLLQPifsgVP-CVLMSPAYFLERPLRwlEAISEYGGTisggPDFAYRLC-SERVSESALERLDLsrwRVAYSG 298
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 919 GEALELSRLE---DWYSRHPHNAPKVINMYGITETTVHVSYIELDESIVSLRANS---------------LIGCSI--PD 978
Cdd:PRK05691 299 SEPIRQDSLErfaEKFAACGFDPDSFFASYGLAEATLFVSGGRRGQGIPALELDAealarnraepgtgsvLMSCGRsqPG 378
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 979 LKVYVLD-NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIAdpfgKPGTRMYRTGDLArWRQDGTLDYIGRADHQ 1057
Cdd:PRK05691 379 HAVLIVDpQSLEVLGDNRVGEIWASGPSIAHGYWRNPEASAKTFVE----HDGRTWLRTGDLG-FLRDGELFVTGRLKDM 453
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1058 IKIRGFRIELGEIEAVIMKHDKV---EQVAVIVREDQPGDKRLVAYIVASNNETIDTNE-----MRQHASGSLPDymVPY 1129
Cdd:PRK05691 454 LIVRGHNLYPQDIEKTVEREVEVvrkGRVAAFAVNHQGEEGIGIAAEISRSVQKILPPQaliksIRQAVAEACQE--APS 531
|
570 580 590 600 610 620 630 640
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1130 AFVVVN--ELPLTPNGKLDRKA---------------LPAPEFIASSSSRGPRTPQEEMLCDLFTEVLSVSQIGIDDGFF 1192
Cdd:PRK05691 532 VVLLLNpgALPKTSSGKLQRSAcrlrladgsldsyalFPALQAVEAAQTAASGDELQARIAAIWCEQLKVEQVAADDHFF 611
|
650 660 670 680 690 700
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1193 DLGGHSLLAVQLMSRMKEALGVELNIGTLFAAPTVAGLA---ERLEIGNGQSALDVllPLRASGDQLP 1257
Cdd:PRK05691 612 LLGGNSIAATQVVARLRDELGIDLNLRQLFEAPTLAAFSaavARQLAGGGAAQAAI--ARLPRGQALP 677
|
|
| MACS_like_2 |
cd05973 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
669-1150 |
1.10e-36 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341277 [Multi-domain] Cd Length: 437 Bit Score: 144.97 E-value: 1.10e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNS 748
Cdd:cd05973 1 LTFGELRALSARFANALQELGVGPGDVVAGLLPRTPELVVTILGIWRLGAVYQPLFTAFGPKAIEHRLRTSGARLVVTDA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 749 SveiecdeSLKILVDDVNVMeeiekyseenidemeclkplapshiayvIYTSGSTGRPKGVMIPhqnvVRLLGATDHWFQ 828
Cdd:cd05973 81 A-------NRHKLDSDPFVM----------------------------MFTSGTTGLPKGVPVP----LRALAAFGAYLR 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 829 FD------------ADDVWTMFHSYAfdfsvweIWGPLLYGgrlvvVPHTVSR---SPKEFLQLLVKEKVTVLNQTPSAF 893
Cdd:cd05973 122 DAvdlrpedsfwnaADPGWAYGLYYA-------ITGPLALG-----HPTILLEggfSVESTWRVIERLGVTNLAGSPTAY 189
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 894 YQLMQADREnEEVGQKLSLRYVVFGGEALElSRLEDWYSR------HPHnapkvinmYGITETTVHVSYIELDESIVslR 967
Cdd:cd05973 190 RLLMAAGAE-VPARPKGRLRRVSSAGEPLT-PEVIRWFDAalgvpiHDH--------YGQTELGMVLANHHALEHPV--H 257
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 968 ANSLiGCSIPDLKVYVLDNYLQPVPPGVVGEMY--VAGAGLA--RGYLGRAgltaerfIADPFGkpgtRMYRTGDLARWR 1043
Cdd:cd05973 258 AGSA-GRAMPGWRVAVLDDDGDELGPGEPGRLAidIANSPLMwfRGYQLPD-------TPAIDG----GYYLTGDTVEFD 325
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1044 QDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDT---NEMRQHASG 1120
Cdd:cd05973 326 PDGSFSFIGRADDVITMSGYRIGPFDVESALIEHPAVAEAAVIGVPDPERTEVVKAFVVLRGGHEGTPalaDELQLHVKK 405
|
490 500 510
....*....|....*....|....*....|
gi 1698252301 1121 SLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05973 406 RLSAHAYPRTIHFVDELPKTPSGKIQRFLL 435
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
668-1150 |
1.60e-36 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 144.03 E-value: 1.60e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 668 KLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCvltn 747
Cdd:cd05912 1 SYTFAELFEEVSRLAEHLAALGVRKGDRVALLSKNSIEMILLIHALWLLGAEAVLLNTRLTPNELAFQLKDSDVKL---- 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 748 ssveiecdeslkilvDDvnvmeeiekyseenidemeclkplapshIAYVIYTSGSTGRPKGVMIPHQNvvrllgatdHWF 827
Cdd:cd05912 77 ---------------DD----------------------------IATIMYTSGTTGKPKGVQQTFGN---------HWW 104
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 828 Q---------FDADDVW----TMFHSYAFdfSVweIWGPLLYGGRLVVVPHTvsrSPKEFLQLLVKEKVTVLNQTPSAFY 894
Cdd:cd05912 105 SaigsalnlgLTEDDNWlcalPLFHISGL--SI--LMRSVIYGMTVYLVDKF---DAEQVLHLINSGKVTIISVVPTMLQ 177
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 895 QLMQADRENEEVgqklSLRYVVFGGEALELSRLEDWYSRhphNAPkVINMYGITETTVHVSYIELDESIVSLranSLIGC 974
Cdd:cd05912 178 RLLEILGEGYPN----NLRCILLGGGPAPKPLLEQCKEK---GIP-VYQSYGMTETCSQIVTLSPEDALNKI---GSAGK 246
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 975 SIPDLKVYVLDNylqPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmyRTGDLARWRQDGTLDYIGRA 1054
Cdd:cd05912 247 PLFPVELKIEDD---GQPPYEVGEILLKGPNVTKGYLNRPDATEESFENGWF--------KTGDIGYLDEEGFLYVLDRR 315
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1055 DHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVAsnNETIDTNEMRQHASGSLPDYMVPYAFVVV 1134
Cdd:cd05912 316 SDLIISGGENIYPAEIEEVLLSHPAIKEAGVVGIPDDKWGQVPVAFVVS--ERPISEEELIAYCSEKLAKYKVPKKIYFV 393
|
490
....*....|....*.
gi 1698252301 1135 NELPLTPNGKLDRKAL 1150
Cdd:cd05912 394 DELPRTASGKLLRHEL 409
|
|
| PRK07788 |
PRK07788 |
acyl-CoA synthetase; Validated |
653-1152 |
5.37e-36 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236097 [Multi-domain] Cd Length: 549 Bit Score: 145.07 E-value: 5.37e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 653 AHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALaMPR-SLNMVVSLLAVLKAGAGYLPLDPDYPS-- 729
Cdd:PRK07788 59 ARRAPDRAALIDERGTLTYAELDEQSNALARGLLALGVRAGDGVAV-LARnHRGFVLALYAAGKVGARIILLNTGFSGpq 137
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 730 -------DRISFMLHDAKPSCVLTNSSVEIEcdeslKILVDDVNVMEEIEKYSE-----ENIDEMECLK-PLAPSHIAYV 796
Cdd:PRK07788 138 laevaarEGVKALVYDDEFTDLLSALPPDLG-----RLRAWGGNPDDDEPSGSTdetldDLIAGSSTAPlPKPPKPGGIV 212
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 797 IYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVW----TMFHSyafdfsvweiWGPLLYGGRLVVVPHTVSR--- 869
Cdd:PRK07788 213 ILTSGTTGTPKGAPRPEPSPLAPLAGLLSRVPFRAGETTllpaPMFHA----------TGWAHLTLAMALGSTVVLRrrf 282
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 870 SPKEFLQLLVKEKVTVLNQTPSAFYQLMQADrenEEVGQKL---SLRYVVFGGEAL--ELSRledwysR-HPHNAPKVIN 943
Cdd:PRK07788 283 DPEATLEDIAKHKATALVVVPVMLSRILDLG---PEVLAKYdtsSLKIIFVSGSALspELAT------RaLEAFGPVLYN 353
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 944 MYGITEttVHVSYIELDESIVslRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYlgragltaerfiA 1023
Cdd:PRK07788 354 LYGSTE--VAFATIATPEDLA--EAPGTVGRPPKGVTVKILDENGNEVPRGVVGRIFVGNGFPFEGY------------T 417
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1024 DPFGKPGTR-MYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIV 1102
Cdd:PRK07788 418 DGRDKQIIDgLLSSGDVGYFDEDGLLFVDGRDDDMIVSGGENVFPAEVEDLLAGHPDVVEAAVIGVDDEEFGQRLRAFVV 497
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1103 ASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPA 1152
Cdd:PRK07788 498 KAPGAALDEDAIKDYVRDNLARYKVPRDVVFLDELPRNPTGKVLKRELRE 547
|
|
| ABCL |
cd05958 |
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate ... |
666-1150 |
5.89e-36 |
|
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate aerobic degradation pathway by activating 2-aminobenzoate to 2-aminobenzoyl-CoA. The reaction is carried out via a two-step process; the first step is ATP-dependent and forms a 2-aminobenzoyl-AMP intermediate, and the second step forms the 2-aminobenzoyl-CoA ester and releases the AMP. 2-Aminobenzoyl-CoA is further converted to 2-amino-5-oxo-cyclohex-1-ene-1-carbonyl-CoA catalyzed by 2-aminobenzoyl-CoA monooxygenase/reductase. ABCL has been purified from cells aerobically grown with 2-aminobenzoate as sole carbon, energy, and nitrogen source, and has been characterized as a monomer.
Pssm-ID: 341268 [Multi-domain] Cd Length: 439 Bit Score: 143.00 E-value: 5.89e-36
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 666 DKKLTYEKLNRKANKIARFLIAKGVG-PDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCV 744
Cdd:cd05958 8 EREWTYRDLLALANRIANVLVGELGIvPGNRVLLRGSNSPELVACWFGIQKAGAIAVATMPLLRPKELAYILDKARITVA 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 745 LtnssveieCDESLKIlVDDVnvmeeiekyseenidemeCLkplapshiayVIYTSGSTGRPKGVMIPHQNV-------- 816
Cdd:cd05958 88 L--------CAHALTA-SDDI------------------CI----------LAFTSGTTGAPKATMHFHRDPlasadrya 130
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 817 VRLLGATDhwfqfdaDDVWTMFHSYAFDFSV-WEIWGPLLYGGRLVVVPhtvSRSPKEFLQLLVKEKVTVLNQTPSAFYQ 895
Cdd:cd05958 131 VNVLRLRE-------DDRFVGSPPLAFTFGLgGVLLFPFGVGASGVLLE---EATPDLLLSAIARYKPTVLFTAPTAYRA 200
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 896 LMQADRENEEVGQklSLRYVVFGGEALELSRLEDWYSRhphNAPKVINMYGITETtVHVsYIELDESivSLRANSLiGCS 975
Cdd:cd05958 201 MLAHPDAAGPDLS--SLRKCVSAGEALPAALHRAWKEA---TGIPIIDGIGSTEM-FHI-FISARPG--DARPGAT-GKP 270
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 976 IPDLKVYVLDNYLQPVPPGVVGEMYVAGAglargylgraglTAERFIADPfgkpGTRMY------RTGDLARWRQDGTLD 1049
Cdd:cd05958 271 VPGYEAKVVDDEGNPVPDGTIGRLAVRGP------------TGCRYLADK----RQRTYvqggwnITGDTYSRDPDGYFR 334
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1050 YIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETID---TNEMRQHASGSLPDYM 1126
Cdd:cd05958 335 HQGRSDDMIVSGGYNIAPPEVEDVLLQHPAVAECAVVGHPDESRGVVVKAFVVLRPGVIPGpvlARELQDHAKAHIAPYK 414
|
490 500
....*....|....*....|....
gi 1698252301 1127 VPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05958 415 YPRAIEFVTELPRTATGKLQRFAL 438
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
793-1150 |
2.06e-35 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 138.23 E-value: 2.06e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 793 IAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVW----TMFH--SYAFdfsvweIWGPLLYGGRLVVVPHt 866
Cdd:cd17630 2 LATVILTSGSTGTPKAVVHTAANLLASAAGLHSRLGFGGGDSWllslPLYHvgGLAI------LVRSLLAGAELVLLER- 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 867 vsRSPkeFLQLLVKEKVTVLNQTPSAFYQLMQADrenEEVGQKLSLRYVVFGG-----EALELSRLEDWysrhphnapKV 941
Cdd:cd17630 75 --NQA--LAEDLAPPGVTHVSLVPTQLQRLLDSG---QGPAALKSLRAVLLGGapippELLERAADRGI---------PL 138
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 942 INMYGITETTVHVSYIELDESivslrANSLIGCSIPDLKVYVLDNylqpvppgvvGEMYVAGAGLARGYLgragltaERF 1021
Cdd:cd17630 139 YTTYGMTETASQVATKRPDGF-----GRGGVGVLLPGRELRIVED----------GEIWVGGASLAMGYL-------RGQ 196
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1022 IADPFGKPGTrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYI 1101
Cdd:cd17630 197 LVPEFNEDGW--FTTKDLGELHADGRLTVLGRADNMIISGGENIQPEEIEAALAAHPAVRDAFVVGVPDEELGQRPVAVI 274
|
330 340 350 360
....*....|....*....|....*....|....*....|....*....
gi 1698252301 1102 VasNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd17630 275 V--GRGPADPAELRAWLKDKLARFKLPKRIYPVPELPRTGGGKVDRRAL 321
|
|
| FAA1 |
COG1022 |
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; |
638-1102 |
5.15e-35 |
|
Long-chain acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism];
Pssm-ID: 440645 [Multi-domain] Cd Length: 603 Bit Score: 142.93 E-value: 5.15e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 638 QIAPEMTLPQLFEKQAHINPNSIAVVFED----KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAV 713
Cdd:COG1022 6 DVPPADTLPDLLRRRAARFPDRVALREKEdgiwQSLTWAEFAERVRALAAGLLALGVKPGDRVAILSDNRPEWVIADLAI 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 714 LKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNS--------SVEIECDESLKILV-------DDVNVM--EEIEKYSE 776
Cdd:COG1022 86 LAAGAVTVPIYPTSSAEEVAYILNDSGAKVLFVEDqeqldkllEVRDELPSLRHIVVldprglrDDPRLLslDELLALGR 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 777 ENIDE---MECLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMF----HSYAFDFSVWe 849
Cdd:COG1022 166 EVADPaelEARRAAVKPDDLATIIYTSGTTGRPKGVMLTHRNLLSNARALLERLPLGPGDRTLSFlplaHVFERTVSYY- 244
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 850 iwgpLLYGGrlVVVPHTvsRSPKEFLQLL--VK-----------EKV------TVLNQTP----------SAFYQLMQAD 900
Cdd:COG1022 245 ----ALAAG--ATVAFA--ESPDTLAEDLreVKptfmlavprvwEKVyagiqaKAEEAGGlkrklfrwalAVGRRYARAR 316
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 901 RENEEVGQKLSLRY-----VVF----------------GGEALElSRLEDWYsrhpHNA--PkVINMYGITETTVHVSYI 957
Cdd:COG1022 317 LAGKSPSLLLRLKHaladkLVFsklrealggrlrfavsGGAALG-PELARFF----RALgiP-VLEGYGLTETSPVITVN 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 958 ELDEsivsLRANSlIGCSIPDLKVYVLDNylqpvppgvvGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTG 1037
Cdd:COG1022 391 RPGD----NRIGT-VGPPLPGVEVKIAED----------GEILVRGPNVMKGYYKNPEATAEAFDADGW-------LHTG 448
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1038 DLARWRQDGTLDYIGRADHQIKIR-GFRIELGEIEAVIMKHDKVEQVAVIvredqpGDKR--LVAYIV 1102
Cdd:COG1022 449 DIGELDEDGFLRITGRKKDLIVTSgGKNVAPQPIENALKASPLIEQAVVV------GDGRpfLAALIV 510
|
|
| PRK12316 |
PRK12316 |
peptide synthase; Provisional |
1-167 |
8.50e-35 |
|
peptide synthase; Provisional
Pssm-ID: 237054 [Multi-domain] Cd Length: 5163 Bit Score: 146.26 E-value: 8.50e-35
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDrPNDKRIIAYIVAEEKEPINLSE--------IRSYVSESLANYMIPSAFVVLEELPLTPNGKV 72
Cdd:PRK12316 4971 LREHPAVREAVVIAQEG-AVGKQLVGYVVPQDPALADADEaqaelrdeLKAALRERLPEYMVPAHLVFLARMPLTPNGKL 5049
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 73 DRKKLPAPDFNGMNNERVArnPKEEILCD---LFAEVLGVSRINIDDNFFEMGGHSLLASRLMARIRETLSVELGIGKLF 149
Cdd:PRK12316 5050 DRKALPQPDASLLQQAYVA--PRSELEQQvaaIWAEVLQLERVGLDDNFFELGGHSLLAIQVTSRIQLELGLELPLRELF 5127
|
170
....*....|....*...
gi 1698252301 150 ESPTVAELAKQLNHAKSA 167
Cdd:PRK12316 5128 QTPTLAAFVELAAAAGSG 5145
|
|
| PRK06060 |
PRK06060 |
p-hydroxybenzoic acid--AMP ligase FadD22; |
669-1235 |
1.23e-34 |
|
p-hydroxybenzoic acid--AMP ligase FadD22;
Pssm-ID: 180374 [Multi-domain] Cd Length: 705 Bit Score: 143.25 E-value: 1.23e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNS 748
Cdd:PRK06060 31 VTHGQIHDGAARLGEVLRNRGLSSGDRVLLCLPDSPDLVQLLLACLARGVMAFLANPELHRDDHALAARNTEPALVVTSD 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 749 SVeieCDEslkilVDDVNVMEEIEKYSEENIDEMECLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGAT-DHWF 827
Cdd:PRK06060 111 AL---RDR-----FQPSRVAEAAELMSEAARVAPGGYEPMGGDALAYATYTSGTTGPPKAAIHRHADPLTFVDAMcRKAL 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 828 QFDADDVW----TMFHSYAFDFSVWeiwGPLLYGGRLVVVPHTVSRSPKEFLQllVKEKVTVLNQTPSAFYQLMQADREN 903
Cdd:PRK06060 183 RLTPEDTGlcsaRMYFAYGLGNSVW---FPLATGGSAVINSAPVTPEAAAILS--ARFGPSVLYGVPNFFARVIDSCSPD 257
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 904 eevgQKLSLRYVVFGGEALELS---RLEDWYSRHPhnapkVINmyGITETTVHVSYIEldESIVSLRANSLiGCSIPDLK 980
Cdd:PRK06060 258 ----SFRSLRCVVSAGEALELGlaeRLMEFFGGIP-----ILD--GIGSTEVGQTFVS--NRVDEWRLGTL-GRVLPPYE 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 981 VYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAgltaerfiaDPFGKPGTRMyRTGDLARWRQDGTLDYIGRADHQIKI 1060
Cdd:PRK06060 324 IRVVAPDGTTAGPGVEGDLWVRGPAIAKGYWNRP---------DSPVANEGWL-DTRDRVCIDSDGWVTYRCRADDTEVI 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1061 RGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMR---QHASGSLPDYMVPYAFVVVNEL 1137
Cdd:PRK06060 394 GGVNVDPREVERLIIEDEAVAEAAVVAVRESTGASTLQAFLVATSGATIDGSVMRdlhRGLLNRLSAFKVPHRFAVVDRL 473
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1138 PLTPNGKLDRKAL----------------------------PAPEFIASSS-SRGPRTPQE-------------EMLCDL 1175
Cdd:PRK06060 474 PRTPNGKLVRGALrkqsptkpiwelsltepgsgvraqrddlSASNMTIAGGnDGGATLRERlvalrqerqrlvvDAVCAE 553
|
570 580 590 600 610 620
....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1698252301 1176 FTEVLSVSQIGI---DDGFFDLGGHSLLAVQLMSRMKEALGVELNIGTLFAAPTVAGLAERLE 1235
Cdd:PRK06060 554 AAKMLGEPDPWSvdqDLAFSELGFDSQMTVTLCKRLAAVTGLRLPETVGWDYGSISGLAQYLE 616
|
|
| PrpE |
cd05967 |
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or ... |
656-1150 |
2.55e-34 |
|
Propionyl-CoA synthetase (PrpE); EC 6.2.1.17: propanoate:CoA ligase (AMP-forming) or propionate#CoA ligase (PrpE) catalyzes the first step of the 2-methylcitric acid cycle for propionate catabolism. It activates propionate to propionyl-CoA in a two-step reaction, which proceeds through a propionyl-AMP intermediate and requires ATP and Mg2+. In Salmonella enterica, the PrpE protein is required for growth of Salmonella enterica on propionate and can substitute for the acetyl-CoA synthetase (Acs) enzyme during growth on acetate. PrpE can also activate acetate, 3HP, and butyrate to their corresponding CoA-thioesters, although with less efficiency.
Pssm-ID: 341271 [Multi-domain] Cd Length: 617 Bit Score: 141.30 E-value: 2.55e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 656 NPNSIAVVFE------DKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPS 729
Cdd:cd05967 64 RGDQIALIYDspvtgtERTYTYAELLDEVSRLAGVLRKLGVVKGDRVIIYMPMIPEAAIAMLACARIGAIHSVVFGGFAA 143
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 730 DRISFMLHDAKPSCVLTnSSVEIE----------CDESLK---------ILVDDVNVMEEIEKySEENIDEMECLK---- 786
Cdd:cd05967 144 KELASRIDDAKPKLIVT-ASCGIEpgkvvpykplLDKALElsghkphhvLVLNRPQVPADLTK-PGRDLDWSELLAkaep 221
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 787 ----PLAPSHIAYVIYTSGSTGRPKGVMIP---HqnVVRL---------LGATDHWFQfdADDV-WTMFHSYAfdfsvwe 849
Cdd:cd05967 222 vdcvPVAATDPLYILYTSGTTGKPKGVVRDnggH--AVALnwsmrniygIKPGDVWWA--ASDVgWVVGHSYI------- 290
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 850 IWGPLLYG-------GRLVVVPhtvsrSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADrENEEVGQKL---SLRYVVFGG 919
Cdd:cd05967 291 VYGPLLHGattvlyeGKPVGTP-----DPGAFWRVIEKYQVNALFTAPTAIRAIRKED-PDGKYIKKYdlsSLRTLFLAG 364
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 920 EALELSRLEdWYSRHPHnAPkVINMYGITETTVHVSYIELDESIVSLRANSlIGCSIPDLKVYVLDNYLQPVPPGVVGEM 999
Cdd:cd05967 365 ERLDPPTLE-WAENTLG-VP-VIDHWWQTETGWPITANPVGLEPLPIKAGS-PGKPVPGYQVQVLDEDGEPVGPNELGNI 440
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1000 YVAGAgLARGYLGRAGLTAERFIADPFGK-PGtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHD 1078
Cdd:cd05967 441 VIKLP-LPPGCLLTLWKNDERFKKLYLSKfPG--YYDTGDAGYKDEDGYLFIMGRTDDVINVAGHRLSTGEMEESVLSHP 517
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 1079 KVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYA----FVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05967 518 AVAECAVVGVRDELKGQVPLGLVVLKEGVKITAEELEKELVALVREQIGPVAafrlVIFVKRLPKTRSGKILRRTL 593
|
|
| PRK13295 |
PRK13295 |
cyclohexanecarboxylate-CoA ligase; Reviewed |
657-1150 |
2.65e-34 |
|
cyclohexanecarboxylate-CoA ligase; Reviewed
Pssm-ID: 171961 [Multi-domain] Cd Length: 547 Bit Score: 140.19 E-value: 2.65e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVV------FEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSD 730
Cdd:PRK13295 38 PDKTAVTavrlgtGAPRRFTYRELAALVDRVAVGLARLGVGRGDVVSCQLPNWWEFTVLYLACSRIGAVLNPLMPIFRER 117
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 731 RISFMLHDAKpSCVLTNSSVEIECD-----ESLK--------ILV---DDVNVMEE--IEKYSEENIDEMECLKPLAPS- 791
Cdd:PRK13295 118 ELSFMLKHAE-SKVLVVPKTFRGFDhaamaRRLRpelpalrhVVVvggDGADSFEAllITPAWEQEPDAPAILARLRPGp 196
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 792 -HIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVW----TMFHSYAFdfsvweiwgplLYGGRLVVV--P 864
Cdd:PRK13295 197 dDVTQLIYTSGTTGEPKGVMHTANTLMANIVPYAERLGLGADDVIlmasPMAHQTGF-----------MYGLMMPVMlgA 265
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 865 HTVSR---SPKEFLQLLVKEKVT-VLNQTPsaFyqLMQADRENEEVGQKL-SLRYVVFGGEALELSRLEDwySRHPHNAp 939
Cdd:PRK13295 266 TAVLQdiwDPARAAELIRTEGVTfTMASTP--F--LTDLTRAVKESGRPVsSLRTFLCAGAPIPGALVER--ARAALGA- 338
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 940 KVINMYGITETTVhVSYIELDESivSLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAE 1019
Cdd:PRK13295 339 KIVSAWGMTENGA-VTLTKLDDP--DERASTTDGCPLPGVEVRVVDADGAPLPAGQIGRLQVRGCSNFGGYLKRPQLNGT 415
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1020 RfiADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIkIRGFR-IELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLV 1098
Cdd:PRK13295 416 D--ADGW-------FDTGDLARIDADGYIRISGRSKDVI-IRGGEnIPVVEIEALLYRHPAIAQVAIVAYPDERLGERAC 485
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 1099 AYIVASNNETIDTNEMRQ--HASGSLPDYMvPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK13295 486 AFVVPRPGQSLDFEEMVEflKAQKVAKQYI-PERLVVRDALPRTPSGKIQKFRL 538
|
|
| EntF |
COG1020 |
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites ... |
1-434 |
3.07e-34 |
|
EntF, seryl-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440643 [Multi-domain] Cd Length: 1329 Bit Score: 143.84 E-value: 3.07e-34
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPAP 80
Cdd:COG1020 892 LLQHPGVREAVVVAREDAPGDKRLVAYVVPEAGAAAAAALLRLALALLLPPYMVPAAVVLLLPLPLTGNGKLDRLALPAP 971
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 81 DFNGMNNERVARNPKEEILCDLFAEVLGVSRINIDDNFFEMGGHSLLASRLMARIRETLSVELGIGKLFESPTVAELAKQ 160
Cdd:COG1020 972 AAAAAAAAAAPPAEEEEEEAALALLLLLVVVVGDDDFFFFGGGLGLLLLLALARAARLLLLLLLLLLLFLAAAAAAAAAA 1051
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 161 LNHAKSARPAIQKASRPNEV-------PLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETL 233
Cdd:COG1020 1052 AAAAAAAAAAPLAAAAAPLPlpplllsLLALLLALLLLLALLALLALLLLLLLLLLLLALLLLLALLLALLAALRARRAV 1131
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 234 RTIFPNVLGSSYQKILDMENLNLEMVITntcKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDG 313
Cdd:COG1020 1132 RQEGPRLRLLVALAAALALAALLALLLA---AAAAAAELLAAAALLLLLALLLLALLLLLLLLLLLLLLLLLLLLLLLLL 1208
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 314 WSLQPLTRDFTAAYKARCQGDRVQLETLPVQYADYALWQQQLLGDETTPESLISTQLDFWKEELKGLPDQMELPTDYQRP 393
Cdd:COG1020 1209 LLLLLLLLLLLLLLLLAAAAAALLALALLLALLALAALLALAALAALAAALLALALALLALALLLLALALLLPALARARA 1288
|
410 420 430 440
....*....|....*....|....*....|....*....|.
gi 1698252301 394 VETSYRGETIHFHIDEGMHSRLVELGRKNGVSLFMVLQAGL 434
Cdd:COG1020 1289 ARTARALALLLLLALLLLLALALALLLLLLLLLALLLLALL 1329
|
|
| caiC |
PRK08008 |
putative crotonobetaine/carnitine-CoA ligase; Validated |
644-1150 |
1.53e-33 |
|
putative crotonobetaine/carnitine-CoA ligase; Validated
Pssm-ID: 181195 [Multi-domain] Cd Length: 517 Bit Score: 137.12 E-value: 1.53e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 644 TLPQLFEKQAHINPNSIAVVFED-----KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGA 718
Cdd:PRK08008 8 HLRQMWDDLADVYGHKTALIFESsggvvRRYSYLELNEEINRTANLFYSLGIRKGDKVALHLDNCPEFIFCWFGLAKIGA 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 719 GYLPLDPDYPSDRISFMLHDAKPSCVLTN-------SSVEIECDESLK-ILVDDVNVMEE-----IEKYSEENIDEMECL 785
Cdd:PRK08008 88 IMVPINARLLREESAWILQNSQASLLVTSaqfypmyRQIQQEDATPLRhICLTRVALPADdgvssFTQLKAQQPATLCYA 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 786 KPLAPSHIAYVIYTSGSTGRPKGVMIPHQNvVRLLGATDHW-FQFDADDVW-TMFHSYAFDFSVWEIWGPLLYGGRLVVV 863
Cdd:PRK08008 168 PPLSTDDTAEILFTSGTTSRPKGVVITHYN-LRFAGYYSAWqCALRDDDVYlTVMPAFHIDCQCTAAMAAFSAGATFVLL 246
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 864 PhtvSRSPKEFLQLLVKEKVTVLNQTPSAFYQLM-QADRENEevgQKLSLRYVVFggeALELSRLE--DWYSRHphnAPK 940
Cdd:PRK08008 247 E---KYSARAFWGQVCKYRATITECIPMMIRTLMvQPPSAND---RQHCLREVMF---YLNLSDQEkdAFEERF---GVR 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 941 VINMYGITETTVHVsyieLDESIVSLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMY---VAGAGLARGYLGRAGLT 1017
Cdd:PRK08008 315 LLTSYGMTETIVGI----IGDRPGDKRRWPSIGRPGFCYEAEIRDDHNRPLPAGEIGEICikgVPGKTIFKEYYLDPKAT 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1018 AERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRL 1097
Cdd:PRK08008 391 AKVLEADGW-------LHTGDTGYVDEEGFFYFVDRRCNMIKRGGENVSCVELENIIATHPKIQDIVVVGIKDSIRDEAI 463
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|...
gi 1698252301 1098 VAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK08008 464 KAFVVLNEGETLSEEEFFAFCEQNMAKFKVPSYLEIRKDLPRNCSGKIIKKNL 516
|
|
| PRK05852 |
PRK05852 |
fatty acid--CoA ligase family protein; |
635-1150 |
6.68e-33 |
|
fatty acid--CoA ligase family protein;
Pssm-ID: 235625 [Multi-domain] Cd Length: 534 Bit Score: 135.78 E-value: 6.68e-33
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 635 GGFQIAPEMTLPQLF---EKQAHINPNSIAVVFEDKK--LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVS 709
Cdd:PRK05852 5 GGAAPMASDFGPRIAdlvEVAATRLPEAPALVVTADRiaISYRDLARLVDDLAGQLTRSGLLPGDRVALRMGSNAEFVVA 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 710 LLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNSSVEIECDE-SLKILVDDVNVMEEieKYSEENIDEMECLKPL 788
Cdd:PRK05852 85 LLAASRADLVVVPLDPALPIAEQRVRSQAAGARVVLIDADGPHDRAEpTTRWWPLTVNVGGD--SGPSGGTLSVHLDAAT 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 789 APSHI-----------AYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADD----VWTMFHSYAFDFSVWEIwgp 853
Cdd:PRK05852 163 EPTPAtstpeglrpddAMIMFTGGTTGLPKMVPWTHANIASSVRAIITGYRLSPRDatvaVMPLYHGHGLIAALLAT--- 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 854 lLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLSLRYVVFGGEALELSR---LEDW 930
Cdd:PRK05852 240 -LASGGAVLLPARGRFSAHTFWDDIKAVGATWYTAVPTIHQILLERAATEPSGRKPAALRFIRSCSAPLTAETaqaLQTE 318
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 931 YSrhphnAPkVINMYGITETTVHVSYIELDESIVS---LRANSLIGCSI-PDLKVYVLDNylQPVPPGVVGEMYVAGAGL 1006
Cdd:PRK05852 319 FA-----AP-VVCAFGMTEATHQVTTTQIEGIGQTenpVVSTGLVGRSTgAQIRIVGSDG--LPLPAGAVGEVWLRGTTV 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1007 ARGYLGRAGLTAERFIADPFgkpgtrmyRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVI 1086
Cdd:PRK05852 391 VRGYLGDPTITAANFTDGWL--------RTGDLGSLSAAGDLSIRGRIKELINRGGEKISPERVEGVLASHPNVMEAAVF 462
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 1087 VREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK05852 463 GVPDQLYGEAVAAVIVPRESAPPTAEELVQFCRERLAAFEIPASFQEASGLPHTAKGSLDRRAV 526
|
|
| AAS_C |
cd05909 |
C-terminal domain of the acyl-acyl carrier protein synthetase (also called ... |
668-1150 |
1.11e-32 |
|
C-terminal domain of the acyl-acyl carrier protein synthetase (also called 2-acylglycerophosphoethanolamine acyltransferase, Aas); Acyl-acyl carrier protein synthase (Aas) is a membrane protein responsible for a minor pathway of incorporating exogenous fatty acids into membrane phospholipids. Its in vitro activity is characterized by the ligation of free fatty acids between 8 and 18 carbons in length to the acyl carrier protein sulfydryl group (ACP-SH) in the presence of ATP and Mg2+. However, its in vivo function is as a 2-acylglycerophosphoethanolamine (2-acyl-GPE) acyltransferase. The reaction occurs in two steps: the acyl chain is first esterified to acyl carrier protein (ACP) via a thioester bond, followed by a second step where the acyl chain is transferred to a 2-acyllysophospholipid, thus completing the transacylation reaction. This model represents the C-terminal domain of the enzyme, which belongs to the class I adenylate-forming enzyme family, including acyl-CoA synthetases.
Pssm-ID: 341235 [Multi-domain] Cd Length: 490 Bit Score: 134.00 E-value: 1.11e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 668 KLTYEKLNRKANKIARfLIAKGVGPDQLVALAMPRSLNMVVSLLAVlkAGAGYLPLDPDYPS--DRISFMLHDAKPSCVL 745
Cdd:cd05909 7 SLTYRKLLTGAIALAR-KLAKMTKEGENVGVMLPPSAGGALANFAL--ALSGKVPVMLNYTAglRELRACIKLAGIKTVL 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 746 TnSSVEIECDESLKILVDDVNV----MEEIE---------------KYSEENIDEMECLKPLAPSHIAYVIYTSGSTGRP 806
Cdd:cd05909 84 T-SKQFIEKLKLHHLFDVEYDArivyLEDLRakiskadkckaflagKFPPKWLLRIFGVAPVQPDDPAVILFTSGSEGLP 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 807 KGVMIPHQNVVRLLGATDHWFQFDADDVW----TMFHSYAFDFSvweIWGPLLYGGRLVVVPHTVsrSPKEFLQLLVKEK 882
Cdd:cd05909 163 KGVVLSHKNLLANVEQITAIFDPNPEDVVfgalPFFHSFGLTGC---LWLPLLSGIKVVFHPNPL--DYKKIPELIYDKK 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 883 VTVLNQTPSAFYQLmqADRENEEvgQKLSLRYVVFGGEALELSRLEDWYSRHphnaPKVINM-YGITETT--VHVSYIEL 959
Cdd:cd05909 238 ATILLGTPTFLRGY--ARAAHPE--DFSSLRLVVAGAEKLKDTLRQEFQEKF----GIRILEgYGTTECSpvISVNTPQS 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 960 DesivslRANSLIGCSIPDLKVYVLD-NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAErfiadpfgKPGTRMYRTGD 1038
Cdd:cd05909 310 P------NKEGTVGRPLPGMEVKIVSvETHEEVPIGEGGLLLVRGPNVMLGYLNEPELTSF--------AFGDGWYDTGD 375
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1039 LARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKH--DKVEQVAVIVREDQPGDKRLVAYIvasnNETIDTNEMRQ 1116
Cdd:cd05909 376 IGKIDGEGFLTITGRLSRFAKIAGEMVSLEAIEDILSEIlpEDNEVAVVSVPDGRKGEKIVLLTT----TTDTDPSSLND 451
|
490 500 510
....*....|....*....|....*....|....*
gi 1698252301 1117 HASGS-LPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05909 452 ILKNAgISNLAKPSYIHQVEEIPLLGTGKPDYVTL 486
|
|
| A_NRPS_TubE_like |
cd05906 |
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) ... |
644-1150 |
1.73e-32 |
|
The adenylation domain (A domain) of a family of nonribosomal peptide synthetases (NRPSs) synthesizing toxins and antitumor agents; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPSs that synthesize toxins and antitumor agents; for example, TubE for Tubulysine, CrpA for cryptophycin, TdiA for terrequinone A, KtzG for kutzneride, and Vlm1/Vlm2 for Valinomycin. Nonribosomal peptide synthetases are large multifunctional enzymes which synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341232 [Multi-domain] Cd Length: 540 Bit Score: 134.33 E-value: 1.73e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 644 TLPQLFEKQAHINPN----SIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAG 719
Cdd:cd05906 11 TLLELLLRAAERGPTkgitYIDADGSEEFQSYQDLLEDARRLAAGLRQLGLRPGDSVILQFDDNEDFIPAFWACVLAGFV 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 720 YLPLDP----DYPSDR------ISFMLHDAKpscVLTNSSVEIECDESLKILVDDVNVMEEIEKYSEENIDEMecLKPLA 789
Cdd:cd05906 91 PAPLTVpptyDEPNARlrklrhIWQLLGSPV---VLTDAELVAEFAGLETLSGLPGIRVLSIEELLDTAADHD--LPQSR 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 790 PSHIAYVIYTSGSTGRPKGVMIPHQNVV-RLLGATDHwFQFDADDV---WTMFHSYAfdfSVWEI-WGPLLYGGRLVVVP 864
Cdd:cd05906 166 PDDLALLMLTSGSTGFPKAVPLTHRNILaRSAGKIQH-NGLTPQDVflnWVPLDHVG---GLVELhLRAVYLGCQQVHVP 241
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 865 -HTVSRSPKEFLQLLVKEKVTVlnqT--PSAFYQLM--QADRENEEVGQKLSLRYVVFGGEALE-------LSRLEdwys 932
Cdd:cd05906 242 tEEILADPLRWLDLIDRYRVTI---TwaPNFAFALLndLLEEIEDGTWDLSSLRYLVNAGEAVVaktirrlLRLLE---- 314
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 933 rhPHNAP--KVINMYGITETTVHVSYIELDESIVSLRANSL--IGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLAR 1008
Cdd:cd05906 315 --PYGLPpdAIRPAFGMTETCSGVIYSRSFPTYDHSQALEFvsLGRPIPGVSMRIVDDEGQLLPEGEVGRLQVRGPVVTK 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1009 GYLGRAGLTAERFIADPFgkpgtrmYRTGDLArWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQ---VAV 1085
Cdd:cd05906 393 GYYNNPEANAEAFTEDGW-------FRTGDLG-FLDNGNLTITGRTKDTIIVNGVNYYSHEIEAAVEEVPGVEPsftAAF 464
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 1086 IVREDQPGDKRL-VAYIVASNN-----ETIDtnEMRQHAS---GSLPDYMVPyafVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05906 465 AVRDPGAETEELaIFFVPEYDLqdalsETLR--AIRSVVSrevGVSPAYLIP---LPKEEIPKTSLGKIQRSKL 533
|
|
| PRK09088 |
PRK09088 |
acyl-CoA synthetase; Validated |
652-1150 |
1.76e-32 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181644 [Multi-domain] Cd Length: 488 Bit Score: 133.39 E-value: 1.76e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 652 QAHINPNSIAVV--FEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPS 729
Cdd:PRK09088 4 HARLQPQRLAAVdlALGRRWTYAELDALVGRLAAVLRRRGCVDGERLAVLARNSVWLVALHFACARVGAIYVPLNWRLSA 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 730 DRISFMLHDAKPSCVLTNSSVEiecdeSLKILVDDVNVMeeiekyseenIDEMECLKP-----LAPSHIAYVIYTSGSTG 804
Cdd:PRK09088 84 SELDALLQDAEPRLLLGDDAVA-----AGRTDVEDLAAF----------IASADALEPadtpsIPPERVSLILFTSGTSG 148
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 805 RPKGVMIPHQNVVR------LLGATDHWFQFDADDvwTMFHSYAFDFSVWEIwgpLLYGGRLVVVPhtvSRSPKEFLQLL 878
Cdd:PRK09088 149 QPKGVMLSERNLQQtahnfgVLGRVDAHSSFLCDA--PMFHIIGLITSVRPV---LAVGGSILVSN---GFEPKRTLGRL 220
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 879 VKEKVTVLNQ--TPsafyQLMQADRENEEV-GQKL-SLRYVVFGGEALELSRLEDWYSrhphNAPKVINMYGITETTVhV 954
Cdd:PRK09088 221 GDPALGITHYfcVP----QMAQAFRAQPGFdAAALrHLTALFTGGAPHAAEDILGWLD----DGIPMVDGFGMSEAGT-V 291
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 955 SYIELDESIVSLRANSlIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmY 1034
Cdd:PRK09088 292 FGMSVDCDVIRAKAGA-AGIPTPTVQTRVVDDQGNDCPAGVPGELLLRGPNLSPGYWRRPQATARAFTGDGW-------F 363
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1035 RTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEM 1114
Cdd:PRK09088 364 RTGDIARRDADGFFWVVDRKKDMFISGGENVYPAEIEAVLADHPGIRECAVVGMADAQWGEVGYLAIVPADGAPLDLERI 443
|
490 500 510
....*....|....*....|....*....|....*.
gi 1698252301 1115 RQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK09088 444 RSHLSTRLAKYKVPKHLRLVDALPRTASGKLQKARL 479
|
|
| PRK08633 |
PRK08633 |
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated |
637-1150 |
2.11e-32 |
|
2-acyl-glycerophospho-ethanolamine acyltransferase; Validated
Pssm-ID: 236315 [Multi-domain] Cd Length: 1146 Bit Score: 137.75 E-value: 2.11e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 637 FQIAPEMTLPQLFEKQAHINPNSIAVVfeD---KKLTYEKLNRKANKIARfLIAKGVGPDQLVALAMPRSLNMVVSLLAV 713
Cdd:PRK08633 609 SRKEALPPLAEAWIDTAKRNWSRLAVA--DstgGELSYGKALTGALALAR-LLKRELKDEENVGILLPPSVAGALANLAL 685
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 714 LKAGAgyLPLDPDYPSDRISFM--LHDAKPSCVLTnSSVEIEcdeSLKILVDDVNVMEEIE-KYSEENIDEME------- 783
Cdd:PRK08633 686 LLAGK--VPVNLNYTASEAALKsaIEQAQIKTVIT-SRKFLE---KLKNKGFDLELPENVKvIYLEDLKAKISkvdklta 759
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 784 ---------------CLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDV----WTMFHSyaFD 844
Cdd:PRK08633 760 llaarllparllkrlYGPTFKPDDTATIIFSSGSEGEPKGVMLSHHNILSNIEQISDVFNLRNDDVilssLPFFHS--FG 837
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 845 FSVwEIWGPLLYGGRLVVVPhtvsrSPKEFL---QLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQklSLRYVVFGGEA 921
Cdd:PRK08633 838 LTV-TLWLPLLEGIKVVYHP-----DPTDALgiaKLVAKHRATILLGTPTFLRLYLRNKKLHPLMFA--SLRLVVAGAEK 909
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 922 LELSRLEDWYSRHPHnapKVINMYGITETT----VHVSYIELDESIVsLRANSL--IGCSIPDLKVYVLD-NYLQPVPPG 994
Cdd:PRK08633 910 LKPEVADAFEEKFGI---RILEGYGATETSpvasVNLPDVLAADFKR-QTGSKEgsVGMPLPGVAVRIVDpETFEELPPG 985
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 995 VVGEMYVAGAGLARGYLGRAGLTAErFIADPFGKpgtRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIE--- 1071
Cdd:PRK08633 986 EDGLILIGGPQVMKGYLGDPEKTAE-VIKDIDGI---GWYVTGDKGHLDEDGFLTITDRYSRFAKIGGEMVPLGAVEeel 1061
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1072 AVIMKHDKVEQVAVIVREDQPGDKRLVAYivasNNETIDTNEMRQH-ASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK08633 1062 AKALGGEEVVFAVTAVPDEKKGEKLVVLH----TCGAEDVEELKRAiKESGLPNLWKPSRYFKVEALPLLGSGKLDLKGL 1137
|
|
| PRK08314 |
PRK08314 |
long-chain-fatty-acid--CoA ligase; Validated |
641-1145 |
2.23e-32 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236235 [Multi-domain] Cd Length: 546 Bit Score: 134.32 E-value: 2.23e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 641 PEMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAK-GVGPDQLVALAMPRSLNMVVSLLAVLKAGAG 719
Cdd:PRK08314 8 PETSLFHNLEVSARRYPDKTAIVFYGRAISYRELLEEAERLAGYLQQEcGVRKGDRVLLYMQNSPQFVIAYYAILRANAV 87
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 720 YLPLDPDYPSDRISFMLHDAKPSCVLT-----------NSSVEIEC-----------DESLKILVDDVNVMEEIEKYSEE 777
Cdd:PRK08314 88 VVPVNPMNREEELAHYVTDSGARVAIVgselapkvapaVGNLRLRHvivaqysdylpAEPEIAVPAWLRAEPPLQALAPG 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 778 NI----DEMEC-LKPLA----PSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWT----MFHSYAFD 844
Cdd:PRK08314 168 GVvawkEALAAgLAPPPhtagPDDLAVLPYTSGTTGVPKGCMHTHRTVMANAVGSVLWSNSTPESVVLavlpLFHVTGMV 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 845 FSVWeiwGPLLYGGRLVVVPhtvsRSPKEF-LQLLVKEKVTVLNQTPSAFYQLMQADRENEevgQKL-SLRYVVFGGEAL 922
Cdd:PRK08314 248 HSMN---APIYAGATVVLMP----RWDREAaARLIERYRVTHWTNIPTMVVDFLASPGLAE---RDLsSLRYIGGGGAAM 317
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 923 ELS---RLEDWYSRhphnapKVINMYGITETTVHvsyieldeSIVSLRANSLIGC-SIPDLKV--YVLD-NYLQPVPPGV 995
Cdd:PRK08314 318 PEAvaeRLKELTGL------DYVEGYGLTETMAQ--------THSNPPDRPKLQClGIPTFGVdaRVIDpETLEELPPGE 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 996 VGEMYVAGAGLARGYLGRAGLTAERFIA-DpfgkpGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVI 1074
Cdd:PRK08314 384 VGEIVVHGPQVFKGYWNRPEATAEAFIEiD-----GKRFFRTGDLGRMDEEGYFFITDRLKRMINASGFKVWPAEVENLL 458
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 1075 MKHDKVEQVAVI-VREDQPGDkRLVAYIV--ASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKL 1145
Cdd:PRK08314 459 YKHPAIQEACVIaTPDPRRGE-TVKAVVVlrPEARGKTTEEEIIAWAREHMAAYKYPRIVEFVDSLPKSGSGKI 531
|
|
| PRK05691 |
PRK05691 |
peptide synthase; Validated |
1-180 |
3.21e-32 |
|
peptide synthase; Validated
Pssm-ID: 235564 [Multi-domain] Cd Length: 4334 Bit Score: 137.99 E-value: 3.21e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREdRPNDKRIIAYIVAEEKEPIN---LSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK05691 4144 LHEQAEVREAAVAVQE-GVNGKHLVGYLVPHQTVLAQgalLERIKQRLRAELPDYMVPLHWLWLDRLPLNANGKLDRKAL 4222
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 78 PAPDFNGMNNE--RVARNPKEEILCDLFAEVLGVSRINIDDNFFEMGGHSLLASRLMARIRETLSVELGIGKLFESPTVA 155
Cdd:PRK05691 4223 PALDIGQLQSQayLAPRNELEQTLATIWADVLKVERVGVHDNFFELGGHSLLATQIASRVQKALQRNVPLRAMFECSTVE 4302
|
170 180
....*....|....*....|....*
gi 1698252301 156 ELAKQLNHAKSARPAIQKASRPNEV 180
Cdd:PRK05691 4303 ELAEYIEGLAGSAIDEQKVDRLSDL 4327
|
|
| AACS_like |
cd05968 |
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This ... |
647-1152 |
7.65e-32 |
|
Uncharacterized acyl-CoA synthetase subfamily similar to Acetoacetyl-CoA synthetase; This uncharacterized acyl-CoA synthetase family (EC 6.2.1.16, or acetoacetate#CoA ligase or acetoacetate:CoA ligase (AMP-forming)) is highly homologous to acetoacetyl-CoA synthetase. However, the proteins in this family exist in only bacteria and archaea. AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms.
Pssm-ID: 341272 [Multi-domain] Cd Length: 610 Bit Score: 133.38 E-value: 7.65e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 647 QLFEKQAHINPNSIAVVFED-----KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYL 721
Cdd:cd05968 65 QLLDKWLADTRTRPALRWEGedgtsRTLTYGELLYEVKRLANGLRALGVGKGDRVGIYLPMIPEIVPAFLAVARIGGIVV 144
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 722 PLDPDYPSDRISFMLHDAKPSCVLTNS---------SVEIECDESL-------KILV-------------DDVNVMEEIE 772
Cdd:cd05968 145 PIFSGFGKEAAATRLQDAEAKALITADgftrrgrevNLKEEADKACaqcptveKVVVvrhlgndftpakgRDLSYDEEKE 224
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 773 KYSEEnIDEMECLKPLApshiayVIYTSGSTGRPKGVMIPHQNVvRLLGATDHWFQFD--ADDVWTMFHSYAFDFSVWEI 850
Cdd:cd05968 225 TAGDG-AERTESEDPLM------IIYTSGTTGKPKGTVHVHAGF-PLKAAQDMYFQFDlkPGDLLTWFTDLGWMMGPWLI 296
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 851 WGPLLYGGRLVV---VP-HTvsrSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLSLRyvVFGGEAlELSR 926
Cdd:cd05968 297 FGGLILGATMVLydgAPdHP---KADRLWRMVEDHEITHLGLSPTLIRALKPRGDAPVNAHDLSSLR--VLGSTG-EPWN 370
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 927 LEDW----YSRHPHNAPkVINMYGITETTvhvSYIELDESIVSLRANSLIGcSIPDLKVYVLDNYLQPVPPgVVGEMYVA 1002
Cdd:cd05968 371 PEPWnwlfETVGKGRNP-IINYSGGTEIS---GGILGNVLIKPIKPSSFNG-PVPGMKADVLDESGKPARP-EVGELVLL 444
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1003 GA--GLARGYLGraglTAERFIADPFGK-PGTRMYrtGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDK 1079
Cdd:cd05968 445 APwpGMTRGFWR----DEDRYLETYWSRfDNVWVH--GDFAYYDEEGYFYILGRSDDTINVAGKRVGPAEIESVLNAHPA 518
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1080 VEQVAVI-VREDQPGDKrLVAYIVASNNET---IDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPA 1152
Cdd:cd05968 519 VLESAAIgVPHPVKGEA-IVCFVVLKPGVTpteALAEELMERVADELGKPLSPERILFVKDLPKTRNAKVMRRVIRA 594
|
|
| MACS_AAE_MA_like |
cd05970 |
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation ... |
653-1150 |
7.98e-32 |
|
Medium-chain acyl-CoA synthetase (MACS) of AAE_MA like; MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This family of MACS enzymes is found in archaea and bacteria. It is represented by the acyl-adenylating enzyme from Methanosarcina acetivorans (AAE_MA). AAE_MA is most active with propionate, butyrate, and the branched analogs: 2-methyl-propionate, butyrate, and pentanoate. The specific activity is weaker for smaller or larger acids.
Pssm-ID: 341274 [Multi-domain] Cd Length: 537 Bit Score: 132.23 E-value: 7.98e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 653 AHINPNSIAVVF-----EDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDY 727
Cdd:cd05970 27 AKEYPDKLALVWcddagEERIFTFAELADYSDKTANFFKAMGIGKGDTVMLTLKRRYEFWYSLLALHKLGAIAIPATHQL 106
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 728 PSDRISFMLHDAKPSCVLTNSSVEI---------EC-DESLKILVDDvNVMEEIEKYSEEnIDEMECL--KPLAPSH--- 792
Cdd:cd05970 107 TAKDIVYRIESADIKMIVAIAEDNIpeeiekaapECpSKPKLVWVGD-PVPEGWIDFRKL-IKNASPDfeRPTANSYpcg 184
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 793 --IAYVIYTSGSTGRPKgvMIPHQNVVRL--LGATDHWFQFDADDVWTMFHSYAFDFSVW-EIWGPLLYGGRLVVVPHTv 867
Cdd:cd05970 185 edILLVYFSSGTTGMPK--MVEHDFTYPLghIVTAKYWQNVREGGLHLTVADTGWGKAVWgKIYGQWIAGAAVFVYDYD- 261
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 868 SRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGqklSLRYVVFGGEALELSRLEDWYSrhpHNAPKVINMYGI 947
Cdd:cd05970 262 KFDPKALLEKLSKYGVTTFCAPPTIYRFLIREDLSRYDLS---SLRYCTTAGEALNPEVFNTFKE---KTGIKLMEGFGQ 335
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 948 TETTVHVSYIELDESivslRANSlIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGA-----GLARGYLGRAGLTAERFi 1022
Cdd:cd05970 336 TETTLTIATFPWMEP----KPGS-MGKPAPGYEIDLIDREGRSCEAGEEGEIVIRTSkgkpvGLFGGYYKDAEKTAEVW- 409
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1023 adpfgKPGtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIV 1102
Cdd:cd05970 410 -----HDG--YYHTGDAAWMDEDGYLWFVGRTDDLIKSSGYRIGPFEVESALIQHPAVLECAVTGVPDPIRGQVVKATIV 482
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|.
gi 1698252301 1103 ASNNETID---TNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05970 483 LAKGYEPSeelKKELQDHVKKVTAPYKYPRIVEFVDELPKTISGKIRRVEI 533
|
|
| ttLC_FACS_AEE21_like |
cd12118 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This ... |
646-1144 |
8.55e-32 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This family includes fatty acyl-CoA synthetases that can activate medium to long-chain fatty acids. These enzymes catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid. Also included in this family are acyl activating enzymes from Arabidopsis, which contains a large number of proteins from this family with up to 63 different genes, many of which are uncharacterized.
Pssm-ID: 341283 [Multi-domain] Cd Length: 486 Bit Score: 131.27 E-value: 8.55e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 646 PQLF-EKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLD 724
Cdd:cd12118 6 PLSFlERAAAVYPDRTSIVYGDRRYTWRQTYDRCRRLASALAALGISRGDTVAVLAPNTPAMYELHFGVPMAGAVLNALN 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 725 PDYPSDRISFMLHDAKPSCVLTNSSVEIECdeslkiLVDDVNVMEEIEKYSEENidemeclKPLApshiayVIYTSGSTG 804
Cdd:cd12118 86 TRLDAEEIAFILRHSEAKVLFVDREFEYED------LLAEGDPDFEWIPPADEW-------DPIA------LNYTSGTTG 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 805 RPKGVMIPHQNV-VRLLGATDHWfQFDADDV--WT--MFHSYAFDFsvweIWGPLLYGGRLVVVPHTvsrSPKEFLQLLV 879
Cdd:cd12118 147 RPKGVVYHHRGAyLNALANILEW-EMKQHPVylWTlpMFHCNGWCF----PWTVAAVGGTNVCLRKV---DAKAIYDLIE 218
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 880 KEKVTVLNQTPSAFYQLMQAdreNEEVGQKLSLRYVVFGGEALElsrledwysrHPHNAPKVINM-------YGITET-- 950
Cdd:cd12118 219 KHKVTHFCGAPTVLNMLANA---PPSDARPLPHRVHVMTAGAPP----------PAAVLAKMEELgfdvthvYGLTETyg 285
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 951 --TVHVSYIELDESIVSLRA--NSLIGCSIPDLK-VYVLD-NYLQPVP-PGV-VGEMYVAGAGLARGYLGRAGLTAERFi 1022
Cdd:cd12118 286 paTVCAWKPEWDELPTEERArlKARQGVRYVGLEeVDVLDpETMKPVPrDGKtIGEIVFRGNIVMKGYLKNPEATAEAF- 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1023 adpfgKPGtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIV 1102
Cdd:cd12118 365 -----RGG--WFHSGDLAVIHPDGYIEIKDRSKDIIISGGENISSVEVEGVLYKHPAVLEAAVVARPDEKWGEVPCAFVE 437
|
490 500 510 520
....*....|....*....|....*....|....*....|..
gi 1698252301 1103 ASNNETIDTNEMRQHASGSLPDYMVPYAfVVVNELPLTPNGK 1144
Cdd:cd12118 438 LKEGAKVTEEEIIAFCREHLAGFMVPKT-VVFGELPKTSTGK 478
|
|
| PRK08316 |
PRK08316 |
acyl-CoA synthetase; Validated |
644-1145 |
9.23e-32 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181381 [Multi-domain] Cd Length: 523 Bit Score: 131.98 E-value: 9.23e-32
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 644 TLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPl 723
Cdd:PRK08316 12 TIGDILRRSARRYPDKTALVFGDRSWTYAELDAAVNRVAAALLDLGLKKGDRVAALGHNSDAYALLWLACARAGAVHVP- 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 724 dpdypsdrISFMLHDAKPSCVLTNS-SVEIECDESLKILVDDVNVMEEIEKY-------------SEENIDEM------- 782
Cdd:PRK08316 91 --------VNFMLTGEELAYILDHSgARAFLVDPALAPTAEAALALLPVDTLilslvlggreapgGWLDFADWaeagsva 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 783 ECLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDV----WTMFHSYAFD-FsvweiWGPLLY- 856
Cdd:PRK08316 163 EPDVELADDDLAQILYTSGTESLPKGAMLTHRALIAEYVSCIVAGDMSADDIplhaLPLYHCAQLDvF-----LGPYLYv 237
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 857 GGRLVVVPhtvSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQ-ADRENEEVGqklSLRYVVFGGEALELSRLEDWYSRHP 935
Cdd:PRK08316 238 GATNVILD---APDPELILRTIEAERITSFFAPPTVWISLLRhPDFDTRDLS---SLRKGYYGASIMPVEVLKELRERLP 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 936 hnAPKVINMYGITETTVHVSYIELDESIvsLRANSligCSIPDLKV--YVLDNYLQPVPPGVVGEMYVAGAGLARGYLGR 1013
Cdd:PRK08316 312 --GLRFYNCYGQTEIAPLATVLGPEEHL--RRPGS---AGRPVLNVetRVVDDDGNDVAPGEVGEIVHRSPQLMLGYWDD 384
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1014 AGLTAERFIADPFgkpgtrmyRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPG 1093
Cdd:PRK08316 385 PEKTAEAFRGGWF--------HSGDLGVMDEEGYITVVDRKKDMIKTGGENVASREVEEALYTHPAVAEVAVIGLPDPKW 456
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 1698252301 1094 DKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKL 1145
Cdd:PRK08316 457 IEAVTAVVVPKAGATVTEDELIAHCRARLAGFKVPKRVIFVDELPRNPSGKI 508
|
|
| ACS |
cd05966 |
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); ... |
650-1150 |
1.06e-31 |
|
Acetyl-CoA synthetase (also known as acetate-CoA ligase and acetyl-activating enzyme); Acetyl-CoA synthetase (ACS, EC 6.2.1.1, acetate#CoA ligase or acetate:CoA ligase (AMP-forming)) catalyzes the formation of acetyl-CoA from acetate, CoA, and ATP. Synthesis of acetyl-CoA is carried out in a two-step reaction. In the first step, the enzyme catalyzes the synthesis of acetyl-AMP intermediate from acetate and ATP. In the second step, acetyl-AMP reacts with CoA to produce acetyl-CoA. This enzyme is widely present in all living organisms. The activity of this enzyme is crucial for maintaining the required levels of acetyl-CoA, a key intermediate in many important biosynthetic and catabolic processes. Acetyl-CoA is used in the biosynthesis of glucose, fatty acids, and cholesterol. It can also be used in the production of energy in the citric acid cycle. Eukaryotes typically have two isoforms of acetyl-CoA synthetase, a cytosolic form involved in biosynthetic processes and a mitochondrial form primarily involved in energy generation.
Pssm-ID: 341270 [Multi-domain] Cd Length: 608 Bit Score: 133.07 E-value: 1.06e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 650 EKQAHINPNSIAVVFE------DKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGA----- 718
Cdd:cd05966 60 DRHLKERGDKVAIIWEgdepdqSRTITYRELLREVCRFANVLKSLGVKKGDRVAIYMPMIPELVIAMLACARIGAvhsvv 139
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 719 --GYlplDPDYPSDRIsfmlHDAKPSCVLTnssveieCDES--------LKILVD--------------------DVNVM 768
Cdd:cd05966 140 faGF---SAESLADRI----NDAQCKLVIT-------ADGGyrggkvipLKEIVDealekcpsvekvlvvkrtggEVPMT 205
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 769 EEIEKYSEENID--EMEC-LKPLAPSHIAYVIYTSGSTGRPKGVMipHQNVVRLLGA--TDHW-FQFDADDV-------- 834
Cdd:cd05966 206 EGRDLWWHDLMAkqSPECePEWMDSEDPLFILYTSGSTGKPKGVV--HTTGGYLLYAatTFKYvFDYHPDDIywctadig 283
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 835 WTMFHSYAfdfsvweIWGPLLYGGRLVV---VPH--TVSRspkeFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQK 909
Cdd:cd05966 284 WITGHSYI-------VYGPLANGATTVMfegTPTypDPGR----YWDIVEKHKVTIFYTAPTAIRALMKFGDEWVKKHDL 352
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 910 LSLRyvVFG--GE-----ALElsrledWYSRHPHN--APkVINMYGITETTVHVsyIELDESIVSLRANSligCSIP--D 978
Cdd:cd05966 353 SSLR--VLGsvGEpinpeAWM------WYYEVIGKerCP-IVDTWWQTETGGIM--ITPLPGATPLKPGS---ATRPffG 418
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 979 LKVYVLDNYLQPVPPGVVGEMYVAGA--GLARGYLGraglTAERFIADPFGK-PGtrMYRTGDLARWRQDGTLDYIGRAD 1055
Cdd:cd05966 419 IEPAILDEEGNEVEGEVEGYLVIKRPwpGMARTIYG----DHERYEDTYFSKfPG--YYFTGDGARRDEDGYYWITGRVD 492
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1056 HQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETID---TNEMRQHASGSLPDYMVPYAFV 1132
Cdd:cd05966 493 DVINVSGHRLGTAEVESALVAHPAVAEAAVVGRPHDIKGEAIYAFVTLKDGEEPSdelRKELRKHVRKEIGPIATPDKIQ 572
|
570
....*....|....*...
gi 1698252301 1133 VVNELPLTPNGKLDRKAL 1150
Cdd:cd05966 573 FVPGLPKTRSGKIMRRIL 590
|
|
| FACL_like_5 |
cd05924 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
795-1146 |
1.08e-31 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341248 [Multi-domain] Cd Length: 364 Bit Score: 128.27 E-value: 1.08e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 795 YVIYTSGSTGRPKGVMIPHQNVVR-LLGATDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYG-----------GRLVV 862
Cdd:cd05924 7 YILYTGGTTGMPKGVMWRQEDIFRmLMGGADFGTGEFTPSEDAHKAAAAAAGTVMFPAPPLMHGtgswtafggllGGQTV 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 863 VPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQ-LMQADRENEEVGQKlSLRYVVFGGEALELSrLEDWYSRHPHNApKV 941
Cdd:cd05924 87 VLPDDRFDPEEVWRTIEKHKVTSMTIVGDAMARpLIDALRDAGPYDLS-SLFAISSGGALLSPE-VKQGLLELVPNI-TL 163
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 942 INMYGITET----TVHVsyielDESIVSLRANSLIGcsiPDlkVYVLDNYLQPVPPGVVGEMYVAGAGL-ARGYLGRAGL 1016
Cdd:cd05924 164 VDAFGSSETgftgSGHS-----AGSGPETGPFTRAN---PD--TVVLDDDGRVVPPGSGGVGWIARRGHiPLGYYGDEAK 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1017 TAERFiadpFGKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKR 1096
Cdd:cd05924 234 TAETF----PEVDGVRYAVPGDRATVEADGTVTLLGRGSVCINTGGEKVFPEEVEEALKSHPAVYDVLVVGRPDERWGQE 309
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1097 LVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLD 1146
Cdd:cd05924 310 VVAVVQLREGAGVDLEELREHCRTRIARYKLPKQVVFVDEIERSPAGKAD 359
|
|
| PRK07638 |
PRK07638 |
acyl-CoA synthetase; Validated |
643-1150 |
1.10e-31 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236071 [Multi-domain] Cd Length: 487 Bit Score: 131.05 E-value: 1.10e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 643 MTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQlVALAMPRSLNMVVSLLAVLKAGAGYLP 722
Cdd:PRK07638 1 MGITKEYKKHASLQPNKIAIKENDRVLTYKDWFESVCKVANWLNEKESKNKT-IAILLENRIEFLQLFAGAAMAGWTCVP 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 723 LDPDYPSDRISFMLHDAKPSCVLTNS--SVEIECDESLKILVDDVNVMEEIEKYSEENIDEMEclkpLAPshiAYVIYTS 800
Cdd:PRK07638 80 LDIKWKQDELKERLAISNADMIVTERykLNDLPDEEGRVIEIDEWKRMIEKYLPTYAPIENVQ----NAP---FYMGFTS 152
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 801 GSTGRPKGVMIPHQNVVRLLGATDHWFQFDADD----VWTMFHSYAFDFSVweiwGPLLYGGRLVVVPhtvSRSPKEFLQ 876
Cdd:PRK07638 153 GSTGKPKAFLRAQQSWLHSFDCNVHDFHMKREDsvliAGTLVHSLFLYGAI----STLYVGQTVHLMR---KFIPNQVLD 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 877 LLVKEKVTVLNQTPS---AFYqlmqadRENEEVGQKLSlryVVFGGEALELSRLEDWYSRHPHnaPKVINMYGITETTVh 953
Cdd:PRK07638 226 KLETENISVMYTVPTmleSLY------KENRVIENKMK---IISSGAKWEAEAKEKIKNIFPY--AKLYEFYGASELSF- 293
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 954 VSYIELDESivSLRANSlIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAErfiadpfgkPGTRM 1033
Cdd:PRK07638 294 VTALVDEES--ERRPNS-VGRPFHNVQVRICNEAGEEVQKGEIGTVYVKSPQFFMGYIIGGVLARE---------LNADG 361
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1034 YRT-GDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNEtidtN 1112
Cdd:PRK07638 362 WMTvRDVGYEDEEGFIYIVGREKNMILFGGINIFPEEIESVLHEHPAVDEIVVIGVPDSYWGEKPVAIIKGSATK----Q 437
|
490 500 510
....*....|....*....|....*....|....*...
gi 1698252301 1113 EMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK07638 438 QLKSFCLQRLSSFKIPKEWHFVDEIPYTNSGKIARMEA 475
|
|
| Ac_CoA_lig_AcsA |
TIGR02188 |
acetate--CoA ligase; This model describes acetate-CoA ligase (EC 6.2.1.1), also called ... |
650-1150 |
1.51e-31 |
|
acetate--CoA ligase; This model describes acetate-CoA ligase (EC 6.2.1.1), also called acetyl-CoA synthetase and acetyl-activating enzyme. It catalyzes the reaction ATP + acetate + CoA = AMP + diphosphate + acetyl-CoA and belongs to the family of AMP-binding enzymes described by pfam00501.
Pssm-ID: 274022 [Multi-domain] Cd Length: 626 Bit Score: 132.76 E-value: 1.51e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 650 EKQAHINPNSIAVVFE------DKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGA----- 718
Cdd:TIGR02188 64 DRHLEARPDKVAIIWEgdepgeVRKITYRELHREVCRFANVLKSLGVKKGDRVAIYMPMIPEAAIAMLACARIGAihsvv 143
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 719 --GYlplDPDYPSDRISfmlhDAKPSCVLT-----------------NSSVEIECDESLKILV-----DDVNVM------ 768
Cdd:TIGR02188 144 fgGF---SAEALADRIN----DAGAKLVITadeglrggkviplkaivDEALEKCPVSVEHVLVvrrtgNPVVPWvegrdv 216
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 769 ---EEIEKYSeeniDEMEClKPLAPSHIAYVIYTSGSTGRPKGVMipHQNVVRLLGA-TDHWFQFD--ADDV-------- 834
Cdd:TIGR02188 217 wwhDLMAKAS----AYCEP-EPMDSEDPLFILYTSGSTGKPKGVL--HTTGGYLLYAaMTMKYVFDikDGDIfwctadvg 289
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 835 WTMFHSYAfdfsvweIWGPLLYGGRLVV---VPHTVSRSpkEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLS 911
Cdd:TIGR02188 290 WITGHSYI-------VYGPLANGATTVMfegVPTYPDPG--RFWEIIEKHKVTIFYTAPTAIRALMRLGDEWVKKHDLSS 360
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 912 LRyvVFG--GEALELSRLEdWY------SRHPhnapkVINMYGITETTVHVsyIELDESIVSLRANSligCS--IPDLKV 981
Cdd:TIGR02188 361 LR--LLGsvGEPINPEAWM-WYykvvgkERCP-----IVDTWWQTETGGIM--ITPLPGATPTKPGS---ATlpFFGIEP 427
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 982 YVLDNYLQPVP-PGVVGEMYVAGA--GLARGYLGraglTAERFIADPFGK-PGtrMYRTGDLARWRQDGTLDYIGRADHQ 1057
Cdd:TIGR02188 428 AVVDEEGNPVEgPGEGGYLVIKQPwpGMLRTIYG----DHERFVDTYFSPfPG--YYFTGDGARRDKDGYIWITGRVDDV 501
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1058 IKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTN---EMRQHASGSLPDYMVPYAFVVV 1134
Cdd:TIGR02188 502 INVSGHRLGTAEIESALVSHPAVAEAAVVGIPDDIKGQAIYAFVTLKDGYEPDDElrkELRKHVRKEIGPIAKPDKIRFV 581
|
570
....*....|....*.
gi 1698252301 1135 NELPLTPNGKLDRKAL 1150
Cdd:TIGR02188 582 PGLPKTRSGKIMRRLL 597
|
|
| FACL_like_2 |
cd05917 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
798-1147 |
2.18e-31 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341241 [Multi-domain] Cd Length: 349 Bit Score: 127.01 E-value: 2.18e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 798 YTSGSTGRPKGVMIPHQNVV---RLLGatdHWFQFDADDVWT----MFHSYAfdfSVWEIWGPLLYGGRLVVVphTVSRS 870
Cdd:cd05917 9 FTSGTTGSPKGATLTHHNIVnngYFIG---ERLGLTEQDRLCipvpLFHCFG---SVLGVLACLTHGATMVFP--SPSFD 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 871 PKEFLQLLVKEKVTVLNQTPSAFY-QLMQADRENEEVGqklSLRYVVFGGEALELSRLEDWYSRhpHNAPKVINMYGITE 949
Cdd:cd05917 81 PLAVLEAIEKEKCTALHGVPTMFIaELEHPDFDKFDLS---SLRTGIMAGAPCPPELMKRVIEV--MNMKDVTIAYGMTE 155
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 950 TTvHVSYIELDESIVSLRANSlIGCSIPDLKVYVLDNYLQPVPP-GVVGEMYVAGAGLARGYLGRAGLTAERFIADpfgk 1028
Cdd:cd05917 156 TS-PVSTQTRTDDSIEKRVNT-VGRIMPHTEAKIVDPEGGIVPPvGVPGELCIRGYSVMKGYWNDPEKTAEAIDGD---- 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1029 pgtRMYRTGDLARWRQDGTLDYIGRADHQIkIRGFR-IELGEIEAVIMKHDKVEQVAVI-VREDQPGDKrLVAYIVASNN 1106
Cdd:cd05917 230 ---GWLHTGDLAVMDEDGYCRIVGRIKDMI-IRGGEnIYPREIEEFLHTHPKVSDVQVVgVPDERYGEE-VCAWIRLKEG 304
|
330 340 350 360
....*....|....*....|....*....|....*....|.
gi 1698252301 1107 ETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDR 1147
Cdd:cd05917 305 AELTEEDIKAYCKGKIAHYKVPRYVFFVDEFPLTVSGKIQK 345
|
|
| VL_LC_FACS_like |
cd05907 |
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA ... |
667-1150 |
2.33e-31 |
|
Long-chain fatty acid CoA synthetases and Bubblegum-like very long-chain fatty acid CoA synthetases; This family includes long-chain fatty acid (C12-C20) CoA synthetases and Bubblegum-like very long-chain (>C20) fatty acid CoA synthetases. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Drosophila melanogaster mutant bubblegum (BGM) have elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene later named bubblegum. The human homolog (hsBG) of bubblegum has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341233 [Multi-domain] Cd Length: 452 Bit Score: 129.25 E-value: 2.33e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 667 KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLdpdYPSDRISFMLHdakpscVLT 746
Cdd:cd05907 4 QPITWAEFAEEVRALAKGLIALGVEPGDRVAILSRNRPEWTIADLAILAIGAVPVPI---YPTSSAEQIAY------ILN 74
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 747 NSSVEIecdeslkILVDDvnvmeeiekyseenidemeclkplaPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHW 826
Cdd:cd05907 75 DSEAKA-------LFVED-------------------------PDDLATIIYTSGTTGRPKGVMLSHRNILSNALALAER 122
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 827 FQFDADDVWTMF----HSYAfdfSVWEIWGPLLYGGRLVVVPhtvsrSPKEFLQLLVKEKVTVLNQTPSaFYQLMQADRE 902
Cdd:cd05907 123 LPATEGDRHLSFlplaHVFE---RRAGLYVPLLAGARIYFAS-----SAETLLDDLSEVRPTVFLAVPR-VWEKVYAAIK 193
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 903 NEEVG---QKL-------SLRYVVFGGEALELsRLEDWYsrHPHNAPkVINMYGITETTVHVSYIELDEsivsLRANSlI 972
Cdd:cd05907 194 VKAVPglkRKLfdlavggRLRFAASGGAPLPA-ELLHFF--RALGIP-VYEGYGLTETSAVVTLNPPGD----NRIGT-V 264
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 973 GCSIPDLKVYVLDNylqpvppgvvGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIG 1052
Cdd:cd05907 265 GKPLPGVEVRIADD----------GEILVRGPNVMLGYYKNPEATAEALDADGW-------LHTGDLGEIDEDGFLHITG 327
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1053 RADHQIKIRGFR-IELGEIEAVIMKHDKVEQVAVIvredqpGDKR--LVAYIV---------ASNNETIDTN-------- 1112
Cdd:cd05907 328 RKKDLIITSGGKnISPEPIENALKASPLISQAVVI------GDGRpfLVALIVpdpealeawAEEHGIAYTDvaelaanp 401
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|..
gi 1698252301 1113 -------EMRQHASGSLPDY-------MVPYAFVVVNELpLTPNGKLDRKAL 1150
Cdd:cd05907 402 avraeieAAVEAANARLSRYeqikkflLLPEPFTIENGE-LTPTLKLKRPVI 452
|
|
| alpha_am_amid |
TIGR03443 |
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are ... |
1-167 |
3.83e-31 |
|
L-aminoadipate-semialdehyde dehydrogenase; Members of this protein family are L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), product of the LYS2 gene. It is also called alpha-aminoadipate reductase. In fungi, lysine is synthesized via aminoadipate. Currently, all members of this family are fungal.
Pssm-ID: 274582 [Multi-domain] Cd Length: 1389 Bit Score: 133.65 E-value: 3.83e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIV-----------------AEEKEPIN---------LSEIRSYVSESLANYMI 54
Cdd:TIGR03443 720 LSQHPLVRENVTLVRRDKDEEPTLVSYIVpqdksdeleefksevddEESSDPVVkglikyrklIKDIREYLKKKLPSYAI 799
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 55 PSAFVVLEELPLTPNGKVDRKKLPAPDFNGMNneRVARN-----------PKEEILCDLFAEVL--GVSRINIDDNFFEM 121
Cdd:TIGR03443 800 PTVIVPLKKLPLNPNGKVDKPALPFPDTAQLA--AVAKNrsasaadeeftETEREIRDLWLELLpnRPATISPDDSFFDL 877
|
170 180 190 200
....*....|....*....|....*....|....*....|....*.
gi 1698252301 122 GGHSLLASRLMARIRETLSVELGIGKLFESPTVAELAKQLNHAKSA 167
Cdd:TIGR03443 878 GGHSILATRMIFELRKKLNVELPLGLIFKSPTIKGFAKEVDRLKKG 923
|
|
| Thioesterase |
pfam00975 |
Thioesterase domain; Peptide synthetases are involved in the non-ribosomal synthesis of ... |
1257-1411 |
5.50e-31 |
|
Thioesterase domain; Peptide synthetases are involved in the non-ribosomal synthesis of peptide antibiotics. Next to the operons encoding these enzymes, in almost all cases, are genes that encode proteins that have similarity to the type II fatty acid thioesterases of vertebrates. There are also modules within the peptide synthetases that also share this similarity. With respect to antibiotic production, thioesterases are required for the addition of the last amino acid to the peptide antibiotic, thereby forming a cyclic antibiotic. Thioesterases (non-integrated) have molecular masses of 25-29 kDa.
Pssm-ID: 395776 [Multi-domain] Cd Length: 223 Bit Score: 122.11 E-value: 5.50e-31
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1257 PLFCVHPAGGLSWCYAGLMKSLGTDYPIYGVQARGIAENEELPKSLEEMAADYLKHVREIQPHGPYRLLGWSLGGNVVHA 1336
Cdd:pfam00975 2 PLFCFPPAGGSASSFRSLARRLPPPAEVLAVQYPGRGRGEPPLNSIEALADEYAEALRQIQPEGPYALFGHSMGGMLAFE 81
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 1337 MAAQLQNEGEEVELLVMLDSYPGHFLPNT-EAPTEEEALIALLALGGYDPDNMDGKPLTMESAVEILRKDGSALAS 1411
Cdd:pfam00975 82 VARRLERQGEAVRSLFLSDASAPHTVRYEaSRAPDDDEVVAEFTDEGGTPEELLEDEELLSMLLPALRADYRALES 157
|
|
| PRK07786 |
PRK07786 |
long-chain-fatty-acid--CoA ligase; Validated |
650-1166 |
1.10e-30 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 169098 [Multi-domain] Cd Length: 542 Bit Score: 129.13 E-value: 1.10e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 650 EKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPS 729
Cdd:PRK07786 24 ARHALMQPDAPALRFLGNTTTWRELDDRVAALAGALSRRGVGFGDRVLILMLNRTEFVESVLAANMLGAIAVPVNFRLTP 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 730 DRISFMLHDAKPSCVLTNSS---VEIECDESLKILVDDVNVMEEIEKYS---EENIDEMEclKPLAPSHI-----AYVIY 798
Cdd:PRK07786 104 PEIAFLVSDCGAHVVVTEAAlapVATAVRDIVPLLSTVVVAGGSSDDSVlgyEDLLAEAG--PAHAPVDIpndspALIMY 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 799 TSGSTGRPKGVMIPHQNVV-RLLGATDHWFQFDADDVW----TMFHSYAFDfSVweiwGPLLYGGRLVVVPHTVSRSPKE 873
Cdd:PRK07786 182 TSGTTGRPKGAVLTHANLTgQAMTCLRTNGADINSDVGfvgvPLFHIAGIG-SM----LPGLLLGAPTVIYPLGAFDPGQ 256
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 874 FLQLLVKEKVTVLNQTPsAFYQLMQADRENEevGQKLSLRYVVFGGEALELSRLEDWYSRHPHNApkVINMYGITETTVH 953
Cdd:PRK07786 257 LLDVLEAEKVTGIFLVP-AQWQAVCAEQQAR--PRDLALRVLSWGAAPASDTLLRQMAATFPEAQ--ILAAFGQTEMSPV 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 954 VSYIELDESIvslRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrm 1033
Cdd:PRK07786 332 TCMLLGEDAI---RKLGSVGKVIPTVAARVVDENMNDVPVGEVGEIVYRAPTLMSGYWNNPEATAEAFAGGWF------- 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1034 yRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYI-VASNNETIDTN 1112
Cdd:PRK07786 402 -HSGDLVRQDEEGYVWVVDRKKDMIISGGENIYCAEVENVLASHPDIVEVAVIGRADEKWGEVPVAVAaVRNDDAALTLE 480
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1113 EMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLD----RKALPAPEFIASSSSRGPRT 1166
Cdd:PRK07786 481 DLAEFLTDRLARYKHPKALEIVDALPRNPAGKVLktelRERYGACVNVERRSASAGFT 538
|
|
| PRK06155 |
PRK06155 |
crotonobetaine/carnitine-CoA ligase; Provisional |
642-1150 |
2.83e-30 |
|
crotonobetaine/carnitine-CoA ligase; Provisional
Pssm-ID: 235719 [Multi-domain] Cd Length: 542 Bit Score: 127.57 E-value: 2.83e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 642 EMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYL 721
Cdd:PRK06155 20 ERTLPAMLARQAERYPDRPLLVFGGTRWTYAEAARAAAAAAHALAAAGVKRGDRVALMCGNRIEFLDVFLGCAWLGAIAV 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 722 PLDPDYPSDRISFMLHDAKPSCVLtnssVEIECDESLKILVDDVNVMEEIEKYSEEN---------------IDEMECLK 786
Cdd:PRK06155 100 PINTALRGPQLEHILRNSGARLLV----VEAALLAALEAADPGDLPLPAVWLLDAPAsvsvpagwstaplppLDAPAPAA 175
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 787 PLAPSHIAYVIYTSGSTGRPKGVMIPH-------QNVVRLLGATdhwfqfdADDVW----TMFHSYAFD--FSVweiwgp 853
Cdd:PRK06155 176 AVQPGDTAAILYTSGTTGPSKGVCCPHaqfywwgRNSAEDLEIG-------ADDVLyttlPLFHTNALNafFQA------ 242
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 854 LLYGGRLVVVPHTvsrSPKEFLQLLVKEKVTV-----------LNQTPSAfyqlmqADRENeevgqklSLRYVVFGGEAL 922
Cdd:PRK06155 243 LLAGATYVLEPRF---SASGFWPAVRRHGATVtyllgamvsilLSQPARE------SDRAH-------RVRVALGPGVPA 306
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 923 ELsrLEDWYSRHphnAPKVINMYGITETTVhVSYIELDESivslRANSLiGCSIPDLKVYVLDNYLQPVPPGVVGEMYVA 1002
Cdd:PRK06155 307 AL--HAAFRERF---GVDLLDGYGSTETNF-VIAVTHGSQ----RPGSM-GRLAPGFEARVVDEHDQELPDGEPGELLLR 375
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1003 GA---GLARGYLGRAGLTAERFiadpfgkpGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDK 1079
Cdd:PRK06155 376 ADepfAFATGYFGMPEKTVEAW--------RNLWFHTGDRVVRDADGWFRFVDRIKDAIRRRGENISSFEVEQVLLSHPA 447
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1698252301 1080 VEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK06155 448 VAAAAVFPVPSELGEDEVMAAVVLRDGTALEPVALVRHCEPRLAYFAVPRYVEFVAALPKTENGKVQKFVL 518
|
|
| PRK12583 |
PRK12583 |
acyl-CoA synthetase; Provisional |
644-1147 |
7.71e-30 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237145 [Multi-domain] Cd Length: 558 Bit Score: 126.43 E-value: 7.71e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 644 TLPQLFEKQAHINPNSIAVVF--EDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYL 721
Cdd:PRK12583 19 TIGDAFDATVARFPDREALVVrhQALRYTWRQLADAVDRLARGLLALGVQPGDRVGIWAPNCAEWLLTQFATARIGAILV 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 722 PLDPDYPSDRISF-----------------------MLHDAKPSCVLTNSSvEIECDE--SLKILVD-DVN--------- 766
Cdd:PRK12583 99 NINPAYRASELEYalgqsgvrwvicadafktsdyhaMLQELLPGLAEGQPG-ALACERlpELRGVVSlAPApppgflawh 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 767 -VMEEIEKYSEENIDEMEC-LKPLAPSHIAYviyTSGSTGRPKGVMIPHQNVV-------RLLGATDHwfqfdadDVWT- 836
Cdd:PRK12583 178 eLQARGETVSREALAERQAsLDRDDPINIQY---TSGTTGFPKGATLSHHNILnngyfvaESLGLTEH-------DRLCv 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 837 ---MFHSYAFDFSVWEIwgplLYGGRLVVVPhTVSRSPKEFLQLLVKEKVTVLNQTPSAFY-QLMQADRENEEVGqklSL 912
Cdd:PRK12583 248 pvpLYHCFGMVLANLGC----MTVGACLVYP-NEAFDPLATLQAVEEERCTALYGVPTMFIaELDHPQRGNFDLS---SL 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 913 RYVVFGGEA--LELSR--LEDWysrhphNAPKVINMYGITETTvHVSYIELDESIVSLRANSlIGCSIPDLKVYVLDNYL 988
Cdd:PRK12583 320 RTGIMAGAPcpIEVMRrvMDEM------HMAEVQIAYGMTETS-PVSLQTTAADDLERRVET-VGRTQPHLEVKVVDPDG 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 989 QPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrMYrTGDLARWRQDGTLDYIGRADHQIkIRGFR-IEL 1067
Cdd:PRK12583 392 ATVPRGEIGELCTRGYSVMKGYWNNPEATAESIDEDGW------MH-TGDLATMDEQGYVRIVGRSKDMI-IRGGEnIYP 463
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1068 GEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDR 1147
Cdd:PRK12583 464 REIEEFLFTHPAVADVQVFGVPDEKYGEEIVAWVRLHPGHAASEEELREFCKARIAHFKVPRYFRFVDEFPMTVTGKVQK 543
|
|
| LC_FACL_like |
cd05914 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are ... |
662-1147 |
9.58e-30 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); The members of this family are bacterial long-chain fatty acid CoA synthetase, most of which are as yet uncharacterized. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341240 [Multi-domain] Cd Length: 463 Bit Score: 124.86 E-value: 9.58e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 662 VVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKP 741
Cdd:cd05914 1 LYYGGEPLTYKDLADNIAKFALLLKINGVGTGDRVALMGENRPEWGIAFFAIWTYGAIAVPILAEFTADEVHHILNHSEA 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 742 SCVLTNssveiecDEslkilvDDVnvmeeiekyseenidemeclkplapshiAYVIYTSGSTGRPKGVMIPHQN------ 815
Cdd:cd05914 81 KAIFVS-------DE------DDV----------------------------ALINYTSGTTGNSKGVMLTYRNivsnvd 119
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 816 ---VVRLLGATDHWFQFdaddvWTMFHSY--AFDFSVweiwgPLLYGGRLVV---VPHTVSRSPKEF-----------LQ 876
Cdd:cd05914 120 gvkEVVLLGKGDKILSI-----LPLHHIYplTFTLLL-----PLLNGAHVVFldkIPSAKIIALAFAqvtptlgvpvpLV 189
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 877 LLVKEKVTVLNQTPSA-FYQLMQA----DRENEEVGQKLS------LRYVVFGGEALELSRLEDWYSRhphNAPKVINmY 945
Cdd:cd05914 190 IEKIFKMDIIPKLTLKkFKFKLAKkinnRKIRKLAFKKVHeafggnIKEFVIGGAKINPDVEEFLRTI---GFPYTIG-Y 265
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 946 GITETTVHVSY-----IELDESivslransliGCSIPDLKVYVLDnylqPVPPGVVGEMYVAGAGLARGYLGRAGLTAER 1020
Cdd:cd05914 266 GMTETAPIISYsppnrIRLGSA----------GKVIDGVEVRIDS----PDPATGEGEIIVRGPNVMKGYYKNPEATAEA 331
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1021 FIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKI-RGFRIELGEIEAVIMKHDKVEQVAVIVREdqpgdKRLVA 1099
Cdd:cd05914 332 FDKDGW-------FHTGDLGKIDAEGYLYIRGRKKEMIVLsSGKNIYPEEIEAKINNMPFVLESLVVVQE-----KKLVA 399
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1698252301 1100 YIVA----------SNNETIDT--NEMRQHASGSLPDYMVPYAFVVVNE-LPLTPNGKLDR 1147
Cdd:cd05914 400 LAYIdpdfldvkalKQRNIIDAikWEVRDKVNQKVPNYKKISKVKIVKEeFEKTPKGKIKR 460
|
|
| PRK07514 |
PRK07514 |
malonyl-CoA synthase; Validated |
669-1150 |
9.75e-30 |
|
malonyl-CoA synthase; Validated
Pssm-ID: 181011 [Multi-domain] Cd Length: 504 Bit Score: 125.37 E-value: 9.75e-30
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNS 748
Cdd:PRK07514 29 YTYGDLDAASARLANLLVALGVKPGDRVAVQVEKSPEALALYLATLRAGAVFLPLNTAYTLAELDYFIGDAEPALVVCDP 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 749 SVEiecdESLKILVDDVNV--------------MEEIEKYSEENIDEmeclkPLAPSHIAYVIYTSGSTGRPKGVMIPHQ 814
Cdd:PRK07514 109 ANF----AWLSKIAAAAGAphvetldadgtgslLEAAAAAPDDFETV-----PRGADDLAAILYTSGTTGRSKGAMLSHG 179
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 815 NVV-RLLGATDHWfQFDADDVWT----MFHSYAFdFSVweIWGPLLYGGRLVVVPhtvSRSPKEFLQLLvkEKVTVLNQT 889
Cdd:PRK07514 180 NLLsNALTLVDYW-RFTPDDVLIhalpIFHTHGL-FVA--TNVALLAGASMIFLP---KFDPDAVLALM--PRATVMMGV 250
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 890 PSaFY-QLMQADRENEEVGQKlsLRYVVFGGEALELSRLEDWYSRHPHnapKVINMYGITETTVHVSYIELDEsivslRA 968
Cdd:PRK07514 251 PT-FYtRLLQEPRLTREAAAH--MRLFISGSAPLLAETHREFQERTGH---AILERYGMTETNMNTSNPYDGE-----RR 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 969 NSLIGCSIPDLKVYVLDNYL-QPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLARWRQDGT 1047
Cdd:PRK07514 320 AGTVGFPLPGVSLRVTDPETgAELPPGEIGMIEVKGPNVFKGYWRMPEKTAEEFRADGF-------FITGDLGKIDERGY 392
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1048 LDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVI-VREDQPGDKrLVAYIVASNNETIDTNEMRQHASGSLPDYM 1126
Cdd:PRK07514 393 VHIVGRGKDLIISGGYNVYPKEVEGEIDELPGVVESAVIgVPHPDFGEG-VTAVVVPKPGAALDEAAILAALKGRLARFK 471
|
490 500
....*....|....*....|....
gi 1698252301 1127 VPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK07514 472 QPKRVFFVDELPRNTMGKVQKNLL 495
|
|
| PRK06710 |
PRK06710 |
long-chain-fatty-acid--CoA ligase; Validated |
645-1154 |
1.33e-29 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 180666 [Multi-domain] Cd Length: 563 Bit Score: 125.92 E-value: 1.33e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 645 LPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLD 724
Cdd:PRK06710 26 LHKYVEQMASRYPEKKALHFLGKDITFSVFHDKVKRFANYLQKLGVEKGDRVAIMLPNCPQAVIGYYGTLLAGGIVVQTN 105
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 725 PDYPSDRISFMLHDAKPSCVL-----------TNSSVEIEC------------------------DESLKILVDD---VN 766
Cdd:PRK06710 106 PLYTERELEYQLHDSGAKVILcldlvfprvtnVQSATKIEHvivtriadflpfpknllypfvqkkQSNLVVKVSEsetIH 185
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 767 VMEEIEKYSEENIDemeclKPLAPSH-IAYVIYTSGSTGRPKGVMIPHQNVVR--LLGAtdHWFQFDADD------VWTM 837
Cdd:PRK06710 186 LWNSVEKEVNTGVE-----VPCDPENdLALLQYTGGTTGFPKGVMLTHKNLVSntLMGV--QWLYNCKEGeevvlgVLPF 258
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 838 FHSYAFDfSVWEIwgPLLYGGRLVVVPHTvsrSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEvgQKLSLRYVVF 917
Cdd:PRK06710 259 FHVYGMT-AVMNL--SIMQGYKMVLIPKF---DMKMVFEAIKKHKVTLFPGAPTIYIALLNSPLLKEY--DISSIRACIS 330
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 918 GGEALELSRLEDWYSRhphNAPKVINMYGITETT--VHVSYIEldesivSLRANSLIGCSIPDLKVYVLD-NYLQPVPPG 994
Cdd:PRK06710 331 GSAPLPVEVQEKFETV---TGGKLVEGYGLTESSpvTHSNFLW------EKRVPGSIGVPWPDTEAMIMSlETGEALPPG 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 995 VVGEMYVAGAGLARGYLGRAGLTAErFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVI 1074
Cdd:PRK06710 402 EIGEIVVKGPQIMKGYWNKPEETAA-VLQDGW-------LHTGDVGYMDEDGFFYVKDRKKDMIVASGFNVYPREVEEVL 473
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1075 MKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPE 1154
Cdd:PRK06710 474 YEHEKVQEVVTIGVPDPYRGETVKAFVVLKEGTECSEEELNQFARKYLAAYKVPKVYEFRDELPKTTVGKILRRVLIEEE 553
|
|
| FACL_like_4 |
cd05944 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
790-1150 |
2.14e-29 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341266 [Multi-domain] Cd Length: 359 Bit Score: 121.43 E-value: 2.14e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 790 PSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDV----WTMFHSYAfdfSVWEIWGPLLYGGRLVVVPH 865
Cdd:cd05944 1 SDDVAAYFHTGGTTGTPKLAQHTHSNEVYNAWMLALNSLFDPDDVllcgLPLFHVNG---SVVTLLTPLASGAHVVLAGP 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 866 TVSRSP---KEFLQLLVKEKVTVLNQTPSAFYQLMQADrENEEVGqklSLRYVVFGGEAL--EL-SRLEDwysrhpHNAP 939
Cdd:cd05944 78 AGYRNPglfDNFWKLVERYRITSLSTVPTVYAALLQVP-VNADIS---SLRFAMSGAAPLpvELrARFED------ATGL 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 940 KVINMYGITETT--VHVSYIELDESIVSlranslIGCSIP--DLKVYVLD---NYLQPVPPGVVGEMYVAGAGLARGYLG 1012
Cdd:cd05944 148 PVVEGYGLTEATclVAVNPPDGPKRPGS------VGLRLPyaRVRIKVLDgvgRLLRDCAPDEVGEICVAGPGVFGGYLY 221
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1013 RAGlTAERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIkIR-GFRIELGEIEAVIMKHDKVEQVAVIVREDQ 1091
Cdd:cd05944 222 TEG-NKNAFVADGW-------LNTGDLGRLDADGYLFITGRAKDLI-IRgGHNIDPALIEEALLRHPAVAFAGAVGQPDA 292
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1092 PGDKRLVAYIVASNNETIDTNEMRQHASGSLPDY-MVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05944 293 HAGELPVAYVQLKPGAVVEEEELLAWARDHVPERaAVPKHIEVLEELPVTAVGKVFKPAL 352
|
|
| PRK06178 |
PRK06178 |
acyl-CoA synthetase; Validated |
653-1150 |
7.87e-29 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235724 [Multi-domain] Cd Length: 567 Bit Score: 123.61 E-value: 7.87e-29
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 653 AHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRI 732
Cdd:PRK06178 43 ARERPQRPAIIFYGHVITYAELDELSDRFAALLRQRGVGAGDRVAVFLPNCPQFHIVFFGILKLGAVHVPVSPLFREHEL 122
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 733 SFMLHDAKPSCVLTNSS----VEIECDE-SLK-ILVDDVNVM-------------EEIEKYSEENIDEMECLK------- 786
Cdd:PRK06178 123 SYELNDAGAEVLLALDQlapvVEQVRAEtSLRhVIVTSLADVlpaeptlplpdslRAPRLAAAGAIDLLPALRactapvp 202
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 787 --PLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVrLLGATDHWF--QFDADDVwtmFHSYAFDFsvWeIWG-------PLL 855
Cdd:PRK06178 203 lpPPALDALAALNYTGGTTGMPKGCEHTQRDMV-YTAAAAYAVavVGGEDSV---FLSFLPEF--W-IAGenfgllfPLF 275
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 856 YGGRLVVVphtvSR-SPKEFLQLLVKEKVTVLNQTPSAFYQLMqadrENEEVGQK--LSLRYVvfgGEALELSRLEDWYS 932
Cdd:PRK06178 276 SGATLVLL----ARwDAVAFMAAVERYRVTRTVMLVDNAVELM----DHPRFAEYdlSSLRQV---RVVSFVKKLNPDYR 344
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 933 RHPHNAPKVINM---YGITET----TVHVSYIELDESIVSlrANSLIGCSIPDLKVYVLD-NYLQPVPPGVVGEMYVAGA 1004
Cdd:PRK06178 345 QRWRALTGSVLAeaaWGMTEThtcdTFTAGFQDDDFDLLS--QPVFVGLPVPGTEFKICDfETGELLPLGAEGEIVVRTP 422
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1005 GLARGYLGRAGLTAERFiadpfgKPGtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVA 1084
Cdd:PRK06178 423 SLLKGYWNKPEATAEAL------RDG--WLHTGDIGKIDEQGFLHYLGRRKEMLKVNGMSVFPSEVEALLGQHPAVLGSA 494
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 1085 VIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPyAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK06178 495 VVGRPDPDKGQVPVAFVQLKPGADLTAAALQAWCRENMAVYKVP-EIRIVDALPMTATGKVRKQDL 559
|
|
| PRK08279 |
PRK08279 |
long-chain-acyl-CoA synthetase; Validated |
641-1140 |
1.21e-27 |
|
long-chain-acyl-CoA synthetase; Validated
Pssm-ID: 236217 [Multi-domain] Cd Length: 600 Bit Score: 120.36 E-value: 1.21e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 641 PEMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAgy 720
Cdd:PRK08279 35 SKRSLGDVFEEAAARHPDRPALLFEDQSISYAELNARANRYAHWAAARGVGKGDVVALLMENRPEYLAAWLGLAKLGA-- 112
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 721 lpldpdypsdrISFML----------H-----DAK---------------PSCVLTNSSVEIECDESLKILVDDVNVMEE 770
Cdd:PRK08279 113 -----------VVALLntqqrgavlaHslnlvDAKhlivgeelveafeeaRADLARPPRLWVAGGDTLDDPEGYEDLAAA 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 771 IEKYSEENIDEMEclkPLAPSHIAYVIYTSGSTGRPKGVMIPHqnvVRLLGATdHWFQ----FDADDVW----TMFHSYA 842
Cdd:PRK08279 182 AAGAPTTNPASRS---GVTAKDTAFYIYTSGTTGLPKAAVMSH---MRWLKAM-GGFGgllrLTPDDVLycclPLYHNTG 254
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 843 FDFSvweiWGPLLYGGRLVVVPHTVSRSpkEFLQLLVKEKVTV-----------LNQTPSAfyqlmqADRENeevgqklS 911
Cdd:PRK08279 255 GTVA----WSSVLAAGATLALRRKFSAS--RFWDDVRRYRATAfqyigelcrylLNQPPKP------TDRDH-------R 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 912 LRYVVfgGEALELSRLEDWYSRhpHNAPKVINMYGITETTvhVSYIELDEsivslRANSlIGCSIPDLKV------YVLD 985
Cdd:PRK08279 316 LRLMI--GNGLRPDIWDEFQQR--FGIPRILEFYAASEGN--VGFINVFN-----FDGT-VGRVPLWLAHpyaivkYDVD 383
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 986 N---------YLQPVPPGVVGEMY--VAGAGLARGYLGRAGlTAERFIADPFgKPGTRMYRTGDLArwRQDGtLDYIGRA 1054
Cdd:PRK08279 384 TgepvrdadgRCIKVKPGEVGLLIgrITDRGPFDGYTDPEA-SEKKILRDVF-KKGDAWFNTGDLM--RDDG-FGHAQFV 458
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1055 DhqikiR-G--FR-----IELGEIEAVIMKHDKVEQ-----VAVivredqPG-DKRL-VAYIVASNNETIDTNEMRQHAS 1119
Cdd:PRK08279 459 D-----RlGdtFRwkgenVATTEVENALSGFPGVEEavvygVEV------PGtDGRAgMAAIVLADGAEFDLAALAAHLY 527
|
570 580
....*....|....*....|..
gi 1698252301 1120 GSLPDYMVPyAFV-VVNELPLT 1140
Cdd:PRK08279 528 ERLPAYAVP-LFVrLVPELETT 548
|
|
| MACS_euk |
cd05928 |
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step ... |
665-1150 |
2.04e-27 |
|
Eukaryotic Medium-chain acyl-CoA synthetase (MACS or ACSM); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The acyl-CoA is a key intermediate in many important biosynthetic and catabolic processes. MACS enzymes are localized to mitochondria. Two murine MACS family proteins are found in liver and kidney. In rodents, a MACS member is detected particularly in the olfactory epithelium and is called O-MACS. O-MACS demonstrates substrate preference for the fatty acid lengths of C6-C12.
Pssm-ID: 341251 [Multi-domain] Cd Length: 530 Bit Score: 118.72 E-value: 2.04e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 665 EDKKLTYEKLNRKANKIARFLI-AKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSC 743
Cdd:cd05928 38 DEVKWSFRELGSLSRKAANVLSgACGLQRGDRVAVILPRVPEWWLVNVACIRTGLVFIPGTIQLTAKDILYRLQASKAKC 117
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 744 VLTNSSVEIECD------ESL--KILVDD------VNVMEEIEKYSEENIdemeCLKplAPSHIAYVIY-TSGSTGRPKg 808
Cdd:cd05928 118 IVTSDELAPEVDsvasecPSLktKLLVSEksrdgwLNFKELLNEASTEHH----CVE--TGSQEPMAIYfTSGTTGSPK- 190
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 809 vMIPHQNVVRLLGAT---DHWFQFDADDV-WTMFHSYAFDFSVWEIWGPLLYGGrLVVVPHTVSRSPKEFLQLLVKEKVT 884
Cdd:cd05928 191 -MAEHSHSSLGLGLKvngRYWLDLTASDImWNTSDTGWIKSAWSSLFEPWIQGA-CVFVHHLPRFDPLVILKTLSSYPIT 268
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 885 VLNQTPSAFYQLMQADRENEevgQKLSLRYVVFGGEALELSRLEDWYSRhphNAPKVINMYGITETTVhvsyIELDESIV 964
Cdd:cd05928 269 TFCGAPTVYRMLVQQDLSSY---KFPSLQHCVTGGEPLNPEVLEKWKAQ---TGLDIYEGYGQTETGL----ICANFKGM 338
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 965 SLRANSLiGCSIPDLKVYVLDNYLQPVPPGVVGEMYV-----AGAGLARGYLGRAGLTAERFIADpfgkpgtrMYRTGDL 1039
Cdd:cd05928 339 KIKPGSM-GKASPPYDVQIIDDNGNVLPPGTEGDIGIrvkpiRPFGLFSGYVDNPEKTAATIRGD--------FYLTGDR 409
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1040 ARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIV-----ASNNETIDTNEM 1114
Cdd:cd05928 410 GIMDEDGYFWFMGRADDVINSSGYRIGPFEVESALIEHPAVVESAVVSSPDPIRGEVVKAFVVlapqfLSHDPEQLTKEL 489
|
490 500 510
....*....|....*....|....*....|....*.
gi 1698252301 1115 RQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05928 490 QQHVKSVTAPYKYPRKVEFVQELPKTVTGKIQRNEL 525
|
|
| FadD3 |
cd17638 |
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ... |
793-1145 |
2.28e-27 |
|
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ligases, including FadD3 which is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. The cholesterol catabolic pathway occurs in most mycolic acid-containing actinobacteria, such as Rhodococcus jostii RHA1, and is critical for Mycobacterium tuberculosis (Mtb) during infection. FadD3 catalyzes the ATP-dependent CoA thioesterification of 3a-alpha-H-4alpha(3'-propanoate)-7a-beta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. Hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP, can also be used.
Pssm-ID: 341293 [Multi-domain] Cd Length: 330 Bit Score: 114.91 E-value: 2.28e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 793 IAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADD----VWTMFHSYAFDFSvweIWGPLLYGGrlVVVPHTVS 868
Cdd:cd17638 2 VSDIMFTSGTTGRSKGVMCAHRQTLRAAAAWADCADLTEDDryliINPFFHTFGYKAG---IVACLLTGA--TVVPVAVF 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 869 RSPKeFLQLLVKEKVTVLNQTPSAFYQLM-QADRENEEVGqklSLRYVVFGGEALELSRLEDWYSRHPHNApkVINMYGI 947
Cdd:cd17638 77 DVDA-ILEAIERERITVLPGPPTLFQSLLdHPGRKKFDLS---SLRAAVTGAATVPVELVRRMRSELGFET--VLTAYGL 150
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 948 TETTVhVSYIELDESIVSLRANSliGCSIPDLKVYVLDNylqpvppgvvGEMYVAGAGLARGYLGRAGLTAERFIADPFg 1027
Cdd:cd17638 151 TEAGV-ATMCRPGDDAETVATTC--GRACPGFEVRIADD----------GEVLVRGYNVMQGYLDDPEATAEAIDADGW- 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1028 kpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNE 1107
Cdd:cd17638 217 ------LHTGDVGELDERGYLRITDRLKDMYIVGGFNVYPAEVEGALAEHPGVAQVAVIGVPDERMGEVGKAFVVARPGV 290
|
330 340 350
....*....|....*....|....*....|....*...
gi 1698252301 1108 TIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKL 1145
Cdd:cd17638 291 TLTEEDVIAWCRERLANYKVPRFVRFLDELPRNASGKV 328
|
|
| A_NRPS |
cd05930 |
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain ... |
1-77 |
3.23e-27 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341253 [Multi-domain] Cd Length: 444 Bit Score: 116.86 E-value: 3.23e-27
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05930 368 LLAHPGVREAAVVAREDGDGEKRLVAYVVPDEGGELDEEELRAHLAERLPDYMVPSAFVVLDALPLTPNGKVDRKAL 444
|
|
| PRK04319 |
PRK04319 |
acetyl-CoA synthetase; Provisional |
658-1154 |
3.53e-27 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 235279 [Multi-domain] Cd Length: 570 Bit Score: 118.46 E-value: 3.53e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 658 NSIAVVFEDK----KLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRIS 733
Cdd:PRK04319 59 DKVALRYLDAsrkeKYTYKELKELSNKFANVLKELGVEKGDRVFIFMPRIPELYFALLGALKNGAIVGPLFEAFMEEAVR 138
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 734 FMLHDAKPSCVLTNSSV--EIECDE--SLK--ILVDDVNvmEEIEKY------SEENIDEMEClKPLAPSHIAYVIYTSG 801
Cdd:PRK04319 139 DRLEDSEAKVLITTPALleRKPADDlpSLKhvLLVGEDV--EEGPGTldfnalMEQASDEFDI-EWTDREDGAILHYTSG 215
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 802 STGRPKGVMIPHQNVVRLLgATDHWFQ-FDADDV--------WTMFHSYAfdfsvweIWGPLLYGGRLVVVphtVSR-SP 871
Cdd:PRK04319 216 STGKPKGVLHVHNAMLQHY-QTGKYVLdLHEDDVywctadpgWVTGTSYG-------IFAPWLNGATNVID---GGRfSP 284
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 872 KEFLQLLVKEKVTVLNQTPSAFYQLMQAdreNEEVGQKL---SLRYVVFGGEAL--ELSRledWysrhphnAPKVINM-- 944
Cdd:PRK04319 285 ERWYRILEDYKVTVWYTAPTAIRMLMGA---GDDLVKKYdlsSLRHILSVGEPLnpEVVR---W-------GMKVFGLpi 351
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 945 ---YGITETTVH--VSYIELDesivsLRANSLiGCSIPDLKVYVLDNYLQPVPPGVVGEmyvagagLA---------RGY 1010
Cdd:PRK04319 352 hdnWWMTETGGImiANYPAMD-----IKPGSM-GKPLPGIEAAIVDDQGNELPPNRMGN-------LAikkgwpsmmRGI 418
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1011 LGRAGLTAERFIADpfgkpgtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVRED 1090
Cdd:PRK04319 419 WNNPEKYESYFAGD--------WYVSGDSAYMDEDGYFWFQGRVDDVIKTSGERVGPFEVESKLMEHPAVAEAGVIGKPD 490
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1091 QPGDKRLVAYIVASNNETIDTN---EMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPE 1154
Cdd:PRK04319 491 PVRGEIIKAFVALRPGYEPSEElkeEIRGFVKKGLGAHAAPREIEFKDKLPKTRSGKIMRRVLKAWE 557
|
|
| FADD10 |
cd17635 |
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain ... |
791-1147 |
5.27e-27 |
|
adenylate forming domain, fatty acid CoA ligase (FadD10); This family contains long chain fatty acid CoA ligases, including FadD10 which is involved in the synthesis of a virulence-related lipopeptide. FadD10 is a fatty acyl-AMP ligase (FAAL) that transfers fatty acids to an acyl carrier protein. Structures of FadD10 in apo- and complexed form with dodecanoyl-AMP, show a novel open conformation, facilitated by its unique inter-domain and intermolecular interactions, which is critical for the enzyme to carry out the acyl transfer onto the acyl carrier protein (Rv0100) rather than coenzyme A.
Pssm-ID: 341290 [Multi-domain] Cd Length: 340 Bit Score: 113.89 E-value: 5.27e-27
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 791 SHIAYVIYTSGSTGRPKGVMIPHQNvvrLLGATDHW----FQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHT 866
Cdd:cd17635 1 EDPLAVIFTSGTTGEPKAVLLANKT---FFAVPDILqkegLNWVVGDVTYLPLPATHIGGLWWILTCLIHGGLCVTGGEN 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 867 VSRspKEFLQLLVKEKVTVLNQTPSAFYQLMQADRE-NEEVGQklsLRYVVFGGEAL--ELSRLEDWYSRhphnaPKVIN 943
Cdd:cd17635 78 TTY--KSLFKILTTNAVTTTCLVPTLLSKLVSELKSaNATVPS---LRLIGYGGSRAiaADVRFIEATGL-----TNTAQ 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 944 MYGITETTVhVSYIELDESIVSLRAnslIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIA 1023
Cdd:cd17635 148 VYGLSETGT-ALCLPTDDDSIEINA---VGRPYPGVDVYLAATDGIAGPSASFGTIWIKSPANMLGYWNNPERTAEVLID 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1024 DPFgkpgtrmyRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVA 1103
Cdd:cd17635 224 GWV--------NTGDLGERREDGFLFITGRSSESINCGGVKIAPDEVERIAEGVSGVQECACYEISDEEFGELVGLAVVA 295
|
330 340 350 360
....*....|....*....|....*....|....*....|....*..
gi 1698252301 1104 SnnETIDTNEMR---QHASGSLPDYMVPYAFVVVNELPLTPNGKLDR 1147
Cdd:cd17635 296 S--AELDENAIRalkHTIRRELEPYARPSTIVIVTDIPRTQSGKVKR 340
|
|
| A_NRPS_ApnA-like |
cd17644 |
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the ... |
1-78 |
1.38e-26 |
|
similar to adenylation domain of anabaenopeptin synthetase (ApnA); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Planktothrix agardhii anabaenopeptin synthetase (ApnA A1), which is capable of activating two chemically distinct amino acids (Arg and Tyr). Structural studies show that the architecture of the active site forces Arg to adopt a Tyr-like conformation, thus explaining the bispecificity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341299 [Multi-domain] Cd Length: 465 Bit Score: 115.22 E-value: 1.38e-26
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLP 78
Cdd:cd17644 388 LSQHNDVKTAVVIVREDQPGNKRLVAYIVPHYEESPSTVELRQFLKAKLPDYMIPSAFVVLEELPLTPNGKIDRRALP 465
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
962-1235 |
1.42e-26 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 111.77 E-value: 1.42e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 962 SIVSLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFGKPGTRMYRTGDLAR 1041
Cdd:COG3433 10 PPTPDEPPPVIPPAIVQARALLLIVDLQGYFGGFGGEGGLLGAGLLLRIRLLAAAARAPFIPVPYPAQPGRQADDLRLLL 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1042 WRQDGTLdyiGRADHQIKIRGFRIELGEIEAVIMK----HDKVEQVAVIVREDQPGDKRLVAYIVASnnETIDTNEMRQH 1117
Cdd:COG3433 90 RRGLGPG---GGLERLVQQVVIRAERGEEEELLLVlraaAVVRVAVLAALRGAGVGLLLIVGAVAAL--DGLAAAAALAA 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1118 ASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPEFI-----ASSSSRGPRTPQEEMLCDLFTEVL--SVSQIGIDDG 1190
Cdd:COG3433 165 LDKVPPDVVAASAVVALDALLLLALKVVARAAPALAAAEallaaASPAPALETALTEEELRADVAELLgvDPEEIDPDDN 244
|
250 260 270 280
....*....|....*....|....*....|....*....|....*
gi 1698252301 1191 FFDLGGHSLLAVQLMSRMKEAlGVELNIGTLFAAPTVAGLAERLE 1235
Cdd:COG3433 245 LFDLGLDSIRLMQLVERWRKA-GLDVSFADLAEHPTLAAWWALLA 288
|
|
| PRK13382 |
PRK13382 |
bile acid CoA ligase; |
642-1153 |
1.45e-26 |
|
bile acid CoA ligase;
Pssm-ID: 172019 [Multi-domain] Cd Length: 537 Bit Score: 116.40 E-value: 1.45e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 642 EMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYL 721
Cdd:PRK13382 42 GMGPTSGFAIAAQRCPDRPGLIDELGTLTWRELDERSDALAAALQALPIGEPRVVGIMCRNHRGFVEALLAANRIGADIL 121
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 722 PLDPDYPSDRISFMLHDAKPSCVLTNSsveiECDESLKILVDDVNVMEEIEKYSEEN--------IDEMECLKPL-APSH 792
Cdd:PRK13382 122 LLNTSFAGPALAEVVTREGVDTVIYDE----EFSATVDRALADCPQATRIVAWTDEDhdltvevlIAAHAGQRPEpTGRK 197
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 793 IAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADD----VWTMFHSYAFdfsvweiwGPLLYGGRLVVVPHTVS 868
Cdd:PRK13382 198 GRVILLTSGTTGTPKGARRSGPGGIGTLKAILDRTPWRAEEptviVAPMFHAWGF--------SQLVLAASLACTIVTRR 269
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 869 R-SPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLSLRYVVFGGEALELSRLEDWYSRHphnAPKVINMYGI 947
Cdd:PRK13382 270 RfDPEATLDLIDRHRATGLAVVPVMFDRIMDLPAEVRNRYSGRSLRFAAASGSRMRPDVVIAFMDQF---GDVIYNNYNA 346
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 948 TEttvhVSYIELdESIVSLRANSLIGCSIPD-LKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYL-GRAGLTAERFIAdp 1025
Cdd:PRK13382 347 TE----AGMIAT-ATPADLRAAPDTAGRPAEgTEIRILDQDFREVPTGEVGTIFVRNDTQFDGYTsGSTKDFHDGFMA-- 419
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1026 fgkpgtrmyrTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASN 1105
Cdd:PRK13382 420 ----------SGDVGYLDENGRLFVVGRDDEMIVSGGENVYPIEVEKTLATHPDVAEAAVIGVDDEQYGQRLAAFVVLKP 489
|
490 500 510 520
....*....|....*....|....*....|....*....|....*...
gi 1698252301 1106 NETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAP 1153
Cdd:PRK13382 490 GASATPETLKQHVRDNLANYKVPRDIVVLDELPRGATGKILRRELQAR 537
|
|
| PLN02574 |
PLN02574 |
4-coumarate--CoA ligase-like |
645-1162 |
2.13e-26 |
|
4-coumarate--CoA ligase-like
Pssm-ID: 215312 [Multi-domain] Cd Length: 560 Bit Score: 116.09 E-value: 2.13e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 645 LPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAK-GVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPL 723
Cdd:PLN02574 43 VSFIFSHHNHNGDTALIDSSTGFSISYSELQPLVKSMAAGLYHVmGVRQGDVVLLLLPNSVYFPVIFLAVLSLGGIVTTM 122
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 724 DPDYPSDRISFMLHDAKPSCVLTnSSVEIECDESLKILVDDV-------NVMEEIEKYSEENIDEMECL-KPLAPSH-IA 794
Cdd:PLN02574 123 NPSSSLGEIKKRVVDCSVGLAFT-SPENVEKLSPLGVPVIGVpenydfdSKRIEFPKFYELIKEDFDFVpKPVIKQDdVA 201
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 795 YVIYTSGSTGRPKGVMIPHQNvvrLLGATDHWFQFDA--------DDVW----TMFHSYAFDFSVWEiwgpLLYGGRLVV 862
Cdd:PLN02574 202 AIMYSSGTTGASKGVVLTHRN---LIAMVELFVRFEAsqyeypgsDNVYlaalPMFHIYGLSLFVVG----LLSLGSTIV 274
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 863 VPHTVSRSpkEFLQLLVKEKVTVLNQTPSAFYQLMQADREneEVGQKL-SLRYVVFGGEALELSRLEDWYSRHPHnaPKV 941
Cdd:PLN02574 275 VMRRFDAS--DMVKVIDRFKVTHFPVVPPILMALTKKAKG--VCGEVLkSLKQVSCGAAPLSGKFIQDFVQTLPH--VDF 348
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 942 INMYGITETTVhVSYIELDESivSLRANSLIGCSIPDLKVYVLD-NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAER 1020
Cdd:PLN02574 349 IQGYGMTESTA-VGTRGFNTE--KLSKYSSVGLLAPNMQAKVVDwSTGCLLPPGNCGELWIQGPGVMKGYLNNPKATQST 425
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1021 FIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAY 1100
Cdd:PLN02574 426 IDKDGW-------LRTGDIAYFDEDGYLYIVDRLKEIIKYKGFQIAPADLEAVLISHPEIIDAAVTAVPDKECGEIPVAF 498
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1698252301 1101 IVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPApEFIASSSSR 1162
Cdd:PLN02574 499 VVRRQGSTLSQEAVINYVAKQVAPYKKVRKVVFVQSIPKSPAGKILRRELKR-SLTNSVSSR 559
|
|
| PRK05677 |
PRK05677 |
long-chain-fatty-acid--CoA ligase; Validated |
789-1150 |
9.33e-26 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 168170 [Multi-domain] Cd Length: 562 Bit Score: 114.09 E-value: 9.33e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 789 APSHIAYVIYTSGSTGRPKGVMIPHQNVV-------RLLGATDHwfqfDADDV----WTMFHSYAFDFSVWEIwgpLLYG 857
Cdd:PRK05677 205 QADDVAVLQYTGGTTGVAKGAMLTHRNLVanmlqcrALMGSNLN----EGCEIliapLPLYHIYAFTFHCMAM---MLIG 277
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 858 GRLVVVPHtvSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMqadreNEEVGQKL---SLRYVVFGGEALELSRLEDWYSRh 934
Cdd:PRK05677 278 NHNILISN--PRDLPAMVKELGKWKFSGFVGLNTLFVALC-----NNEAFRKLdfsALKLTLSGGMALQLATAERWKEV- 349
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 935 phNAPKVINMYGITETTVHVS-----YIELdesivslranSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARG 1009
Cdd:PRK05677 350 --TGCAICEGYGMTETSPVVSvnpsqAIQV----------GTIGIPVPSTLCKVIDDDGNELPLGEVGELCVKGPQVMKG 417
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1010 YLGRAGLTAERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVRE 1089
Cdd:PRK05677 418 YWQRPEATDEILDSDGW-------LKTGDIALIQEDGYMRIVDRKKDMILVSGFNVYPNELEDVLAALPGVLQCAAIGVP 490
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1698252301 1090 DQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK05677 491 DEKSGEAIKVFVVVKPGETLTKEQVMEHMRANLTGYKVPKAVEFRDELPTTNVGKILRREL 551
|
|
| PRK12406 |
PRK12406 |
long-chain-fatty-acid--CoA ligase; Provisional |
666-1153 |
9.84e-26 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 183506 [Multi-domain] Cd Length: 509 Bit Score: 113.25 E-value: 9.84e-26
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 666 DKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVL 745
Cdd:PRK12406 9 DRRRSFDELAQRAARAAGGLAALGVRPGDCVALLMRNDFAFFEAAYAAMRLGAYAVPVNWHFKPEEIAYILEDSGARVLI 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 746 TNS----SVEIECDESLKILVddVNVMEEI-EKYSeenIDEMECLKPlaPSHIAY--------------------VIYTS 800
Cdd:PRK12406 89 AHAdllhGLASALPAGVTVLS--VPTPPEIaAAYR---ISPALLTPP--AGAIDWegwlaqqepydgppvpqpqsMIYTS 161
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 801 GSTGRPKGVM----IPHQNVVR-LLGATDHWFQFDADDVWT--MFHS--YAFDFSVWEIwgpllyGGRLVVVPHTvsrSP 871
Cdd:PRK12406 162 GTTGHPKGVRraapTPEQAAAAeQMRALIYGLKPGIRALLTgpLYHSapNAYGLRAGRL------GGVLVLQPRF---DP 232
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 872 KEFLQLLVKEKVTVLNQTPSAFYQLMqadRENEEVGQKL---SLRYVVFGGE--ALELSR-LEDWYsrhphnAPKVINMY 945
Cdd:PRK12406 233 EELLQLIERHRITHMHMVPTMFIRLL---KLPEEVRAKYdvsSLRHVIHAAApcPADVKRaMIEWW------GPVIYEYY 303
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 946 GITETTVhvsyIELDESIVSLRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLAR-GYLG----RAGLTAER 1020
Cdd:PRK12406 304 GSTESGA----VTFATSEDALSHPGTVGKAAPGAELRFVDEDGRPLPQGEIGEIYSRIAGNPDfTYHNkpekRAEIDRGG 379
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1021 FIAdpfgkpgtrmyrTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAY 1100
Cdd:PRK12406 380 FIT------------SGDVGYLDADGYLFLCDRKRDMVISGGVNIYPAEIEAVLHAVPGVHDCAVFGIPDAEFGEALMAV 447
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|...
gi 1698252301 1101 IVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAP 1153
Cdd:PRK12406 448 VEPQPGATLDEADIRAQLKARLAGYKVPKHIEIMAELPREDSGKIFKRRLRDP 500
|
|
| Firefly_Luc |
cd17642 |
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect ... |
670-1150 |
1.56e-25 |
|
insect luciferase, similar to plant 4-coumarate: CoA ligases; This family contains insect firefly luciferases that share significant sequence similarity to plant 4-coumarate:coenzyme A ligases, despite their functional diversity. Luciferase catalyzes the production of light in the presence of MgATP, molecular oxygen, and luciferin. In the first step, luciferin is activated by acylation of its carboxylate group with ATP, resulting in an enzyme-bound luciferyl adenylate. In the second step, luciferyl adenylate reacts with molecular oxygen, producing an enzyme-bound excited state product (Luc=O*) and releasing AMP. This excited-state product then decays to the ground state (Luc=O), emitting a quantum of visible light.
Pssm-ID: 341297 [Multi-domain] Cd Length: 532 Bit Score: 113.01 E-value: 1.56e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 670 TYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNss 749
Cdd:cd17642 46 SYAEYLEMSVRLAEALKKYGLKQNDRIAVCSENSLQFFLPVIAGLFIGVGVAPTNDIYNERELDHSLNISKPTIVFCS-- 123
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 750 vEIECDESLKI-----LVDDVNVMEEIEKYSEENIDEMECLKPLAPS---------------HIAYVIYTSGSTGRPKGV 809
Cdd:cd17642 124 -KKGLQKVLNVqkklkIIKTIIILDSKEDYKGYQCLYTFITQNLPPGfneydfkppsfdrdeQVALIMNSSGSTGLPKGV 202
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 810 MIPHQN-VVRLLGATDHWF--QFDAD----DVWTMFHSyafdFSVWEIWGPLLYGGRLVVVPhtvSRSPKEFLQLLVKEK 882
Cdd:cd17642 203 QLTHKNiVARFSHARDPIFgnQIIPDtailTVIPFHHG----FGMFTTLGYLICGFRVVLMY---KFEEELFLRSLQDYK 275
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 883 VTVLNQTPSAFYQLMQADRENEevgQKLSLRYVVFGGEAlELSR-LEDWYSRHpHNAPKVINMYGITETTVHVsYIELDE 961
Cdd:cd17642 276 VQSALLVPTLFAFFAKSTLVDK---YDLSNLHEIASGGA-PLSKeVGEAVAKR-FKLPGIRQGYGLTETTSAI-LITPEG 349
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 962 SIvslRANSlIGCSIPDLKVYVLD-NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLA 1040
Cdd:cd17642 350 DD---KPGA-VGKVVPFFYAKVVDlDTGKTLGPNERGELCVKGPMIMKGYVNNPEATKALIDKDGW-------LHSGDIA 418
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1041 RWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASG 1120
Cdd:cd17642 419 YYDEDGHFFIVDRLKSLIKYKGYQVPPAELESILLQHPKIFDAGVAGIPDEDAGELPAAVVVLEAGKTMTEKEVMDYVAS 498
|
490 500 510
....*....|....*....|....*....|.
gi 1698252301 1121 SL-PDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd17642 499 QVsTAKRLRGGVKFVDEVPKGLTGKIDRRKI 529
|
|
| PRK06164 |
PRK06164 |
acyl-CoA synthetase; Validated |
642-1140 |
1.72e-25 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235722 [Multi-domain] Cd Length: 540 Bit Score: 112.91 E-value: 1.72e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 642 EMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYL 721
Cdd:PRK06164 9 ADTLASLLDAHARARPDAVALIDEDRPLSRAELRALVDRLAAWLAAQGVRRGDRVAVWLPNCIEWVVLFLACARLGATVI 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 722 PLDPDYPSDRISFM-----------------------LHDAKPSCVLTNSSVEIECDESLKI---------LVDDVNVME 769
Cdd:PRK06164 89 AVNTRYRSHEVAHIlgrgrarwlvvwpgfkgidfaaiLAAVPPDALPPLRAIAVVDDAADATpapapgarvQLFALPDPA 168
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 770 EIEKYSEENIDemeclkplaPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTMFHSY--AFDFSV 847
Cdd:PRK06164 169 PPAAAGERAAD---------PDAGALLFTTSGTTSGPKLVLHRQATLLRHARAIARAYGYDPGAVLLAALPFcgVFGFST 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 848 weIWGPLLYGGRLVVVPhtVSRSPKEfLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGqklSLRYVVFGGEALELSRL 927
Cdd:PRK06164 240 --LLGALAGGAPLVCEP--VFDAART-ARALRRHRVTHTFGNDEMLRRILDTAGERADFP---SARLFGFASFAPALGEL 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 928 EDWYSRhpHNAPkVINMYGITETTVHVSYIELDESiVSLRANSLIGCSIPDLKVYVLDNYLQPV-PPGVVGEMYVAGAGL 1006
Cdd:PRK06164 312 AALARA--RGVP-LTGLYGSSEVQALVALQPATDP-VSVRIEGGGRPASPEARVRARDPQDGALlPDGESGEIEIRAPSL 387
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1007 ARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVE--QVA 1084
Cdd:PRK06164 388 MRGYLDNPDATARALTDDGY-------FRTGDLGYTRGDGQFVYQTRMGDSLRLGGFLVNPAEIEHALEALPGVAaaQVV 460
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 1085 VIVREDQPgdkRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLT 1140
Cdd:PRK06164 461 GATRDGKT---VPVAFVIPTDGASPDEAGLMAACREALAGFKVPARVQVVEAFPVT 513
|
|
| PRK09029 |
PRK09029 |
O-succinylbenzoic acid--CoA ligase; Provisional |
653-1150 |
2.17e-25 |
|
O-succinylbenzoic acid--CoA ligase; Provisional
Pssm-ID: 236363 [Multi-domain] Cd Length: 458 Bit Score: 111.50 E-value: 2.17e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 653 AHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDri 732
Cdd:PRK09029 13 AQVRPQAIALRLNDEVLTWQQLCARIDQLAAGFAQQGVVEGSGVALRGKNSPETLLAYLALLQCGARVLPLNPQLPQP-- 90
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 733 sfMLHDAKPScvLTNSSVEIECDESLKILVDDVNVMEEIEKYSEenidemeclkPLAPSHIAYVIYTSGSTGRPKGVMIP 812
Cdd:PRK09029 91 --LLEELLPS--LTLDFALVLEGENTFSALTSLHLQLVEGAHAV----------AWQPQRLATMTLTSGSTGLPKAAVHT 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 813 HQN-------VVRLlgatdhwFQFDADDVW----TMFHsyafdFS----VWEiWgpLLYGGRLVVvphtvsRSPKEFLQL 877
Cdd:PRK09029 157 AQAhlasaegVLSL-------MPFTAQDSWllslPLFH-----VSgqgiVWR-W--LYAGATLVV------RDKQPLEQA 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 878 LvkEKVTVLNQTPSAFYQLMQADReneevgQKLSLRYVVFGGEA--LELSR------LEDWYSrhphnapkvinmYGITE 949
Cdd:PRK09029 216 L--AGCTHASLVPTQLWRLLDNRS------EPLSLKAVLLGGAAipVELTEqaeqqgIRCWCG------------YGLTE 275
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 950 --TTVHVSyieldesivslRANSLIGCSIP----DLKVyvldnylqpvppgVVGEMYVAGAGLARGYLGRAGLTAerfIA 1023
Cdd:PRK09029 276 maSTVCAK-----------RADGLAGVGSPlpgrEVKL-------------VDGEIWLRGASLALGYWRQGQLVP---LV 328
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1024 DPFGKPGTRmyrtgDLARWrQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVA 1103
Cdd:PRK09029 329 NDEGWFATR-----DRGEW-QNGELTILGRLDNLFFSGGEGIQPEEIERVINQHPLVQQVFVVPVADAEFGQRPVAVVES 402
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1104 SNNETIDtnEMRQHASGSLPDYMVPYAFVVvneLPLT-PNG--KLDRKAL 1150
Cdd:PRK09029 403 DSEAAVV--NLAEWLQDKLARFQQPVAYYL---LPPElKNGgiKISRQAL 447
|
|
| PRK07529 |
PRK07529 |
AMP-binding domain protein; Validated |
647-1150 |
3.04e-25 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236043 [Multi-domain] Cd Length: 632 Bit Score: 113.13 E-value: 3.04e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 647 QLFEKQAHINPNSIAVVF--------EDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGA 718
Cdd:PRK07529 29 ELLSRAAARHPDAPALSFlldadpldRPETWTYAELLADVTRTANLLHSLGVGPGDVVAFLLPNLPETHFALWGGEAAGI 108
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 719 GYlPLDPDYPSDRISFMLHDAKPSCV------------------------------------LTNSSVEIECDESLKILV 762
Cdd:PRK07529 109 AN-PINPLLEPEQIAELLRAAGAKVLvtlgpfpgtdiwqkvaevlaalpelrtvvevdlaryLPGPKRLAVPLIRRKAHA 187
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 763 DDVNVMEEIEKYSEeniDEMECLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVrllgaTDHW-----FQFDADDV--- 834
Cdd:PRK07529 188 RILDFDAELARQPG---DRLFSGRPIGPDDVAAYFHTGGTTGMPKLAQHTHGNEV-----ANAWlgallLGLGPGDTvfc 259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 835 -WTMFHSYAfdfSVWEIWGPLLYGGRLVVVPHTVSRSP---KEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGqkl 910
Cdd:PRK07529 260 gLPLFHVNA---LLVTGLAPLARGAHVVLATPQGYRGPgviANFWKIVERYRINFLSGVPTVYAALLQVPVDGHDIS--- 333
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 911 SLRYVVFGGEAL--EL-SRLEDwysrhpHNAPKVINMYGITETT--VHVSYIELDESIVSlranslIGCSIP--DLKVYV 983
Cdd:PRK07529 334 SLRYALCGAAPLpvEVfRRFEA------ATGVRIVEGYGLTEATcvSSVNPPDGERRIGS------VGLRLPyqRVRVVI 401
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 984 LD---NYLQPVPPGVVGEMYVAGAGLARGYLGRA---GLTAERfiadpfgkpgtRMYRTGDLARWRQDGTLDYIGRADHQ 1057
Cdd:PRK07529 402 LDdagRYLRDCAVDEVGVLCIAGPNVFSGYLEAAhnkGLWLED-----------GWLNTGDLGRIDADGYFWLTGRAKDL 470
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1058 IkIR-GFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPD-YMVPYAFVVVN 1135
Cdd:PRK07529 471 I-IRgGHNIDPAAIEEALLRHPAVALAAAVGRPDAHAGELPVAYVQLKPGASATEAELLAFARDHIAErAAVPKHVRILD 549
|
570
....*....|....*
gi 1698252301 1136 ELPLTPNGKLDRKAL 1150
Cdd:PRK07529 550 ALPKTAVGKIFKPAL 564
|
|
| PRK13383 |
PRK13383 |
acyl-CoA synthetase; Provisional |
657-1152 |
6.81e-25 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139531 [Multi-domain] Cd Length: 516 Bit Score: 110.86 E-value: 6.81e-25
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFML 736
Cdd:PRK13383 49 PGRTAIIDDDGALSYRELQRATESLARRLTRDGVAPGRAVGVMCRNGRGFVTAVFAVGLLGADVVPISTEFRSDALAAAL 128
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 737 HDAKPSCVLTNSsveiECDESLKILVDDVNVMEEIEKYSEENIDEMeclKPLAPSHIayVIYTSGSTGRPKGVmiPHQNV 816
Cdd:PRK13383 129 RAHHISTVVADN----EFAERIAGADDAVAVIDPATAGAEESGGRP---AVAAPGRI--VLLTSGTTGKPKGV--PRAPQ 197
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 817 VR--------LLGATDHWFQFDADDVWTMFHSYAFDFSVWEIwgplLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQ 888
Cdd:PRK13383 198 LRsavgvwvtILDRTRLRTGSRISVAMPMFHGLGLGMLMLTI----ALGGTVLTHRHFDAEAALAQASLHRADAFTAVPV 273
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 889 TPSAFYQLMQADRENEEVGQklsLRYVVFGGEALELS---RLEDWYsrhphnAPKVINMYGITETTVHVSYIELDesivs 965
Cdd:PRK13383 274 VLARILELPPRVRARNPLPQ---LRVVMSSGDRLDPTlgqRFMDTY------GDILYNGYGSTEVGIGALATPAD----- 339
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 966 LR-ANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGltaeRFIADPfgkpgtrMYRTGDLARWRQ 1044
Cdd:PRK13383 340 LRdAPETVGKPVAGCPVRILDRNNRPVGPRVTGRIFVGGELAGTRYTDGGG----KAVVDG-------MTSTGDMGYLDN 408
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1045 DGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPD 1124
Cdd:PRK13383 409 AGRLFIVGREDDMIISGGENVYPRAVENALAAHPAVADNAVIGVPDERFGHRLAAFVVLHPGSGVDAAQLRDYLKDRVSR 488
|
490 500
....*....|....*....|....*...
gi 1698252301 1125 YMVPYAFVVVNELPLTPNGKLDRKALPA 1152
Cdd:PRK13383 489 FEQPRDINIVSSIPRNPTGKVLRKELPG 516
|
|
| PLN03102 |
PLN03102 |
acyl-activating enzyme; Provisional |
646-1150 |
1.47e-24 |
|
acyl-activating enzyme; Provisional
Pssm-ID: 215576 [Multi-domain] Cd Length: 579 Bit Score: 110.49 E-value: 1.47e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 646 PQLFEKQA-HINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLD 724
Cdd:PLN03102 16 PITFLKRAsECYPNRTSIIYGKTRFTWPQTYDRCCRLAASLISLNITKNDVVSVLAPNTPAMYEMHFAVPMAGAVLNPIN 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 725 PDYPSDRISFMLHDAKPSCVLTNSSVEIECDESLKILVDD----------VNVMEEIEKYSEENIDeMECL----KPlAP 790
Cdd:PLN03102 96 TRLDATSIAAILRHAKPKILFVDRSFEPLAREVLHLLSSEdsnlnlpvifIHEIDFPKRPSSEELD-YECLiqrgEP-TP 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 791 SHIAYVI------------YTSGSTGRPKGVMIPHQNV-VRLLGATDHWfQFDADDV--WT--MFHSYAFDFSvweiWGP 853
Cdd:PLN03102 174 SLVARMFriqdehdpislnYTSGTTADPKGVVISHRGAyLSTLSAIIGW-EMGTCPVylWTlpMFHCNGWTFT----WGT 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 854 LLYGGRLVVVPHTVSrspKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEvgQKLSLRYVVFGGE---ALELSRLEDW 930
Cdd:PLN03102 249 AARGGTSVCMRHVTA---PEIYKNIEMHNVTHMCCVPTVFNILLKGNSLDLS--PRSGPVHVLTGGSpppAALVKKVQRL 323
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 931 ysrhphnAPKVINMYGITETTVHVSYIELDESIVSLRANSLI------GCSIPDLKVYVLDN--YLQPVPPG--VVGEMY 1000
Cdd:PLN03102 324 -------GFQVMHAYGLTEATGPVLFCEWQDEWNRLPENQQMelkarqGVSILGLADVDVKNkeTQESVPRDgkTMGEIV 396
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1001 VAGAGLARGYLGRAGLTAERFiadpfgKPGtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKV 1080
Cdd:PLN03102 397 IKGSSIMKGYLKNPKATSEAF------KHG--WLNTGDVGVIHPDGHVEIKDRSKDIIISGGENISSVEVENVLYKYPKV 468
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1081 EQVAVIVREDQPGDKRLVAYIVASNNET--------IDTNE--MRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PLN03102 469 LETAVVAMPHPTWGETPCAFVVLEKGETtkedrvdkLVTRErdLIEYCRENLPHFMCPRKVVFLQELPKNGNGKILKPKL 548
|
|
| FATP_FACS |
cd05940 |
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its ... |
666-1144 |
1.77e-24 |
|
Fatty acid transport proteins (FATP) play dual roles as fatty acid transporters and its activation enzymes; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. At least five copies of FATPs are identified in mammalian cells. This family also includes prokaryotic FATPs. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341263 [Multi-domain] Cd Length: 449 Bit Score: 108.60 E-value: 1.77e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 666 DKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAgylpldpdypsdrisfmlhdaKPSCVL 745
Cdd:cd05940 1 DEALTYAELDAMANRYARWLKSLGLKPGDVVALFMENRPEYVLLWLGLVKIGA---------------------VAALIN 59
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 746 TNssveiecdESLKILVddvnvmeeiekyseenidemECLKPLAPSHI----AYVIYTSGSTGRPKGVMIPHQNVVRLLG 821
Cdd:cd05940 60 YN--------LRGESLA--------------------HCLNVSSAKHLvvdaALYIYTSGTTGLPKAAIISHRRAWRGGA 111
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 822 ATDHWFQFDADDVW--TM--FHSYAFDFSvweiWGPLLYGGRLVVVPHTVSRSpkEFLQLLVKEKVTVLNQTPSAFYQLM 897
Cdd:cd05940 112 FFAGSGGALPSDVLytCLplYHSTALIVG----WSACLASGATLVIRKKFSAS--NFWDDIRKYQATIFQYIGELCRYLL 185
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 898 QADRENEEVGQKLSlryVVFgGEALELSRLEDWYSRhpHNAPKVINMYGITETTvhVSYIELDESIVSL-RANSLIGCSI 976
Cdd:cd05940 186 NQPPKPTERKHKVR---MIF-GNGLRPDIWEEFKER--FGVPRIAEFYAATEGN--SGFINFFGKPGAIgRNPSLLRKVA 257
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 977 PDLKV-YVLDN---------YLQPVPPGVVGEMYVAGAGLAR--GYLGrAGLTAERFIADPFgKPGTRMYRTGDLARWRQ 1044
Cdd:cd05940 258 PLALVkYDLESgepirdaegRCIKVPRGEPGLLISRINPLEPfdGYTD-PAATEKKILRDVF-KKGDAWFNTGDLMRLDG 335
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1045 DGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRL-VAYIVASNNETIDTNEMRQHASGSLP 1123
Cdd:cd05940 336 EGFWYFVDRLGDTFRWKGENVSTTEVAAVLGAFPGVEEANVYGVQVPGTDGRAgMAAIVLQPNEEFDLSALAAHLEKNLP 415
|
490 500
....*....|....*....|.
gi 1698252301 1124 DYMVPYAFVVVNELPLTPNGK 1144
Cdd:cd05940 416 GYARPLFLRLQPEMEITGTFK 436
|
|
| A_NRPS_Bac |
cd17655 |
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of ... |
1-81 |
2.28e-24 |
|
bacitracin synthetase and related proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetases 1, 2, and 3 (BA1, also known as ATP-dependent cysteine adenylase or cysteine activase, BA2, also known as ATP-dependent lysine adenylase or lysine activase, and BA3, also known as ATP-dependent isoleucine adenylase or isoleucine activase) in Bacilli. Bacitracin is a mixture of related cyclic peptides used as a polypeptide antibiotic. This family also includes gramicidin synthetase 1 involved in synthesis of the cyclic peptide antibiotic gramicidin S via activation of phenylalanine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341310 [Multi-domain] Cd Length: 490 Bit Score: 108.95 E-value: 2.28e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEkePINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPAP 80
Cdd:cd17655 412 LLQHPDIKEAVVIARKDEQGQNYLCAYIVSEK--ELPVAQLREFLARELPDYMIPSYFIKLDEIPLTPNGKVDRKALPEP 489
|
.
gi 1698252301 81 D 81
Cdd:cd17655 490 D 490
|
|
| PTZ00237 |
PTZ00237 |
acetyl-CoA synthetase; Provisional |
668-1150 |
2.47e-24 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 240325 [Multi-domain] Cd Length: 647 Bit Score: 110.22 E-value: 2.47e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 668 KLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPS----DRISFM-------- 735
Cdd:PTZ00237 92 KLTYYQLYEKVCEFSRVLLNLNISKNDNVLIYMANTLEPLIAMLSCARIGATHCVLFDGYSVksliDRIETItpkliitt 171
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 736 ---------------LHDA------KPSCVLTNSSVEIECDESLKILVD------DVNVMEEIEKYSEENIDEMECLKPL 788
Cdd:PTZ00237 172 nygilndeiitftpnLKEAielstfKPSNVITLFRNDITSESDLKKIETiptipnTLSWYDEIKKIKENNQSPFYEYVPV 251
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 789 APSHIAYVIYTSGSTGRPKGVMipHQNVVRLLGATDHWFQFDADDVWTMFHSYAfdfSV-WEIWGPLLYG----GRLVVV 863
Cdd:PTZ00237 252 ESSHPLYILYTSGTTGNSKAVV--RSNGPHLVGLKYYWRSIIEKDIPTVVFSHS---SIgWVSFHGFLYGslslGNTFVM 326
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 864 PHTVSRSPK----EFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKL---SLRYVVFGGEALELSRLEdwYSRHPH 936
Cdd:PTZ00237 327 FEGGIIKNKhiedDLWNTIEKHKVTHTLTLPKTIRYLIKTDPEATIIRSKYdlsNLKEIWCGGEVIEESIPE--YIENKL 404
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 937 NApKVINMYGITETTVhvSYIeLDESIVSLRANSLiGCSIPDLKVYVLDN--------------YLQPVPPGVVGEMYVa 1002
Cdd:PTZ00237 405 KI-KSSRGYGQTEIGI--TYL-YCYGHINIPYNAT-GVPSIFIKPSILSEdgkelnvneigevaFKLPMPPSFATTFYK- 478
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1003 gaglargylgraglTAERFiADPFGK-PGtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVE 1081
Cdd:PTZ00237 479 --------------NDEKF-KQLFSKfPG--YYNSGDLGFKDENGYYTIVSRSDDQIKISGNKVQLNTIETSILKHPLVL 541
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 1082 QVAVIVREDQPGDKRLVAYIV---ASNNETIDTNEMRQHASGSLPDYMVPYAF----VVVNELPLTPNGKLDRKAL 1150
Cdd:PTZ00237 542 ECCSIGIYDPDCYNVPIGLLVlkqDQSNQSIDLNKLKNEINNIITQDIESLAVlrkiIIVNQLPKTKTGKIPRQII 617
|
|
| A_NRPS_CmdD_like |
cd17652 |
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) ... |
1-78 |
2.54e-24 |
|
similar to adenylation domain of chondramide synthase cmdD; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes phosphinothricin tripeptide (PTT, phosphinothricylalanylalanine) synthetase, where PTT is a natural-product antibiotic and potent herbicide that is produced by Streptomyces hygroscopicus. This adenylation domain has been confirmed to directly activate beta-tyrosine, and fluorinated chondramides are produced through precursor-directed biosynthesis. Also included in this family is chondramide synthase D (also known as ATP-dependent phenylalanine adenylase or phenylalanine activase or tyrosine activase). Chondramides A-D are depsipeptide antitumor and antifungal antibiotics produced by C. crocatus, are a class of mixed peptide/polyketide depsipeptides comprised of three amino acids (alanine, N-methyltryptophan, plus the unusual amino acid beta-tyrosine or alpha-methoxy-beta-tyrosine) and a polyketide chain ([E]-7-hydroxy-2,4,6-trimethyloct-4-enoic acid).
Pssm-ID: 341307 [Multi-domain] Cd Length: 436 Bit Score: 108.11 E-value: 2.54e-24
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLP 78
Cdd:cd17652 359 LTEHPGVAEAVVVVRDDRPGDKRLVAYVVPAPGAAPTAAELRAHLAERLPGYMVPAAFVVLDALPLTPNGKLDRRALP 436
|
|
| PRK07059 |
PRK07059 |
Long-chain-fatty-acid--CoA ligase; Validated |
644-1150 |
2.62e-24 |
|
Long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235923 [Multi-domain] Cd Length: 557 Bit Score: 109.34 E-value: 2.62e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 644 TLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPL 723
Cdd:PRK07059 24 SLADLLEESFRQYADRPAFICMGKAITYGELDELSRALAAWLQSRGLAKGARVAIMMPNVLQYPVAIAAVLRAGYVVVNV 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 724 DPDYPSDRISFMLHD--AKPSCVLTN--SSVE-IECDESLKILVddVNVMEE-------IEKYSEENIDEM--------- 782
Cdd:PRK07059 104 NPLYTPRELEHQLKDsgAEAIVVLENfaTTVQqVLAKTAVKHVV--VASMGDllgfkghIVNFVVRRVKKMvpawslpgh 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 783 ------------ECLKP--LAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQF------DADDVWTM----- 837
Cdd:PRK07059 182 vrfndalaegarQTFKPvkLGPDDVAFLQYTGGTTGVSKGATLLHRNIVANVLQMEAWLQPafekkpRPDQLNFVcalpl 261
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 838 FHSYAFdfSVWEIWGpLLYGGRLVVVPHtvSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMqadreNEEVGQKL---SLRY 914
Cdd:PRK07059 262 YHIFAL--TVCGLLG-MRTGGRNILIPN--PRDIPGFIKELKKYQVHIFPAVNTLYNALL-----NNPDFDKLdfsKLIV 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 915 VVFGGEALELSRLEDWYSRHphNAPkVINMYGITETTVHVSYIELDESIVSlranSLIGCSIPDLKVYVLDNYLQPVPPG 994
Cdd:PRK07059 332 ANGGGMAVQRPVAERWLEMT--GCP-ITEGYGLSETSPVATCNPVDATEFS----GTIGLPLPSTEVSIRDDDGNDLPLG 404
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 995 VVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVI 1074
Cdd:PRK07059 405 EPGEICIRGPQVMAGYWNRPDETAKVMTADGF-------FRTGDVGVMDERGYTKIVDRKKDMILVSGFNVYPNEIEEVV 477
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 1075 MKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDtNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK07059 478 ASHPGVLEVAAVGVPDEHSGEAVKLFVVKKDPALTE-EDVKAFCKERLTNYKRPKFVEFRTELPKTNVGKILRREL 552
|
|
| A_NRPS_Srf_like |
cd12117 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis ... |
1-77 |
2.66e-24 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Bacillus subtilis termination module Surfactin (SrfA-C); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the adenylation domain of the Bacillus subtilis termination module (Surfactin domain, SrfA-C) which recognizes a specific amino acid building block, which is then activated and transferred to the terminal thiol of the 4'-phosphopantetheine (Ppan) arm of the downstream peptidyl carrier protein (PCP) domain.
Pssm-ID: 341282 [Multi-domain] Cd Length: 483 Bit Score: 108.44 E-value: 2.66e-24
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEkePINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd12117 409 LRAHPGVREAVVVVREDAGGDKRLVAYVVAEG--ALDAAELRAFLRERLPAYMVPAAFVVLDELPLTANGKVDRRAL 483
|
|
| LC_FACS_like |
cd17640 |
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA ... |
667-1102 |
8.33e-24 |
|
Long-chain fatty acid CoA synthetase; This family includes long-chain fatty acid (C12-C20) CoA synthetases, including an Arabidopsis gene At4g14070 that plays a role in activation and elongation of exogenous fatty acids. FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Eukaryotes generally have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341295 [Multi-domain] Cd Length: 468 Bit Score: 106.67 E-value: 8.33e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 667 KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAkpscvlt 746
Cdd:cd17640 4 KRITYKDLYQEILDFAAGLRSLGVKAGEKVALFADNSPRWLIADQGIMALGAVDVVRGSDSSVEELLYILNHS------- 76
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 747 nssveiecdESLKILVDDvnvmeeiekyseenidemeclkplAPSHIAYVIYTSGSTGRPKGVMIPHQNVVrllgatdhw 826
Cdd:cd17640 77 ---------ESVALVVEN------------------------DSDDLATIIYTSGTTGNPKGVMLTHANLL--------- 114
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 827 fqFDADDVWTMFHSYAFD--FSVWEIWgpllyggrlvvvpHTVSR----------------SPKEFLQLLVKEKVTVLNQ 888
Cdd:cd17640 115 --HQIRSLSDIVPPQPGDrfLSILPIW-------------HSYERsaeyfifacgcsqaytSIRTLKDDLKRVKPHYIVS 179
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 889 TP---SAFYQLMQADRENEEVGQKLSLRYVVFGGE---------ALELSrLEDWYsrhphNAP--KVINMYGITETTVHV 954
Cdd:cd17640 180 VPrlwESLYSGIQKQVSKSSPIKQFLFLFFLSGGIfkfgisgggALPPH-VDTFF-----EAIgiEVLNGYGLTETSPVV 253
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 955 SYIELDESIvslraNSLIGCSIPDLKVYVLD-NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrm 1033
Cdd:cd17640 254 SARRLKCNV-----RGSVGRPLPGTEIKIVDpEGNVVLPPGEKGIVWVRGPQVMKGYYKNPEATSKVLDSDGW------- 321
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1034 YRTGDLARWRQDGTLDYIGRADHQIKIR-GFRIELGEIEAVIMKHDKVEQVaVIVREDQpgdKRLVAYIV 1102
Cdd:cd17640 322 FNTGDLGWLTCGGELVLTGRAKDTIVLSnGENVEPQPIEEALMRSPFIEQI-MVVGQDQ---KRLGALIV 387
|
|
| PRK08751 |
PRK08751 |
long-chain fatty acid--CoA ligase; |
667-1150 |
9.84e-24 |
|
long-chain fatty acid--CoA ligase;
Pssm-ID: 181546 [Multi-domain] Cd Length: 560 Bit Score: 107.66 E-value: 9.84e-24
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 667 KKLTYEKLNRKANKIARFLIakgvGPDQL-----VALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKP 741
Cdd:PRK08751 49 KTITYREADQLVEQFAAYLL----GELQLkkgdrVALMMPNCLQYPIATFGVLRAGLTVVNVNPLYTPRELKHQLIDSGA 124
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 742 SC--VLTNSSVEIE---CDESLKILVDD-------------VN-VMEEIEKYSEE-----NIDEMECLK----------P 787
Cdd:PRK08751 125 SVlvVIDNFGTTVQqviADTPVKQVITTglgdmlgfpkaalVNfVVKYVKKLVPEyringAIRFREALAlgrkhsmptlQ 204
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 788 LAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDA------DDVWT---MFHSYAfdfsvweiwgplLYGG 858
Cdd:PRK08751 205 IEPDDIAFLQYTGGTTGVAKGAMLTHRNLVANMQQAHQWLAGTGkleegcEVVITalpLYHIFA------------LTAN 272
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 859 RLVVVP-----HTVS--RSPKEFLQLLVKEKVTVLNQTPSAFYQLMqadreNEEVGQKL---SLRYVVFGGEALELSRLE 928
Cdd:PRK08751 273 GLVFMKiggcnHLISnpRDMPGFVKELKKTRFTAFTGVNTLFNGLL-----NTPGFDQIdfsSLKMTLGGGMAVQRSVAE 347
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 929 DWYSRhphNAPKVINMYGITETT--VHVSYIELDESivslraNSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGL 1006
Cdd:PRK08751 348 RWKQV---TGLTLVEAYGLTETSpaACINPLTLKEY------NGSIGLPIPSTDACIKDDAGTVLAIGEIGELCIKGPQV 418
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1007 ARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVI 1086
Cdd:PRK08751 419 MKGYWKRPEETAKVMDADGW-------LHTGDIARMDEQGFVYIVDRKKDMILVSGFNVYPNEIEDVIAMMPGVLEVAAV 491
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1698252301 1087 -VREDQPGDkrLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK08751 492 gVPDEKSGE--IVKVVIVKKDPALTAEDVKAHARANLTGYKQPRIIEFRKELPKTNVGKILRREL 554
|
|
| PRK07470 |
PRK07470 |
acyl-CoA synthetase; Validated |
643-1150 |
1.47e-23 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 180988 [Multi-domain] Cd Length: 528 Bit Score: 106.66 E-value: 1.47e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 643 MTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLP 722
Cdd:PRK07470 7 MNLAHFLRQAARRFPDRIALVWGDRSWTWREIDARVDALAAALAARGVRKGDRILVHSRNCNQMFESMFAAFRLGAVWVP 86
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 723 LDPDYPSDRISFMLHDAKPSCVLTNSSV--------EIECDESLKILVDDVNVMEEIEKYSEENIDEMecLKPLAPSH-- 792
Cdd:PRK07470 87 TNFRQTPDEVAYLAEASGARAMICHADFpehaaavrAASPDLTHVVAIGGARAGLDYEALVARHLGAR--VANAAVDHdd 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 793 IAYVIYTSGSTGRPKGVMIPHQNVVRLLgaTDHWfqfdADDVWTMFHSyafDFSVweIWGPLLYG-----------GRLV 861
Cdd:PRK07470 165 PCWFFFTSGTTGRPKAAVLTHGQMAFVI--TNHL----ADLMPGTTEQ---DASL--VVAPLSHGagihqlcqvarGAAT 233
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 862 VVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMqadrENEEVGQ--KLSLRYVVFGG-------EALELSRLedwys 932
Cdd:PRK07470 234 VLLPSERFDPAEVWALVERHRVTNLFTVPTILKMLV----EHPAVDRydHSSLRYVIYAGapmyradQKRALAKL----- 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 933 rhphnAPKVINMYGITETTVHVSYI-----ELDESivslrANSLIG-CSIP--DLKVYVLDNYLQPVPPGVVGEMYVAGA 1004
Cdd:PRK07470 305 -----GKVLVQYFGLGEVTGNITVLppalhDAEDG-----PDARIGtCGFErtGMEVQIQDDEGRELPPGETGEICVIGP 374
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1005 GLARGYLGRAGLTAERFIADPFgkpgtrmyRTGDLARWRQDGTLdYI-GRADHQIKIRGFRIELGEIEAVIMKHDKVEQV 1083
Cdd:PRK07470 375 AVFAGYYNNPEANAKAFRDGWF--------RTGDLGHLDARGFL-YItGRASDMYISGGSNVYPREIEEKLLTHPAVSEV 445
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1084 AVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK07470 446 AVLGVPDPVWGEVGVAVCVARDGAPVDEAELLAWLDGKVARYKLPKRFFFWDALPKSGYGKITKKMV 512
|
|
| MACS_like_1 |
cd05974 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
669-1154 |
1.53e-23 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341278 [Multi-domain] Cd Length: 432 Bit Score: 105.34 E-value: 1.53e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLP----LDPDYPSDRIsfmlhdakpscv 744
Cdd:cd05974 1 VSFAEMSARSSRVANFLRSIGVGRGDRILLMLGNVVELWEAMLAAMKLGAVVIPattlLTPDDLRDRV------------ 68
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 745 ltnssveiECDESLKILVDDVNVMEEiekyseenidemeclkPLapshiaYVIYTSGSTGRPKgvMIPHQNVVRLLG--A 822
Cdd:cd05974 69 --------DRGGAVYAAVDENTHADD----------------PM------LLYFTSGTTSKPK--LVEHTHRSYPVGhlS 116
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 823 TDHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVVVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRE 902
Cdd:cd05974 117 TMYWIGLKPGDVHWNISSPGWAKHAWSCFFAPWNAGATVFLFNYARFDAKRVLAALVRYGVTTLCAPPTVWRMLIQQDLA 196
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 903 NEEVGqklsLRYVVFGGEALElsrledwysrhphnaPKVINM------------YGITETTVHVSyielDESIVSLRANS 970
Cdd:cd05974 197 SFDVK----LREVVGAGEPLN---------------PEVIEQvrrawgltirdgYGQTETTALVG----NSPGQPVKAGS 253
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 971 LiGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAG--AGLARGYLGRAGLTAERFiadpfgkpGTRMYRTGDLARWRQDGTL 1048
Cdd:cd05974 254 M-GRPLPGYRVALLDPDGAPATEGEVALDLGDTrpVGLMKGYAGDPDKTAHAM--------RGGYYRTGDIAMRDEDGYL 324
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1049 DYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIvreDQPGDKRLV---AYIV--ASNNETIDTN-EMRQHasgsL 1122
Cdd:cd05974 325 TYVGRADDVFKSSDYRISPFELESVLIEHPAVAEAAVV---PSPDPVRLSvpkAFIVlrAGYEPSPETAlEIFRF----S 397
|
490 500 510
....*....|....*....|....*....|....*
gi 1698252301 1123 PDYMVPYAFV---VVNELPLTPNGKLDRKALPAPE 1154
Cdd:cd05974 398 RERLAPYKRIrrlEFAELPKTISGKIRRVELRRRE 432
|
|
| ACLS-CaiC |
cd17637 |
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ... |
796-1147 |
1.56e-23 |
|
acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II; This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized, but may be similar to Carnitine-CoA ligase (CaiC) which catalyzes the transfer of CoA to carnitine. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341292 [Multi-domain] Cd Length: 333 Bit Score: 103.50 E-value: 1.56e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 796 VIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVW----TMFHSYAFDFSVweiwGPLLYGGRLVVVPHTvsrSP 871
Cdd:cd17637 5 IIHTAAVAGRPRGAVLSHGNLIAANLQLIHAMGLTEADVYlnmlPLFHIAGLNLAL----ATFHAGGANVVMEKF---DP 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 872 KEFLQLLVKEKVTVLNQTPSAFYQLMQAdreNEEVGQKL-SLRYVvFGGEALE-LSRLEDwysrhpHNAPKVINMYGITE 949
Cdd:cd17637 78 AEALELIEEEKVTLMGSFPPILSNLLDA---AEKSGVDLsSLRHV-LGLDAPEtIQRFEE------TTGATFWSLYGQTE 147
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 950 TTVHVSYIELDEsivslRANSlIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFiadpfgKP 1029
Cdd:cd17637 148 TSGLVTLSPYRE-----RPGS-AGRPGPLVRVRIVDDNDRPVPAGETGEIVVRGPLVFQGYWNLPELTAYTF------RN 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1030 GtrMYRTGDLARWRQDGTLDYIGRADHQ--IKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNE 1107
Cdd:cd17637 216 G--WHHTGDLGRFDEDGYLWYAGRKPEKelIKPGGENVYPAEVEKVILEHPAIAEVCVIGVPDPKWGEGIKAVCVLKPGA 293
|
330 340 350 360
....*....|....*....|....*....|....*....|
gi 1698252301 1108 TIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDR 1147
Cdd:cd17637 294 TLTADELIEFVGSRIARYKKPRYVVFVEALPKTADGSIDR 333
|
|
| PRK08974 |
PRK08974 |
long-chain-fatty-acid--CoA ligase FadD; |
644-1150 |
2.09e-23 |
|
long-chain-fatty-acid--CoA ligase FadD;
Pssm-ID: 236359 [Multi-domain] Cd Length: 560 Bit Score: 106.68 E-value: 2.09e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 644 TLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFL-----IAKGvgpDQlVALAMPRSLNMVVSLLAVLKAGA 718
Cdd:PRK08974 24 SLVDMFEQAVARYADQPAFINMGEVMTFRKLEERSRAFAAYLqnglgLKKG---DR-VALMMPNLLQYPIALFGILRAGM 99
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 719 GYLPLDPDYPSDRISFMLHD--AKPSCVLTNSSVEIEcdeslKIlVDDVNVMEEI-------------------EKYSEE 777
Cdd:PRK08974 100 IVVNVNPLYTPRELEHQLNDsgAKAIVIVSNFAHTLE-----KV-VFKTPVKHVIltrmgdqlstakgtlvnfvVKYIKR 173
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 778 NIDE------------------MECLKP-LAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLgatdhwFQFDAddvwtmf 838
Cdd:PRK08974 174 LVPKyhlpdaisfrsalhkgrrMQYVKPeLVPEDLAFLQYTGGTTGVAKGAMLTHRNMLANL------EQAKA------- 240
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 839 hsyafdfsvweIWGPLLYGG-RLVVVP----H----TVS-----------------RSPKEFLQLLVKEKVTVLNQTPSA 892
Cdd:PRK08974 241 -----------AYGPLLHPGkELVVTAlplyHifalTVNcllfielggqnllitnpRDIPGFVKELKKYPFTAITGVNTL 309
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 893 FYQLMQadreNEEVgQKL---SLRYVVFGGEALELSRLEDWysrHPHNAPKVINMYGITETT--VHVSYIELDESivslr 967
Cdd:PRK08974 310 FNALLN----NEEF-QELdfsSLKLSVGGGMAVQQAVAERW---VKLTGQYLLEGYGLTECSplVSVNPYDLDYY----- 376
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 968 aNSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAErFIADPFgkpgtrmYRTGDLARWRQDGT 1047
Cdd:PRK08974 377 -SGSIGLPVPSTEIKLVDDDGNEVPPGEPGELWVKGPQVMLGYWQRPEATDE-VIKDGW-------LATGDIAVMDEEGF 447
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1048 LDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVI-VREDQPGDkrLVAYIVASNNETIDTNEMRQHASGSLPDYM 1126
Cdd:PRK08974 448 LRIVDRKKDMILVSGFNVYPNEIEDVVMLHPKVLEVAAVgVPSEVSGE--AVKIFVVKKDPSLTEEELITHCRRHLTGYK 525
|
570 580
....*....|....*....|....
gi 1698252301 1127 VPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK08974 526 VPKLVEFRDELPKSNVGKILRREL 549
|
|
| beta-lac_NRPS |
cd19547 |
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis ... |
181-611 |
2.55e-23 |
|
Condensation domain of nonribosomal peptide synthetases (NRPSs) similar to Nocardia uniformis NocB which exhibits an unusual cyclization to form beta-lactam rings in pro-nocardicin G synthesis; Nocardia uniformis NRPS NocB acts centrally in the biosynthesis of the nocardicin monocyclic beta-lactam antibiotics. Along with another NRPS NocA, it mediates an unusual cyclization to form beta-lactam rings in the synthesis of the beta-lactam-containing pentapeptide pro-nocardicin G. This small subfamily is related to DCL-type Condensation (C) domains, which catalyze condensation between a D-aminoacyl/peptidyl-PCP donor and a L-aminoacyl-PCP acceptor. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; domains belonging to this subfamily have an HHHxxxD motif at the active site.
Pssm-ID: 380469 [Multi-domain] Cd Length: 422 Bit Score: 104.70 E-value: 2.55e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 181 PLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFP-NVLGSSYQKILD-----MENL 254
Cdd:cd19547 3 PLAPMQEGMLFRGLFWPDSDAYFNQNVLELVGGTDEDVLREAWRRVADRYEILRTGFTwRDRAEPLQYVRDdlappWALL 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 255 NLEMVITNTCKDELESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQGD 334
Cdd:cd19547 83 DWSGEDPDRRAELLERLLADDRAAGLSLADCPLYRLTLVRLGGGRHYLLWSHHHILLDGWCLSLIWGDVFRVYEELAHGR 162
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 335 RVQLEtlPVQ-YADYALWQQQLLGDETTPESlistqldFWKEELKGLPdqmelPTDY-QRPVETSYRGETIHFHIDEGMH 412
Cdd:cd19547 163 EPQLS--PCRpYRDYVRWIRARTAQSEESER-------FWREYLRDLT-----PSPFsTAPADREGEFDTVVHEFPEQLT 228
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 413 SRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDVLSD--IVGLFVNTLVLRTNTSGDPSFKELLNR 490
Cdd:cd19547 229 RLVNEAARGYGVTTNAISQAAWSMLLALQTGARDVVHGLTIAGRPPELEGSehMVGIFINTIPLRIRLDPDQTVTGLLET 308
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 491 VKQvNLAAYENQ-DVPFERLVEVLNPVRTRNSHpLFQVMLAFQNTPEAtfNAPDLEASLEIqsvgsakFDLtfeisESNE 569
Cdd:cd19547 309 IHR-DLATTAAHgHVPLAQIKSWASGERLSGGR-VFDNLVAFENYPED--NLPGDDLSIQI-------IDL-----HAQE 372
|
410 420 430 440 450
....*....|....*....|....*....|....*....|....*....|
gi 1698252301 570 VDGTPNGLHGL--------LEFSTDLYKRETVQKLIERFILLLDDAATNP 611
Cdd:cd19547 373 KTEYPIGLIVLplqklafhFNYDTTHFTRAQVDRFIEVFRLLTEQLCRRP 422
|
|
| PtmA |
cd17636 |
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, ... |
796-1146 |
2.83e-23 |
|
long-chain fatty acid CoA ligase (FadD); This family contains fatty acid CoA ligases, including acyl-CoA synthetase (AMP-forming)/AMP-acid ligase II, most of which are yet to be characterized. Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341291 [Multi-domain] Cd Length: 331 Bit Score: 102.77 E-value: 2.83e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 796 VIYTSGSTGRPKGVMIPHQN------VVRLLGATDHWFQFDadDVWTMFHSYAFDFSVweiwGPLLYGGRLVVVPHTvsr 869
Cdd:cd17636 5 AIYTAAFSGRPNGALLSHQAllaqalVLAVLQAIDEGTVFL--NSGPLFHIGTLMFTL----ATFHAGGTNVFVRRV--- 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 870 SPKEFLQLLVKEKVTVLNQTPSAFYQLMQAdreNEEVGQKLSLRYVVFGgealelsrLEDWYS-RHPHNAPKVINM--YG 946
Cdd:cd17636 76 DAEEVLELIEAERCTHAFLLPPTIDQIVEL---NADGLYDLSSLRSSPA--------APEWNDmATVDTSPWGRKPggYG 144
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 947 ITETTVHVSYIELDESivslrANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIAdpf 1026
Cdd:cd17636 145 QTEVMGLATFAALGGG-----AIGGAGRPSPLVQVRILDEDGREVPDGEVGEIVARGPTVMAGYWNRPEVNARRTRG--- 216
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1027 gkpgtRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNN 1106
Cdd:cd17636 217 -----GWHHTNDLGRREPDGSLSFVGPKTRMIKSGAENIYPAEVERCLRQHPAVADAAVIGVPDPRWAQSVKAIVVLKPG 291
|
330 340 350 360
....*....|....*....|....*....|....*....|
gi 1698252301 1107 ETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLD 1146
Cdd:cd17636 292 ASVTEAELIEHCRARIASYKKPKSVEFADALPRTAGGADD 331
|
|
| PRK08276 |
PRK08276 |
long-chain-fatty-acid--CoA ligase; Validated |
662-1145 |
2.91e-23 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236215 [Multi-domain] Cd Length: 502 Bit Score: 105.76 E-value: 2.91e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 662 VVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKp 741
Cdd:PRK08276 5 MAPSGEVVTYGELEARSNRLAHGLRALGLREGDVVAILLENNPEFFEVYWAARRSGLYYTPINWHLTAAEIAYIVDDSG- 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 742 SCVLTNSSveiECDESLKILVDDVN--------VMEEIEKYSeeniDEMECLKPLAPSHIAYVI------YTSGSTGRPK 807
Cdd:PRK08276 84 AKVLIVSA---ALADTAAELAAELPagvplllvVAGPVPGFR----SYEEALAAQPDTPIADETagadmlYSSGTTGRPK 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 808 GVMI------PHQNVVRLLGATDHWFQFDADDVWTM----FHSYAFDFSVWEiwgpLLYGGRLVVVPHTvsrSPKEFLQL 877
Cdd:PRK08276 157 GIKRplpgldPDEAPGMMLALLGFGMYGGPDSVYLSpaplYHTAPLRFGMSA----LALGGTVVVMEKF---DAEEALAL 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 878 LVKEKVTVLNQTPSAFYQLMQADrenEEVGQKL---SLRYVVFGGE--ALELSR-LEDWYsrhphnAPKVINMYGITE-- 949
Cdd:PRK08276 230 IERYRVTHSQLVPTMFVRMLKLP---EEVRARYdvsSLRVAIHAAApcPVEVKRaMIDWW------GPIIHEYYASSEgg 300
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 950 -TTVHVSYIELDESIVSLRAnsLIGcsipdlKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIadpfgk 1028
Cdd:PRK08276 301 gVTVITSEDWLAHPGSVGKA--VLG------EVRILDEDGNELPPGEIGTVYFEMDGYPFEYHNDPEKTAAARN------ 366
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1029 pGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVI-VREDQPGDkRLVAYIVASNNE 1107
Cdd:PRK08276 367 -PHGWVTVGDVGYLDEDGYLYLTDRKSDMIISGGVNIYPQEIENLLVTHPKVADVAVFgVPDEEMGE-RVKAVVQPADGA 444
|
490 500 510 520
....*....|....*....|....*....|....*....|.
gi 1698252301 1108 TID---TNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKL 1145
Cdd:PRK08276 445 DAGdalAAELIAWLRGRLAHYKCPRSIDFEDELPRTPTGKL 485
|
|
| DCL_NRPS-like |
cd19536 |
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal ... |
181-536 |
3.26e-23 |
|
DCL-type Condensation domains of nonribosomal peptide synthetases (NRPSs), such as terminal fungal CT domains and Dual Epimerization/Condensation (E/C) domains; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type [D-specific for the peptidyl donor and L-specific for the aminoacyl acceptor ((D)C(L))], which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380459 [Multi-domain] Cd Length: 419 Bit Score: 104.45 E-value: 3.26e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 181 PLSFAQRRLWFLNCLEGPSPTYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNV-LGSSYQKILdmENLNLEMV 259
Cdd:cd19536 3 PLSSLQEGMLFHSLLNPGGSVYLHNYTYTVGRRLNLDLLLEALQVLIDRHDILRTSFIEDgLGQPVQVVH--RQAQVPVT 80
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 260 ITNTCKDE-----LESVLSEAVRYSFNLDFEPAVRLQLFTVSENEHVLL-ILLHHIVGDGWSLQPLTRDFTAAYKARCQG 333
Cdd:cd19536 81 ELDLTPLEeqldpLRAYKEETKIRRFDLGRAPLVRAALVRKDERERFLLvISDHHSILDGWSLYLLVKEILAVYNQLLEY 160
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 334 DRVQLetLPVQ-YADYALWQQQLLGDETTpeslistqLDFWKEELKGLPDQmelPTDYQRPVETSYRGETIHFHIDEGMH 412
Cdd:cd19536 161 KPLSL--PPAQpYRDFVAHERASIQQAAS--------ERYWREYLAGATLA---TLPALSEAVGGGPEQDSELLVSVPLP 227
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 413 SRLVELGRKNGVSLFMVLQAGLSALFTRLGAGTDIPIGSPIAGRNDDV--LSDIVGLFVNTLVLRTNTSgDPSFKELLNR 490
Cdd:cd19536 228 VRSRSLAKRSGIPLSTLLLAAWALVLSRHSGSDDVVFGTVVHGRSEETtgAERLLGLFLNTLPLRVTLS-EETVEDLLKR 306
|
330 340 350 360
....*....|....*....|....*....|....*....|....*.
gi 1698252301 491 VKQVNLAAYENQDVPferlveVLNPVRTRNSHPLFQVMLAFQNTPE 536
Cdd:cd19536 307 AQEQELESLSHEQVP------LADIQRCSEGEPLFDSIVNFRHFDL 346
|
|
| PRK05850 |
PRK05850 |
acyl-CoA synthetase; Validated |
643-1053 |
4.47e-23 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235624 [Multi-domain] Cd Length: 578 Bit Score: 105.79 E-value: 4.47e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 643 MTLPQLFEKQAHINPNSIAVVFED---------KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAmPRSLNMVVSLLAV 713
Cdd:PRK05850 1 SSVPSLLRERASLQPDDAAFTFIDyeqdpagvaETLTWSQLYRRTLNVAEELRRHGSTGDRAVILA-PQGLEYIVAFLGA 79
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 714 LKAGAGYLPLDPDYPS---DRISFMLHDAKPSCVLTNSSVeiecdeslkilVDDVnvMEEIEKYSEEN------IDEME- 783
Cdd:PRK05850 80 LQAGLIAVPLSVPQGGahdERVSAVLRDTSPSVVLTTSAV-----------VDDV--TEYVAPQPGQSappvieVDLLDl 146
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 784 ------CLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVV--------RLLGATDHWFQFDADDV-WTMF-HSYAFdfsV 847
Cdd:PRK05850 147 dsprgsDARPRDLPSTAYLQYTSGSTRTPAGVMVSHRNVIanfeqlmsDYFGDTGGVPPPDTTVVsWLPFyHDMGL---V 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 848 WEIWGPLLyGGRLVVVPHTVS--RSPKEFLQLLVKEkvtvlnqtPSAF-------YQLmQADRENEEVGQKLSLRYV--- 915
Cdd:PRK05850 224 LGVCAPIL-GGCPAVLTSPVAflQRPARWMQLLASN--------PHAFsaapnfaFEL-AVRKTSDDDMAGLDLGGVlgi 293
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 916 VFGGEALE---LSRLEDWYSRHpHNAPKVIN-MYGITETTVHVSYIELDESIVSLR------------------ANSLIG 973
Cdd:PRK05850 294 ISGSERVHpatLKRFADRFAPF-NLRETAIRpSYGLAEATVYVATREPGQPPESVRfdyeklsaghakrcetggGTPLVS 372
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 974 CSIPDLK-VYVLD-NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERF---IADPF-GKPGTRMYRTGDLArWRQDGT 1047
Cdd:PRK05850 373 YGSPRSPtVRIVDpDTCIECPAGTVGEIWVHGDNVAAGYWQKPEETERTFgatLVDPSpGTPEGPWLRTGDLG-FISEGE 451
|
....*.
gi 1698252301 1048 LDYIGR 1053
Cdd:PRK05850 452 LFIVGR 457
|
|
| entE |
PRK10946 |
(2,3-dihydroxybenzoyl)adenylate synthase; |
654-1150 |
7.65e-23 |
|
(2,3-dihydroxybenzoyl)adenylate synthase;
Pssm-ID: 236803 [Multi-domain] Cd Length: 536 Bit Score: 104.69 E-value: 7.65e-23
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 654 HINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAgyLPLDPDYpSDRIS 733
Cdd:PRK10946 34 HAASDAIAVICGERQFSYRELNQASDNLACSLRRQGIKPGDTALVQLGNVAEFYITFFALLKLGV--APVNALF-SHQRS 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 734 FMLHDAK---PSCVLTN------------SSVEIECDESLKILVDDVNVMEEIEKYSEENIDEMECLkPLAPSHIAYVIY 798
Cdd:PRK10946 111 ELNAYASqiePALLIADrqhalfsdddflNTLVAEHSSLRVVLLLNDDGEHSLDDAINHPAEDFTAT-PSPADEVAFFQL 189
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 799 TSGSTGRPKgvMIP--HQNVVRLLGATDHWFQFDADdvwTMF-------HSYAFdfSVWEIWGPLLYGGRLVVVPhtvSR 869
Cdd:PRK10946 190 SGGSTGTPK--LIPrtHNDYYYSVRRSVEICGFTPQ---TRYlcalpaaHNYPM--SSPGALGVFLAGGTVVLAP---DP 259
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 870 SPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLSLRYVVFGGealelSRLEDWYSRHphnAPKVIN-----M 944
Cdd:PRK10946 260 SATLCFPLIEKHQVNVTALVPPAVSLWLQAIAEGGSRAQLASLKLLQVGG-----ARLSETLARR---IPAELGcqlqqV 331
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 945 YGITETTVhvSYIELDESivSLRANSLIGCSI-PDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIA 1023
Cdd:PRK10946 332 FGMAEGLV--NYTRLDDS--DERIFTTQGRPMsPDDEVWVADADGNPLPQGEVGRLMTRGPYTFRGYYKSPQHNASAFDA 407
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1024 DPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVRED-QPGDKRlVAYIV 1102
Cdd:PRK10946 408 NGF-------YCSGDLVSIDPDGYITVVGREKDQINRGGEKIAAEEIENLLLRHPAVIHAALVSMEDeLMGEKS-CAFLV 479
|
490 500 510 520
....*....|....*....|....*....|....*....|....*....
gi 1698252301 1103 AsnNETIDTNEMRQHASG-SLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK10946 480 V--KEPLKAVQLRRFLREqGIAEFKLPDRVECVDSLPLTAVGKVDKKQL 526
|
|
| A_NRPS_VisG_like |
cd17651 |
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) ... |
1-78 |
8.78e-23 |
|
similar to adenylation domain of virginiamycin S synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes virginiamycin S synthetase (VisG) in Streptomyces virginiae; VisG is involved in virginiamycin S (VS) biosynthesis as the provider of an L-pheGly molecule, a highly specific substrate for the last condensation step by VisF. This family also includes linear gramicidin synthetase B (LgrB) in Brevibacillus brevis. Substrate specificity analysis using residues of the substrate-binding pockets of all 16 adenylation domains has shown good agreement of the substrate amino acids predicted with the sequence of linear gramicidin. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341306 [Multi-domain] Cd Length: 491 Bit Score: 103.96 E-value: 8.78e-23
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLP 78
Cdd:cd17651 414 LARHPGVREAVVLAREDRPGEKRLVAYVVGDPEAPVDAAELRAALATHLPEYMVPSAFVLLDALPLTPNGKLDRRALP 491
|
|
| A_NRPS_Cytc1-like |
cd17643 |
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation ... |
1-77 |
1.37e-22 |
|
similar to adenylation domain of cytotrienin synthetase CytC1; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes Streptomyces sp. cytotrienin synthetase (CytC1), a relatively promiscuous adenylation enzyme that installs the aminoacyl moieties on the phosphopantetheinyl arm of the holo carrier protein CytC2. Also included are Streptomyces sp Thr1, involved in the biosynthesis of 4-chlorothreonine, Pseudomonas aeruginosa pyoverdine synthetase D (PvdD), involved in the biosynthesis of the siderophore pyoverdine and Pseudomonas syringae syringopeptin synthetase, where syringpeptin is a necrosis-inducing phytotoxin that functions as a virulence determinant in the plant-pathogen interaction. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341298 [Multi-domain] Cd Length: 450 Bit Score: 102.77 E-value: 1.37e-22
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd17643 374 LATHPSVRDAAVIVREDEPGDTRLVAYVVADDGAAADIAELRALLKELLPDYMVPARYVPLDALPLTVNGKLDRAAL 450
|
|
| FUM14_C_NRPS-like |
cd19545 |
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond ... |
206-611 |
1.84e-22 |
|
Condensation domains of nonribosomal peptide synthetases (NRPSs) similar to the ester-bond forming Fusarium verticillioides FUM14 protein; Condensation (C) domains of nonribosomal peptide synthetases (NRPSs) typically catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. However, some C-domains have ester-bond forming activity. This subfamily includes Fusarium verticillioides FUM14 (also known as NRPS8), a bi-domain protein with an ester-bond forming NRPS C-domain, which catalyzes linkages between an aminoacyl/peptidyl-PCP donor and a hydroxyl-containing acceptor. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity. FUM14 has an altered active site motif DHTHCD instead of the typical HHxxxD motif seen in other subfamily members. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380467 [Multi-domain] Cd Length: 395 Bit Score: 101.61 E-value: 1.84e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 206 LVIRMNGILNRQALQGAFYDVVEKHETLRT-IFPNVLGSSYQKILDmenlnlEMVITNTCKDELESVLSEAVRYSFNLDf 284
Cdd:cd19545 26 RVFELPPDIDLARLQAAWEQVVQANPILRTrIVQSDSGGLLQVVVK------ESPISWTESTSLDEYLEEDRAAPMGLG- 98
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 285 EPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCqgdrvqlETLPVQYADYalwqQQLLGDETTPES 364
Cdd:cd19545 99 GPLVRLALVEDPDTERYFVWTIHHALYDGWSLPLILRQVLAAYQGEP-------VPQPPPFSRF----VKYLRQLDDEAA 167
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 365 listqLDFWKEELKGLPDQM--ELPTDYQRPVETSYRgeTIHFHIDEGMHSrlvelgrknGVSLFMVLQAGLSALFTRLG 442
Cdd:cd19545 168 -----AEFWRSYLAGLDPAVfpPLPSSRYQPRPDATL--EHSISLPSSASS---------GVTLATVLRAAWALVLSRYT 231
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 443 AGTDIPIGSPIAGRN---DDVLsDIVGLFVNTLVLRTNTSGDPSFKELLNRVKQVNLAAyenqdVPFE----RLVEVLNP 515
Cdd:cd19545 232 GSDDVVFGVTLSGRNapvPGIE-QIVGPTIATVPLRVRIDPEQSVEDFLQTVQKDLLDM-----IPFEhtglQNIRRLGP 305
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 516 vRTRnSHPLFQVMLAFQNTPEATfNAPDLEASLEIQSVGSAKFD---LTFEIsesnEVDGTPNGLHGLleFSTDLYKRET 592
Cdd:cd19545 306 -DAR-AACNFQTLLVVQPALPSS-TSESLELGIEEESEDLEDFSsygLTLEC----QLSGSGLRVRAR--YDSSVISEEQ 376
|
410
....*....|....*....
gi 1698252301 593 VQKLIERFILLLDDAATNP 611
Cdd:cd19545 377 VERLLDQFEHVLQQLASAP 395
|
|
| PRK12492 |
PRK12492 |
long-chain-fatty-acid--CoA ligase; Provisional |
669-1150 |
2.00e-22 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 171539 [Multi-domain] Cd Length: 562 Bit Score: 103.75 E-value: 2.00e-22
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAK-GVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSC---- 743
Cdd:PRK12492 50 LSYAELERHSAAFAAYLQQHtDLVPGDRIAVQMPNVLQYPIAVFGALRAGLIVVNTNPLYTAREMRHQFKDSGARAlvyl 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 744 ---------VLTNSSVE--IECD-----------------ESLKILVDDVNVMEEIEKYSEENIDEMECLKPLAPSH--I 793
Cdd:PRK12492 130 nmfgklvqeVLPDTGIEylIEAKmgdllpaakgwlvntvvDKVKKMVPAYHLPQAVPFKQALRQGRGLSLKPVPVGLddI 209
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 794 AYVIYTSGSTGRPKGVMIPHQNVV----------RLLGATDHWFQFDADDVWT----MFHSYAFDFSVWEIwgpLLYGGR 859
Cdd:PRK12492 210 AVLQYTGGTTGLAKGAMLTHGNLVanmlqvraclSQLGPDGQPLMKEGQEVMIaplpLYHIYAFTANCMCM---MVSGNH 286
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 860 LVVVphTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMqadreNEEVGQKL---SLRYVVFGGEALELSRLEDWYSRhph 936
Cdd:PRK12492 287 NVLI--TNPRDIPGFIKELGKWRFSALLGLNTLFVALM-----DHPGFKDLdfsALKLTNSGGTALVKATAERWEQL--- 356
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 937 NAPKVINMYGITETTVHVS---YIELDesivslRANSlIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGR 1013
Cdd:PRK12492 357 TGCTIVEGYGLTETSPVAStnpYGELA------RLGT-VGIPVPGTALKVIDDDGNELPLGERGELCIKGPQVMKGYWQQ 429
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1014 AGLTAERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVI-VREDQP 1092
Cdd:PRK12492 430 PEATAEALDAEGW-------FKTGDIAVIDPDGFVRIVDRKKDLIIVSGFNVYPNEIEDVVMAHPKVANCAAIgVPDERS 502
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1093 GDKrlVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK12492 503 GEA--VKLFVVARDPGLSVEELKAYCKENFTGYKVPKHIVLRDSLPMTPVGKILRREL 558
|
|
| BACL_like |
cd05929 |
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes ... |
795-1150 |
1.24e-21 |
|
Bacterial Bile acid CoA ligases and similar proteins; Bile acid-Coenzyme A ligase catalyzes the formation of bile acid-CoA conjugates in a two-step reaction: the formation of a bile acid-AMP molecule as an intermediate, followed by the formation of a bile acid-CoA. This ligase requires a bile acid with a free carboxyl group, ATP, Mg2+, and CoA for synthesis of the final bile acid-CoA conjugate. The bile acid-CoA ligation is believed to be the initial step in the bile acid 7alpha-dehydroxylation pathway in the intestinal bacterium Eubacterium sp.
Pssm-ID: 341252 [Multi-domain] Cd Length: 473 Bit Score: 100.14 E-value: 1.24e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 795 YVIYTSGSTGRPKGVMIPH-----QNVVRLLGATDHWFQFDadDVW----TMFHSYAFDFSVweiwGPLLYGGRLVVVPH 865
Cdd:cd05929 129 KMLYSGGTTGRPKGIKRGLpggppDNDTLMAAALGFGPGAD--SVYlspaPLYHAAPFRWSM----TALFMGGTLVLMEK 202
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 866 TvsrSPKEFLQLLVKEKVTVLNQTPSAFYQLM---QADRENEEVGqklSLRYVVFGGEALELSRLEDWYSRHPhnaPKVI 942
Cdd:cd05929 203 F---DPEEFLRLIERYRVTFAQFVPTMFVRLLklpEAVRNAYDLS---SLKRVIHAAAPCPPWVKEQWIDWGG---PIIW 273
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 943 NMYGITETtVHVSYIELDESivsLRANSLIGCSIPDlKVYVLDNYLQPVPPGVVGEMYVAGAGlARGYLGRAGLTAERFI 1022
Cdd:cd05929 274 EYYGGTEG-QGLTIINGEEW---LTHPGSVGRAVLG-KVHILDEDGNEVPPGEIGEVYFANGP-GFEYTNDPEKTAAARN 347
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1023 ADPFgkpgtrmyRT-GDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYI 1101
Cdd:cd05929 348 EGGW--------STlGDVGYLDEDGYLYLTDRRSDMIISGGVNIYPQEIENALIAHPKVLDAAVVGVPDEELGQRVHAVV 419
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|..
gi 1698252301 1102 ---VASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05929 420 qpaPGADAGTALAEELIAFLRDRLSRYKCPRSIEFVAELPRDDTGKLYRRLL 471
|
|
| E_NRPS |
cd19534 |
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
179-600 |
1.34e-21 |
|
Epimerization domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Epimerization (E) domains of nonribosomal peptide synthetases (NRPS) flip the chirality of the end amino acid of a peptide being manufactured by the NRPS. E-domains are homologous to the Condensation (C) domains. NRPSs catalyze peptide bond formation within (usually) large multi-modular enzymatic complexes. Specialized tailoring NRPS domains such as E-domains greatly increase the range of possible peptide products created by the NRPS machinery. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and heterocyclization (Cyc) domains which catalyze both peptide bond formation and cyclization of Cys, Ser, or Thr residues. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the E-domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain. C-domains typically have a conserved HHxxxD motif at the active site; mutations in this motif can abolish or diminish condensation activity.
Pssm-ID: 380457 [Multi-domain] Cd Length: 428 Bit Score: 99.63 E-value: 1.34e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 179 EVPLSFAQRrlWFLN-CLEGPSPtYNIPLVIRMNGILNRQALQGAFYDVVEKHETLRTIFPNVLGSSYQKILDMENLN-- 255
Cdd:cd19534 1 EVPLTPIQR--WFFEqNLAGRHH-FNQSVLLRVPQGLDPDALRQALRALVEHHDALRMRFRREDGGWQQRIRGDVEELfr 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 256 LEM--VITNTCKDELESVLSEAVRySFNLDFEPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYKARCQG 333
Cdd:cd19534 78 LEVvdLSSLAQAAAIEALAAEAQS-SLDLEEGPLLAAALFDGTDGGDRLLLVIHHLVVDGVSWRILLEDLEAAYEQALAG 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 334 DRVQLETLPvQYADYALWQQQLLGDETTpesliSTQLDFWKEELKglPDQMELPTDYQRPVETSyrgETIHFHIDEGMHS 413
Cdd:cd19534 157 EPIPLPSKT-SFQTWAELLAEYAQSPAL-----LEELAYWRELPA--ADYWGLPKDPEQTYGDA---RTVSFTLDEEETE 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 414 RLveLGRKNGvslfmVLQAG-----LSALFTRLGAGTDipiGSPIA------GRNDDV----LSDIVGLFvnT----LVL 474
Cdd:cd19534 226 AL--LQEANA-----AYRTEindllLAALALAFQDWTG---RAPPAifleghGREEIDpgldLSRTVGWF--TsmypVVL 293
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 475 RTNTSGDPSfkELLNRVKQvNLAAYENQDVPFERLvevlnpvrtRNSHPLFQVMLAFQNTPEATFN------APDLEASL 548
Cdd:cd19534 294 DLEASEDLG--DTLKRVKE-QLRRIPNKGIGYGIL---------RYLTPEGTKRLAFHPQPEISFNylgqfdQGERDDAL 361
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 549 EIQSVGSAKFDLT--------FEISESNEvDGTpngLHGLLEFSTDLYKRETVQKLIERF 600
Cdd:cd19534 362 FVSAVGGGGSDIGpdtprfalLDINAVVE-GGQ---LVITVSYSRNMYHEETIQQLADSY 417
|
|
| PRK12476 |
PRK12476 |
putative fatty-acid--CoA ligase; Provisional |
635-1149 |
1.78e-21 |
|
putative fatty-acid--CoA ligase; Provisional
Pssm-ID: 171527 [Multi-domain] Cd Length: 612 Bit Score: 100.97 E-value: 1.78e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 635 GGFQIAPEMTLPQLFEKQAHINPNSIAVVFED---------KKLTYEKLNRKANKI-ARflIAKGVGPDQLVALAMPRSL 704
Cdd:PRK12476 26 GNIALPPGTTLISLIERNIANVGDTVAYRYLDhshsaagcaVELTWTQLGVRLRAVgAR--LQQVAGPGDRVAILAPQGI 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 705 NMVVSLLAVLKAGAGYLPL-DPDYP--SDRISFMLHDAKPSCVLTNSSVEIECDESLK----------ILVDDVnvmeei 771
Cdd:PRK12476 104 DYVAGFFAAIKAGTIAVPLfAPELPghAERLDTALRDAEPTVVLTTTAAAEAVEGFLRnlprlrrprvIAIDAI------ 177
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 772 ekysEENIDEMECLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQ----NVVRLLGATDhWFQFDADDV-W-TMFHsyafDF 845
Cdd:PRK12476 178 ----PDSAGESFVPVELDTDDVSHLQYTSGSTRPPVGVEITHRavgtNLVQMILSID-LLDRNTHGVsWlPLYH----DM 248
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 846 SVWEIWGPLLYGGRLVVV-PHTVSRSPKEFLQLLVKEKVT--VLNQTPSAFYQLmQADRENEEVGQKLSLRYVVF--GGE 920
Cdd:PRK12476 249 GLSMIGFPAVYGGHSTLMsPTAFVRRPQRWIKALSEGSRTgrVVTAAPNFAYEW-AAQRGLPAEGDDIDLSNVVLiiGSE 327
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 921 ALELSRLEDWYSRH-PHNAPK--VINMYGITETTVHVSYIELDE--SIVSL------------------RANSLIGCSIP 977
Cdd:PRK12476 328 PVSIDAVTTFNKAFaPYGLPRtaFKPSYGIAEATLFVATIAPDAepSVVYLdreqlgagravrvaadapNAVAHVSCGQV 407
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 978 ---DLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIAD-----PFGK------PGTRMYRTGDLARWR 1043
Cdd:PRK12476 408 arsQWAVIVDPDTGAELPDGEVGEIWLHGDNIGRGYWGRPEETERTFGAKlqsrlAEGShadgaaDDGTWLRTGDLGVYL 487
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1044 qDGTLDYIGRADHQIKIRGFRIELGEIEAVimkhdkVEQVAVIVREDQ------PGDKRLVAYIVASNN----------- 1106
Cdd:PRK12476 488 -DGELYITGRIADLIVIDGRNHYPQDIEAT------VAEASPMVRRGYvtaftvPAEDNERLVIVAERAagtsradpapa 560
|
570 580 590 600
....*....|....*....|....*....|....*....|....*..
gi 1698252301 1107 -ETIDTNEMRQHAsgslpdymVPYA---FVVVNELPLTPNGKLDRKA 1149
Cdd:PRK12476 561 iDAIRAAVSRRHG--------LAVAdvrLVPAGAIPRTTSGKLARRA 599
|
|
| PLN02330 |
PLN02330 |
4-coumarate--CoA ligase-like 1 |
639-1150 |
3.03e-21 |
|
4-coumarate--CoA ligase-like 1
Pssm-ID: 215189 [Multi-domain] Cd Length: 546 Bit Score: 99.67 E-value: 3.03e-21
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 639 IAPEMTLPQLFEKQAHINPNSIAVV--FEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKA 716
Cdd:PLN02330 24 VPDKLTLPDFVLQDAELYADKVAFVeaVTGKAVTYGEVVRDTRRFAKALRSLGLRKGQVVVVVLPNVAEYGIVALGIMAA 103
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 717 GAGYLPLDPDYPSDRISFMLHDAKPSCVLTNSS-----------VEIECDESLKILVDDVNVMEEIEKYSEENIDEmECL 785
Cdd:PLN02330 104 GGVFSGANPTALESEIKKQAEAAGAKLIVTNDTnygkvkglglpVIVLGEEKIEGAVNWKELLEAADRAGDTSDNE-EIL 182
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 786 KplapSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGAT------DHWFQFDADDVWTMFHSYAFdfsVWEIWGPLLYGGR 859
Cdd:PLN02330 183 Q----TDLCALPFSSGTTGISKGVMLTHRNLVANLCSSlfsvgpEMIGQVVTLGLIPFFHIYGI---TGICCATLRNKGK 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 860 LVVVPHTVSRSpkeFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLSLRYVVFGGEALELSRLEDWYSRHPhnAP 939
Cdd:PLN02330 256 VVVMSRFELRT---FLNALITQEVSFAPIVPPIILNLVKNPIVEEFDLSKLKLQAIMTAAAPLAPELLTAFEAKFP--GV 330
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 940 KVINMYGITE-TTVHVSYIELDESIVSLRANSlIGCSIPDLKVYVLD-NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLT 1017
Cdd:PLN02330 331 QVQEAYGLTEhSCITLTHGDPEKGHGIAKKNS-VGFILPNLEVKFIDpDTGRSLPKNTPGELCVRSQCVMQGYYNNKEET 409
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1018 AERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRL 1097
Cdd:PLN02330 410 DRTIDEDGW-------LHTGDIGYIDDDGDIFIVDRIKELIKYKGFQVAPAELEAILLTHPSVEDAAVVPLPDEEAGEIP 482
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|...
gi 1698252301 1098 VAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PLN02330 483 AACVVINPKAKESEEDILNFVAANVAHYKKVRVVQFVDSIPKSLSGKIMRRLL 535
|
|
| A_NRPS_Ta1_like |
cd12116 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A ... |
1-77 |
4.55e-21 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including salinosporamide A polyketide synthase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the myxovirescin (TA) antibiotic biosynthetic gene in Myxococcus xanthus; TA production plays a role in predation. It also includes the salinosporamide A polyketide synthase which is involved in the biosynthesis of salinosporamide A, a marine microbial metabolite whose chlorine atom is crucial for potent proteasome inhibition and anticancer activity.
Pssm-ID: 341281 [Multi-domain] Cd Length: 470 Bit Score: 98.52 E-value: 4.55e-21
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRpNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd12116 395 LAAHPGVAQAAVVVREDG-GDRRLVAYVVLKAGAAPDAAALRAHLRATLPAYMVPSAFVRLDALPLTANGKLDRKAL 470
|
|
| AFD_YhfT-like |
cd17633 |
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, ... |
792-1147 |
2.60e-20 |
|
fatty acid-CoA ligase VraA; This family of acyl-CoA ligases includes Bacillus subtilis YhfT, as well as long-chain fatty acid-CoA ligase VraA, all of which are as yet to be characterized. These proteins belong to the adenylate-forming enzymes which catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain
Pssm-ID: 341288 [Multi-domain] Cd Length: 320 Bit Score: 93.62 E-value: 2.60e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 792 HIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVW----TMFHSYAfdfsvweIWGPL--LYGGRLVVVPH 865
Cdd:cd17633 1 NPFYIGFTSGTTGLPKAYYRSERSWIESFVCNEDLFNISGEDAIlapgPLSHSLF-------LYGAIsaLYLGGTFIGQR 73
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 866 TVSrsPKEFLQLLVKEKVTVLNQTPSAFYQLMqadRENEEVgqkLSLRYVVFGGEALELSRLEDWYSRHPHnaPKVINMY 945
Cdd:cd17633 74 KFN--PKSWIRKINQYNATVIYLVPTMLQALA---RTLEPE---SKIKSIFSSGQKLFESTKKKLKNIFPK--ANLIEFY 143
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 946 GITETTvHVSYIELDESivsLRANSlIGCSIPDLKVYVLDNylqpvPPGVVGEMYVAGAGLARGYLGRAGLTAerfiadp 1025
Cdd:cd17633 144 GTSELS-FITYNFNQES---RPPNS-VGRPFPNVEIEIRNA-----DGGEIGKIFVKSEMVFSGYVRGGFSNP------- 206
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1026 fgkpgTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVAsn 1105
Cdd:cd17633 207 -----DGWMSVGDIGYVDEEGYLYLVGRESDMIIIGGINIFPTEIESVLKAIPGIEEAIVVGIPDARFGEIAVALYSG-- 279
|
330 340 350 360
....*....|....*....|....*....|....*....|..
gi 1698252301 1106 nETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDR 1147
Cdd:cd17633 280 -DKLTYKQLKRFLKQKLSRYEIPKKIIFVDSLPYTSSGKIAR 320
|
|
| PRK13391 |
PRK13391 |
acyl-CoA synthetase; Provisional |
650-1150 |
3.38e-20 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 184022 [Multi-domain] Cd Length: 511 Bit Score: 96.30 E-value: 3.38e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 650 EKQAHINPNSIAVVF--EDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDY 727
Cdd:PRK13391 4 GIHAQTTPDKPAVIMasTGEVVTYRELDERSNRLAHLFRSLGLKRGDHVAIFMENNLRYLEVCWAAERSGLYYTCVNSHL 83
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 728 PSDRISFMLHDAKPSCVLTNSSVEIECDESLK--------ILVDDVNVMEEIEKYSEenidemeCLKPLAPSHIA----- 794
Cdd:PRK13391 84 TPAEAAYIVDDSGARALITSAAKLDVARALLKqcpgvrhrLVLDGDGELEGFVGYAE-------AVAGLPATPIAdeslg 156
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 795 -YVIYTSGSTGRPKGVM--IPHQNVVRLLGATD---HWFQFDADDVW----TMFHSyafdfsvweiwGPLLY-------G 857
Cdd:PRK13391 157 tDMLYSSGTTGRPKGIKrpLPEQPPDTPLPLTAflqRLWGFRSDMVYlspaPLYHS-----------APQRAvmlvirlG 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 858 GRLVVVPHTvsrSPKEFLQLLVKEKVTVLNQTPSAFYQLMqadRENEEVGQKL---SLRYVVFGGE---ALELSRLEDWY 931
Cdd:PRK13391 226 GTVIVMEHF---DAEQYLALIEEYGVTHTQLVPTMFSRML---KLPEEVRDKYdlsSLEVAIHAAApcpPQVKEQMIDWW 299
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 932 srhphnAPKVINMYGITE---TTVHVSYIELDESIVSLRAnsLIGcsipdlKVYVLDNYLQPVPPGVVGEMYVAGaGLAR 1008
Cdd:PRK13391 300 ------GPIIHEYYAATEglgFTACDSEEWLAHPGTVGRA--MFG------DLHILDDDGAELPPGEPGTIWFEG-GRPF 364
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1009 GYLGRAGLTAERFIADPfgkpgtRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVI-V 1087
Cdd:PRK13391 365 EYLNDPAKTAEARHPDG------TWSTVGDIGYVDEDGYLYLTDRAAFMIISGGVNIYPQEAENLLITHPKVADAAVFgV 438
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1088 REDQPGDkrlVAYIVASNNETIDTN-----EMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK13391 439 PNEDLGE---EVKAVVQPVDGVDPGpalaaELIAFCRQRLSRQKCPRSIDFEDELPRLPTGKLYKRLL 503
|
|
| A_NRPS_Sfm_like |
cd12115 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene ... |
1-77 |
5.56e-20 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Saframycin A gene cluster from Streptomyces lavendulae; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the saframycin A gene cluster from Streptomyces lavendulae which implicates the NRPS system for assembling the unusual tetrapeptidyl skeleton in an iterative manner. It also includes saframycin Mx1 produced by Myxococcus xanthus NRPS.
Pssm-ID: 341280 [Multi-domain] Cd Length: 447 Bit Score: 94.69 E-value: 5.56e-20
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd12115 371 LRSIPGVREAVVVAIGDAAGERRLVAYIVAEPGAAGLVEDLRRHLGTRLPAYMVPSRFVRLDALPLTPNGKIDRSAL 447
|
|
| PRK13388 |
PRK13388 |
acyl-CoA synthetase; Provisional |
777-1152 |
5.83e-20 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237374 [Multi-domain] Cd Length: 540 Bit Score: 95.48 E-value: 5.83e-20
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 777 ENIDEMECLKPLA---PSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDV----WTMFHSYAfdfsVWE 849
Cdd:PRK13388 133 ELVAAAGALTPHRevdAMDPFMLIFTSGTTGAPKAVRCSHGRLAFAGRALTERFGLTRDDVcyvsMPLFHSNA----VMA 208
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 850 IWGPLLYGGRLVVVPHTVSRSpkEFLQLLVKEKVTVLNQTPSAFYQLMQA-----DRENeevgqklSLRyVVFGGEALEL 924
Cdd:PRK13388 209 GWAPAVASGAAVALPAKFSAS--GFLDDVRRYGATYFNYVGKPLAYILATperpdDADN-------PLR-VAFGNEASPR 278
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 925 SRLEdwYSRHphNAPKVINMYGITETTVhvsyieldesIVSLRAN---SLIGCSIPDLKVYVLDNyLQPVPPGV------ 995
Cdd:PRK13388 279 DIAE--FSRR--FGCQVEDGYGSSEGAV----------IVVREPGtppGSIGRGAPGVAIYNPET-LTECAVARfdahga 343
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 996 -------VGEMY-VAGAGLARGYLGRAGLTAERFiadpfgKPGtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIEL 1067
Cdd:PRK13388 344 llnadeaIGELVnTAGAGFFEGYYNNPEATAERM------RHG--MYWSGDLAYRDADGWIYFAGRTADWMRVDGENLSA 415
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1068 GEIEAVIMKHDKVEQVAVI-VREDQPGDKrLVAYIVASNNETIDTNEMRQ--HASGSLPDYMVPYAFVVVNELPLTPNGK 1144
Cdd:PRK13388 416 APIERILLRHPAINRVAVYaVPDERVGDQ-VMAALVLRDGATFDPDAFAAflAAQPDLGTKAWPRYVRIAADLPSTATNK 494
|
....*...
gi 1698252301 1145 LDRKALPA 1152
Cdd:PRK13388 495 VLKRELIA 502
|
|
| A_NRPS_ProA |
cd17656 |
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the ... |
1-78 |
6.60e-20 |
|
gramicidin S synthase 2, also known as ATP-dependent proline adenylase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains gramicidin S synthase 2 (also known as ATP-dependent proline adenylase or proline activase or ProA). ProA is a multifunctional enzyme involved in synthesis of the cyclic peptide antibiotic gramicidin S and able to activate and polymerize the amino acids proline, valine, ornithine and leucine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341311 [Multi-domain] Cd Length: 479 Bit Score: 94.85 E-value: 6.60e-20
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKepINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLP 78
Cdd:cd17656 404 LLNHPGVSEAVVLDKADDKGEKYLCAYFVMEQE--LNISQLREYLAKQLPEYMIPSFFVPLDQLPLTPNGKVDRKALP 479
|
|
| A_NRPS_PpsD_like |
cd17650 |
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation ... |
1-77 |
9.84e-20 |
|
similar to adenylation domain of plipastatin synthase (PpsD); This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes bacitracin synthetase 1 (BacA) in Bacillus licheniformis, tyrocidine synthetase in Brevibacillus brevis, plipastatin synthase (PpsD, an important antifungal protein) in Bacillus subtilis and mannopeptimycin peptide synthetase (MppB) in Streptomyces hygroscopicus. Plipastatin has strong fungitoxic activity and is involved in inhibition of phospholipase A2 and biofilm formation. Bacitracin, a mixture of related cyclic peptides, is used as a polypeptide antibiotic while function of tyrocidine is thought to be regulation of sporulation. MppB is involved in biosynthetic pathway of mannopeptimycin, a novel class of mannosylated lipoglycopeptides. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341305 [Multi-domain] Cd Length: 447 Bit Score: 94.07 E-value: 9.84e-20
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKepINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd17650 373 LARHPAIDEAVVAVREDKGGEARLCAYVVAAAT--LNTAELRAFLAKELPSYMIPSYYVQLDALPLTPNGKVDRRAL 447
|
|
| PRK07768 |
PRK07768 |
long-chain-fatty-acid--CoA ligase; Validated |
787-1149 |
3.51e-19 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236091 [Multi-domain] Cd Length: 545 Bit Score: 93.14 E-value: 3.51e-19
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 787 PLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDAD-DV---W-TMFHSYAFdfsVWEIWGPLLYGGRLV 861
Cdd:PRK07768 148 ETGEDDLALMQLTSGSTGSPKAVQITHGNLYANAEAMFVAAEFDVEtDVmvsWlPLFHDMGM---VGFLTVPMYFGAELV 224
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 862 VV-PHTVSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQ-KLS-LRYVVFGGEALELSRLEDWY---SRHP 935
Cdd:PRK07768 225 KVtPMDFLRDPLLWAELISKYRGTMTAAPNFAYALLARRLRRQAKPGAfDLSsLRFALNGAEPIDPADVEDLLdagARFG 304
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 936 HNAPKVINMYGITETTVHVSYIELDESIV---------------------SLRANSLIGCSIPDLKVYVLDNYLQPVPPG 994
Cdd:PRK07768 305 LRPEAILPAYGMAEATLAVSFSPCGAGLVvdevdadllaalrravpatkgNTRRLATLGPPLPGLEVRVVDEDGQVLPPR 384
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 995 VVGEMYVAGAGLARGYlgragLTAERFIA--DPFGkpgtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEA 1072
Cdd:PRK07768 385 GVGVIELRGESVTPGY-----LTMDGFIPaqDADG-----WLDTGDLGYLTEEGEVVVCGRVKDVIIMAGRNIYPTDIER 454
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1073 VIMkhdKVEQV----AVIVREDQPGDKRLVAYIVASNN--ETIDTNEMRQ---HASGSLPDyMVPYAFVVV--NELPLTP 1141
Cdd:PRK07768 455 AAA---RVEGVrpgnAVAVRLDAGHSREGFAVAVESNAfeDPAEVRRIRHqvaHEVVAEVG-VRPRNVVVLgpGSIPKTP 530
|
....*...
gi 1698252301 1142 NGKLDRKA 1149
Cdd:PRK07768 531 SGKLRRAN 538
|
|
| A_NRPS_AB3403-like |
cd17646 |
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or ... |
1-77 |
7.99e-19 |
|
Peptide Synthetase; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341301 [Multi-domain] Cd Length: 488 Bit Score: 91.57 E-value: 7.99e-19
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIV-AEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd17646 411 LAAHPAVTHAVVVARAAPAGAARLVGYVVpAAGAAGPDTAALRAHLAERLPEYMVPAAFVVLDALPLTANGKLDRAAL 488
|
|
| DltA |
cd05945 |
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes ... |
1-77 |
4.06e-18 |
|
D-alanine:D-alanyl carrier protein ligase (DltA) and similar proteins; This family includes D-alanyl carrier protein ligase DltA and aliphatic beta-amino acid adenylation enzymes IdnL1 and CmiS6. DltA incorporates D-ala in techoic acids in gram-positive bacteria via a two-step process, starting with adenylation of D-alanine that transfers D-alanine to the D-alanyl carrier protein. IdnL1, a short-chain aliphatic beta-amino acid adenylation enzyme, recognizes 3-aminobutanoic acid, and is involved in the synthesis of the macrolactam antibiotic incednine. CmiS6 is a medium-chain beta-amino acid adenylation enzyme that recognizes 3-aminononanoic acid, and is involved in the synthesis of cremimycin, also a macrolactam antibiotic. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341267 [Multi-domain] Cd Length: 449 Bit Score: 89.23 E-value: 4.06e-18
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEE-KEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05945 372 LRQVPGVKEAVVVPKYKGEKVTELIAFVVPKPgAEAGLTKAIKAELAERLPPYMIPRRFVYLDELPLNANGKIDRKAL 449
|
|
| FACL_like_1 |
cd05910 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
668-1150 |
4.56e-18 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341236 [Multi-domain] Cd Length: 457 Bit Score: 89.06 E-value: 4.56e-18
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 668 KLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPscvltn 747
Cdd:cd05910 2 RLSFRELDERSDRIAQGLTAYGIRRGMRAVLMVPPGPDFFALTFALFKAGAVPVLIDPGMGRKNLKQCLQEAEP------ 75
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 748 ssveiecDESLKIlvddvnvmeeiekyseenidemeclkPLApSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWF 827
Cdd:cd05910 76 -------DAFIGI--------------------------PKA-DEPAAILFTSGSTGTPKGVVYRHGTFAAQIDALRQLY 121
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 828 QFDADDVwtmfhsyafD---FSVWEIWGPLLygGRLVVVP---HT--VSRSPKEFLQLLVKEKVTVLNQTPSAFYQLMqa 899
Cdd:cd05910 122 GIRPGEV---------DlatFPLFALFGPAL--GLTSVIPdmdPTrpARADPQKLVGAIRQYGVSIVFGSPALLERVA-- 188
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 900 dRENEEVGQKL-SLRYVVFGGEALELSRLEDwYSRHPHNAPKVINMYGITEtTVHVSYIELDESIVSLR------ANSLI 972
Cdd:cd05910 189 -RYCAQHGITLpSLRRVLSAGAPVPIALAAR-LRKMLSDEAEILTPYGATE-ALPVSSIGSRELLATTTaatsggAGTCV 265
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 973 GCSIPDLKVYVL----------DNYLQpVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPfgkPGTRMYRTGDLARW 1042
Cdd:cd05910 266 GRPIPGVRVRIIeiddepiaewDDTLE-LPRGEIGEITVTGPTVTPTYVNRPVATALAKIDDN---SEGFWHRMGDLGYL 341
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1043 RQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAvIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSL 1122
Cdd:cd05910 342 DDEGRLWFCGRKAHRVITTGGTLYTEPVERVFNTHPGVRRSA-LVGVGKPGCQLPVLCVEPLPGTITPRARLEQELRALA 420
|
490 500 510
....*....|....*....|....*....|...
gi 1698252301 1123 PDYMVPY---AFVVVNELPLTP--NGKLDRKAL 1150
Cdd:cd05910 421 KDYPHTQrigRFLIHPSFPVDIrhNAKIFREKL 453
|
|
| PRK07867 |
PRK07867 |
acyl-CoA synthetase; Validated |
789-1152 |
1.02e-17 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236120 [Multi-domain] Cd Length: 529 Bit Score: 88.58 E-value: 1.02e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 789 APSHIAYVIYTSGSTGRPKGVMIPHQNVV---RLLgaTDHwFQFDADDV----WTMFHSYAfdfsVWEIWGPLLYGGRLV 861
Cdd:PRK07867 150 DPDDLFMLIFTSGTSGDPKAVRCTHRKVAsagVML--AQR-FGLGPDDVcyvsMPLFHSNA----VMAGWAVALAAGASI 222
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 862 VVPHTVSRSpkEFLQLLVKEKVTVLNQTPSAFYQLMQA-----DRENeevgqklSLRyVVFGGEAL--ELSRLEDWYSRH 934
Cdd:PRK07867 223 ALRRKFSAS--GFLPDVRRYGATYANYVGKPLSYVLATperpdDADN-------PLR-IVYGNEGApgDIARFARRFGCV 292
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 935 phnapkVINMYGITETTVHVSYIEldesivSLRANSLiGCSIPDLKVYVLDNyLQPVPPGV------------VGEMY-V 1001
Cdd:PRK07867 293 ------VVDGFGSTEGGVAITRTP------DTPPGAL-GPLPPGVAIVDPDT-GTECPPAEdadgrllnadeaIGELVnT 358
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1002 AGAGLARGYLGRAGLTAERfIADPfgkpgtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVE 1081
Cdd:PRK07867 359 AGPGGFEGYYNDPEADAER-MRGG-------VYWSGDLAYRDADGYAYFAGRLGDWMRVDGENLGTAPIERILLRYPDAT 430
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 1082 QVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQ--HASGSLPDYMVPyAFV-VVNELPLTPNGKLDRKALPA 1152
Cdd:PRK07867 431 EVAVYAVPDPVVGDQVMAALVLAPGAKFDPDAFAEflAAQPDLGPKQWP-SYVrVCAELPRTATFKVLKRQLSA 503
|
|
| PRK06334 |
PRK06334 |
long chain fatty acid--[acyl-carrier-protein] ligase; Validated |
790-1077 |
1.03e-17 |
|
long chain fatty acid--[acyl-carrier-protein] ligase; Validated
Pssm-ID: 180533 [Multi-domain] Cd Length: 539 Bit Score: 88.72 E-value: 1.03e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 790 PSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVWTM----FHSYAFD----FsvweiwgPLLYGgrLV 861
Cdd:PRK06334 182 PEDVAVILFTSGTEKLPKGVPLTHANLLANQRACLKFFSPKEDDVMMSflppFHAYGFNsctlF-------PLLSG--VP 252
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 862 VVPHTVSRSPKEFLQLLVKEKVTVLNQTPSAF-YQLMQADRENEEVGqklSLRYVVFGGEALELSRLEDWYSRHPHNAPK 940
Cdd:PRK06334 253 VVFAYNPLYPKKIVEMIDEAKVTFLGSTPVFFdYILKTAKKQESCLP---SLRFVVIGGDAFKDSLYQEALKTFPHIQLR 329
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 941 viNMYGITETTVHVSYIELDesivSLRANSLIGCSIPDLKVYVLDNYLQ-PVPPGVVGEMYVAGAGLARGYLGragltae 1019
Cdd:PRK06334 330 --QGYGTTECSPVITINTVN----SPKHESCVGMPIRGMDVLIVSEETKvPVSSGETGLVLTRGTSLFSGYLG------- 396
|
250 260 270 280 290 300
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1698252301 1020 rfiADP----FGKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKH 1077
Cdd:PRK06334 397 ---EDFgqgfVELGGETWYVTGDLGYVDRHGELFLKGRLSRFVKIGAEMVSLEALESILMEG 455
|
|
| PRK08315 |
PRK08315 |
AMP-binding domain protein; Validated |
642-1144 |
1.22e-17 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236236 [Multi-domain] Cd Length: 559 Bit Score: 88.33 E-value: 1.22e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 642 EMTLPQLFEKQAHINPNSIAVVFEDK--KLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAG 719
Cdd:PRK08315 15 EQTIGQLLDRTAARYPDREALVYRDQglRWTYREFNEEVDALAKGLLALGIEKGDRVGIWAPNVPEWVLTQFATAKIGAI 94
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 720 YLPLDPDYPSDRISFMLHDAKPSCVLTNSS------VEI------ECDES------------LK--ILVDDVN------- 766
Cdd:PRK08315 95 LVTINPAYRLSELEYALNQSGCKALIAADGfkdsdyVAMlyelapELATCepgqlqsarlpeLRrvIFLGDEKhpgmlnf 174
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 767 --VMEEIEKYSEENIDE-MECLKPLAPSHIAYviyTSGSTGRPKGVMIPHQNVV---RLLGATdhwFQFDADD-----Vw 835
Cdd:PRK08315 175 deLLALGRAVDDAELAArQATLDPDDPINIQY---TSGTTGFPKGATLTHRNILnngYFIGEA---MKLTEEDrlcipV- 247
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 836 TMFHSYafdfsvweiwGPLLygGRLVVVPH---TV----SRSPKEFLQLLVKEKVTVLNQTPSAFY-QLMQADRENEEVG 907
Cdd:PRK08315 248 PLYHCF----------GMVL--GNLACVTHgatMVypgeGFDPLATLAAVEEERCTALYGVPTMFIaELDHPDFARFDLS 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 908 qklSLRYVVFGGEA--LELSRledwysrhphnapKVI---NM------YGITETTvHVSYI-ELDESIvSLRANSlIGCS 975
Cdd:PRK08315 316 ---SLRTGIMAGSPcpIEVMK-------------RVIdkmHMsevtiaYGMTETS-PVSTQtRTDDPL-EKRVTT-VGRA 376
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 976 IPDLKVYVLDNYL-QPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrMyRTGDLARWRQDGTLDYIGRa 1054
Cdd:PRK08315 377 LPHLEVKIVDPETgETVPRGEQGELCTRGYSVMKGYWNDPEKTAEAIDADGW------M-HTGDLAVMDEEGYVNIVGR- 448
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1055 dhqIK---IRGfrielGE------IEAVIMKHDKVEQVAVIvredqpG--DKR----LVAYIVASNNETIDTNEMRQHAS 1119
Cdd:PRK08315 449 ---IKdmiIRG-----GEniypreIEEFLYTHPKIQDVQVV------GvpDEKygeeVCAWIILRPGATLTEEDVRDFCR 514
|
570 580
....*....|....*....|....*
gi 1698252301 1120 GSLPDYMVPYAFVVVNELPLTPNGK 1144
Cdd:PRK08315 515 GKIAHYKIPRYIRFVDEFPMTVTGK 539
|
|
| PLN02860 |
PLN02860 |
o-succinylbenzoate-CoA ligase |
652-1147 |
1.23e-17 |
|
o-succinylbenzoate-CoA ligase
Pssm-ID: 215464 [Multi-domain] Cd Length: 563 Bit Score: 88.32 E-value: 1.23e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 652 QAHI----------NPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYL 721
Cdd:PLN02860 6 QAHIcqcltrlatlRGNAVVTISGNRRRTGHEFVDGVLSLAAGLLRLGLRNGDVVAIAALNSDLYLEWLLAVACAGGIVA 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 722 PLDPDYPSDRISFMLHDAKPSCVLTNSSVEIECDE-------SLK--ILVDDVNVMEEIEKYSEENIDEM--ECLKPL-- 788
Cdd:PLN02860 86 PLNYRWSFEEAKSAMLLVRPVMLVTDETCSSWYEElqndrlpSLMwqVFLESPSSSVFIFLNSFLTTEMLkqRALGTTel 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 789 ----APSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVwtmfhsYAFDFSVWEIWG------PLLYGG 858
Cdd:PLN02860 166 dyawAPDDAVLICFTSGTTGRPKGVTISHSALIVQSLAKIAIVGYGEDDV------YLHTAPLCHIGGlssalaMLMVGA 239
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 859 RLVVVPHTvsrSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLSLRYVVFGGEALELSRLEDWYSRHPhNA 938
Cdd:PLN02860 240 CHVLLPKF---DAKAALQAIKQHNVTSMITVPAMMADLISLTRKSMTWKVFPSVRKILNGGGSLSSRLLPDAKKLFP-NA 315
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 939 pKVINMYGITETTVHVSYIELDESIVSLRANSLIGCSIPdlkvyvldnYLQPVPPGV----------------------V 996
Cdd:PLN02860 316 -KLFSAYGMTEACSSLTFMTLHDPTLESPKQTLQTVNQT---------KSSSVHQPQgvcvgkpaphvelkigldessrV 385
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 997 GEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMK 1076
Cdd:PLN02860 386 GRILTRGPHVMLGYWGQNSETASVLSNDGW-------LDTGDIGWIDKAGNLWLIGRSNDRIKTGGENVYPEEVEAVLSQ 458
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1077 HDKVEQVAVIvredqpG--DKRLVAYIVA----------SNNE--------TIDTNEMRQHAS-GSLPDYMVPYAFVVVN 1135
Cdd:PLN02860 459 HPGVASVVVV------GvpDSRLTEMVVAcvrlrdgwiwSDNEkenakknlTLSSETLRHHCReKNLSRFKIPKLFVQWR 532
|
570
....*....|...
gi 1698252301 1136 E-LPLTPNGKLDR 1147
Cdd:PLN02860 533 KpFPLTTTGKIRR 545
|
|
| PRK07824 |
PRK07824 |
o-succinylbenzoate--CoA ligase; |
793-1150 |
1.77e-17 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 236108 [Multi-domain] Cd Length: 358 Bit Score: 85.87 E-value: 1.77e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 793 IAYVIYTSGSTGRPKGVMIPHQNVVRLLGATdhwfqfdaddvwtmfHSYafdfsvweIWGPllyGGRLVVVP-HTVSRsp 871
Cdd:PRK07824 37 VALVVATSGTTGTPKGAMLTAAALTASADAT---------------HDR--------LGGP---GQWLLALPaHHIAG-- 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 872 kefLQLLVKEKV-----TVLNQT----PSAF------------Y------QLMQADRENEEVGQKLSLRYVVFGGEALEL 924
Cdd:PRK07824 89 ---LQVLVRSVIagsepVELDVSagfdPTALpravaelgggrrYtslvpmQLAKALDDPAATAALAELDAVLVGGGPAPA 165
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 925 SRLEdwysRHPHNAPKVINMYGITETTVHVSYielDesivslransliGCSIPDLKVYVLDnylqpvppgvvGEMYVAGA 1004
Cdd:PRK07824 166 PVLD----AAAAAGINVVRTYGMSETSGGCVY---D------------GVPLDGVRVRVED-----------GRIALGGP 215
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1005 GLARGYlgRAGLTAerfiaDPFGKPGtrMYRTGDLARWrQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVA 1084
Cdd:PRK07824 216 TLAKGY--RNPVDP-----DPFAEPG--WFRTDDLGAL-DDGVLTVLGRADDAISTGGLTVLPQVVEAALATHPAVADCA 285
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 1085 VIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK07824 286 VFGLPDDRLGQRVVAAVVGDGGPAPTLEALRAHVARTLDRTAAPRELHVVDELPRRGIGKVDRRAL 351
|
|
| PRK08308 |
PRK08308 |
acyl-CoA synthetase; Validated |
1028-1154 |
1.97e-17 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236231 [Multi-domain] Cd Length: 414 Bit Score: 86.63 E-value: 1.97e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1028 KPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASnnE 1107
Cdd:PRK08308 287 KMGDKEIFTKDLGYKSERGTLHFMGRMDDVINVSGLNVYPIEVEDVMLRLPGVQEAVVYRGKDPVAGERVKAKVISH--E 364
|
90 100 110 120
....*....|....*....|....*....|....*....|....*..
gi 1698252301 1108 TIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPAPE 1154
Cdd:PRK08308 365 EIDPVQLREWCIQHLAPYQVPHEIESVTEIPKNANGKVSRKLLELGE 411
|
|
| PLN02479 |
PLN02479 |
acetate-CoA ligase |
648-1152 |
3.66e-17 |
|
acetate-CoA ligase
Pssm-ID: 178097 [Multi-domain] Cd Length: 567 Bit Score: 86.82 E-value: 3.66e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 648 LFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDY 727
Cdd:PLN02479 25 FLERAAVVHPTRKSVVHGSVRYTWAQTYQRCRRLASALAKRSIGPGSTVAVIAPNIPAMYEAHFGVPMAGAVVNCVNIRL 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 728 PSDRISFMLHDAKPSCVLTNSSVEIECDESLKILVDDVN---------VME------------------EIEKYSEENID 780
Cdd:PLN02479 105 NAPTIAFLLEHSKSEVVMVDQEFFTLAEEALKILAEKKKssfkpplliVIGdptcdpkslqyalgkgaiEYEKFLETGDP 184
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 781 EMECLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQN--VVRLLGATDHWFQFDADDVWT--MFHSYAFDFSvweiWGPLLY 856
Cdd:PLN02479 185 EFAWKPPADEWQSIALGYTSGTTASPKGVVLHHRGayLMALSNALIWGMNEGAVYLWTlpMFHCNGWCFT----WTLAAL 260
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 857 GGRLVVVPHTvsrSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADREnEEVGQKLSLRYVVFGGEALELSRLedwySRHPH 936
Cdd:PLN02479 261 CGTNICLRQV---TAKAIYSAIANYGVTHFCAAPVVLNTIVNAPKS-ETILPLPRVVHVMTAGAAPPPSVL----FAMSE 332
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 937 NAPKVINMYGITET----TVHVSYIELDESIVSLRAN----------SLIGCSIPDLKVyvldnyLQPVPP--GVVGEMY 1000
Cdd:PLN02479 333 KGFRVTHTYGLSETygpsTVCAWKPEWDSLPPEEQARlnarqgvryiGLEGLDVVDTKT------MKPVPAdgKTMGEIV 406
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1001 VAGAGLARGYLGRAGLTAERFiadpfgkpGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKV 1080
Cdd:PLN02479 407 MRGNMVMKGYLKNPKANEEAF--------ANGWFHSGDLGVKHPDGYIEIKDRSKDIIISGGENISSLEVENVVYTHPAV 478
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1081 EQVAVIVREDQPGDKRLVAYI-----VASNNETIDTNEMRQHASGSLPDYMVPYAfVVVNELPLTPNGKLDRKALPA 1152
Cdd:PLN02479 479 LEASVVARPDERWGESPCAFVtlkpgVDKSDEAALAEDIMKFCRERLPAYWVPKS-VVFGPLPKTATGKIQKHVLRA 554
|
|
| LC_FACS_euk1 |
cd17639 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The ... |
669-1150 |
3.78e-17 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS), including fungal proteins; The members of this family are eukaryotic fatty acid CoA synthetases (EC 6.2.1.3) that activate fatty acids with chain lengths of 12 to 20 and includes fungal proteins. They act on a wide range of long-chain saturated and unsaturated fatty acids, but the enzymes from different tissues show some variation in specificity. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells. In Schizosaccharomyces pombe, lcf1 gene encodes a new fatty acyl-CoA synthetase that preferentially recognizes myristic acid as a substrate.
Pssm-ID: 341294 [Multi-domain] Cd Length: 507 Bit Score: 86.50 E-value: 3.78e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGagyLPLDPDYPS---DRISFMLHDAKPSCVL 745
Cdd:cd17639 6 MSYAEVWERVLNFGRGLVELGLKPGDKVAIFAETRAEWLITALGCWSQN---IPIVTVYATlgeDALIHSLNETECSAIF 82
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 746 TNSSveiecdeslkilvddvnvmeeiekyseenidemeclkplaPSHIAYVIYTSGSTGRPKGVMIPHQNVVR-LLGATD 824
Cdd:cd17639 83 TDGK----------------------------------------PDDLACIMYTSGSTGNPKGVMLTHGNLVAgIAGLGD 122
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 825 HWFQF-DADDVWTMF----HSYAFDF-SVWEIWGPLL-YGGRLVVVPHTVSRSPKEFLQL---------LVKEKV--TVL 886
Cdd:cd17639 123 RVPELlGPDDRYLAYlplaHIFELAAeNVCLYRGGTIgYGSPRTLTDKSKRGCKGDLTEFkptlmvgvpAIWDTIrkGVL 202
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 887 NQTPSA-------FYQLMQADRE-----------NEEVGQKL------SLRYVVFGGEALelsrledwySRHPHN----- 937
Cdd:cd17639 203 AKLNPMgglkrtlFWTAYQSKLKalkegpgtpllDELVFKKVraalggRLRYMLSGGAPL---------SADTQEflniv 273
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 938 -APkVINMYGITETTVHVSYIELDESIVSlRANSLIGC------SIPDLKvYVLDNylqPVPPGvvgEMYVAGAGLARGY 1010
Cdd:cd17639 274 lCP-VIQGYGLTETCAGGTVQDPGDLETG-RVGPPLPCceiklvDWEEGG-YSTDK---PPPRG---EILIRGPNVFKGY 344
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1011 LGRAGLTAERFIADpfgkpgtRMYRTGDLARWRQDGTLDYIGRADHQIKIR-GFRIELGEIEAVIMKHDKVEQVAVIVRE 1089
Cdd:cd17639 345 YKNPEKTKEAFDGD-------GWFHTGDIGEFHPDGTLKIIDRKKDLVKLQnGEYIALEKLESIYRSNPLVNNICVYADP 417
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1090 DQ--------PGDKRLVAYIVASNNETID--------------TNEMRQHA-SGSLPDYMVPYAFVVVNElPLTP-NG-- 1143
Cdd:cd17639 418 DKsypvaivvPNEKHLTKLAEKHGVINSEweelcedkklqkavLKSLAETArAAGLEKFEIPQGVVLLDE-EWTPeNGlv 496
|
570
....*....|.
gi 1698252301 1144 ----KLDRKAL 1150
Cdd:cd17639 497 taaqKLKRKEI 507
|
|
| PRK09274 |
PRK09274 |
peptide synthase; Provisional |
653-1095 |
3.97e-17 |
|
peptide synthase; Provisional
Pssm-ID: 236443 [Multi-domain] Cd Length: 552 Bit Score: 86.88 E-value: 3.97e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 653 AHINPNSIAVVFEDKK----------LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLP 722
Cdd:PRK09274 16 AQERPDQLAVAVPGGRgadgklaydeLSFAELDARSDAIAHGLNAAGIGRGMRAVLMVTPSLEFFALTFALFKAGAVPVL 95
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 723 LDPDYPSDRISFMLHDAKPSCVLTN--------------SSVEiecdesLKILVDD-----VNVMEEIEKYSEENIDEME 783
Cdd:PRK09274 96 VDPGMGIKNLKQCLAEAQPDAFIGIpkahlarrlfgwgkPSVR------RLVTVGGrllwgGTTLATLLRDGAAAPFPMA 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 784 CLKPLAPshiAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDVwtmfhsyafD---FSVWEIWGPLLyGGRL 860
Cdd:PRK09274 170 DLAPDDM---AAILFTSGSTGTPKGVVYTHGMFEAQIEALREDYGIEPGEI---------DlptFPLFALFGPAL-GMTS 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 861 VVVPHTVSR----SPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENeevGQKL-SLRYVVFGGEALELSRLEDWYSRHP 935
Cdd:PRK09274 237 VIPDMDPTRpatvDPAKLFAAIERYGVTNLFGSPALLERLGRYGEAN---GIKLpSLRRVISAGAPVPIAVIERFRAMLP 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 936 HNAPkVINMYGITEtTVHVSYIELDESIVSLRANS------LIGCSIPDLKVYVL---DNYL------QPVPPGVVGEMY 1000
Cdd:PRK09274 314 PDAE-ILTPYGATE-ALPISSIESREILFATRAATdngagiCVGRPVDGVEVRIIaisDAPIpewddaLRLATGEIGEIV 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1001 VAGAGLARGYLGRAGLTAERFIADPFGkpGTRmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKV 1080
Cdd:PRK09274 392 VAGPMVTRSYYNRPEATRLAKIPDGQG--DVW-HRMGDLGYLDAQGRLWFCGRKAHRVETAGGTLYTIPCERIFNTHPGV 468
|
490 500
....*....|....*....|....*..
gi 1698252301 1081 ------------EQVAVIVREDQPGDK 1095
Cdd:PRK09274 469 krsalvgvgvpgAQRPVLCVELEPGVA 495
|
|
| prpE |
PRK10524 |
propionyl-CoA synthetase; Provisional |
657-1152 |
5.52e-17 |
|
propionyl-CoA synthetase; Provisional
Pssm-ID: 182517 [Multi-domain] Cd Length: 629 Bit Score: 86.54 E-value: 5.52e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 657 PNSIAVVF------EDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSD 730
Cdd:PRK10524 67 PEQLALIAvstetdEERTYTFRQLHDEVNRMAAMLRSLGVQRGDRVLIYMPMIAEAAFAMLACARIGAIHSVVFGGFASH 146
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 731 RISFMLHDAKPSCVLTNSS-------VEIEC--DESLK---------ILVD------------DVNVMEEIEKYSEENId 780
Cdd:PRK10524 147 SLAARIDDAKPVLIVSADAgsrggkvVPYKPllDEAIAlaqhkprhvLLVDrglapmarvagrDVDYATLRAQHLGARV- 225
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 781 emeclkP---LAPSHIAYVIYTSGSTGRPKGVmiphQN-----VVRLLGATDHWFQ-------FDADDV-WTMFHSYAfd 844
Cdd:PRK10524 226 ------PvewLESNEPSYILYTSGTTGKPKGV----QRdtggyAVALATSMDTIFGgkagetfFCASDIgWVVGHSYI-- 293
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 845 fsvweIWGPLLYGGRLVVVPHTVSR-SPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLSLRYVVFGGEALE 923
Cdd:PRK10524 294 -----VYAPLLAGMATIMYEGLPTRpDAGIWWRIVEKYKVNRMFSAPTAIRVLKKQDPALLRKHDLSSLRALFLAGEPLD 368
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 924 LSRLEdWYSRHPhNAPkVINMYGITET----TVHVSYIELDESivslRANSligcsiPDLKVYVLDNYL------QPVPP 993
Cdd:PRK10524 369 EPTAS-WISEAL-GVP-VIDNYWQTETgwpiLAIARGVEDRPT----RLGS------PGVPMYGYNVKLlnevtgEPCGP 435
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 994 GVVGeMYVAGAGLARGYLGRAGLTAERFIADPFGKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAV 1073
Cdd:PRK10524 436 NEKG-VLVIEGPLPPGCMQTVWGDDDRFVKTYWSLFGRQVYSTFDWGIRDADGYYFILGRTDDVINVAGHRLGTREIEES 514
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1074 IMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMV--------PYAFVVVNELPLTPNGKL 1145
Cdd:PRK10524 515 ISSHPAVAEVAVVGVKDALKGQVAVAFVVPKDSDSLADREARLALEKEIMALVDsqlgavarPARVWFVSALPKTRSGKL 594
|
....*..
gi 1698252301 1146 DRKALPA 1152
Cdd:PRK10524 595 LRRAIQA 601
|
|
| PLN02246 |
PLN02246 |
4-coumarate--CoA ligase |
667-1152 |
6.08e-17 |
|
4-coumarate--CoA ligase
Pssm-ID: 215137 [Multi-domain] Cd Length: 537 Bit Score: 86.19 E-value: 6.08e-17
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 667 KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLT 746
Cdd:PLN02246 49 RVYTYADVELLSRRVAAGLHKLGIRQGDVVMLLLPNCPEFVLAFLGASRRGAVTTTANPFYTPAEIAKQAKASGAKLIIT 128
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 747 NSSV-----EIECDESLKILVDDVNVmEEIEKYSE-ENIDEMECLKP-LAPSHIAYVIYTSGSTGRPKGVMIPHQNVV-- 817
Cdd:PLN02246 129 QSCYvdklkGLAEDDGVTVVTIDDPP-EGCLHFSElTQADENELPEVeISPDDVVALPYSSGTTGLPKGVMLTHKGLVts 207
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 818 ---RLLGATDHwFQFDADD----VWTMFHSYAFDfSVweiwgpLLYGGRlvvVPHTVSRSPK----EFLQLLVKEKVTVL 886
Cdd:PLN02246 208 vaqQVDGENPN-LYFHSDDvilcVLPMFHIYSLN-SV------LLCGLR---VGAAILIMPKfeigALLELIQRHKVTIA 276
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 887 NQTPSafyqLMQADRENEEVGQK--LSLRYVVFGGEALElSRLEDWYSRHPHNApKVINMYGITET-------------- 950
Cdd:PLN02246 277 PFVPP----IVLAIAKSPVVEKYdlSSIRMVLSGAAPLG-KELEDAFRAKLPNA-VLGQGYGMTEAgpvlamclafakep 350
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 951 ---------TVhVSYIELdeSIVSLRAnsliGCSIPdlkvyvldnYLQPvppgvvGEMYVAGAGLARGYLGRAGLTAERF 1021
Cdd:PLN02246 351 fpvksgscgTV-VRNAEL--KIVDPET----GASLP---------RNQP------GEICIRGPQIMKGYLNDPEATANTI 408
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1022 IADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYI 1101
Cdd:PLN02246 409 DKDGW-------LHTGDIGYIDDDDELFIVDRLKELIKYKGFQVAPAELEALLISHPSIADAAVVPMKDEVAGEVPVAFV 481
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|.
gi 1698252301 1102 VASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALPA 1152
Cdd:PLN02246 482 VRSNGSEITEDEIKQFVAKQVVFYKRIHKVFFVDSIPKAPSGKILRKDLRA 532
|
|
| A_NRPS_LgrA-like |
cd17645 |
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This ... |
1-78 |
9.36e-17 |
|
adenylation (A) domain of linear gramicidin synthetase (LgrA) and similar proteins; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes linear gramicidin synthetase (LgrA) in Brevibacillus brevis. LgrA has a formylation domain fused to the N-terminal end that formylates its substrate for linear gramicidin synthesis to proceed. This formyl group is essential for the clinically important antibacterial activity of gramicidin by enabling head-to-head gramicidin dimers to make a beta-helical pore in gram-positive bacterial membranes, allowing free passage of monovalent cations, destroying the ion gradient and killing bacteria. This family also includes bacitracin synthetase 1 (known as ATP-dependent cysteine adenylase or BA1); it activates cysteine, incorporates two D-amino acids, releases and cyclizes the mature bacitracin, an antibiotic that is a mixture of related cyclic peptides that disrupt gram positive bacteria by interfering with cell wall and peptidoglycan synthesis. Also included is surfactin synthetase which activates and polymerizes the amino acids Leu, Glu, Asp, and Val to form the antibiotic surfactin.
Pssm-ID: 341300 [Multi-domain] Cd Length: 440 Bit Score: 84.91 E-value: 9.36e-17
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPInlSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLP 78
Cdd:cd17645 365 LMNHPLIELAAVLAKEDADGRKYLVAYVTAPEEIPH--EELREWLKNDLPDYMIPTYFVHLKALPLTANGKVDRKALP 440
|
|
| AMP-binding_C |
pfam13193 |
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to ... |
1069-1144 |
1.55e-16 |
|
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to pfam00501. It has a central beta sheet core that is flanked by alpha helices.
Pssm-ID: 463804 [Multi-domain] Cd Length: 76 Bit Score: 75.66 E-value: 1.55e-16
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 1069 EIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGK 1144
Cdd:pfam13193 1 EVESALVSHPAVAEAAVVGVPDELKGEAPVAFVVLKPGVELLEEELVAHVREELGPYAVPKEVVFVDELPKTRSGK 76
|
|
| PaaK |
COG1541 |
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and ... |
799-1090 |
1.88e-16 |
|
Phenylacetate-coenzyme A ligase PaaK, adenylate-forming domain family [Coenzyme transport and metabolism];
Pssm-ID: 441150 [Multi-domain] Cd Length: 423 Bit Score: 83.66 E-value: 1.88e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 799 TSGSTGRPKGVM-------IPHQNVVRLLgatdHWFQFDADDVwtMFHSYAFDFSVweiWGPLLYGG--RL--VVVPHTV 867
Cdd:COG1541 91 SSGTTGKPTVVGytrkdldRWAELFARSL----RAAGVRPGDR--VQNAFGYGLFT---GGLGLHYGaeRLgaTVIPAGG 161
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 868 SRSPKEfLQLLVKEKVTVLNQTPS-AFYQLMQADRENEEVgQKLSLRYVVFGGEAL--EL-SRLEDWYsrhphNApKVIN 943
Cdd:COG1541 162 GNTERQ-LRLMQDFGPTVLVGTPSyLLYLAEVAEEEGIDP-RDLSLKKGIFGGEPWseEMrKEIEERW-----GI-KAYD 233
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 944 MYGITETTVHVSYieldESivslRANSliGCSIPDLKVYV--LD-NYLQPVPPGVVGEMYVAGaglargyLGRAGLtaer 1020
Cdd:COG1541 234 IYGLTEVGPGVAY----EC----EAQD--GLHIWEDHFLVeiIDpETGEPVPEGEEGELVVTT-------LTKEAM---- 292
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1021 fiadpfgkPGTRmYRTGDLARWRQD----GT----LDYI-GRADHQIKIRGFRIELGEIEAVIMKHDKVEQ--VAVIVRE 1089
Cdd:COG1541 293 --------PLIR-YRTGDLTRLLPEpcpcGRthprIGRIlGRADDMLIIRGVNVFPSQIEEVLLRIPEVGPeyQIVVDRE 363
|
.
gi 1698252301 1090 D 1090
Cdd:COG1541 364 G 364
|
|
| LC-FACS_euk |
cd05927 |
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are ... |
669-1150 |
2.14e-16 |
|
Eukaryotic long-chain fatty acid CoA synthetase (LC-FACS); The members of this family are eukaryotic fatty acid CoA synthetases that activate fatty acids with chain lengths of 12 to 20. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Organisms tend to have multiple isoforms of LC-FACS genes with multiple splice variants. For example, nine genes are found in Arabidopsis and six genes are expressed in mammalian cells.
Pssm-ID: 341250 [Multi-domain] Cd Length: 545 Bit Score: 84.19 E-value: 2.14e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGV--GPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLt 746
Cdd:cd05927 6 ISYKEVAERADNIGSALRSLGGkpAPASFVGIYSINRPEWIISELACYAYSLVTVPLYDTLGPEAIEYILNHAEISIVF- 84
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 747 nssveieCDESLKILVddvnvMEEIEKYSEENIDEmecLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDH- 825
Cdd:cd05927 85 -------CDAGVKVYS-----LEEFEKLGKKNKVP---PPPPKPEDLATICYTSGTTGNPKGVMLTHGNIVSNVAGVFKi 149
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 826 ---WFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGR----------------------LVVVPH-----------TVSR 869
Cdd:cd05927 150 leiLNKINPTDVYISYLPLAHIFERVVEALFLYHGAKigfysgdirlllddikalkptvFPGVPRvlnriydkifnKVQA 229
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 870 SP--KEFL-QLLVKEKVTVLNQ---TPSAFYQLMQADRENEEVGQKlsLRYVVFGGEALELSRLEdwYSRHPHNAPkVIN 943
Cdd:cd05927 230 KGplKRKLfNFALNYKLAELRSgvvRASPFWDKLVFNKIKQALGGN--VRLMLTGSAPLSPEVLE--FLRVALGCP-VLE 304
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 944 MYGITETTVHVSYIELDESIVslranSLIGCSIPDLKVYVLD----NYLQPVPPGvVGEMYVAGAGLARGYLGRAGLTAE 1019
Cdd:cd05927 305 GYGQTECTAGATLTLPGDTSV-----GHVGGPLPCAEVKLVDvpemNYDAKDPNP-RGEVCIRGPNVFSGYYKDPEKTAE 378
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1020 RFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKI-RGFRIELGEIEAVIMKHDKVEQ------------VAVI 1086
Cdd:cd05927 379 ALDEDGW-------LHTGDIGEWLPNGTLKIIDRKKNIFKLsQGEYVAPEKIENIYARSPFVAQifvygdslksflVAIV 451
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1087 V---------REDQPG----------DKRLVAYIVASNNETIDTN-----EMRQHAsgslpdYMVPYAFVVVNELpLTPN 1142
Cdd:cd05927 452 VpdpdvlkewAASKGGgtgsfeelckNPEVKKAILEDLVRLGKENglkgfEQVKAI------HLEPEPFSVENGL-LTPT 524
|
....*...
gi 1698252301 1143 GKLDRKAL 1150
Cdd:cd05927 525 FKLKRPQL 532
|
|
| PRK00174 |
PRK00174 |
acetyl-CoA synthetase; Provisional |
658-1150 |
2.34e-16 |
|
acetyl-CoA synthetase; Provisional
Pssm-ID: 234677 [Multi-domain] Cd Length: 637 Bit Score: 84.42 E-value: 2.34e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 658 NSIAVVFE------DKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGA-------GYlplD 724
Cdd:PRK00174 82 DKVAIIWEgddpgdSRKITYRELHREVCRFANALKSLGVKKGDRVAIYMPMIPEAAVAMLACARIGAvhsvvfgGF---S 158
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 725 PDYPSDRISfmlhDAKPSCVLTnssveieCDES--------LKILVDDV--------NVM-------------------- 768
Cdd:PRK00174 159 AEALADRII----DAGAKLVIT-------ADEGvrggkpipLKANVDEAlancpsveKVIvvrrtggdvdwvegrdlwwh 227
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 769 EEIEKYSEENIDE-MECLKPLapshiaYVIYTSGSTGRPKGVMipHQNVVRLLGA--TDHW-FQFDADDV--------WT 836
Cdd:PRK00174 228 ELVAGASDECEPEpMDAEDPL------FILYTSGSTGKPKGVL--HTTGGYLVYAamTMKYvFDYKDGDVywctadvgWV 299
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 837 MFHSYAfdfsvweIWGPLLYGGRLVV---VPH--TVSRspkeFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLS 911
Cdd:PRK00174 300 TGHSYI-------VYGPLANGATTLMfegVPNypDPGR----FWEVIDKHKVTIFYTAPTAIRALMKEGDEHPKKYDLSS 368
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 912 LRyvVFG--GE-----ALElsrledWY------SRHPhnapkVINMYGITETTVHVsyIELDESIVSLRANSligCS--I 976
Cdd:PRK00174 369 LR--LLGsvGEpinpeAWE------WYykvvggERCP-----IVDTWWQTETGGIM--ITPLPGATPLKPGS---ATrpL 430
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 977 PDLKVYVLDNYLQPVPPGVVGEMYVAGA--GLARGYLGraglTAERFIADPFGK-PGtrMYRTGDLARWRQDGtldYI-- 1051
Cdd:PRK00174 431 PGIQPAVVDEEGNPLEGGEGGNLVIKDPwpGMMRTIYG----DHERFVKTYFSTfKG--MYFTGDGARRDEDG---YYwi 501
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1052 -GRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETID---TNEMRQHAS---GSL-- 1122
Cdd:PRK00174 502 tGRVDDVLNVSGHRLGTAEIESALVAHPKVAEAAVVGRPDDIKGQGIYAFVTLKGGEEPSdelRKELRNWVRkeiGPIak 581
|
570 580
....*....|....*....|....*...
gi 1698252301 1123 PDYMvpyafVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK00174 582 PDVI-----QFAPGLPKTRSGKIMRRIL 604
|
|
| PRK12582 |
PRK12582 |
acyl-CoA synthetase; Provisional |
640-1041 |
5.10e-16 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237144 [Multi-domain] Cd Length: 624 Bit Score: 83.56 E-value: 5.10e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 640 APEMTLPQLFEKQAHINPNSIAVVFED------KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAV 713
Cdd:PRK12582 46 PYPRSIPHLLAKWAAEAPDRPWLAQREpghgqwRKVTYGEAKRAVDALAQALLDLGLDPGRPVMILSGNSIEHALMTLAA 125
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 714 LKAGAGYLPLDPDYpsdriSFMLHD----------AKPSCVLTNSSVEIEcdESLKIL----VDDVNVMEEIEKYSEENI 779
Cdd:PRK12582 126 MQAGVPAAPVSPAY-----SLMSHDhaklkhlfdlVKPRVVFAQSGAPFA--RALAALdlldVTVVHVTGPGEGIASIAF 198
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 780 DEMECLKP----------LAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQFDADDV------W-----TMF 838
Cdd:PRK12582 199 ADLAATPPtaavaaaiaaITPDTVAKYLFTSGSTGMPKAVINTQRMMCANIAMQEQLRPREPDPPppvsldWmpwnhTMG 278
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 839 HSYAFDFSVWEiwGPLLY--GGRLVvvphtvsrsPKEF---LQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKL--S 911
Cdd:PRK12582 279 GNANFNGLLWG--GGTLYidDGKPL---------PGMFeetIRNLREISPTVYGNVPAGYAMLAEAMEKDDALRRSFfkN 347
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 912 LRYVVFGGEALElsrlEDWYSRHPHNAPK-------VINMYGITET---TVHVSYIEldesivslRANSLIGCSIPDLKv 981
Cdd:PRK12582 348 LRLMAYGGATLS----DDLYERMQALAVRttghripFYTGYGATETaptTTGTHWDT--------ERVGLIGLPLPGVE- 414
|
410 420 430 440 450 460
....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 982 yvldnyLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLAR 1041
Cdd:PRK12582 415 ------LKLAPVGDKYEVRVKGPNVTPGYHKDPELTAAAFDEEGF-------YRLGDAAR 461
|
|
| A_NRPS_PvdJ-like |
cd17649 |
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal ... |
1-78 |
5.16e-16 |
|
non-ribosomal peptide synthetase; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) includes pyoverdine biosynthesis protein PvdJ involved in the synthesis of pyoverdine, which consists of a chromophore group attached to a variable peptide chain and comprises around 6-12 amino acids that are specific for each Pseudomonas species, and for which the peptide might be first synthesized before the chromophore assembly. Also included is ornibactin biosynthesis protein OrbI; ornibactin is a tetrapeptide siderophore with an l-ornithine-d-hydroxyaspartate-l-serine-l-ornithine backbone. The adenylation domain at the N-terminal of OrbI possibly initiates the ornibactin with the binding of N5-hydroxyornithine. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341304 [Multi-domain] Cd Length: 450 Bit Score: 82.42 E-value: 5.16e-16
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVmVREDRPNDKRIIAYIVAE--EKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLP 78
Cdd:cd17649 372 LLEHPGVREAAV-VALDGAGGKQLVAYVVLRaaAAQPELRAQLRTALRASLPDYMVPAHLVFLARLPLTPNGKLDRKALP 450
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
1164-1235 |
1.36e-15 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 72.96 E-value: 1.36e-15
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1698252301 1164 PRTPQEEMLCDLFTEVLSV--SQIGIDDGFF-DLGGHSLLAVQLMSRMKEALGVELNIGTLFAAPTVAGLAERLE 1235
Cdd:COG0236 2 PREELEERLAEIIAEVLGVdpEEITPDDSFFeDLGLDSLDAVELIAALEEEFGIELPDTELFEYPTVADLADYLE 76
|
|
| PRK06018 |
PRK06018 |
putative acyl-CoA synthetase; Provisional |
798-1150 |
1.46e-15 |
|
putative acyl-CoA synthetase; Provisional
Pssm-ID: 235673 [Multi-domain] Cd Length: 542 Bit Score: 81.72 E-value: 1.46e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 798 YTSGSTGRPKGVMIPHQ-NVVRLLGAT--DHWFQFDAD---DVWTMFH--SYAFDFSvweiwGPLLyGGRLVVvphtvsr 869
Cdd:PRK06018 184 YTSGTTGDPKGVLYSHRsNVLHALMANngDALGTSAADtmlPVVPLFHanSWGIAFS-----APSM-GTKLVM------- 250
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 870 sPKEFL------QLLVKEKVTVLNQTPSAFYQLMQADRENeevGQKL-SLRYVVFGGEALELSRL---EDWYSrhphnap 939
Cdd:PRK06018 251 -PGAKLdgasvyELLDTEKVTFTAGVPTVWLMLLQYMEKE---GLKLpHLKMVVCGGSAMPRSMIkafEDMGV------- 319
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 940 KVINMYGITET----TVHVSYIELDESIVSLRANSLIGCSIP----DLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYL 1011
Cdd:PRK06018 320 EVRHAWGMTEMsplgTLAALKPPFSKLPGDARLDVLQKQGYPpfgvEMKITDDAGKELPWDGKTFGRLKVRGPAVAAAYY 399
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1012 gRAGltAERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQ 1091
Cdd:PRK06018 400 -RVD--GEILDDDGF-------FDTGDVATIDAYGYMRITDRSKDVIKSGGEWISSIDLENLAVGHPKVAEAAVIGVYHP 469
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|....*....
gi 1698252301 1092 PGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK06018 470 KWDERPLLIVQLKPGETATREEILKYMDGKIAKWWMPDDVAFVDAIPHTATGKILKTAL 528
|
|
| PLN02654 |
PLN02654 |
acetate-CoA ligase |
656-1086 |
2.52e-15 |
|
acetate-CoA ligase
Pssm-ID: 215353 [Multi-domain] Cd Length: 666 Bit Score: 81.48 E-value: 2.52e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 656 NPNSIAVVFE------DKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPS 729
Cdd:PLN02654 102 NGDKIAIYWEgnepgfDASLTYSELLDRVCQLANYLKDVGVKKGDAVVIYLPMLMELPIAMLACARIGAVHSVVFAGFSA 181
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 730 DRISFMLHDAKPSCVLTNSSVEIECDE-SLKILVDDVNVMEEIEKYS------EENIDEM---------------ECLKP 787
Cdd:PLN02654 182 ESLAQRIVDCKPKVVITCNAVKRGPKTiNLKDIVDAALDESAKNGVSvgicltYENQLAMkredtkwqegrdvwwQDVVP 261
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 788 LAPSHIA----------YVIYTSGSTGRPKGVMipHQNVVRLL-GATDHWFQFD----------ADDVWTMFHSYAfdfs 846
Cdd:PLN02654 262 NYPTKCEvewvdaedplFLLYTSGSTGKPKGVL--HTTGGYMVyTATTFKYAFDykptdvywctADCGWITGHSYV---- 335
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 847 vweIWGPLLYGGRLVVVPHTVSR-SPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLSLRYVVFGGEALELS 925
Cdd:PLN02654 336 ---TYGPMLNGATVLVFEGAPNYpDSGRCWDIVDKYKVTIFYTAPTLVRSLMRDGDEYVTRHSRKSLRVLGSVGEPINPS 412
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 926 RLEdWY------SRHPhnapkVINMYGITETTvhvsyieldesivSLRANSLIGC--------SIPDLKVyvldnylQPV 991
Cdd:PLN02654 413 AWR-WFfnvvgdSRCP-----ISDTWWQTETG-------------GFMITPLPGAwpqkpgsaTFPFFGV-------QPV 466
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 992 ppgVVGEMYVAGAGLARGYLGRAGL----------TAERFIADPFgKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIR 1061
Cdd:PLN02654 467 ---IVDEKGKEIEGECSGYLCVKKSwpgafrtlygDHERYETTYF-KPFAGYYFSGDGCSRDKDGYYWLTGRVDDVINVS 542
|
490 500
....*....|....*....|....*
gi 1698252301 1062 GFRIELGEIEAVIMKHDKVEQVAVI 1086
Cdd:PLN02654 543 GHRIGTAEVESALVSHPQCAEAAVV 567
|
|
| A_NRPS_TlmIV_like |
cd12114 |
The adenylation domain of nonribosomal peptide synthetases (NRPS), including ... |
1-77 |
3.01e-15 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS), including Streptoalloteichus tallysomycin biosynthesis genes; The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions. This family includes the TLM biosynthetic gene cluster from Streptoalloteichus that consists of nine NRPS genes; the N-terminal module of TlmVI (NRPS-5) and the starter module of BlmVI (NRPS-5) are comprised of the acyl CoA ligase (AL) and acyl carrier protein (ACP)-like domains, which are thought to be involved in the biosynthesis of the beta-aminoalaninamide moiety.
Pssm-ID: 341279 [Multi-domain] Cd Length: 477 Bit Score: 80.39 E-value: 3.01e-15
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVReDRPNDKRIIAYIVAEEK-EPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd12114 401 LQAHPGVARAVVVVL-GDPGGKRLAAFVVPDNDgTPIAPDALRAFLAQTLPAYMIPSRVIALEALPLTANGKVDRAAL 477
|
|
| PRK13390 |
PRK13390 |
acyl-CoA synthetase; Provisional |
652-1145 |
3.17e-15 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139538 [Multi-domain] Cd Length: 501 Bit Score: 80.44 E-value: 3.17e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 652 QAHINPNSIAVVFED--KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPS 729
Cdd:PRK13390 6 HAQIAPDRPAVIVAEtgEQVSYRQLDDDSAALARVLYDAGLRTGDVVALLSDNSPEALVVLWAALRSGLYITAINHHLTA 85
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 730 DRISFMLHDAK-----PSCVLTNSSVEIECDESLKIL----VDDVNVMEEIEKYSEENIDEMECLkplapshiAYVIYTS 800
Cdd:PRK13390 86 PEADYIVGDSGarvlvASAALDGLAAKVGADLPLRLSfggeIDGFGSFEAALAGAGPRLTEQPCG--------AVMLYSS 157
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 801 GSTGRPKGVM---------IPHQNVVRLLGAtdhWFQFDADDVWtmfhsyafdFSVWEIW--GPLLYGGRLVVVPHTVSR 869
Cdd:PRK13390 158 GTTGFPKGIQpdlpgrdvdAPGDPIVAIARA---FYDISESDIY---------YSSAPIYhaAPLRWCSMVHALGGTVVL 225
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 870 SpKEF-----LQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLSLRYVVFGGEALELS---RLEDWYsrhphnAPKV 941
Cdd:PRK13390 226 A-KRFdaqatLGHVERYRITVTQMVPTMFVRLLKLDADVRTRYDVSSLRAVIHAAAPCPVDvkhAMIDWL------GPIV 298
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 942 INMYGITEttVH-VSYIELDEsivSLRANSLIGCSIPDlKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAE- 1019
Cdd:PRK13390 299 YEYYSSTE--AHgMTFIDSPD---WLAHPGSVGRSVLG-DLHICDDDGNELPAGRIGTVYFERDRLPFRYLNDPEKTAAa 372
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1020 RFIADPFgkpgtrMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVI-VREDQPGDK--- 1095
Cdd:PRK13390 373 QHPAHPF------WTTVGDLGSVDEDGYLYLADRKSFMIISGGVNIYPQETENALTMHPAVHDVAVIgVPDPEMGEQvka 446
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|....*
gi 1698252301 1096 --RLVAYIVASNN---ETIDTNEMRqhasgsLPDYMVPYAFVVVNELPLTPNGKL 1145
Cdd:PRK13390 447 viQLVEGIRGSDElarELIDYTRSR------IAHYKAPRSVEFVDELPRTPTGKL 495
|
|
| PRK06814 |
PRK06814 |
acyl-[ACP]--phospholipid O-acyltransferase; |
664-1146 |
6.53e-15 |
|
acyl-[ACP]--phospholipid O-acyltransferase;
Pssm-ID: 235865 [Multi-domain] Cd Length: 1140 Bit Score: 80.39 E-value: 6.53e-15
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 664 FEDKKLTYEKLNRKANKIARfLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGagylpldpdypsdRISFMLH------ 737
Cdd:PRK06814 654 PVNGPLTYRKLLTGAFVLGR-KLKKNTPPGENVGVMLPNANGAAVTFFALQSAG-------------RVPAMINfsagia 719
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 738 DAKPSC-------VLTnSSVEIEcdeslKILVDDVnvMEEIEK-----YSEE---NIDEMECLKPLA------------- 789
Cdd:PRK06814 720 NILSACkaaqvktVLT-SRAFIE-----KARLGPL--IEALEFgiriiYLEDvraQIGLADKIKGLLagrfplvyfcnrd 791
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 790 PSHIAYVIYTSGSTGRPKGVMIPHQNVV--------RL-LGATDHWFqfdadDVWTMFHSyaFDFSVWEIWgPLLYGGRL 860
Cdd:PRK06814 792 PDDPAVILFTSGSEGTPKGVVLSHRNLLanraqvaaRIdFSPEDKVF-----NALPVFHS--FGLTGGLVL-PLLSGVKV 863
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 861 VVVPhtvsrSPKEFLqlLVKEKVTVLNQT-----------------PSAFYqlmqadreneevgqklSLRYVVFGGEALE 923
Cdd:PRK06814 864 FLYP-----SPLHYR--IIPELIYDTNATilfgtdtflngyaryahPYDFR----------------SLRYVFAGAEKVK 920
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 924 LSRLEDWYSRHPHnapKVINMYGITETTvhvsyieldeSIVSL------RANSlIGCSIPDLkvyvlDNYLQPVPpGVV- 996
Cdd:PRK06814 921 EETRQTWMEKFGI---RILEGYGVTETA----------PVIALntpmhnKAGT-VGRLLPGI-----EYRLEPVP-GIDe 980
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 997 -GEMYVAGAGLARGYLgraglTAErfiadpfgKPGT------RMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGE 1069
Cdd:PRK06814 981 gGRLFVRGPNVMLGYL-----RAE--------NPGVleppadGWYDTGDIVTIDEEGFITIKGRAKRFAKIAGEMISLAA 1047
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1070 IEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVAsnnETIDTNEMRQHASG-SLPDYMVPYAFVVVNELPLTPNGKLD 1146
Cdd:PRK06814 1048 VEELAAELWPDALHAAVSIPDARKGERIILLTTA---SDATRAAFLAHAKAaGASELMVPAEIITIDEIPLLGTGKID 1122
|
|
| MenE/FadK |
COG0318 |
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid ... |
1-79 |
7.09e-15 |
|
O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) [Lipid transport and metabolism]; O-succinylbenzoic acid-CoA ligase MenE or related acyl-CoA synthetase (AMP-forming) is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440087 [Multi-domain] Cd Length: 452 Bit Score: 79.08 E-value: 7.09e-15
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPA 79
Cdd:COG0318 365 LAAHPGVAEAAVVGVPDEKWGERVVAFVVLRPGAELDAEELRAFLRERLARYKVPRRVEFVDELPRTASGKIDRRALRE 443
|
|
| PRK07769 |
PRK07769 |
long-chain-fatty-acid--CoA ligase; Validated |
634-1053 |
1.01e-14 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 181109 [Multi-domain] Cd Length: 631 Bit Score: 79.39 E-value: 1.01e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 634 NGGFQIAPEMTLPQLFEKQAHINPNSIAVVFED---------KKLTYEKLNRKANKIARFL--IAKgvgPDQLVALAMPR 702
Cdd:PRK07769 12 NGKIRFPPNTNLVRHVERWAKVRGDKLAYRFLDfsterdgvaRDLTWSQFGARNRAVGARLqqVTK---PGDRVAILAPQ 88
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 703 SLNMVVSLLAVLKAGAGYLPL-DPDYP--SDRISFMLHDAKPSCVLTNSsveiECDESLKILVDDVNVMEEIEKYSEENI 779
Cdd:PRK07769 89 NLDYLIAFFGALYAGRIAVPLfDPAEPghVGRLHAVLDDCTPSAILTTT----DSAEGVRKFFRARPAKERPRVIAVDAV 164
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 780 -DEM-ECLKPLAPSH--IAYVIYTSGSTGRPKGVMIPHQ----NVVRLLGAtdhwFQFDADD---VW-TMFHsyafDFSV 847
Cdd:PRK07769 165 pDEVgATWVPPEANEdtIAYLQYTSGSTRIPAGVQITHLnlptNVLQVIDA----LEGQEGDrgvSWlPFFH----DMGL 236
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 848 WEIWGPLLYGGRLVVV-PHTVSRSPKEFLQLLVKEK---VTVLNQTPSAFYQLMQA---DRENEEvgqKLSLRYV---VF 917
Cdd:PRK07769 237 ITVLLPALLGHYITFMsPAAFVRRPGRWIRELARKPggtGGTFSAAPNFAFEHAAArglPKDGEP---PLDLSNVkglLN 313
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 918 GGEALELSRLEDWYSRH-PHNAPK--VINMYGITETTVHVSYIELDE--SIVSLRANSL------------------IGC 974
Cdd:PRK07769 314 GSEPVSPASMRKFNEAFaPYGLPPtaIKPSYGMAEATLFVSTTPMDEepTVIYVDRDELnagrfvevpadapnavaqVSA 393
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 975 ---SIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERF-------IADPFG---KPGTRMYRTGDLAR 1041
Cdd:PRK07769 394 gkvGVSEWAVIVDPETASELPDGQIGEIWLHGNNIGTGYWGKPEETAATFqnilksrLSESHAegaPDDALWVRTGDYGV 473
|
490
....*....|...
gi 1698252301 1042 WrQDGTLdYI-GR 1053
Cdd:PRK07769 474 Y-FDGEL-YItGR 484
|
|
| hsFATP4_like |
cd05939 |
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty ... |
666-1150 |
2.13e-14 |
|
Fatty acid transport proteins (FATP), including FATP4 and FATP1, and similar proteins; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. At least five copies of FATPs are identified in mammalian cells. This family includes FATP4, FATP1, and homologous proteins. Each FATP has unique patterns of tissue distribution. FATP4 is mainly expressed in the brain, testis, colon and kidney. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis.
Pssm-ID: 341262 [Multi-domain] Cd Length: 474 Bit Score: 77.47 E-value: 2.13e-14
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 666 DKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAgylpldpdyPSDRISFMLH-DAKPSCV 744
Cdd:cd05939 1 DRHWTFRELNEYSNKVANFFQAQGYRSGDVVALFMENRLEFVALWLGLAKIGV---------ETALINSNLRlESLLHCI 71
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 745 LTNSSveiecdeslKILVddVNVMEEIEKYSEENIDEMECLKplAPSHIAYvIYTSGSTGRPKGVMIPHQNVVRLLGATD 824
Cdd:cd05939 72 TVSKA---------KALI--FNLLDPLLTQSSTEPPSQDDVN--FRDKLFY-IYTSGTTGLPKAAVIVHSRYYRIAAGAY 137
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 825 HWFQFDADDVW----TMFHSYAFDFSVweiwGPLLYGGRLVVVPHTVSRSpkEFLQLLVKEKVTVLNQTPS-AFYQLMQA 899
Cdd:cd05939 138 YAFGMRPEDVVydclPLYHSAGGIMGV----GQALLHGSTVVIRKKFSAS--NFWDDCVKYNCTIVQYIGEiCRYLLAQP 211
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 900 DRENEevgQKLSLRYVVfgGEALELSRLEDWYSRhpHNAPKVINMYGITETTvhVSYIELDESIVSLRANSLIGCSIPDL 979
Cdd:cd05939 212 PSEEE---QKHNVRLAV--GNGLRPQIWEQFVRR--FGIPQIGEFYGATEGN--SSLVNIDNHVGACGFNSRILPSVYPI 282
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 980 KVYVLDNYL-----------QPVPPGVVGEMY---VAGAGLAR--GYLGRaGLTAERFIADPFgKPGTRMYRTGDLARWR 1043
Cdd:cd05939 283 RLIKVDEDTgelirdsdglcIPCQPGEPGLLVgkiIQNDPLRRfdGYVNE-GATNKKIARDVF-KKGDSAFLSGDVLVMD 360
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1044 QDGTLDYIGRADHQIKIRGFRIELGEIEAVI-----MKHDKVEQVAVIVREDQPGdkrlVAYIVASNNETiDTNEMRQHA 1118
Cdd:cd05939 361 ELGYLYFKDRTGDTFRWKGENVSTTEVEGILsnvlgLEDVVVYGVEVPGVEGRAG----MAAIVDPERKV-DLDRFSAVL 435
|
490 500 510
....*....|....*....|....*....|..
gi 1698252301 1119 SGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05939 436 AKSLPPYARPQFIRLLPEVDKTGTFKLQKTDL 467
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
97-156 |
4.84e-14 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 67.97 E-value: 4.84e-14
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1698252301 97 EILCDLFAEVLGVS--RINIDDNFFEMGGHSLLASRLMARIRETLSVELGIGKLFESPTVAE 156
Cdd:pfam00550 1 ERLRELLAEVLGVPaeEIDPDTDLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPTLAE 62
|
|
| GrsT |
COG3208 |
Surfactin synthase thioesterase subunit [Secondary metabolites biosynthesis, transport and ... |
1250-1405 |
1.83e-13 |
|
Surfactin synthase thioesterase subunit [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442441 [Multi-domain] Cd Length: 237 Bit Score: 71.81 E-value: 1.83e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1250 RASGDQLPLFCVHPAGGLSWCYAGLMKSLGTDYPIYGVQ--ARGIAENEELPKSLEEMAADYlkhVREIQPH--GPYRLL 1325
Cdd:COG3208 1 PRPDARLRLFCFPYAGGSASAYRPWAAALPPDIEVLAVQlpGRGDRLGEPPLTSLEELADDL---AEELAPLldRPFALF 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1326 GWSLGGNVVHAMAAQLQNEGEEVELLVMLDSYPGHFLPNTEAPT---EEEALIALL-ALGGYDPDNMDGKPLtMESAVEI 1401
Cdd:COG3208 78 GHSMGALLAFELARRLERRGRPLPAHLFVSGRRAPHLPRRRRPLhdlSDAELLAELrRLGGTPEEVLADPEL-LELFLPI 156
|
....
gi 1698252301 1402 LRKD 1405
Cdd:COG3208 157 LRAD 160
|
|
| AACS |
cd05943 |
Acetoacetyl-CoA synthetase (acetoacetate-CoA ligase, AACS); AACS is a cytosolic ligase that ... |
653-1144 |
2.24e-13 |
|
Acetoacetyl-CoA synthetase (acetoacetate-CoA ligase, AACS); AACS is a cytosolic ligase that specifically activates acetoacetate to its coenzyme A ester by a two-step reaction. Acetoacetate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is the first step of the mevalonate pathway of isoprenoid biosynthesis via isopentenyl diphosphate. Isoprenoids are a large class of compounds found in all living organisms. AACS is widely distributed in bacteria, archaea and eukaryotes. In bacteria, AACS is known to exhibit an important role in the metabolism of poly-b-hydroxybutyrate, an intracellular reserve of organic carbon and chemical energy by some microorganisms. In mammals, AACS influences the rate of ketone body utilization for the formation of physiologically important fatty acids and cholesterol.
Pssm-ID: 341265 [Multi-domain] Cd Length: 629 Bit Score: 75.00 E-value: 2.24e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 653 AHINPNSIAVVFEDK-----KLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDY 727
Cdd:cd05943 78 RHADADDPAAIYAAEdgertEVTWAELRRRVARLAAALRALGVKPGDRVAGYLPNIPEAVVAMLATASIGAIWSSCSPDF 157
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 728 PS----DRISfmlhDAKPSCVLTNSSV-----EIECDESLKILVDDVNVMEEI----EKYSEENIDEMECLK-------- 786
Cdd:cd05943 158 GVpgvlDRFG----QIEPKVLFAVDAYtyngkRHDVREKVAELVKGLPSLLAVvvvpYTVAAGQPDLSKIAKaltledfl 233
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 787 -----------PLAPSHIAYVIYTSGSTGRPK-------GVMIPHQNVVRL---LGATDHWFQFDADDvWTMFHsyafdf 845
Cdd:cd05943 234 atgaagelefePLPFDHPLYILYSSGTTGLPKcivhgagGTLLQHLKEHILhcdLRPGDRLFYYTTCG-WMMWN------ 306
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 846 svWEIWGpLLYGGRLVV------VPhtvsrSPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQKLSLRYVVFGG 919
Cdd:cd05943 307 --WLVSG-LAVGATIVLydgspfYP-----DTNALWDLADEEGITVFGTSAKYLDALEKAGLKPAETHDLSSLRTILSTG 378
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 920 EALeLSRLEDWYSRHPHNAPKVINMYGITEttvhvsyieldesivslransLIGCsipdlkvYVLDNYLQPVPPGvvgEM 999
Cdd:cd05943 379 SPL-KPESFDYVYDHIKPDVLLASISGGTD---------------------IISC-------FVGGNPLLPVYRG---EI 426
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1000 YVAGAGLAR---GYLGRA--GLTAERFIADPF--------GKPGTRMYRT------------GDLARWRQDGTLDYIGRA 1054
Cdd:cd05943 427 QCRGLGMAVeafDEEGKPvwGEKGELVCTKPFpsmpvgfwNDPDGSRYRAayfakypgvwahGDWIEITPRGGVVILGRS 506
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1055 DHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDtNEMRQH-----ASGSLPDYmVPY 1129
Cdd:cd05943 507 DGTLNPGGVRIGTAEIYRVVEKIPEVEDSLVVGQEWKDGDERVILFVKLREGVELD-DELRKRirstiRSALSPRH-VPA 584
|
570
....*....|....*
gi 1698252301 1130 AFVVVNELPLTPNGK 1144
Cdd:cd05943 585 KIIAVPDIPRTLSGK 599
|
|
| PRK05620 |
PRK05620 |
long-chain fatty-acid--CoA ligase; |
643-1150 |
3.16e-13 |
|
long-chain fatty-acid--CoA ligase;
Pssm-ID: 180167 [Multi-domain] Cd Length: 576 Bit Score: 74.43 E-value: 3.16e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 643 MTLPQLFEKQAHINPNSIAVVFED---KKLTYEKLNRKANKIARFLIAK-GVGPDQLVALAMPRSLNMVVSLLAVLKAGA 718
Cdd:PRK05620 10 LSLTRILEYGSTVHGDTTVTTWGGaeqEQTTFAAIGARAAALAHALHDElGITGDQRVGSMMYNCAEHLEVLFAVACMGA 89
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 719 GYLPLDPDYPSDRISFMLHDAKP-----SCVLTNSSVEI--ECDESLKILV---DDVN-----VMEEIEKYSEEN-IDEM 782
Cdd:PRK05620 90 VFNPLNKQLMNDQIVHIINHAEDevivaDPRLAEQLGEIlkECPCVRAVVFigpSDADsaaahMPEGIKVYSYEAlLDGR 169
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 783 ECLK--PLAPSHIAYVI-YTSGSTGRPKGVMIPHQNVVRllgatdHWFQFDADDVWTMFHSYAFDFSV--WEI--WG-PL 854
Cdd:PRK05620 170 STVYdwPELDETTAAAIcYSTGTTGAPKGVVYSHRSLYL------QSLSLRTTDSLAVTHGESFLCCVpiYHVlsWGvPL 243
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 855 ---LYGGRLVVVPHTVSrsPKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEvgQKLSLRYVVFGGEALELSRLEDWY 931
Cdd:PRK05620 244 aafMSGTPLVFPGPDLS--APTLAKIIATAMPRVAHGVPTLWIQLMVHYLKNPP--ERMSLQEIYVGGSAVPPILIKAWE 319
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 932 SRHphnAPKVINMYGITETTVhVSYIELDESIVS--LRANSLI--GCSIPDLKVYVLDN------------YLQPVPPGV 995
Cdd:PRK05620 320 ERY---GVDVVHVWGMTETSP-VGTVARPPSGVSgeARWAYRVsqGRFPASLEYRIVNDgqvmestdrnegEIQVRGNWV 395
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 996 VGEMYVA----GAGLARGYLGRAGLTA-ERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEI 1070
Cdd:PRK05620 396 TASYYHSpteeGGGAASTFRGEDVEDAnDRFTADGW-------LRTGDVGSVTRDGFLTIHDRARDVIRSGGEWIYSAQL 468
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1071 EAVIMKHDKVEQVAVI-VREDQPGDKRLVAYIVASNNE-TIDTNE-MRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDR 1147
Cdd:PRK05620 469 ENYIMAAPEVVECAVIgYPDDKWGERPLAVTVLAPGIEpTRETAErLRDQLRDRLPNWMLPEYWTFVDEIDKTSVGKFDK 548
|
...
gi 1698252301 1148 KAL 1150
Cdd:PRK05620 549 KDL 551
|
|
| AcpP |
COG0236 |
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the ... |
96-166 |
3.32e-13 |
|
Acyl carrier protein [Lipid transport and metabolism]; Acyl carrier protein is part of the Pathway/BioSystem: Fatty acid biosynthesis
Pssm-ID: 440006 [Multi-domain] Cd Length: 80 Bit Score: 66.42 E-value: 3.32e-13
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 96 EEILCDLFAEVLGV--SRINIDDNFF-EMGGHSLLASRLMARIRETLSVELGIGKLFESPTVAELAKQLNHAKS 166
Cdd:COG0236 7 EERLAEIIAEVLGVdpEEITPDDSFFeDLGLDSLDAVELIAALEEEFGIELPDTELFEYPTVADLADYLEEKLA 80
|
|
| PRK08162 |
PRK08162 |
acyl-CoA synthetase; Validated |
650-1150 |
5.28e-13 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236169 [Multi-domain] Cd Length: 545 Bit Score: 73.44 E-value: 5.28e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 650 EKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPS 729
Cdd:PRK08162 25 ERAAEVYPDRPAVIHGDRRRTWAETYARCRRLASALARRGIGRGDTVAVLLPNIPAMVEAHFGVPMAGAVLNTLNTRLDA 104
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 730 DRISFMLHDAKPSCVLTN---SSV---EIECDESLKILVDDVnVMEEiekYSE-ENIDEMECLKPLAPSHIAYVI----- 797
Cdd:PRK08162 105 ASIAFMLRHGEAKVLIVDtefAEVareALALLPGPKPLVIDV-DDPE---YPGgRFIGALDYEAFLASGDPDFAWtlpad 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 798 --------YTSGSTGRPKGVMIPHQNV-VRLLGATDHWfQFDADDV--WT--MFHSYAFDFSvweiWGPLLYGGRLVVVp 864
Cdd:PRK08162 181 ewdaialnYTSGTTGNPKGVVYHHRGAyLNALSNILAW-GMPKHPVylWTlpMFHCNGWCFP----WTVAARAGTNVCL- 254
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 865 htvsR--SPKEFLQLLVKEKVTVLNQTPSAFYQLMQADrenEEVGQKLSLRYVVFGGEAlelsrledwysrhphnAP--- 939
Cdd:PRK08162 255 ----RkvDPKLIFDLIREHGVTHYCGAPIVLSALINAP---AEWRAGIDHPVHAMVAGA----------------APpaa 311
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 940 ----------KVINMYGITET----TVHVSYIELDESIVSLRA--NSLIGCSIPDLK-VYVLD-NYLQPVPPG--VVGEM 999
Cdd:PRK08162 312 viakmeeigfDLTHVYGLTETygpaTVCAWQPEWDALPLDERAqlKARQGVRYPLQEgVTVLDpDTMQPVPADgeTIGEI 391
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1000 YVAGAGLARGYLGRAGLTAERFiADPFgkpgtrmYRTGDLARWRQDGtldYIgradhQIKIR--------GFRIELGEIE 1071
Cdd:PRK08162 392 MFRGNIVMKGYLKNPKATEEAF-AGGW-------FHTGDLAVLHPDG---YI-----KIKDRskdiiisgGENISSIEVE 455
|
490 500 510 520 530 540 550
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1698252301 1072 AVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAfVVVNELPLTPNGKLDRKAL 1150
Cdd:PRK08162 456 DVLYRHPAVLVAAVVAKPDPKWGEVPCAFVELKDGASATEEEIIAHCREHLAGFKVPKA-VVFGELPKTSTGKIQKFVL 533
|
|
| D-ala-DACP-lig |
TIGR01734 |
D-alanine--poly(phosphoribitol) ligase, subunit 1; This model represents the enzyme (also ... |
1-77 |
7.07e-13 |
|
D-alanine--poly(phosphoribitol) ligase, subunit 1; This model represents the enzyme (also called D-alanine-D-alanyl carrier protein ligase) which activates D-alanine as an adenylate via the reaction D-ala + ATP -> D-ala-AMP + PPi, and further catalyzes the condensation of the amino acid adenylate with the D-alanyl carrier protein (D-ala-ACP). The D-alanine is then further transferred to teichoic acid in the biosynthesis of lipoteichoic acid (LTA) and wall teichoic acid (WTA) in gram positive bacteria, both polysacchatides. [Cell envelope, Biosynthesis and degradation of murein sacculus and peptidoglycan]
Pssm-ID: 273780 [Multi-domain] Cd Length: 502 Bit Score: 72.87 E-value: 7.07e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDrPNDK--RIIAYIVAE----EKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDR 74
Cdd:TIGR01734 415 LRQSSYIESAVVVPKYN-KDHKveYLIAAIVPEtedfEKEFQLTKAIKKELKKSLPAYMIPRKFIYRDQLPLTANGKIDR 493
|
...
gi 1698252301 75 KKL 77
Cdd:TIGR01734 494 KAL 496
|
|
| LC_FACS_bac |
cd05932 |
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter ... |
669-1086 |
8.10e-13 |
|
Bacterial long-chain fatty acid CoA synthetase (LC-FACS), including Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase; The members of this family are bacterial long-chain fatty acid CoA synthetase. Marinobacter hydrocarbonoclasticus isoprenoid Coenzyme A synthetase in this family is involved in the synthesis of isoprenoid wax ester storage compounds when grown on phytol as the sole carbon source. LC-FACS catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341255 [Multi-domain] Cd Length: 508 Bit Score: 72.89 E-value: 8.10e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFmlhdakpscVLTNS 748
Cdd:cd05932 7 FTWGEVADKARRLAAALRALGLEPGSKIALISKNCAEWFITDLAIWMAGHISVPLYPTLNPDTIRY---------VLEHS 77
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 749 sveiECDESLKILVDDVNVM-----EEIEKYSEENIDEMECLK----------PL------APSHIAYVIYTSGSTGRPK 807
Cdd:cd05932 78 ----ESKALFVGKLDDWKAMapgvpEGLISISLPPPSAANCQYqwddliaqhpPLeerptrFPEQLATLIYTSGTTGQPK 153
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 808 GVMIPH-------QNVVRLLGATDhwfqfdaDDvwTMFhSYAFDFSVWE---IWGPLLYGGRLVVVPHT-------VSRS 870
Cdd:cd05932 154 GVMLTFgsfawaaQAGIEHIGTEE-------ND--RML-SYLPLAHVTErvfVEGGSLYGGVLVAFAESldtfvedVQRA 223
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 871 -PKEFL---QLLVKEKVTVLNQTPSAFYQ-LMQADRENEEVGQKL-------SLRYVVFGGEALELSRLeDWYSRHPHNa 938
Cdd:cd05932 224 rPTLFFsvpRLWTKFQQGVQDKIPQQKLNlLLKIPVVNSLVKRKVlkglgldQCRLAGCGSAPVPPALL-EWYRSLGLN- 301
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 939 pkVINMYGITETTV--HVSYIELDESivslranSLIGCSIPDLKVYVLDNylqpvppgvvGEMYVAGAGLARGYLGRAGL 1016
Cdd:cd05932 302 --ILEAYGMTENFAysHLNYPGRDKI-------GTVGNAGPGVEVRISED----------GEILVRSPALMMGYYKDPEA 362
|
410 420 430 440 450 460 470
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1698252301 1017 TAERFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKI-RGFRIELGEIEAVIMKHDKVEQVAVI 1086
Cdd:cd05932 363 TAEAFTADGF-------LRTGDKGELDADGNLTITGRVKDIFKTsKGKYVAPAPIENKLAEHDRVEMVCVI 426
|
|
| AcpA |
COG3433 |
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites ... |
1-169 |
8.51e-13 |
|
Acyl carrier protein/domain [Lipid transport and metabolism, Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442659 [Multi-domain] Cd Length: 295 Bit Score: 70.93 E-value: 8.51e-13
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVsesLANYMIPSAFVVLEELPLTPNGKVDRKKLPAP 80
Cdd:COG3433 123 RAAAVVRVAVLAALRGAGVGLLLIVGAVAALDGLAAAAALAALDK---VPPDVVAASAVVALDALLLLALKVVARAAPAL 199
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 81 DFNGMNNE------RVARNPKEEILCDLFAEVLGVS--RINIDDNFFEMGGHSLLASRLMARIRETlSVELGIGKLFESP 152
Cdd:COG3433 200 AAAEALLAaaspapALETALTEEELRADVAELLGVDpeEIDPDDNLFDLGLDSIRLMQLVERWRKA-GLDVSFADLAEHP 278
|
170
....*....|....*..
gi 1698252301 153 TVAELAKQLNHAKSARP 169
Cdd:COG3433 279 TLAAWWALLAAAQAAAA 295
|
|
| Cyc_NRPS |
cd19535 |
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the ... |
214-504 |
1.07e-12 |
|
Cyc (heterocyclization) domain of nonribosomal peptide synthetases (NRPSs); belongs to the Condensation-domain family; Cyc (heterocyclization) domains catalyze two separate reactions in the creation of heterocyclized peptide products in nonribosomal peptide synthesis: amide bond formation followed by intramolecular cyclodehydration between a Cys, Ser, or Thr side chain and a carbonyl carbon on the peptide backbone to form a thiazoline, oxazoline, or methyloxazoline ring. Cyc-domains are homologous to standard NRPS Condensation (C) domains. C-domains typically have a conserved HHxxxD motif at the active site; Cyc-domains have an alternative, conserved DxxxxD active site motif, mutation of the aspartate residues in this motif can abolish or diminish condensation activity. NRPS can use a large variety of acyl monomers (approximately 500 different possible monomer substrates as opposed to the 20 standard amino acids in ribosomal protein synthesis) to construct bioactive secondary metabolites of 2 to 18 units long (with various activities such as antibiotic, antifungal, antitumor and immunosuppression). There are various subtypes of C-domains such as the LCL-type which catalyzes peptide bond formation between two L-amino acids, the DCL-type which links an L-amino acid to the D-amino acid at the end of a growing peptide, starter C-domains which acylate the first amino acid with a beta-hydroxy carboxylic acid, and Cyc-domains. Typically, an NRPS module consists of an adenylation domain, a peptidyl carrier protein (PCP) domain (also known as thiolation (T) domain) and a C-domain. NRPS modules may also include specialized domains such as the terminal-module thioesterase (Te) domain that releases the product via hydrolysis or macrocyclization and any of various C-domain family members such as the epimerization (E) domain, the ester-bond forming C-domain, dual E/C (epimerization and condensation) domains, and the X-domain.
Pssm-ID: 380458 [Multi-domain] Cd Length: 423 Bit Score: 71.75 E-value: 1.07e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 214 LNRQALQGAFYDVVEKHETLRTIFpnvLGSSYQKIL------DMENLNLEMVITNTCKDELESV---LSEAVrysFNLDF 284
Cdd:cd19535 37 LDPDRLERAWNKLIARHPMLRAVF---LDDGTQQILpevpwyGITVHDLRGLSEEEAEAALEELrerLSHRV---LDVER 110
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 285 EPAVRLQLFTVSENEHVLLILLHHIVGDGWSLQPLTRDFTAAYkarcQGDRVQLETLPVQYADYALWQQQLlgdettPES 364
Cdd:cd19535 111 GPLFDIRLSLLPEGRTRLHLSIDLLVADALSLQILLRELAALY----EDPGEPLPPLELSFRDYLLAEQAL------RET 180
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 365 LISTQLDFWKEELKGLPDQMELPTdYQRPvetsyrgETI--------HFHIDEGMHSRLVELGRKNGVSLFMVLqagLSA 436
Cdd:cd19535 181 AYERARAYWQERLPTLPPAPQLPL-AKDP-------EEIkeprftrrEHRLSAEQWQRLKERARQHGVTPSMVL---LTA 249
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 437 -------------------LFTRLGAGTDIPigspiagrnddvlsDIVGLFVNTLVLRTNTSGDPSFKELLNRVKQVNLA 497
Cdd:cd19535 250 yaevlarwsgqprfllnltLFNRLPLHPDVN--------------DVVGDFTSLLLLEVDGSEGQSFLERARRLQQQLWE 315
|
....*..
gi 1698252301 498 AYENQDV 504
Cdd:cd19535 316 DLDHSSY 322
|
|
| PRK04813 |
PRK04813 |
D-alanine--poly(phosphoribitol) ligase subunit DltA; |
1-77 |
2.17e-12 |
|
D-alanine--poly(phosphoribitol) ligase subunit DltA;
Pssm-ID: 235313 [Multi-domain] Cd Length: 503 Bit Score: 71.46 E-value: 2.17e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREdrPNDK--RIIAYIVAE----EKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDR 74
Cdd:PRK04813 417 LRQSSYVESAVVVPYN--KDHKvqYLIAYVVPKeedfEREFELTKAIKKELKERLMEYMIPRKFIYRDSLPLTPNGKIDR 494
|
...
gi 1698252301 75 KKL 77
Cdd:PRK04813 495 KAL 497
|
|
| PRK09192 |
PRK09192 |
fatty acyl-AMP ligase; |
669-1147 |
2.86e-12 |
|
fatty acyl-AMP ligase;
Pssm-ID: 236403 [Multi-domain] Cd Length: 579 Bit Score: 71.19 E-value: 2.86e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYP-------SDRISFMLHDAKP 741
Cdd:PRK09192 50 LPYQTLRARAEAGARRLLALGLKPGDRVALIAETDGDFVEAFFACQYAGLVPVPLPLPMGfggresyIAQLRGMLASAQP 129
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 742 SCVLTNssveiecDESLKILVDDVNVMEEIEKYSEENIDEMEC----LKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVV 817
Cdd:PRK09192 130 AAIITP-------DELLPWVNEATHGNPLLHVLSHAWFKALPEadvaLPRPTPDDIAYLQYSSGSTRFPRGVIITHRALM 202
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 818 -RLLGATDHWFQFDADDVWtmfhsyafdFSvweiWGPL-----LYGGRLVVVPHTVS----------RSPKEFLQLLVKE 881
Cdd:PRK09192 203 aNLRAISHDGLKVRPGDRC---------VS----WLPFyhdmgLVGFLLTPVATQLSvdylptrdfaRRPLQWLDLISRN 269
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 882 KVTVlNQTPSAFYQLMqADRENEEVGQKLSL---RYVVFGGEALELSRLEDW---YSRHPHNAPKVINMYGITETTVHVS 955
Cdd:PRK09192 270 RGTI-SYSPPFGYELC-ARRVNSKDLAELDLscwRVAGIGADMIRPDVLHQFaeaFAPAGFDDKAFMPSYGLAEATLAVS 347
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 956 YIELDESIVSL---------------------RANSLIGC--SIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLG 1012
Cdd:PRK09192 348 FSPLGSGIVVEevdrdrleyqgkavapgaetrRVRTFVNCgkALPGHEIEIRNEAGMPLPERVVGHICVRGPSLMSGYFR 427
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1013 RAgLTAERFIADPFgkpgtrmYRTGDLArWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQ--VAVIVRED 1090
Cdd:PRK09192 428 DE-ESQDVLAADGW-------LDTGDLG-YLLDGYLYITGRAKDLIIINGRNIWPQDIEWIAEQEPELRSgdAAAFSIAQ 498
|
490 500 510 520 530 540
....*....|....*....|....*....|....*....|....*....|....*....|..
gi 1698252301 1091 QPGDKrLVAYIVASNNETIDTNEMRQHASGSLpdYMVPYAFVVV-----NELPLTPNGKLDR 1147
Cdd:PRK09192 499 ENGEK-IVLLVQCRISDEERRGQLIHALAALV--RSEFGVEAAVelvppHSLPRTSSGKLSR 557
|
|
| A_NRPS_MycA_like |
cd05908 |
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin ... |
779-1102 |
2.88e-12 |
|
The adenylation domain of nonribosomal peptide synthetases (NRPS) similar to mycosubtilin synthase subunit A (MycA); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as (amino)-acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family includes NRPS similar to mycosubtilin synthase subunit A (MycA). Mycosubtilin, which is characterized by a beta-amino fatty acid moiety linked to the circular heptapeptide Asn-Tyr-Asn-Gln-Pro-Ser-Asn, belongs to the iturin family of lipopeptide antibiotics. The mycosubtilin synthase subunit A (MycA) combines functional domains derived from peptide synthetases, amino transferases, and fatty acid synthases. Nonribosomal peptide synthetases are large multifunction enzymes that synthesize many therapeutically useful peptides. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and, in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341234 [Multi-domain] Cd Length: 499 Bit Score: 70.98 E-value: 2.88e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 779 IDEMECLKPLaPSHIAYVIYTSGSTGRPKGVMIPHQNVVR----LLGATDhWFQFDADDVW-TMFHSY---AFDFSvwei 850
Cdd:cd05908 95 ITEEEVLCEL-ADELAFIQFSSGSTGDPKGVMLTHENLVHnmfaILNSTE-WKTKDRILSWmPLTHDMgliAFHLA---- 168
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 851 wgPLLYGGRLVVVPHTV-SRSPKEFLQLLVKEKVTVLNqTPSAFYQLMqADRENEEVGQKL---SLRYVVFGGE--ALEL 924
Cdd:cd05908 169 --PLIAGMNQYLMPTRLfIRRPILWLKKASEHKATIVS-SPNFGYKYF-LKTLKPEKANDWdlsSIRMILNGAEpiDYEL 244
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 925 -SRLEDWYSRHPHNAPKVINMYGITETTVHVSYIELDESIVSL---RANSLIGCSIPDL--------------------K 980
Cdd:cd05908 245 cHEFLDHMSKYGLKRNAILPVYGLAEASVGASLPKAQSPFKTItlgRRHVTHGEPEPEVdkkdsecltfvevgkpidetD 324
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 981 VYVLDNYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTGDLARWRqDGTLDYIGRADHQIKI 1060
Cdd:cd05908 325 IRICDEDNKILPDGYIGHIQIRGKNVTPGYYNNPEATAKVFTDDGW-------LKTGDLGFIR-NGRLVITGREKDIIFV 396
|
330 340 350 360
....*....|....*....|....*....|....*....|....*
gi 1698252301 1061 RGFRIELGEIEAVIMKHDKVE--QVAVI-VREDQPGDKRLVAYIV 1102
Cdd:cd05908 397 NGQNVYPHDIERIAEELEGVElgRVVACgVNNSNTRNEEIFCFIE 441
|
|
| A_NRPS_alphaAR |
cd17647 |
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as ... |
1-80 |
6.93e-12 |
|
Alpha-aminoadipate reductase; This family contains L-2-aminoadipate reductase, also known as alpha-aminoadipate reductase (EC 1.2.1.95) or alpha-AR or L-aminoadipate-semialdehyde dehydrogenase (EC 1.2.1.31), which catalyzes the activation of alpha-aminoadipate by ATP-dependent adenylation and the reduction of activated alpha-aminoadipate by NADPH. The activated alpha-aminoadipate is bound to the phosphopantheinyl group of the enzyme itself before it is reduced to (S)-2-amino-6-oxohexanoate.
Pssm-ID: 341302 [Multi-domain] Cd Length: 520 Bit Score: 69.85 E-value: 6.93e-12
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSE---------------------------IRSYVSESLANYM 53
Cdd:cd17647 414 ISQHPLVRENITLVRRDKDEEPTLVSYIVPRFDKPDDESFaqedvpkevstdpivkgligyrklikdIREFLKKRLASYA 493
|
90 100
....*....|....*....|....*..
gi 1698252301 54 IPSAFVVLEELPLTPNGKVDRKKLPAP 80
Cdd:cd17647 494 IPSLIVVLDKLPLNPNGKVDKPKLQFP 520
|
|
| PP-binding |
pfam00550 |
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached ... |
1172-1228 |
9.34e-12 |
|
Phosphopantetheine attachment site; A 4'-phosphopantetheine prosthetic group is attached through a serine. This prosthetic group acts as a a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups. This domain forms a four helix bundle. This family includes members not included in Prosite. The inclusion of these members is supported by sequence analysis and functional evidence. The related domain of Swiss:P19828 has the attachment serine replaced by an alanine.
Pssm-ID: 425746 [Multi-domain] Cd Length: 62 Bit Score: 61.43 E-value: 9.34e-12
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*....
gi 1698252301 1172 LCDLFTEVL--SVSQIGIDDGFFDLGGHSLLAVQLMSRMKEALGVELNIGTLFAAPTVA 1228
Cdd:pfam00550 3 LRELLAEVLgvPAEEIDPDTDLFDLGLDSLLAVELIARLEEEFGVEIPPSDLFEHPTLA 61
|
|
| PRK05857 |
PRK05857 |
fatty acid--CoA ligase; |
651-1152 |
1.94e-11 |
|
fatty acid--CoA ligase;
Pssm-ID: 180293 [Multi-domain] Cd Length: 540 Bit Score: 68.50 E-value: 1.94e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 651 KQAHINPNSIAVVFED--KKLTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYP 728
Cdd:PRK05857 22 EQARQQPEAIALRRCDgtSALRYRELVAEVGGLAADLRAQSVSRGSRVLVISDNGPETYLSVLACAKLGAIAVMADGNLP 101
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 729 SDRISFMLHDAKPSCVLTNSSVEIECDESLKILVDDVNVMEEIEKYSEENIDEMECLKPLA-PSHIA----YVIYTSGST 803
Cdd:PRK05857 102 IAAIERFCQITDPAAALVAPGSKMASSAVPEALHSIPVIAVDIAAVTRESEHSLDAASLAGnADQGSedplAMIFTSGTT 181
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 804 GRPKGVMIPHQ------NVVRLLGAtdHWFQFDADDVWTMFHSYAFDFSVWEIWGPLLYGGRLVvvphTVSRSPKEFLQL 877
Cdd:PRK05857 182 GEPKAVLLANRtffavpDILQKEGL--NWVTWVVGETTYSPLPATHIGGLWWILTCLMHGGLCV----TGGENTTSLLEI 255
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 878 LVKEKVTVLNQTPSAFYQLMQADRENEEVGQklSLRYVVFGGE---ALELSRLEdwysrhpHNAPKVINMYGITETTVHV 954
Cdd:PRK05857 256 LTTNAVATTCLVPTLLSKLVSELKSANATVP--SLRLVGYGGSraiAADVRFIE-------ATGVRTAQVYGLSETGCTA 326
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 955 SYIELD-ESIVSLRANSlIGCSIPDLKVYVLD------NYLQPVPPGVVGEMYVAGAGLARGYLGRAGLTAErFIADPFg 1027
Cdd:PRK05857 327 LCLPTDdGSIVKIEAGA-VGRPYPGVDVYLAAtdgigpTAPGAGPSASFGTLWIKSPANMLGYWNNPERTAE-VLIDGW- 403
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1028 kpgtrmYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVI-VREDQPGDKRLVAYIVASNN 1106
Cdd:PRK05857 404 ------VNTGDLLERREDGFFYIKGRSSEMIICGGVNIAPDEVDRIAEGVSGVREAACYeIPDEEFGALVGLAVVASAEL 477
|
490 500 510 520 530
....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1107 ETIDTNEMRQHASGSL---PDYMV-PYAFVVVNELPLTPNGKLDRKALPA 1152
Cdd:PRK05857 478 DESAARALKHTIAARFrreSEPMArPSTIVIVTDIPRTQSGKVMRASLAA 527
|
|
| A_NRPS_SidN3_like |
cd05918 |
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); ... |
1-77 |
3.71e-11 |
|
The adenylation (A) domain of siderophore-synthesizing nonribosomal peptide synthetases (NRPS); The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. This family of siderophore-synthesizing NRPS includes the third adenylation domain of SidN from the endophytic fungus Neotyphodium lolii, ferrichrome siderophore synthetase, HC-toxin synthetase, and enniatin synthase. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341242 [Multi-domain] Cd Length: 481 Bit Score: 67.57 E-value: 3.71e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRH-ENIQQAVVMV--REDRPNDKRIIAYIVAEEKEP-----------------INLSEIRSYVSESLANYMIPSAFVV 60
Cdd:cd05918 377 LRQSlPGAKEVVVEVvkPKDGSSSPQLVAFVVLDGSSSgsgdgdslflepsdefrALVAELRSKLRQRLPSYMVPSVFLP 456
|
90
....*....|....*..
gi 1698252301 61 LEELPLTPNGKVDRKKL 77
Cdd:cd05918 457 LSHLPLTASGKIDRRAL 473
|
|
| PRK07445 |
PRK07445 |
O-succinylbenzoic acid--CoA ligase; Reviewed |
945-1151 |
5.68e-11 |
|
O-succinylbenzoic acid--CoA ligase; Reviewed
Pssm-ID: 236019 [Multi-domain] Cd Length: 452 Bit Score: 66.56 E-value: 5.68e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 945 YGITETTVHVSYIELDESivsLRANSLIGCSIPDLKVYVLDNylqpvppgVVGEMYVAGAGLARGYLgragltaerfiad 1024
Cdd:PRK07445 261 YGMTETASQIATLKPDDF---LAGNNSSGQVLPHAQITIPAN--------QTGNITIQAQSLALGYY------------- 316
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1025 PFGKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAyIVAS 1104
Cdd:PRK07445 317 PQILDSQGIFETDDLGYLDAQGYLHILGRNSQKIITGGENVYPAEVEAAILATGLVQDVCVLGLPDPHWGEVVTA-IYVP 395
|
170 180 190 200
....*....|....*....|....*....|....*....|....*..
gi 1698252301 1105 NNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKALP 1151
Cdd:PRK07445 396 KDPSISLEELKTAIKDQLSPFKQPKHWIPVPQLPRNPQGKINRQQLQ 442
|
|
| AFD_class_I |
cd04433 |
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as ... |
1-73 |
6.66e-11 |
|
Adenylate forming domain, Class I, also known as the ANL superfamily; This family is known as the ANL (acyl-CoA synthetases, the NRPS adenylation domains, and the Luciferase enzymes) superfamily. It includes acyl- and aryl-CoA ligases, as well as the adenylation domain of nonribosomal peptide synthetases and firefly luciferases.The adenylate-forming enzymes catalyze an ATP-dependent two-step reaction to first activate a carboxylate substrate as an adenylate and then transfer the carboxylate to the pantetheine group of either coenzyme A or an acyl-carrier protein. The active site of the domain is located at the interface of a large N-terminal subdomain and a smaller C-terminal subdomain.
Pssm-ID: 341228 [Multi-domain] Cd Length: 336 Bit Score: 65.77 E-value: 6.66e-11
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVD 73
Cdd:cd04433 264 LLGHPGVAEAAVVGVPDPEWGERVVAVVVLRPGADLDAEELRAHVRERLAPYKVPRRVVFVDALPRTASGKID 336
|
|
| PRK07008 |
PRK07008 |
long-chain-fatty-acid--CoA ligase; Validated |
798-1145 |
9.66e-11 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235908 [Multi-domain] Cd Length: 539 Bit Score: 66.27 E-value: 9.66e-11
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 798 YTSGSTGRPKGVMIPHQNVV--RLLGATDHWFQFDADD----VWTMFHSYAfdfsvweiWG-PL---LYGGRLVVV-PHT 866
Cdd:PRK07008 183 YTSGTTGNPKGALYSHRSTVlhAYGAALPDAMGLSARDavlpVVPMFHVNA--------WGlPYsapLTGAKLVLPgPDL 254
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 867 VSRSPKEflqLLVKEKVTVLNQTPSAFYQLMQADRENeevGQKLS-LRYVVFGGEALE---LSRLEDWYSrhphnaPKVI 942
Cdd:PRK07008 255 DGKSLYE---LIEAERVTFSAGVPTVWLGLLNHMREA---GLRFStLRRTVIGGSACPpamIRTFEDEYG------VEVI 322
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 943 NMYGITE----------TTVHVSYIELDESIVSLRANSLIgCSIpDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGYLG 1012
Cdd:PRK07008 323 HAWGMTEmsplgtlcklKWKHSQLPLDEQRKLLEKQGRVI-YGV-DMKIVGDDGRELPWDGKAFGDLQVRGPWVIDRYFR 400
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1013 RAGltaerfiaDPFGKpgtRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQP 1092
Cdd:PRK07008 401 GDA--------SPLVD---GWFPTGDVATIDADGFMQITDRSKDVIKSGGEWISSIDIENVAVAHPAVAEAACIACAHPK 469
|
330 340 350 360 370
....*....|....*....|....*....|....*....|....*....|...
gi 1698252301 1093 GDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKL 1145
Cdd:PRK07008 470 WDERPLLVVVKRPGAEVTREELLAFYEGKVAKWWIPDDVVFVDAIPHTATGKL 522
|
|
| PKS_PP |
smart00823 |
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ... |
1164-1234 |
3.18e-10 |
|
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.
Pssm-ID: 214834 [Multi-domain] Cd Length: 86 Bit Score: 58.03 E-value: 3.18e-10
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1164 PRTPQEEMLCDLF-TEVLSV------SQIGIDDGFFDLGGHSLLAVQLMSRMKEALGVELNIGTLFAAPTVAGLAERL 1234
Cdd:smart00823 5 PPAERRRLLLDLVrEQVAAVlghaaaEAIDPDRPFRDLGLDSLMAVELRNRLEAATGLRLPATLVFDHPTPAALAEHL 82
|
|
| AMP-binding_C |
pfam13193 |
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to ... |
1-71 |
3.45e-10 |
|
AMP-binding enzyme C-terminal domain; This is a small domain that is found C terminal to pfam00501. It has a central beta sheet core that is flanked by alpha helices.
Pssm-ID: 463804 [Multi-domain] Cd Length: 76 Bit Score: 57.55 E-value: 3.45e-10
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGK 71
Cdd:pfam13193 6 LVSHPAVAEAAVVGVPDELKGEAPVAFVVLKPGVELLEEELVAHVREELGPYAVPKEVVFVDELPKTRSGK 76
|
|
| PLN02387 |
PLN02387 |
long-chain-fatty-acid-CoA ligase family protein |
769-1106 |
3.56e-10 |
|
long-chain-fatty-acid-CoA ligase family protein
Pssm-ID: 215217 [Multi-domain] Cd Length: 696 Bit Score: 64.75 E-value: 3.56e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 769 EEIEKYSEENidEMECLKPLaPSHIAYVIYTSGSTGRPKGVMIPHQNVVRL----------LGATD---------HWFQF 829
Cdd:PLN02387 231 SEVEKLGKEN--PVDPDLPS-PNDIAVIMYTSGSTGLPKGVMMTHGNIVATvagvmtvvpkLGKNDvylaylplaHILEL 307
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 830 DADDVwtmfhsyafdfsVWEIWGPLLYGGrlvvvPHTVSRSPKEfLQLLVKEKVTVLNQTpsafyqLMQA-----DRENE 904
Cdd:PLN02387 308 AAESV------------MAAVGAAIGYGS-----PLTLTDTSNK-IKKGTKGDASALKPT------LMTAvpailDRVRD 363
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 905 EVGQKLSLRyvvfGGEALELSRLEdwYSRH---------------------------------------PHNAP------ 939
Cdd:PLN02387 364 GVRKKVDAK----GGLAKKLFDIA--YKRRlaaiegswfgawglekllwdalvfkkiravlggrirfmlSGGAPlsgdtq 437
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 940 KVINM---------YGITETTVHVSYIELDESIVSlRANSLIGCSIPDLKVYVLDNYLQPVPPGVVGEMYVAGAGLARGY 1010
Cdd:PLN02387 438 RFINIclgapigqgYGLTETCAGATFSEWDDTSVG-RVGPPLPCCYVKLVSWEEGGYLISDKPMPRGEIVIGGPSVTLGY 516
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1011 LGRAGLTAERFIADpfgKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIR-GFRIELGEIEAVIMKHDKVEQvaVIVRE 1089
Cdd:PLN02387 517 FKNQEKTDEVYKVD---ERGMRWFYTGDIGQFHPDGCLEIIDRKKDIVKLQhGEYVSLGKVEAALSVSPYVDN--IMVHA 591
|
410
....*....|....*..
gi 1698252301 1090 DqPGDKRLVAYIVASNN 1106
Cdd:PLN02387 592 D-PFHSYCVALVVPSQQ 607
|
|
| A_NRPS_GliP_like |
cd17653 |
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of ... |
1-77 |
3.57e-10 |
|
nonribosomal peptide synthase GliP-like; This family includes the adenylation (A) domain of nonribosomal peptide synthases (NRPS) gliotoxin biosynthesis protein P (GliP), thioclapurine biosynthesis protein P (tcpP) and Sirodesmin biosynthesis protein P (SirP). In the filamentous fungus Aspergillus fumigatus, NRPS GliP is involved in the biosynthesis of gliotoxin, which is initiated by the condensation of serine and phenylalanine. Studies show that GliP is not required for invasive aspergillosis, suggesting that the principal targets of gliotoxin are neutrophils or other phagocytes. SirP is a phytotoxin produced by the fungus Leptosphaeria maculans, which causes blackleg disease of canola (Brassica napus). In the fungus Claviceps purpurea, NRPS tcpP catalyzes condensation of tyrosine and glycine, part of biosynthesis of an unusual class of epipolythiodioxopiperazines (ETPs) that lacks the reactive thiol group for toxicity. The adenylation (A) domain of NRPS recognizes a specific amino acid or hydroxy acid and activates it as an (amino) acyl adenylate by hydrolysis of ATP. The activated acyl moiety then forms a thioester bond to the enzyme-bound cofactor phosphopantetheine of a peptidyl carrier protein domain. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341308 [Multi-domain] Cd Length: 433 Bit Score: 63.87 E-value: 3.57e-10
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRpndkrIIAYIVAEEkepINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd17653 363 LQSQPEVTQAAAIVVNGR-----LVAFVTPET---VDVDGLRSELAKHLPSYAVPDRIIALDSFPLTANGKVDRKAL 431
|
|
| FATP_chFAT1_like |
cd05937 |
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA ... |
664-1150 |
4.36e-10 |
|
Uncharacterized subfamily of bifunctional fatty acid transporter/very-long-chain acyl-CoA synthetase in fungi; Fatty acid transport protein (FATP) transports long-chain or very-long-chain fatty acids across the plasma membrane. FATPs also have fatty acid CoA synthetase activity, thus playing dual roles as fatty acid transporters and its activation enzymes. FATPs are the key players in the trafficking of exogenous fatty acids into the cell and in intracellular fatty acid homeostasis. Members of this family are fungal FATPs, including FAT1 from Cochliobolus heterostrophus.
Pssm-ID: 341260 [Multi-domain] Cd Length: 468 Bit Score: 63.99 E-value: 4.36e-10
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 664 FEDKKLTYEKLNRKANKIARFLI-AKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRisfMLHdakps 742
Cdd:cd05937 1 FEGKTWTYSETYDLVLRYAHWLHdDLGVQAGDFVAIDLTNSPEFVFLWLGLWSIGAAPAFINYNLSGDP---LIH----- 72
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 743 CV-LTNSSVEIECDESLKILvddvnvmeeiekyseenidemeclkplapshiayvIYTSGSTGRPKGVMIPHQNVVRLLG 821
Cdd:cd05937 73 CLkLSGSRFVIVDPDDPAIL-----------------------------------IYTSGTTGLPKAAAISWRRTLVTSN 117
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 822 ATDHWFQFDADDVW----TMFHSYAFDFSVWEIwgplLYGGRLVVVPHTVSRSpkEFLQLLVKEKVTVLNQTPSAFYQLM 897
Cdd:cd05937 118 LLSHDLNLKNGDRTytcmPLYHGTAAFLGACNC----LMSGGTLALSRKFSAS--QFWKDVRDSGATIIQYVGELCRYLL 191
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 898 QADRENEEVGQKLSLRYvvfgGEALelsRLEDWYS-RHPHNAPKVINMYGITE----TTVHVS----------------- 955
Cdd:cd05937 192 STPPSPYDRDHKVRVAW----GNGL---RPDIWERfRERFNVPEIGEFYAATEgvfaLTNHNVgdfgagaighhglirrw 264
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 956 YIELDESIVSLRANSliGCSIPDLKvyvlDNYLQPVPPGVVGEMYVA----GAGLARGYLGRAGLTAERFIADPFGKpGT 1031
Cdd:cd05937 265 KFENQVVLVKMDPET--DDPIRDPK----TGFCVRAPVGEPGEMLGRvpfkNREAFQGYLHNEDATESKLVRDVFRK-GD 337
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1032 RMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVAVIVREDQPGDKRLVAYIVASNNE---- 1107
Cdd:cd05937 338 IYFRTGDLLRQDADGRWYFLDRLGDTFRWKSENVSTTEVADVLGAHPDIAEANVYGVKVPGHDGRAGCAAITLEESsavp 417
|
490 500 510 520
....*....|....*....|....*....|....*....|....
gi 1698252301 1108 -TIDTNEMRQHASGSLPDYMVPYAFVVVNELPLTPNGKLDRKAL 1150
Cdd:cd05937 418 tEFTKSLLASLARKNLPSYAVPLFLRLTEEVATTDNHKQQKGVL 461
|
|
| PRK08043 |
PRK08043 |
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase; |
787-1146 |
1.18e-09 |
|
bifunctional acyl-ACP--phospholipid O-acyltransferase/long-chain-fatty-acid--ACP ligase;
Pssm-ID: 181207 [Multi-domain] Cd Length: 718 Bit Score: 63.19 E-value: 1.18e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 787 PLAPSHIAYVIYTSGSTGRPKGVMIPHQ----NVVRLLGATDhwfqFDADDVWT----MFHsyAFDFSVwEIWGPLLYGG 858
Cdd:PRK08043 361 KQQPEDAALILFTSGSEGHPKGVVHSHKsllaNVEQIKTIAD----FTPNDRFMsalpLFH--SFGLTV-GLFTPLLTGA 433
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 859 RLVVVPhtvsrSPKEFL---QLLVKEKVTVLNQT------------PSAFYQlmqadreneevgqklsLRYVVFGGEALE 923
Cdd:PRK08043 434 EVFLYP-----SPLHYRivpELVYDRNCTVLFGTstflgnyarfanPYDFAR----------------LRYVVAGAEKLQ 492
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 924 LSRLEDWYSRHphnAPKVINMYGITETTVHVSyIELDesiVSLRANSlIGCSIPDlkvyvLDNYLQPVpPGVV--GEMYV 1001
Cdd:PRK08043 493 ESTKQLWQDKF---GLRILEGYGVTECAPVVS-INVP---MAAKPGT-VGRILPG-----MDARLLSV-PGIEqgGRLQL 558
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1002 AGAGLARGYL--GRAGLTAERFIADPFGKPGTRMYRTGDLARWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMKHDK 1079
Cdd:PRK08043 559 KGPNIMNGYLrvEKPGVLEVPTAENARGEMERGWYDTGDIVRFDEQGFVQIQGRAKRFAKIAGEMVSLEMVEQLALGVSP 638
|
330 340 350 360 370 380
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1080 VEQVAVIVREDQPGDKRLVAYivaSNNETIDTNEMRQHASGS-LPDYMVPYAFVVVNELPLTPNGKLD 1146
Cdd:PRK08043 639 DKQHATAIKSDASKGEALVLF---TTDSELTREKLQQYAREHgVPELAVPRDIRYLKQLPLLGSGKPD 703
|
|
| PKS_TE |
smart00824 |
Thioesterase; Peptide synthetases are involved in the non-ribosomal synthesis of peptide ... |
1271-1384 |
1.46e-09 |
|
Thioesterase; Peptide synthetases are involved in the non-ribosomal synthesis of peptide antibiotics. Next to the operons encoding these enzymes, in almost all cases, are genes that encode proteins that have similarity to the type II fatty acid thioesterases of vertebrates. There are also modules within the peptide synthetases that also share this similarity. With respect to antibiotic production, thioesterases are required for the addition of the last amino acid to the peptide antibiotic, thereby forming a cyclic antibiotic. Thioesterases (non-integrated) have molecular masses of 25-29 kDa.
Pssm-ID: 214835 [Multi-domain] Cd Length: 212 Bit Score: 59.55 E-value: 1.46e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1271 YAGLMKSLGTDYPIYGVQARGIAENEELPKSLEeMAADYLKH-VREIQPHGPYRLLGWSLGGNVVHAMAAQLQNEGEEVE 1349
Cdd:smart00824 15 YARLAAALRGRRDVSALPLPGFGPGEPLPASAD-ALVEAQAEaVLRAAGGRPFVLVGHSSGGLLAHAVAARLEARGIPPA 93
|
90 100 110 120
....*....|....*....|....*....|....*....|....*...
gi 1698252301 1350 LLVMLDSY-PGHFLPNTEAPTEEEALIA------------LLALGGYD 1384
Cdd:smart00824 94 AVVLLDTYpPGDPAPEGWLPELLRGVFEredsfvpmddarLTAMGAYL 141
|
|
| EntE |
COG1021 |
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase ... |
1-77 |
2.71e-09 |
|
EntE, 2,3-dihydroxybenzoate-AMP synthase component of non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 440644 [Multi-domain] Cd Length: 533 Bit Score: 61.70 E-value: 2.71e-09
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEkEPINLSEIRSYVSES-LANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:COG1021 451 LLAHPAVHDAAVVAMPDEYLGERSCAFVVPRG-EPLTLAELRRFLRERgLAAFKLPDRLEFVDALPLTAVGKIDKKAL 527
|
|
| A_NRPS_ACVS-like |
cd17648 |
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV ... |
7-78 |
4.37e-09 |
|
N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase; This family contains ACV synthetase (ACVS, EC 6.3.2.26; also known as N-(5-amino-5-carboxypentanoyl)-L-cysteinyl-D-valine synthase or delta-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine synthetase) is involved in medically important antibiotic biosynthesis. ACV synthetase is active in an early step in the penicillin G biosynthesis pathway which involves the formation of the tripeptide 6-(L-alpha-aminoadipyl)-L-cysteinyl-D-valine (ACV); each of the constituent amino acids of the tripeptide ACV are activated as aminoacyl-adenylates with peptide bonds formed through the participation of amino acid thioester intermediates. ACV is then cyclized by the action of isopenicillin N synthase.
Pssm-ID: 341303 [Multi-domain] Cd Length: 453 Bit Score: 60.49 E-value: 4.37e-09
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 7 IQQAVVMVRED-----RPNDKRIIAYIVAEEkEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLP 78
Cdd:cd17648 378 VRECAVVAKEDasqaqSRIQKYLVGYYLPEP-GHVPESDLLSFLRAKLPRYMVPARLVRLEGIPVTINGKLDVRALP 453
|
|
| PRK06187 |
PRK06187 |
long-chain-fatty-acid--CoA ligase; Validated |
10-77 |
4.67e-09 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235730 [Multi-domain] Cd Length: 521 Bit Score: 60.59 E-value: 4.67e-09
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1698252301 10 AVVMVredrPNDK---RIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK06187 447 AVIGV----PDEKwgeRPVAVVVLKPGATLDAKELRAFLRGRLAKFKLPKRIAFVDELPRTSVGKILKRVL 513
|
|
| PaaK |
cd05913 |
Phenylacetate-CoA ligase (also known as PaaK); PaaK catalyzes the first step in the aromatic ... |
875-1098 |
5.31e-09 |
|
Phenylacetate-CoA ligase (also known as PaaK); PaaK catalyzes the first step in the aromatic degradation pathway, by converting phenylacetic acid (PA) into phenylacetyl-CoA (PA-CoA). Phenylacetate-CoA ligase has been found in proteobacteria as well as gram positive prokaryotes. The enzyme is specifically induced after aerobic growth in a chemically defined medium containing PA or phenylalanine (Phe) as the sole carbon source. PaaKs are members of the adenylate-forming enzyme (AFE) family. However, sequence comparison reveals divergent features of PaaK with respect to the superfamily, including a novel N-terminal sequence.
Pssm-ID: 341239 [Multi-domain] Cd Length: 425 Bit Score: 60.33 E-value: 5.31e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 875 LQLLVKEKVTVLNQTPS-AFYQLMQADRENEEvGQKLSLRYVVFGGEAL------ELSRLEDWysrhphnapKVINMYGI 947
Cdd:cd05913 163 LQLIKDFGPTVLCCTPSyALYLAEEAEEEGID-PRELSLKVGIFGAEPWteemrkRIERRLGI---------KAYDIYGL 232
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 948 TETtvhvsyIELDESIVSLRANSLIG---CSIPDLkvyVLDNYLQPVPPGVVGEMYVAGaglargyLGRAGLtaerfiad 1024
Cdd:cd05913 233 TEI------IGPGVAFECEEKDGLHIwedHFIPEI---IDPETGEPVPPGEVGELVFTT-------LTKEAM-------- 288
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1025 pfgkPGTRmYRTGDLARW------------RQDGTldyIGRADHQIKIRGFRIELGEIEAVIMKHDKVEQVA-VIVREDQ 1091
Cdd:cd05913 289 ----PLIR-YRTRDITRLlpgpcpcgrthrRIDRI---TGRSDDMLIIRGVNVFPSQIEDVLLKIPGLGPHYqLILTRQE 360
|
....*..
gi 1698252301 1092 PGDKRLV 1098
Cdd:cd05913 361 HLDELTI 367
|
|
| OSB_CoA_lg |
cd05912 |
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA ... |
1-77 |
6.49e-09 |
|
O-succinylbenzoate-CoA ligase (also known as O-succinylbenzoate-CoA synthase, OSB-CoA synthetase, or MenE); O-succinylbenzoic acid-CoA synthase catalyzes the coenzyme A (CoA)- and ATP-dependent conversion of o-succinylbenzoic acid to o-succinylbenzoyl-CoA. The reaction is the fourth step of the biosynthesis pathway of menaquinone (vitamin K2). In certain bacteria, menaquinone is used during fumarate reduction in anaerobic respiration. In cyanobacteria, the product of the menaquinone pathway is phylloquinone (2-methyl-3-phytyl-1,4-naphthoquinone), a molecule used exclusively as an electron transfer cofactor in Photosystem 1. In green sulfur bacteria and heliobacteria, menaquinones are used as loosely bound secondary electron acceptors in the photosynthetic reaction center.
Pssm-ID: 341238 [Multi-domain] Cd Length: 411 Bit Score: 60.05 E-value: 6.49e-09
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEkePINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05912 335 LLSHPAIKEAGVVGIPDDKWGQVPVAFVVSER--PISEEELIAYCSEKLAKYKVPKKIYFVDELPRTASGKLLRHEL 409
|
|
| PRK05851 |
PRK05851 |
long-chain-fatty acid--ACP ligase MbtM; |
785-1147 |
6.86e-09 |
|
long-chain-fatty acid--ACP ligase MbtM;
Pssm-ID: 180289 [Multi-domain] Cd Length: 525 Bit Score: 60.16 E-value: 6.86e-09
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 785 LKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVV-RLLGATDHWFQFDADDV---W-TMFHSYAFDFSVWEIWGpllyGGR 859
Cdd:PRK05851 146 LTPPDSGGPAVLQGTAGSTGTPRTAILSPGAVLsNLRGLNARVGLDAATDVgcsWlPLYHDMGLAFLLTAALA----GAP 221
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 860 LVVVPHTV-SRSPKEFLQLLVKEKVTvLNQTPSAFYQLM--QADRENE-EVGqklSLRYVVFGGEALE---LSRLEDWYS 932
Cdd:PRK05851 222 LWLAPTTAfSASPFRWLSWLSDSRAT-LTAAPNFAYNLIgkYARRVSDvDLG---ALRVALNGGEPVDcdgFERFATAMA 297
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 933 RHPHNAPKVINMYGITETTVHVSY------IELDESI----VSLRANSLIGCSIPDLKVYVldnylQPV--PPGV----V 996
Cdd:PRK05851 298 PFGFDAGAAAPSYGLAESTCAVTVpvpgigLRVDEVTtddgSGARRHAVLGNPIPGMEVRI-----SPGdgAAGVagreI 372
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 997 GEMYVAGAGLARGYLGRAGLTAERFiadpfgkpgtrmYRTGDLArWRQDGTLDYIGRADHQIKIRGFRIELGEIEAVIMK 1076
Cdd:PRK05851 373 GEIEIRGASMMSGYLGQAPIDPDDW------------FPTGDLG-YLVDGGLVVCGRAKELITVAGRNIFPTEIERVAAQ 439
|
330 340 350 360 370 380 390
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1698252301 1077 HDKVEQVAVIV-----REDQPGdkRLVAYIVASNNETIDTNEMRQH-AS--GSLPDYMVpyaFVVVNELPLTPNGKLDR 1147
Cdd:PRK05851 440 VRGVREGAVVAvgtgeGSARPG--LVIAAEFRGPDEAGARSEVVQRvASecGVVPSDVV---FVAPGSLPRTSSGKLRR 513
|
|
| PRK13382 |
PRK13382 |
bile acid CoA ligase; |
1-80 |
1.50e-08 |
|
bile acid CoA ligase;
Pssm-ID: 172019 [Multi-domain] Cd Length: 537 Bit Score: 59.00 E-value: 1.50e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPAP 80
Cdd:PRK13382 458 LATHPDVAEAAVIGVDDEQYGQRLAAFVVLKPGASATPETLKQHVRDNLANYKVPRDIVVLDELPRGATGKILRRELQAR 537
|
|
| FACL_fum10p_like |
cd05926 |
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL ... |
1-77 |
1.90e-08 |
|
Subfamily of fatty acid CoA ligase (FACL) similar to Fum10p of Gibberella moniliformis; FACL catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Fum10p is a fatty acid CoA ligase involved in the synthesis of fumonisin, a polyketide mycotoxin, in Gibberella moniliformis.
Pssm-ID: 341249 [Multi-domain] Cd Length: 493 Bit Score: 58.86 E-value: 1.90e-08
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05926 415 LLSHPAVLEAVAFGVPDEKYGEEVAAAVVLREGASVTEEELRAFCRKHLAAFKVPKKVYFVDELPKTATGKIQRRKV 491
|
|
| FC-FACS_FadD_like |
cd05936 |
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This ... |
1-77 |
3.74e-08 |
|
Prokaryotic long-chain fatty acid CoA synthetases similar to Escherichia coli FadD; This subfamily of the AMP-forming adenylation family contains Escherichia coli FadD and similar prokaryotic fatty acid CoA synthetases. FadD was characterized as a long-chain fatty acid CoA synthetase. The gene fadD is regulated by the fatty acid regulatory protein FadR. Fatty acid CoA synthetase catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, followed by the formation of a fatty acyl-CoA. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341259 [Multi-domain] Cd Length: 468 Bit Score: 57.57 E-value: 3.74e-08
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05936 391 LYEHPAVAEAAVVGVPDPYSGEAVKAFVVLKEGASLTEEEIIAFCREQLAGYKVPRQVEFRDELPKSAVGKILRREL 467
|
|
| PRK08308 |
PRK08308 |
acyl-CoA synthetase; Validated |
1-79 |
4.59e-08 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236231 [Multi-domain] Cd Length: 414 Bit Score: 57.35 E-value: 4.59e-08
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEkePINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPA 79
Cdd:PRK08308 333 MLRLPGVQEAVVYRGKDPVAGERVKAKVISHE--EIDPVQLREWCIQHLAPYQVPHEIESVTEIPKNANGKVSRKLLEL 409
|
|
| EntF2 |
COG3319 |
Thioesterase domain of type I polyketide synthase or non-ribosomal peptide synthetase ... |
8-158 |
4.66e-08 |
|
Thioesterase domain of type I polyketide synthase or non-ribosomal peptide synthetase [Secondary metabolites biosynthesis, transport and catabolism];
Pssm-ID: 442548 [Multi-domain] Cd Length: 855 Bit Score: 57.79 E-value: 4.66e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 8 QQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPAPDFNGMNN 87
Cdd:COG3319 427 VAAAVAAAAAAAAAAAALAAAVVAAAALAAAALLLLLLLLLLPPPLPPALLLLLLLLLLLLLAALLLAAAAPAAAAAAAA 506
|
90 100 110 120 130 140 150
....*....|....*....|....*....|....*....|....*....|....*....|....*....|.
gi 1698252301 88 ERVARNPKEEILCDLFAEVLGVSRINIDDNFFEMGGHSLLASRLMARIRETLSVELGIGKLFESPTVAELA 158
Cdd:COG3319 507 APAPAAALELALALLLLLLLGLGLVGDDDDFFGGGGGSLLALLLLLLLLALLLRLLLLLALLLAPTLAALA 577
|
|
| PRK07788 |
PRK07788 |
acyl-CoA synthetase; Validated |
1-81 |
8.88e-08 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236097 [Multi-domain] Cd Length: 549 Bit Score: 56.86 E-value: 8.88e-08
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPAP 80
Cdd:PRK07788 469 LAGHPDVVEAAVIGVDDEEFGQRLRAFVVKAPGAALDEDAIKDYVRDNLARYKVPRDVVFLDELPRNPTGKVLKRELREM 548
|
.
gi 1698252301 81 D 81
Cdd:PRK07788 549 D 549
|
|
| 23DHB-AMP_lg |
cd05920 |
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2, ... |
1-77 |
9.28e-08 |
|
2,3-dihydroxybenzoate-AMP ligase; 2,3-dihydroxybenzoate-AMP ligase activates 2,3-dihydroxybenzoate (DHB) by ligation of AMP from ATP with the release of pyrophosphate. However, it can also catalyze the ATP-PPi exchange for 2,3-DHB analogs, such as salicyclic acid (o-hydrobenzoate), as well as 2,4-DHB and 2,5-DHB, but with less efficiency. Proteins in this family are the stand-alone adenylation components of non-ribosomal peptide synthases (NRPSs) involved in the biosynthesis of siderophores, which are low molecular weight iron-chelating compounds synthesized by many bacteria to aid in the acquisition of this vital trace elements. In Escherichia coli, the 2,3-dihydroxybenzoate-AMP ligase is called EntE, the adenylation component of the enterobactin NRPS system.
Pssm-ID: 341244 [Multi-domain] Cd Length: 482 Bit Score: 56.57 E-value: 9.28e-08
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEkEPINLSEIRSYVSE-SLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05920 406 LLRHPAVHDAAVVAMPDELLGERSCAFVVLRD-PPPSAAQLRRFLRErGLAAYKLPDRIEFVDSLPLTAVGKIDKKAL 482
|
|
| PKS_PP |
smart00823 |
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the ... |
96-161 |
9.43e-08 |
|
Phosphopantetheine attachment site; Phosphopantetheine (or pantetheine 4' phosphate) is the prosthetic group of acyl carrier proteins (ACP) in some multienzyme complexes where it serves as a 'swinging arm' for the attachment of activated fatty acid and amino-acid groups.
Pssm-ID: 214834 [Multi-domain] Cd Length: 86 Bit Score: 51.10 E-value: 9.43e-08
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1698252301 96 EEILCDLFAEVLGVS---RINIDDNFFEMGGHSLLASRLMARIRETLSVELGIGKLFESPTVAELAKQL 161
Cdd:smart00823 14 LDLVREQVAAVLGHAaaeAIDPDRPFRDLGLDSLMAVELRNRLEAATGLRLPATLVFDHPTPAALAEHL 82
|
|
| PRK03640 |
PRK03640 |
o-succinylbenzoate--CoA ligase; |
1-77 |
1.62e-07 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 235146 [Multi-domain] Cd Length: 483 Bit Score: 55.74 E-value: 1.62e-07
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEkePINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK03640 402 LLSHPGVAEAGVVGVPDDKWGQVPVAFVVKSG--EVTEEELRHFCEEKLAKYKVPKRFYFVEELPRNASGKLLRHEL 476
|
|
| BCL_like |
cd05919 |
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate ... |
1-77 |
9.93e-07 |
|
Benzoate CoA ligase (BCL) and similar adenylate forming enzymes; This family contains benzoate CoA ligase (BCL) and related ligases that catalyze the acylation of benzoate derivatives, 2-aminobenzoate and 4-hydroxybenzoate. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Xenobiotic aromatic compounds are also a major class of man-made pollutants. Some bacteria use benzoate as the sole source of carbon and energy through benzoate degradation. Benzoate degradation starts with its activation to benzoyl-CoA by benzoate CoA ligase. The reaction catalyzed by benzoate CoA ligase proceeds via a two-step process; the first ATP-dependent step forms an acyl-AMP intermediate, and the second step forms the acyl-CoA ester with release of the AMP.
Pssm-ID: 341243 [Multi-domain] Cd Length: 436 Bit Score: 53.23 E-value: 9.93e-07
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLS---EIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05919 356 IIQHPAVAEAAVVAVPESTGLSRLTAFVVLKSPAAPQESlarDIHRHLLERLSAHKVPRRIAFVDELPRTATGKLQRFKL 435
|
|
| AFD_CAR-like |
cd17632 |
adenylation domain of carboxylic acid reductase (CAR); This family contains the adenylation ... |
669-1145 |
1.11e-06 |
|
adenylation domain of carboxylic acid reductase (CAR); This family contains the adenylation domain of carboxylic acid reductase enzymes (CARs), and performs an equivalent function to that of the ANL superfamily of adenylating enzymes. It takes a carboxylic acid substrate and ATP, and produces an AMP-acyl phosphoester intermediate, releasing pyrophosphate. Kinetic analysis using various substrates shows that this enzyme has a broad but similar substrate specificity, preferring electron-rich acids. This suggests that attack by the carboxylate on the alpha-phosphate of adenosine triphosphate (ATP) is the step that determines the substrate specificity and reaction kinetics. CAR is an important enzyme for use as a biocatalyst providing regiospecific route to aldehydes from their respective carboxylic acids.
Pssm-ID: 341287 [Multi-domain] Cd Length: 588 Bit Score: 53.23 E-value: 1.11e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIA-RFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKP------ 741
Cdd:cd17632 68 ITYAELWERVGAVAaAHDPEQPVRPGDFVAVLGFTSPDYATVDLALTRLGAVSVPLQAGASAAQLAPILAETEPrllavs 147
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 742 --------SCVLTNSSV--------------EIECDESLKILVDDVNVMEEIEkysEENIDEMECLKPLAPSHI------ 793
Cdd:cd17632 148 aehldlavEAVLEGGTPprlvvfdhrpevdaHRAALESARERLAAVGIPVTTL---TLIAVRGRDLPPAPLFRPepdddp 224
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 794 -AYVIYTSGSTGRPKGVMIPHQNVVRLlgatdhWFQFDADDVWTMFHSYAFDF--------SVWeIWGPLLYGGrlvvVP 864
Cdd:cd17632 225 lALLIYTSGSTGTPKGAMYTERLVATF------WLKVSSIQDIRPPASITLNFmpmshiagRIS-LYGTLARGG----TA 293
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 865 HTVSRS-------------PKEFL------QLLVKEKVTVLNQTPSAfyqlmQADRENEEVGQKLSLRYVVFGGEALels 925
Cdd:cd17632 294 YFAAASdmstlfddlalvrPTELFlvprvcDMLFQRYQAELDRRSVA-----GADAETLAERVKAELRERVLGGRLL--- 365
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 926 rledwySRHPHNAPKVINMYGITETTVHVSYIE---LDESIVSLRANSLigcsipdLKVYVLDNYLQPVP---------P 993
Cdd:cd17632 366 ------AAVCGSAPLSAEMKAFMESLLDLDLHDgygSTEAGAVILDGVI-------VRPPVLDYKLVDVPelgyfrtdrP 432
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 994 GVVGEMYVAGAGLARGYLGRAGLTAERFIADPFgkpgtrmYRTGD-LARWRQDgTLDYIGRADHQIKI-RGFRIELGEIE 1071
Cdd:cd17632 433 HPRGELLVKTDTLFPGYYKRPEVTAEVFDEDGF-------YRTGDvMAELGPD-RLVYVDRRNNVLKLsQGEFVTVARLE 504
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1072 AVIMKHDKVEQV------------AVIVredqPGDKRLVAYIVASNNETIDTNEMRQHASGSLPDYMVPYAFVVVNElPL 1139
Cdd:cd17632 505 AVFAASPLVRQIfvygnserayllAVVV----PTQDALAGEDTARLRAALAESLQRIAREAGLQSYEIPRDFLIETE-PF 579
|
....*..
gi 1698252301 1140 TP-NGKL 1145
Cdd:cd17632 580 TIaNGLL 586
|
|
| Dip2 |
cd05905 |
Disco-interacting protein 2 (Dip2); Dip2 proteins show sequence similarity to other members of ... |
653-1143 |
1.22e-06 |
|
Disco-interacting protein 2 (Dip2); Dip2 proteins show sequence similarity to other members of the adenylate forming enzyme family, including insect luciferase, acetyl CoA ligases and the adenylation domain of nonribosomal peptide synthetases (NRPS). However, its function may have diverged from other members of the superfamily. In mouse embryo, Dip2 homolog A plays an important role in the development of both vertebrate and invertebrate nervous systems. Dip2A appears to regulate cell growth and the arrangement of cells in organs. Biochemically, Dip2A functions as a receptor of FSTL1, an extracellular glycoprotein, and may play a role as a cardiovascular protective agent.
Pssm-ID: 341231 [Multi-domain] Cd Length: 571 Bit Score: 53.12 E-value: 1.22e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 653 AHINPNSIAVvfEDKKLTYEKLNRKANKIARFLIAK-GVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDR 731
Cdd:cd05905 1 AYTLLDSKGK--EATTLTWGKLLSRAEKIAAVLQKKvGLKPGDRVALMYPDPLDFVAAFYGCLYAGVVPIPIEPPDISQQ 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 732 ISFML-----HDAKPSCVLT--------NSSVEIECDESLKI--LVDDVNVMEEIEKYSEENIDEmeclKPLAPSHIAYV 796
Cdd:cd05905 79 LGFLLgtckvRVALTVEACLkglpkkllKSKTAAEIAKKKGWpkILDFVKIPKSKRSKLKKWGPH----PPTRDGDTAYI 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 797 IYTSGSTGRPKGVMIPHQ---NVVRLLGATDHWFQfdADDVWTMFHSY-AFDFSVWEIWGplLYGGRLVVV--PHTVSRS 870
Cdd:cd05905 155 EYSFSSDGSLSGVAVSHSsllAHCRALKEACELYE--SRPLVTVLDFKsGLGLWHGCLLS--VYSGHHTILipPELMKTN 230
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 871 PKEFLQLLVKEKVTVLNQTPSAFYQLMQADRENEEVGQK----LS-LRY-VVFGGEALELSRLEDW-------------- 930
Cdd:cd05905 231 PLLWLQTLSQYKVRDAYVKLRTLHWCLKDLSSTLASLKNrdvnLSsLRMcMVPCENRPRISSCDSFlklfqtlglsprav 310
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 931 ---YSRHPHNAPKVINMYGITETTVHVSYIELDESIVSLR----ANSLI----GCSIPDLKVYVLD-NYLQPVPPGVVGE 998
Cdd:cd05905 311 steFGTRVNPFICWQGTSGPEPSRVYLDMRALRHGVVRLDerdkPNSLPlqdsGKVLPGAQVAIVNpETKGLCKDGEIGE 390
|
410 420 430 440 450 460 470 480
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 999 MYVAGAGLARGYLGRAG---LTAERFIADPFGKP--GTRMYRTGDLARWRQDGTLDY----------IGRADHQIKIRGF 1063
Cdd:cd05905 391 IWVNSPANASGYFLLDGetnDTFKVFPSTRLSTGitNNSYARTGLLGFLRPTKCTDLnveehdllfvVGSIDETLEVRGL 470
|
490 500 510 520 530 540 550 560
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1064 RIELGEIEAVIMK-HDKVEQVA--------VIVREDQPGDKRLVAYIVASNNETIDTnemrQHASGSlpdYMVpyAFVVV 1134
Cdd:cd05905 471 RHHPSDIEATVMRvHPYRGRCAvfsitglvVVVAEQPPGSEEEALDLVPLVLNAILE----EHQVIV---DCV--ALVPP 541
|
....*....
gi 1698252301 1135 NELPLTPNG 1143
Cdd:cd05905 542 GSLPKNPLG 550
|
|
| MenH |
COG0596 |
2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase MenH and related esterases, ... |
1257-1379 |
1.45e-06 |
|
2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase MenH and related esterases, alpha/beta hydrolase fold [Coenzyme transport and metabolism, General function prediction only]; 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase MenH and related esterases, alpha/beta hydrolase fold is part of the Pathway/BioSystem: Menaquinone biosynthesis
Pssm-ID: 440361 [Multi-domain] Cd Length: 221 Bit Score: 50.77 E-value: 1.45e-06
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1257 PLFCVHPAGGLSWCYAGLMKSLGTDYPIYGVQARGIAENE--ELPKSLEEMAADyLKHVREIQPHGPYRLLGWSLGGNVV 1334
Cdd:COG0596 25 PVVLLHGLPGSSYEWRPLIPALAAGYRVIAPDLRGHGRSDkpAGGYTLDDLADD-LAALLDALGLERVVLVGHSMGGMVA 103
|
90 100 110 120
....*....|....*....|....*....|....*....|....*.
gi 1698252301 1335 HAMAAQlqnEGEEVELLVMLDSYPGHFLPNTEAPTE-EEALIALLA 1379
Cdd:COG0596 104 LELAAR---HPERVAGLVLVDEVLAALAEPLRRPGLaPEALAALLR 146
|
|
| entE |
PRK10946 |
(2,3-dihydroxybenzoyl)adenylate synthase; |
1-77 |
2.08e-06 |
|
(2,3-dihydroxybenzoyl)adenylate synthase;
Pssm-ID: 236803 [Multi-domain] Cd Length: 536 Bit Score: 52.30 E-value: 2.08e-06
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAeeKEPINLSEIRSYVSE-SLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK10946 451 LLRHPAVIHAALVSMEDELMGEKSCAFLVV--KEPLKAVQLRRFLREqGIAEFKLPDRVECVDSLPLTAVGKVDKKQL 526
|
|
| OSB_MenE-like |
cd17630 |
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) ... |
1-75 |
2.15e-06 |
|
O-succinylbenzoic acid-CoA ligase; This family contains O-succinylbenzoyl-CoA (OSB-CoA) synthetase (also known as O-succinylbenzoic acid CoA ligase) that belongs to the ANL superfamily and catalyzes the ligation of CoA to o-succinylbenzoate (OSB). It includes MenE in the bacterial menaquinone biosynthesis pathway which is a promising target for the development of novel antibacterial agents. MenE catalyzes CoA ligation via an acyl-adenylate intermediate; tight-binding inhibitors of MenE based on stable acyl-sulfonyladenosine analogs of this intermediate provide a pathway toward the development of optimized MenE inhibitors.
Pssm-ID: 341285 [Multi-domain] Cd Length: 325 Bit Score: 51.56 E-value: 2.15e-06
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEkePINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRK 75
Cdd:cd17630 247 LAAHPAVRDAFVVGVPDEELGQRPVAVIVGRG--PADPAELRAWLKDKLARFKLPKRIYPVPELPRTGGGKVDRR 319
|
|
| ttLC_FACS_AlkK_like |
cd12119 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes ... |
4-77 |
3.29e-06 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles; This family includes fatty acyl-CoA synthetases that can activate medium-chain to long-chain fatty acids. They catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. The fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family catalyzes the long-chain fatty acid, myristoyl acid, while another member in this family, the AlkK protein identified from Pseudomonas oleovorans, targets medium chain fatty acids. This family also includes uncharacterized FACS proteins.
Pssm-ID: 341284 [Multi-domain] Cd Length: 518 Bit Score: 51.48 E-value: 3.29e-06
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 4 HENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd12119 443 HPAVAEAAVIGVPHPKWGERPLAVVVLKEGATVTAEELLEFLADKVAKWWLPDDVVFVDEIPKTSTGKIDKKAL 516
|
|
| PRK07656 |
PRK07656 |
long-chain-fatty-acid--CoA ligase; Validated |
1-77 |
3.71e-06 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 236072 [Multi-domain] Cd Length: 513 Bit Score: 51.44 E-value: 3.71e-06
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK07656 434 LYEHPAVAEAAVIGVPDERLGEVGKAYVVLKPGAELTEEELIAYCREHLAKYKVPRSIEFLDELPKNATGKVLKRAL 510
|
|
| FACL_like_2 |
cd05917 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1-77 |
4.47e-06 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341241 [Multi-domain] Cd Length: 349 Bit Score: 50.74 E-value: 4.47e-06
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQA-VVMVREDRPNDKrIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05917 272 LHTHPKVSDVqVVGVPDERYGEE-VCAWIRLKEGAELTEEDIKAYCKGKIAHYKVPRYVFFVDEFPLTVSGKIQKFKL 348
|
|
| FACL_DitJ_like |
cd05934 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
1-78 |
4.68e-06 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions. Members of this family include DitJ from Pseudomonas and similar proteins.
Pssm-ID: 341257 [Multi-domain] Cd Length: 422 Bit Score: 50.75 E-value: 4.68e-06
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLP 78
Cdd:cd05934 345 ILRHPAVREAAVVAVPDEVGEDEVKAVVVLRPGETLDPEELFAFCEGQLAYFKVPRYIRFVDDLPKTPTEKVAKAQLR 422
|
|
| FACL_like_6 |
cd05922 |
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ... |
11-77 |
8.40e-06 |
|
Uncharacterized subfamily of fatty acid CoA ligase (FACL); Fatty acyl-CoA ligases catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. This is a required step before free fatty acids can participate in most catabolic and anabolic reactions.
Pssm-ID: 341246 [Multi-domain] Cd Length: 457 Bit Score: 50.13 E-value: 8.40e-06
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 11 VVMVREDRPNDKRIIAYIVAEEKepINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05922 392 AAAVGLPDPLGEKLALFVTAPDK--IDPKDVLRSLAERLPPYKVPATVRVVDELPLTASGKVDYAAL 456
|
|
| caiC |
PRK08008 |
putative crotonobetaine/carnitine-CoA ligase; Validated |
1-77 |
1.20e-05 |
|
putative crotonobetaine/carnitine-CoA ligase; Validated
Pssm-ID: 181195 [Multi-domain] Cd Length: 517 Bit Score: 49.68 E-value: 1.20e-05
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK08008 440 IATHPKIQDIVVVGIKDSIRDEAIKAFVVLNEGETLSEEEFFAFCEQNMAKFKVPSYLEIRKDLPRNCSGKIIKKNL 516
|
|
| FACL_FadD13-like |
cd17631 |
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, ... |
1-74 |
1.82e-05 |
|
fatty acyl-CoA synthetase, including FadD13; This family contains fatty acyl-CoA synthetases, including Mycobacterium tuberculosis acid-induced operon MymA encoding the fatty acyl-CoA synthetase FadD13 which is essential for virulence and intracellular growth of the pathogen. The fatty acyl-CoA synthetase activates lipids before entering into the metabolic pathways and is also involved in transmembrane lipid transport. However, unlike soluble fatty acyl-CoA synthetases, but like the mammalian integral-membrane very-long-chain acyl-CoA synthetases, FadD13 accepts lipid substrates up to the maximum length of C26, and this is facilitated by an extensive hydrophobic tunnel from the active site to a positively charged patch. Also included is feruloyl-CoA synthetase (Fcs) in Rhodococcus strains where it is involved in biotechnological vanillin production from eugenol and ferulic acid via a non-beta-oxidative pathway.
Pssm-ID: 341286 [Multi-domain] Cd Length: 435 Bit Score: 49.15 E-value: 1.82e-05
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQ-AVVMVredrPNDK---RIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDR 74
Cdd:cd17631 362 LYEHPAVAEvAVIGV----PDEKwgeAVVAVVVPRPGAELDEDELIAHCRERLARYKIPKSVEFVDALPRNATGKILK 435
|
|
| PRK07824 |
PRK07824 |
o-succinylbenzoate--CoA ligase; |
1-77 |
2.37e-05 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 236108 [Multi-domain] Cd Length: 358 Bit Score: 48.50 E-value: 2.37e-05
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK07824 275 LATHPAVADCAVFGLPDDRLGQRVVAAVVGDGGPAPTLEALRAHVARTLDRTAAPRELHVVDELPRRGIGKVDRRAL 351
|
|
| PRK07868 |
PRK07868 |
acyl-CoA synthetase; Validated |
638-727 |
2.97e-05 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236121 [Multi-domain] Cd Length: 994 Bit Score: 48.95 E-value: 2.97e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 638 QIAP--EMTLPQLFEKQAHINPNSIAVVFEDKKLTYEKLNRKANKIARFLIAKGVGPDQLVALAM---PRSLnMVVSLLA 712
Cdd:PRK07868 440 QINDhtRISLGRIIAEQARDAPKGEFLLFDGRVHTYEAVNRRINNVVRGLIAVGVRQGDRVGVLMetrPSAL-VAIAALS 518
|
90
....*....|....*
gi 1698252301 713 VLKAGAGYLPLDPDY 727
Cdd:PRK07868 519 RLGAVAVLMPPDTDL 533
|
|
| PLN02430 |
PLN02430 |
long-chain-fatty-acid-CoA ligase |
754-1108 |
3.02e-05 |
|
long-chain-fatty-acid-CoA ligase
Pssm-ID: 178049 [Multi-domain] Cd Length: 660 Bit Score: 48.66 E-value: 3.02e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 754 CDESLKILVDDVNVMEEiEKYSEENI-------DEMECL--------KPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVR 818
Cdd:PLN02430 169 SAKRLKAIVSFTSVTEE-ESDKASQIgvktyswIDFLHMgkenpsetNPPKPLDICTIMYTSGTSGDPKGVVLTHEAVAT 247
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 819 LLGATDHWF-QFD----ADDVWTMFHSYA---------FDF----SVWEIWGPL---------LYGGRLVVVPHTVSR-- 869
Cdd:PLN02430 248 FVRGVDLFMeQFEdkmtHDDVYLSFLPLAhildrmieeYFFrkgaSVGYYHGDLnalrddlmeLKPTLLAGVPRVFERih 327
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 870 ----------SP--KEFLQLLVKEKVTVLN-----QTPSAFYQLMQADRENEEVGQKlsLRYVVFGGEALELSRLEdwYS 932
Cdd:PLN02430 328 egiqkalqelNPrrRLIFNALYKYKLAWMNrgyshKKASPMADFLAFRKVKAKLGGR--LRLLISGGAPLSTEIEE--FL 403
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 933 RHPHNApKVINMYGITETTVHVSYIELDE----SIVSLRA--NSLIGCSIPDLKVYVLDNylqpvPPgvVGEMYVAGAGL 1006
Cdd:PLN02430 404 RVTSCA-FVVQGYGLTETLGPTTLGFPDEmcmlGTVGAPAvyNELRLEEVPEMGYDPLGE-----PP--RGEICVRGKCL 475
|
330 340 350 360 370 380 390 400
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1007 ARGYLGRAGLTAErFIADPFgkpgtrmYRTGDLARWRQDGTLDYIGRADHQIKI-RGFRIELGEIEAVIMKHDKVEQVAV 1085
Cdd:PLN02430 476 FSGYYKNPELTEE-VMKDGW-------FHTGDIGEILPNGVLKIIDRKKNLIKLsQGEYVALEYLENVYGQNPIVEDIWV 547
|
410 420
....*....|....*....|....*
gi 1698252301 1086 IvredqpGD--KRLVAYIVASNNET 1108
Cdd:PLN02430 548 Y------GDsfKSMLVAVVVPNEEN 566
|
|
| Acs |
COG0365 |
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism]; |
1-77 |
3.32e-05 |
|
Acyl-coenzyme A synthetase/AMP-(fatty) acid ligase [Lipid transport and metabolism];
Pssm-ID: 440134 [Multi-domain] Cd Length: 565 Bit Score: 48.57 E-value: 3.32e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAeeKEPINLS-----EIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRK 75
Cdd:COG0365 460 LVSHPAVAEAAVVGVPDEIRGQVVKAFVVL--KPGVEPSdelakELQAHVREELGPYAYPREIEFVDELPKTRSGKIMRR 537
|
..
gi 1698252301 76 KL 77
Cdd:COG0365 538 LL 539
|
|
| ACSBG_like |
cd05933 |
Bubblegum-like very long-chain fatty acid CoA synthetase (VL-FACS); This family of very ... |
752-858 |
3.71e-05 |
|
Bubblegum-like very long-chain fatty acid CoA synthetase (VL-FACS); This family of very long-chain fatty acid CoA synthetase is named bubblegum because Drosophila melanogaster mutant bubblegum (BGM) has elevated levels of very-long-chain fatty acids (VLCFA) caused by a defective gene of this family. The human homolog (hsBG) has been characterized as a very long chain fatty acid CoA synthetase that functions specifically in the brain; hsBG may play a central role in brain VLCFA metabolism and myelinogenesis. VL-FACS is involved in the first reaction step of very long chain fatty acid degradation. It catalyzes the formation of fatty acyl-CoA in a two-step reaction: the formation of a fatty acyl-AMP molecule as an intermediate, and the formation of a fatty acyl-CoA. Free fatty acids must be "activated" to their CoA thioesters before participating in most catabolic and anabolic reactions.
Pssm-ID: 341256 [Multi-domain] Cd Length: 596 Bit Score: 48.12 E-value: 3.71e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 752 IECDESLKILVDDVNVMEEIEKYSEENIDE--MECLKPLAPSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQF 829
Cdd:cd05933 109 IQYKEPLKEKEPNLYSWDEFMELGRSIPDEqlDAIISSQKPNQCCTLIYTSGTTGMPKGVMLSHDNITWTAKAASQHMDL 188
|
90 100 110
....*....|....*....|....*....|....*
gi 1698252301 830 D-ADDVWTMFHSYaFDFS-----VWEIWGPLLYGG 858
Cdd:cd05933 189 RpATVGQESVVSY-LPLShiaaqILDIWLPIKVGG 222
|
|
| PRK05852 |
PRK05852 |
fatty acid--CoA ligase family protein; |
1-75 |
3.92e-05 |
|
fatty acid--CoA ligase family protein;
Pssm-ID: 235625 [Multi-domain] Cd Length: 534 Bit Score: 47.96 E-value: 3.92e-05
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRK 75
Cdd:PRK05852 450 LASHPNVMEAAVFGVPDQLYGEAVAAVIVPRESAPPTAEELVQFCRERLAAFEIPASFQEASGLPHTAKGSLDRR 524
|
|
| PLN02614 |
PLN02614 |
long-chain acyl-CoA synthetase |
790-1085 |
5.51e-05 |
|
long-chain acyl-CoA synthetase
Pssm-ID: 166255 [Multi-domain] Cd Length: 666 Bit Score: 47.71 E-value: 5.51e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 790 PSHIAYVIYTSGSTGRPKGVMIPHQNVVRLLGATDHWFQ-----FDADDVWTMFHSYA--FDFSVWEIWgpLLYGGRLVV 862
Cdd:PLN02614 222 KSDICTIMYTSGTTGDPKGVMISNESIVTLIAGVIRLLKsanaaLTVKDVYLSYLPLAhiFDRVIEECF--IQHGAAIGF 299
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 863 VPHTVsrspKEFLQLLVKEKVTVLNQTPSAFyqlmqaDRENEEVGQKLS----LRYVVF-------------GGEALELS 925
Cdd:PLN02614 300 WRGDV----KLLIEDLGELKPTIFCAVPRVL------DRVYSGLQKKLSdggfLKKFVFdsafsykfgnmkkGQSHVEAS 369
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 926 RLED--WYSRHPHN------------AP---------------KVINMYGITETTVHvSYIELDESIVSLranSLIGCSI 976
Cdd:PLN02614 370 PLCDklVFNKVKQGlggnvriilsgaAPlashvesflrvvaccHVLQGYGLTESCAG-TFVSLPDELDML---GTVGPPV 445
|
250 260 270 280 290 300 310 320
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 977 PDlkvyvLDNYLQPVP--------PGVVGEMYVAGAGLARGYLGRAGLTAERFIADpfgkpgtrMYRTGDLARWRQDGTL 1048
Cdd:PLN02614 446 PN-----VDIRLESVPemeydalaSTPRGEICIRGKTLFSGYYKREDLTKEVLIDG--------WLHTGDVGEWQPNGSM 512
|
330 340 350
....*....|....*....|....*....|....*...
gi 1698252301 1049 DYIGRADHQIKI-RGFRIELGEIEAVIMKHDKVEQVAV 1085
Cdd:PLN02614 513 KIIDRKKNIFKLsQGEYVAVENIENIYGEVQAVDSVWV 550
|
|
| PRK13295 |
PRK13295 |
cyclohexanecarboxylate-CoA ligase; Reviewed |
1-77 |
5.77e-05 |
|
cyclohexanecarboxylate-CoA ligase; Reviewed
Pssm-ID: 171961 [Multi-domain] Cd Length: 547 Bit Score: 47.74 E-value: 5.77e-05
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYV-SESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK13295 461 LYRHPAIAQVAIVAYPDERLGERACAFVVPRPGQSLDFEEMVEFLkAQKVAKQYIPERLVVRDALPRTPSGKIQKFRL 538
|
|
| PRK05605 |
PRK05605 |
long-chain-fatty-acid--CoA ligase; Validated |
1-76 |
7.58e-05 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 235531 [Multi-domain] Cd Length: 573 Bit Score: 47.30 E-value: 7.58e-05
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVV--MVREDrpNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKK 76
Cdd:PRK05605 487 LREHPGVEDAAVvgLPRED--GSEEVVAAVVLEPGAALDPEGLRAYCREHLTRYKVPRRFYHVDELPRDQLGKVRRRE 562
|
|
| BCL_4HBCL |
cd05959 |
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate ... |
1-77 |
9.37e-05 |
|
Benzoate CoA ligase (BCL) and 4-Hydroxybenzoate-Coenzyme A Ligase (4-HBA-CoA ligase); Benzoate CoA ligase and 4-hydroxybenzoate-coenzyme A ligase catalyze the first activating step for benzoate and 4-hydroxybenzoate catabolic pathways, respectively. Although these two enzymes share very high sequence homology, they have their own substrate preference. The reaction proceeds via a two-step process; the first ATP-dependent step forms the substrate-AMP intermediate, while the second step forms the acyl-CoA ester, releasing the AMP. Aromatic compounds represent the second most abundant class of organic carbon compounds after carbohydrates. Some bacteria can use benzoic acid or benzenoid compounds as the sole source of carbon and energy through degradation. Benzoate CoA ligase and 4-hydroxybenzoate-Coenzyme A ligase are key enzymes of this process.
Pssm-ID: 341269 [Multi-domain] Cd Length: 508 Bit Score: 46.98 E-value: 9.37e-05
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIV--AEEKEPINL-SEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05959 428 LVQHPAVLEAAVVGVEDEDGLTKPKAFVVlrPGYEDSEALeEELKEFVKDRLAPYKYPRWIVFVDELPKTATGKIQRFKL 507
|
|
| MCS |
cd05941 |
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step ... |
4-77 |
9.39e-05 |
|
Malonyl-CoA synthetase (MCS); MCS catalyzes the formation of malonyl-CoA in a two-step reaction consisting of the adenylation of malonate with ATP, followed by malonyl transfer from malonyl-AMP to CoA. Malonic acid and its derivatives are the building blocks of polyketides and malonyl-CoA serves as the substrate of polyketide synthases. Malonyl-CoA synthetase has broad substrate tolerance and can activate a variety of malonyl acid derivatives. MCS may play an important role in biosynthesis of polyketides, the important secondary metabolites with therapeutic and agrochemical utility.
Pssm-ID: 341264 [Multi-domain] Cd Length: 442 Bit Score: 46.90 E-value: 9.39e-05
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*
gi 1698252301 4 HENIQQAVVMVREDRPNDKRIIAYIVAEE-KEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05941 366 HPGVSECAVIGVPDPDWGERVVAVVVLRAgAAALSLEELKEWAKQRLAPYKRPRRLILVDELPRNAMGKVNKKEL 440
|
|
| PRK06710 |
PRK06710 |
long-chain-fatty-acid--CoA ligase; Validated |
1-77 |
1.28e-04 |
|
long-chain-fatty-acid--CoA ligase; Validated
Pssm-ID: 180666 [Multi-domain] Cd Length: 563 Bit Score: 46.56 E-value: 1.28e-04
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK06710 473 LYEHEKVQEVVTIGVPDPYRGETVKAFVVLKEGTECSEEELNQFARKYLAAYKVPKVYEFRDELPKTTVGKILRRVL 549
|
|
| PRK07638 |
PRK07638 |
acyl-CoA synthetase; Validated |
1-74 |
1.29e-04 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 236071 [Multi-domain] Cd Length: 487 Bit Score: 46.31 E-value: 1.29e-04
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEkepiNLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDR 74
Cdd:PRK07638 403 LHEHPAVDEIVVIGVPDSYWGEKPVAIIKGSA----TKQQLKSFCLQRLSSFKIPKEWHFVDEIPYTNSGKIAR 472
|
|
| A_NRPS_acs4 |
cd17654 |
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal ... |
1-77 |
1.33e-04 |
|
acyl-CoA synthetase family member 4; This family of the adenylation (A) domain of nonribosomal peptide synthases (NRPS) contains acyl-CoA synthethase family member 4, also known as 2-aminoadipic 6-semialdehyde dehydrogenase or aminoadipate-semialdehyde dehydrogenase, most of which are uncharacterized. Acyl-CoA synthetase catalyzes the initial reaction in fatty acid metabolism, by forming a thioester with CoA. NRPSs are large multifunctional enzymes which synthesize many therapeutically useful peptides in bacteria and fungi via a template-directed, nucleic acid independent nonribosomal mechanism. These natural products include antibiotics, immunosuppressants, plant and animal toxins, and enzyme inhibitors. NRPS has a distinct modular structure in which each module is responsible for the recognition, activation, and in some cases, modification of a single amino acid residue of the final peptide product. The modules can be subdivided into domains that catalyze specific biochemical reactions.
Pssm-ID: 341309 [Multi-domain] Cd Length: 449 Bit Score: 46.31 E-value: 1.33e-04
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVRedrpNDKRIIAYIVAEEKEpinlSEIRSYV-SESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd17654 380 IESCLGVESCAVTLS----DQQRLIAFIVGESSS----SRIHKELqLTLLSSHAIPDTFVQIDKLPLTSHGKVDKSEL 449
|
|
| PRK06839 |
PRK06839 |
o-succinylbenzoate--CoA ligase; |
1-77 |
1.41e-04 |
|
o-succinylbenzoate--CoA ligase;
Pssm-ID: 168698 [Multi-domain] Cd Length: 496 Bit Score: 46.39 E-value: 1.41e-04
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK06839 413 INKLSDVYEVAVVGRQHVKWGEIPIAFIVKKSSSVLIEKDVIEHCRLFLAKYKIPKEIVFLKELPKNATGKIQKAQL 489
|
|
| PLN02861 |
PLN02861 |
long-chain-fatty-acid-CoA ligase |
669-845 |
1.52e-04 |
|
long-chain-fatty-acid-CoA ligase
Pssm-ID: 178452 [Multi-domain] Cd Length: 660 Bit Score: 46.37 E-value: 1.52e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 669 LTYEKLNRKANKIARFLIAKGVGPDQLVALAMPRSLNMVVSLLAVLKAGAGYLPLDPDYPSDRISFMLHDAKPSCVLTNS 748
Cdd:PLN02861 78 LTYKEVYDAAIRIGSAIRSRGVNPGDRCGIYGSNCPEWIIAMEACNSQGITYVPLYDTLGANAVEFIINHAEVSIAFVQE 157
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 749 S-------VEIECDESLKILVDDVNVMEEIEKYSEE------------NIDEMEC-LKPLAPSHIAYVIYTSGSTGRPKG 808
Cdd:PLN02861 158 SkissilsCLPKCSSNLKTIVSFGDVSSEQKEEAEElgvscfsweefsLMGSLDCeLPPKQKTDICTIMYTSGTTGEPKG 237
|
170 180 190
....*....|....*....|....*....|....*..
gi 1698252301 809 VMIPHQNVVRLLGATDHWFqFDADDVWTMFHSYaFDF 845
Cdd:PLN02861 238 VILTNRAIIAEVLSTDHLL-KVTDRVATEEDSY-FSY 272
|
|
| PLN02736 |
PLN02736 |
long-chain acyl-CoA synthetase |
787-817 |
2.75e-04 |
|
long-chain acyl-CoA synthetase
Pssm-ID: 178337 [Multi-domain] Cd Length: 651 Bit Score: 45.48 E-value: 2.75e-04
10 20 30
....*....|....*....|....*....|.
gi 1698252301 787 PLAPSHIAYVIYTSGSTGRPKGVMIPHQNVV 817
Cdd:PLN02736 217 PPKPEDVATICYTSGTTGTPKGVVLTHGNLI 247
|
|
| PRK09088 |
PRK09088 |
acyl-CoA synthetase; Validated |
26-77 |
3.08e-04 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 181644 [Multi-domain] Cd Length: 488 Bit Score: 45.18 E-value: 3.08e-04
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|..
gi 1698252301 26 AYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK09088 428 LAIVPADGAPLDLERIRSHLSTRLAKYKVPKHLRLVDALPRTASGKLQKARL 479
|
|
| PRK08315 |
PRK08315 |
AMP-binding domain protein; Validated |
1-77 |
4.68e-04 |
|
AMP-binding domain protein; Validated
Pssm-ID: 236236 [Multi-domain] Cd Length: 559 Bit Score: 44.80 E-value: 4.68e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQA-VVMVredrPNDK---RIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKK 76
Cdd:PRK08315 469 LYTHPKIQDVqVVGV----PDEKygeEVCAWIILRPGATLTEEDVRDFCRGKIAHYKIPRYIRFVDEFPMTVTGKIQKFK 544
|
.
gi 1698252301 77 L 77
Cdd:PRK08315 545 M 545
|
|
| PRK06178 |
PRK06178 |
acyl-CoA synthetase; Validated |
1-77 |
4.84e-04 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235724 [Multi-domain] Cd Length: 567 Bit Score: 44.65 E-value: 4.84e-04
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVlEELPLTPNGKVDRKKL 77
Cdd:PRK06178 484 LGQHPAVLGSAVVGRPDPDKGQVPVAFVQLKPGADLTAAALQAWCRENMAVYKVPEIRIV-DALPMTATGKVRKQDL 559
|
|
| Abhydrolase_6 |
pfam12697 |
Alpha/beta hydrolase family; This family contains alpha/beta hydrolase enzymes of diverse ... |
1258-1393 |
6.29e-04 |
|
Alpha/beta hydrolase family; This family contains alpha/beta hydrolase enzymes of diverse specificity.
Pssm-ID: 463673 [Multi-domain] Cd Length: 211 Bit Score: 42.85 E-value: 6.29e-04
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1258 LFCVHpagGLSWCYAGLMKSLGTDYPIYGVQARGIAENEELPKSLEEmAADYLKHVREIQPHGPYRLLGWSLGGNVVHAM 1337
Cdd:pfam12697 1 VVLVH---GAGLSAAPLAALLAAGVAVLAPDLPGHGSSSPPPLDLAD-LADLAALLDELGAARPVVLVGHSLGGAVALAA 76
|
90 100 110 120 130
....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 1338 AAQLQNEGeevellVMLDSYPGHFLPNTEAPTEEEALIALLALGGYDPDNMDGKPL 1393
Cdd:pfam12697 77 AAAALVVG------VLVAPLAAPPGLLAALLALLARLGAALAAPAWLAAESLARGF 126
|
|
| CHC_CoA_lg |
cd05903 |
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); ... |
1-77 |
6.56e-04 |
|
Cyclohexanecarboxylate-CoA ligase (also called cyclohex-1-ene-1-carboxylate:CoA ligase); Cyclohexanecarboxylate-CoA ligase activates the aliphatic ring compound, cyclohexanecarboxylate, for degradation. It catalyzes the synthesis of cyclohexanecarboxylate-CoA thioesters in a two-step reaction involving the formation of cyclohexanecarboxylate-AMP anhydride, followed by the nucleophilic substitution of AMP by CoA.
Pssm-ID: 341229 [Multi-domain] Cd Length: 437 Bit Score: 43.91 E-value: 6.56e-04
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVS-ESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05903 358 LLGHPGVIEAAVVALPDERLGERACAVVVTKSGALLTFDELVAYLDrQGVAKQYWPERLVHVDDLPRTPSGKVQKFRL 435
|
|
| PRK06145 |
PRK06145 |
acyl-CoA synthetase; Validated |
10-77 |
1.09e-03 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 102207 [Multi-domain] Cd Length: 497 Bit Score: 43.34 E-value: 1.09e-03
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 10 AVVMVREDRPNDkRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK06145 425 AVIGVHDDRWGE-RITAVVVLNPGATLTLEALDRHCRQRLASFKVPRQLKVRDELPRNPSGKVLKRVL 491
|
|
| PTZ00342 |
PTZ00342 |
acyl-CoA synthetase; Provisional |
760-815 |
1.30e-03 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 240370 [Multi-domain] Cd Length: 746 Bit Score: 43.55 E-value: 1.30e-03
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 760 ILVDDVnVMEEIEKYSEENIDemeclkplaPSHIAYVIYTSGSTGRPKGVMIPHQN 815
Cdd:PTZ00342 283 ILFDDM-TKNKTTNYKIQNED---------PDFITSIVYTSGTSGKPKGVMLSNKN 328
|
|
| PRK06087 |
PRK06087 |
medium-chain fatty-acid--CoA ligase; |
1-77 |
1.96e-03 |
|
medium-chain fatty-acid--CoA ligase;
Pssm-ID: 180393 [Multi-domain] Cd Length: 547 Bit Score: 42.81 E-value: 1.96e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIV-AEEKEPINLSEIRSYVSES-LANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK06087 452 LLQHPKIHDACVVAMPDERLGERSCAYVVlKAPHHSLTLEEVVAFFSRKrVAKYKYPEHIVVIDKLPRTASGKIQKFLL 530
|
|
| CBAL |
cd05923 |
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) ... |
1-77 |
1.99e-03 |
|
4-Chlorobenzoate-CoA ligase (CBAL); CBAL catalyzes the conversion of 4-chlorobenzoate (4-CB) to 4-chlorobenzoyl-coenzyme A (4-CB-CoA) by the two-step adenylation and thioester-forming reactions. 4-Chlorobenzoate (4-CBA) is an environmental pollutant derived from microbial breakdown of aromatic pollutants, such as polychlorinated biphenyls (PCBs), DDT, and certain herbicides. The 4-CBA degrading pathway converts 4-CBA to the metabolite 4-hydroxybezoate (4-HBA), allowing some soil-dwelling microbes to utilize 4-CBA as an alternate carbon source. This pathway consists of three chemical steps catalyzed by 4-CBA-CoA ligase, 4-CBA-CoA dehalogenase, and 4HBA-CoA thioesterase in sequential reactions.
Pssm-ID: 341247 [Multi-domain] Cd Length: 493 Bit Score: 42.50 E-value: 1.99e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKePINLSEIRSYVSES-LANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05923 417 LSRHPGVTEVVVIGVADERWGQSVTACVVPREG-TLSADELDQFCRASeLADFKRPRRYFFLDELPKNAMNKVLRRQL 493
|
|
| ABCL |
cd05958 |
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate ... |
1-77 |
2.33e-03 |
|
2-aminobenzoate-CoA ligase (ABCL); ABCL catalyzes the initial step in the 2-aminobenzoate aerobic degradation pathway by activating 2-aminobenzoate to 2-aminobenzoyl-CoA. The reaction is carried out via a two-step process; the first step is ATP-dependent and forms a 2-aminobenzoyl-AMP intermediate, and the second step forms the 2-aminobenzoyl-CoA ester and releases the AMP. 2-Aminobenzoyl-CoA is further converted to 2-amino-5-oxo-cyclohex-1-ene-1-carbonyl-CoA catalyzed by 2-aminobenzoyl-CoA monooxygenase/reductase. ABCL has been purified from cells aerobically grown with 2-aminobenzoate as sole carbon, energy, and nitrogen source, and has been characterized as a monomer.
Pssm-ID: 341268 [Multi-domain] Cd Length: 439 Bit Score: 42.08 E-value: 2.33e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVA---EEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05958 359 LLQHPAVAECAVVGHPDESRGVVVKAFVVLrpgVIPGPVLARELQDHAKAHIAPYKYPRAIEFVTELPRTATGKLQRFAL 438
|
|
| MACS_like_3 |
cd05971 |
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the ... |
1-77 |
2.60e-03 |
|
Uncharacterized subfamily of medium-chain acyl-CoA synthetase (MACS); MACS catalyzes the two-step activation of medium chain fatty acids (containing 4-12 carbons). The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. MACS enzymes are localized to mitochondria.
Pssm-ID: 341275 [Multi-domain] Cd Length: 439 Bit Score: 42.03 E-value: 2.60e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIV---AEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05971 358 LLKHPAVLMAAVVGIPDPIRGEIVKAFVVlnpGETPSDALAREIQELVKTRLAAHEYPREIEFVNELPRTATGKIRRREL 437
|
|
| bioH |
TIGR01738 |
pimelyl-[acyl-carrier protein] methyl ester esterase; This CoA-binding enzyme is required for ... |
1258-1358 |
2.61e-03 |
|
pimelyl-[acyl-carrier protein] methyl ester esterase; This CoA-binding enzyme is required for the production of pimeloyl-coenzyme A, the substrate of the BioF protein early in the biosynthesis of biotin. Its exact function is unknown, but is proposed in ref 2. This enzyme belongs to the alpha/beta hydrolase fold family (pfam00561). Members of this family are restricted to the Proteobacteria. [Biosynthesis of cofactors, prosthetic groups, and carriers, Biotin]
Pssm-ID: 273783 [Multi-domain] Cd Length: 245 Bit Score: 41.34 E-value: 2.61e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1258 LFCVHPAGGLSWCYAGLMKSLGTDYPIYGVQARGIAENEEL-PKSLEEMAADYLKHVREiqphgPYRLLGWSLGGNVVHA 1336
Cdd:TIGR01738 7 LVLIHGWGMNAEVFRCLDEELSAHFTLHLVDLPGHGRSRGFgPLSLADMAEAIAAQAPD-----PAIWLGWSLGGLVALH 81
|
90 100
....*....|....*....|..
gi 1698252301 1337 MAAQLQnegEEVELLVMLDSYP 1358
Cdd:TIGR01738 82 IAATHP---DRVRALVTVASSP 100
|
|
| PRK13383 |
PRK13383 |
acyl-CoA synthetase; Provisional |
1-79 |
2.68e-03 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 139531 [Multi-domain] Cd Length: 516 Bit Score: 42.29 E-value: 2.68e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPA 79
Cdd:PRK13383 438 LAAHPAVADNAVIGVPDERFGHRLAAFVVLHPGSGVDAAQLRDYLKDRVSRFEQPRDINIVSSIPRNPTGKVLRKELPG 516
|
|
| PRK12583 |
PRK12583 |
acyl-CoA synthetase; Provisional |
1-74 |
3.10e-03 |
|
acyl-CoA synthetase; Provisional
Pssm-ID: 237145 [Multi-domain] Cd Length: 558 Bit Score: 42.07 E-value: 3.10e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDR 74
Cdd:PRK12583 470 LFTHPAVADVQVFGVPDEKYGEEIVAWVRLHPGHAASEEELREFCKARIAHFKVPRYFRFVDEFPMTVTGKVQK 543
|
|
| FadD3 |
cd17638 |
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ... |
1-72 |
3.52e-03 |
|
acyl-CoA synthetase FadD3 and similar proteins; This family contains long chain fatty acid CoA ligases, including FadD3 which is an acyl-CoA synthetase that initiates catabolism of cholesterol rings C and D in actinobacteria. The cholesterol catabolic pathway occurs in most mycolic acid-containing actinobacteria, such as Rhodococcus jostii RHA1, and is critical for Mycobacterium tuberculosis (Mtb) during infection. FadD3 catalyzes the ATP-dependent CoA thioesterification of 3a-alpha-H-4alpha(3'-propanoate)-7a-beta-methylhexahydro-1,5-indanedione (HIP) to yield HIP-CoA. Hydroxylated analogs of HIP, 5alpha-OH HIP and 1beta-OH HIP, can also be used.
Pssm-ID: 341293 [Multi-domain] Cd Length: 330 Bit Score: 41.33 E-value: 3.52e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|...
gi 1698252301 1 LQRHENIQQ-AVVMVREDRPNDKRIiAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKV 72
Cdd:cd17638 257 LAEHPGVAQvAVIGVPDERMGEVGK-AFVVARPGVTLTEEDVIAWCRERLANYKVPRFVRFLDELPRNASGKV 328
|
|
| ttLC_FACS_AEE21_like |
cd12118 |
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This ... |
1-77 |
3.57e-03 |
|
Fatty acyl-CoA synthetases similar to LC-FACS from Thermus thermophiles and Arabidopsis; This family includes fatty acyl-CoA synthetases that can activate medium to long-chain fatty acids. These enzymes catalyze the ATP-dependent acylation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters. The fatty acyl-CoA synthetase from Thermus thermophiles in this family has been shown to catalyze the long-chain fatty acid, myristoyl acid. Also included in this family are acyl activating enzymes from Arabidopsis, which contains a large number of proteins from this family with up to 63 different genes, many of which are uncharacterized.
Pssm-ID: 341283 [Multi-domain] Cd Length: 486 Bit Score: 41.90 E-value: 3.57e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*..
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAfVVLEELPLTPNGKVDRKKL 77
Cdd:cd12118 409 LYKHPAVLEAAVVARPDEKWGEVPCAFVELKEGAKVTEEEIIAFCREHLAGFMVPKT-VVFGELPKTSTGKIQKFVL 484
|
|
| PRK12492 |
PRK12492 |
long-chain-fatty-acid--CoA ligase; Provisional |
10-77 |
3.69e-03 |
|
long-chain-fatty-acid--CoA ligase; Provisional
Pssm-ID: 171539 [Multi-domain] Cd Length: 562 Bit Score: 41.73 E-value: 3.69e-03
10 20 30 40 50 60
....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 1698252301 10 AVVMVREDRPNDKrIIAYIVAEEKEpINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:PRK12492 493 AAIGVPDERSGEA-VKLFVVARDPG-LSVEELKAYCKENFTGYKVPKHIVLRDSLPMTPVGKILRREL 558
|
|
| PRK06188 |
PRK06188 |
acyl-CoA synthetase; Validated |
8-86 |
4.71e-03 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 235731 [Multi-domain] Cd Length: 524 Bit Score: 41.51 E-value: 4.71e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 8 QQAVVMVredrPNDK---RIIAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLPAPDFNG 84
Cdd:PRK06188 443 QVAVIGV----PDEKwgeAVTAVVVLRPGAAVDAAELQAHVKERKGSVHAPKQVDFVDSLPLTALGKPDKKALRARYWEG 518
|
..
gi 1698252301 85 MN 86
Cdd:PRK06188 519 RG 520
|
|
| PRK07445 |
PRK07445 |
O-succinylbenzoic acid--CoA ligase; Reviewed |
23-78 |
4.80e-03 |
|
O-succinylbenzoic acid--CoA ligase; Reviewed
Pssm-ID: 236019 [Multi-domain] Cd Length: 452 Bit Score: 41.13 E-value: 4.80e-03
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|....*.
gi 1698252301 23 RIIAyIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKLP 78
Cdd:PRK07445 388 VVTA-IYVPKDPSISLEELKTAIKDQLSPFKQPKHWIPVPQLPRNPQGKINRQQLQ 442
|
|
| PRK07470 |
PRK07470 |
acyl-CoA synthetase; Validated |
25-75 |
5.26e-03 |
|
acyl-CoA synthetase; Validated
Pssm-ID: 180988 [Multi-domain] Cd Length: 528 Bit Score: 41.18 E-value: 5.26e-03
10 20 30 40 50
....*....|....*....|....*....|....*....|....*....|.
gi 1698252301 25 IAYIVAEEKEPINLSEIRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRK 75
Cdd:PRK07470 460 VAVCVARDGAPVDEAELLAWLDGKVARYKLPKRFFFWDALPKSGYGKITKK 510
|
|
| Abhydrolase_1 |
pfam00561 |
alpha/beta hydrolase fold; This catalytic domain is found in a very wide range of enzymes. |
1257-1480 |
7.90e-03 |
|
alpha/beta hydrolase fold; This catalytic domain is found in a very wide range of enzymes.
Pssm-ID: 395444 [Multi-domain] Cd Length: 245 Bit Score: 39.80 E-value: 7.90e-03
10 20 30 40 50 60 70 80
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1257 PLFCVH--PAGGLSWCyaGLMKSLG-TDYPIYGVQARGIAENEElPKSLEEMA----ADYLKHVREIQPHGPYRLLGWSL 1329
Cdd:pfam00561 2 PVLLLHglPGSSDLWR--KLAPALArDGFRVIALDLRGFGKSSR-PKAQDDYRtddlAEDLEYILEALGLEKVNLVGHSM 78
|
90 100 110 120 130 140 150 160
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1330 GGNVVHAMAAQLQN----------------EGEEVELLVM-----LDSYPGHFLPNTEAPTEEealiALLALGGYDPDNM 1388
Cdd:pfam00561 79 GGLIALAYAAKYPDrvkalvllgaldppheLDEADRFILAlfpgfFDGFVADFAPNPLGRLVA----KLLALLLLRLRLL 154
|
170 180 190 200 210 220 230 240
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1698252301 1389 DGKPLTMESAVEilrkDGSALASLEEETILNLKETYvnSVGLLGKYVPKvYNGDILFFRSTvipdwFDPISPNTWLNYLD 1468
Cdd:pfam00561 155 KALPLLNKRFPS----GDYALAKSLVTGALLFIETW--STELRAKFLGR-LDEPTLIIWGD-----QDPLVPPQALEKLA 222
|
250
....*....|....*.
gi 1698252301 1469 GDI----VQHDIDCRH 1480
Cdd:pfam00561 223 QLFpnarLVVIPDAGH 238
|
|
| LC_FACS_like |
cd05935 |
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain ... |
1-77 |
9.51e-03 |
|
Putative long-chain fatty acid CoA ligase; The members of this family are putative long-chain fatty acyl-CoA synthetases, which catalyze the ATP-dependent activation of fatty acids in a two-step reaction. The carboxylate substrate first reacts with ATP to form an acyl-adenylate intermediate, which then reacts with CoA to produce an acyl-CoA ester. Fatty acyl-CoA synthetases are responsible for fatty acid degradation as well as physiological regulation of cellular functions via the production of fatty acyl-CoA esters.
Pssm-ID: 341258 [Multi-domain] Cd Length: 430 Bit Score: 40.15 E-value: 9.51e-03
10 20 30 40 50 60 70
....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 1698252301 1 LQRHENIQQAVVMVREDRPNDKRIIAYIVAEEKEPINLSE--IRSYVSESLANYMIPSAFVVLEELPLTPNGKVDRKKL 77
Cdd:cd05935 352 LYKHPAI*EVCVISVPDERVGEEVKAFIVLRPEYRGKVTEedIIEWAREQMAAYKYPREVEFVDELPRSASGKILWRLL 430
|
|
|